,compound_chembl_id,canonical_smiles,standard_type,standard_relation,standard_value,standard_units,target_name,organism,assay_description,assay_type,Ki [nM]
20,CHEMBL6437,CN1CCN2C(C1)c3ccccc3Cc4ccccc24,IC50,=,7079.46,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human cloned Dopamine receptor D2L,B,3539.73
21,CHEMBL6437,CN1CCN2C(C1)c3ccccc3Cc4ccccc24,IC50,=,7079.46,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human cloned Dopamine receptor D2L,B,3539.73
22,CHEMBL6437,CN1CCN2C(C1)c3ccccc3Cc4ccccc24,Ki,=,2197.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,2197.0
44,CHEMBL411,CC\C(=C(\CC)/c1ccc(O)cc1)\c2ccc(O)cc2,IC50,=,13321.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,6660.5
45,CHEMBL411,CC\C(=C(\CC)/c1ccc(O)cc1)\c2ccc(O)cc2,Ki,=,4440.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,4440.0
98,CHEMBL27,CC(C)NCC(O)COc1cccc2ccccc12,IC50,>,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as dopamine-induced cAMP by HTRF assay,B,2505.935
99,CHEMBL27,CC(C)NCC(O)COc1cccc2ccccc12,EC50,>,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as cAMP level by HTRF assay,B,2505.935
116,CHEMBL434,CC(C)NCC(O)c1ccc(O)c(O)c1,Ki,=,48000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,48000.0
117,CHEMBL434,CC(C)NCC(O)c1ccc(O)c(O)c1,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,12000.0
158,CHEMBL267014,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,=,54000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,54000.0
159,CHEMBL267014,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,=,38000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,38000.0
160,CHEMBL267014,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,=,53703.18,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,53703.18
162,CHEMBL267014,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,=,54000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,54000.0
163,CHEMBL267014,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,=,38000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,38000.0
166,CHEMBL267014,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,=,1621.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,A,1621.81
206,CHEMBL42,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24,Log Ki,=,6.87,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,7413102.413009178
263,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,B,3200.0
264,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,4300.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,B,4300.0
265,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,B,3200.0
266,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,4300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,B,4300.0
267,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,3200.0
268,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,4300.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,4300.0
269,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 long,B,3200.0
270,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,4300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,4300.0
271,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,3200.0
272,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,2818.38,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,2818.38
273,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,B,2900.0
274,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,B,2200.0
275,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,3200.0
276,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,4300.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 (short) receptor,B,4300.0
277,CHEMBL7927,Clc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 (long) receptor (unknown origin),B,3200.0
288,CHEMBL266723,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C)c4ccccc24,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,B,1100.0
301,CHEMBL7549,CCCN1CCC[C@H](C1)c2cccc(O)c2,Ki,=,2268.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,2268.0
319,CHEMBL269396,CC1CCN(CC1)C2=Cc3cc(Cl)ccc3Cc4ccccc24,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,B,1400.0
425,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Log Ki,=,9.05,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,1122018454.3019652
448,CHEMBL54,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Ki,=,6400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,6400.0
504,CHEMBL56,CCCN(CCC)C1CCc2cccc(O)c2C1,Ki,=,3243.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against [125I]- NCQ298 binding to dopamine receptor D2 in Sf 9 cells,B,3243.0
531,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,7940.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,7940.0
538,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on low Affinity Site of Dopamine receptor D2L,B,1900.0
539,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity of Compound of Dopamine receptor D2S,B,1100.0
542,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2L,B,15000.0
543,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2S,B,15000.0
555,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,2100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,2100.0
562,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,2100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,2100.0
574,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,2100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,B,2100.0
593,CHEMBL59,NCCc1ccc(O)c(O)c1,Ki,=,3690.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,3690.0
672,CHEMBL8946,CCN1CCC[C@H]1CNC(=O)c2c(O)c(CC)cc(Cl)c2OC,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,5000.0
711,CHEMBL9666,COc1ccccc1N2CCNCC2,Ki,=,4110.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,4110.0
712,CHEMBL9666,COc1ccccc1N2CCNCC2,Ki,=,4073.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,4073.8
756,CHEMBL83,CC\C(=C(/c1ccccc1)\c2ccc(OCCN(C)C)cc2)\c3ccccc3,IC50,=,13885.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,6942.5
757,CHEMBL83,CC\C(=C(/c1ccccc1)\c2ccc(OCCN(C)C)cc2)\c3ccccc3,Ki,=,4628.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,4628.0
828,CHEMBL11262,CCCN(CCC)CC1COc2cccc(OC)c2C1,IC50,=,2570.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,B,1285.2
863,CHEMBL91,Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1,IC50,=,12504.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,6252.0
864,CHEMBL91,Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1,Ki,=,4168.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,4168.0
872,CHEMBL11608,NCCc1ccc(O)cc1,Ki,>,17000.0,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,17000.0
873,CHEMBL11608,NCCc1ccc(O)cc1,Ki,=,160000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,160000.0
902,CHEMBL11493,CCCCN1C2CCC1CC(C2)OC(c3ccc(F)cc3)c4ccc(F)cc4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,5000.0
922,CHEMBL12264,C[C@H](CCN1CCC(C)CC1)N(C)S(=O)(=O)c2cccc(C)c2,Ki,=,3981.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,B,3981.0
923,CHEMBL12264,C[C@H](CCN1CCC(C)CC1)N(C)S(=O)(=O)c2cccc(C)c2,Ki,=,3981.07,nM,Dopamine D2 receptor,Homo sapiens,The compound was tested for its binding affinity towards cloned human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride.,B,3981.07
928,CHEMBL12624,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c3cccc(C)c3)CC1,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2. (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,B,1584.89
929,CHEMBL275707,C[C@@H]1CN(CCCn2c3ccccc3c4ccccc24)C[C@H](C)N1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,10000.0
987,CHEMBL104,Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4,IC50,=,12186.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,6093.0
988,CHEMBL104,Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4,Ki,=,4062.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,4062.0
1017,CHEMBL15245,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12,IC50,=,2060.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1030.0
1037,CHEMBL15928,COc1ccc(NC(=O)c2ccc(cc2)c3ccc(cc3C)c4noc(C)n4)cc1N5CCN(C)CC5,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine D2 receptor,B,10000.0
1038,CHEMBL15928,COc1ccc(NC(=O)c2ccc(cc2)c3ccc(cc3C)c4noc(C)n4)cc1N5CCN(C)CC5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
1115,CHEMBL17157,CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4,IC50,=,6167.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,3083.5
1116,CHEMBL17157,CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4,Ki,=,2056.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,2056.0
1123,CHEMBL18174,C1Cc2ccccc2c3n[nH]cc3C1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
1132,CHEMBL603,COc1cc(ccc1Cc2cn(C)c3ccc(NC(=O)OC4CCCC4)cc23)C(=O)NS(=O)(=O)c5ccccc5C,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against Dopamine receptor D2,B,5000.0
1144,CHEMBL276042,CN1CCc2cc(N)cc3c2[C@H]1Cc4ccc(O)c(O)c34,Kd,=,3300.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as low affinity state,B,3300.0
1155,CHEMBL19331,Oc1ccc2NCCc2c1,Ki,=,9400.0,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,9400.0
1159,CHEMBL19344,Oc1ccc(CC2NCCc3cc(O)c(O)cc23)cc1,Ki,=,3900.0,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,3900.0
1162,CHEMBL19844,CN1CCc2cc(O)c(O)cc2C1Cc3ccc(O)c(O)c3,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,1900.0
1163,CHEMBL19068,Oc1ccc(CC2NCCc3cc(O)c(O)cc23)cc1O,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,3400.0
1167,CHEMBL416732,CC1NCCc2cc(O)c(O)cc12,Ki,=,5400.0,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,5400.0
1170,CHEMBL21252,CC(=O)NCCCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,1584.89
1172,CHEMBL423287,CC(C)(C)C(=O)NCCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,10000.0
1173,CHEMBL20114,CC(C)C(=O)NCCCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,1995.26
1175,CHEMBL283353,CCC(C)(C)C(=O)NCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,2511.89
1176,CHEMBL283353,CCC(C)(C)C(=O)NCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,2519.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,B,2519.0
1181,CHEMBL277937,CC(C)(C)C(=O)NCCCCN1CCN(CC1)c2ccc(F)cc2,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,1995.26
1182,CHEMBL21059,CC(C)(C)C(=O)NCCCCN1CCN(CC1)c2ccc(cc2)C(F)(F)F,Ki,=,3981.07,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,3981.07
1184,CHEMBL20725,CCCC(C)(C)C(=O)NCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,2511.89
1187,CHEMBL277669,CC(C)(C)C(=O)NCCCCN1CCN(CC1)c2ccc(Br)cc2,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,1584.89
1189,CHEMBL20996,CCCCC(C)(C)C(=O)NCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,1584.89
1191,CHEMBL20854,CC1CN(CCCCNC(=O)C(C)(C)C)CCN1c2ccc(Cl)cc2,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,1584.89
1193,CHEMBL20493,CC(C)(C)C(=O)NCCCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,2511.89
1194,CHEMBL20819,COc1ccc(cc1)N2CCN(CCCCNC(=O)C(C)(C)C)CC2,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,10000.0
1195,CHEMBL20444,CCCC(C)(C)C(=O)NCCCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,1584.89
1197,CHEMBL282008,CC(C)(C)C(=O)NCCN1CCN(CC1)c2ccc(Cl)cc2,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",B,2511.89
1214,CHEMBL20407,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCOCC3)[nH]2,Ki,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,3162.28
1247,CHEMBL633,CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3,IC50,=,19952.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,9976.0
1248,CHEMBL633,CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3,Ki,=,6651.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,6651.0
1272,CHEMBL21343,CCN(CC)C(=O)[C@H]1CN[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,5000.0
1279,CHEMBL654,CN1CCN2C(C1)c3ccccc3Cc4cccnc24,Ki,>,5454.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,B,5454.0
1294,CHEMBL21731,CNCCCC12CCC(c3ccccc13)c4ccccc24,IC50,=,3463.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1731.5
1295,CHEMBL21731,CNCCCC12CCC(c3ccccc13)c4ccccc24,Ki,=,1154.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1154.0
1307,CHEMBL22778,CCCN(CCC)[C@H]1CCc2c(F)ccc(O)c2C1,Ki,=,3760.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,B,3760.0
1331,CHEMBL25887,Cc1nnn(C2CCN(Cc3ccccc3)CC2)c1c4ccccc4,Ki,=,1200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1200.0
1335,CHEMBL24539,C(N1CCC(CC1)n2nnc(n2)c3ccccc3)c4ccccc4,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1100.0
1339,CHEMBL24052,Cc1c(cnn1C2CCN(Cc3cccc(c3)C#N)CC2)c4ccccc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1700.0
1341,CHEMBL24603,C(N1CCC(CC1)n2nnnc2c3ccccc3)c4ccccc4,Ki,>,1800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1800.0
1342,CHEMBL284346,Cc1c(nnn1C2CCN(Cc3ccccc3)CC2)c4ccccc4,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1600.0
1411,CHEMBL24077,Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,Ki,=,6500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,6500.0
1412,CHEMBL24077,Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,Ki,=,4670.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,B,4670.0
1413,CHEMBL24077,Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D2,B,2500.0
1415,CHEMBL24077,Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,Ki,=,9550.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,9550.0
1416,CHEMBL24077,Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,Kd,=,9500.0,nM,Dopamine D2 receptor,Homo sapiens,Equilibrium dissociation constant against recombinant Dopamine receptor D2A expressed in COS7 cells,B,9500.0
1417,CHEMBL24077,Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production,F,5000.0
1537,CHEMBL27162,N#Cc1ccc2CCNCc2c1,Kb,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor,B,2500.0
1538,CHEMBL27162,N#Cc1ccc2CCNCc2c1,Ki,=,11400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,11400.0
1540,CHEMBL27162,N#Cc1ccc2CCNCc2c1,Kb,=,4270.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,4270.0
1555,CHEMBL282413,CN1CCc2cccc3c2[C@H]1Cc4cccc(c34)c5c(OS(=O)(=O)C(F)(F)F)cccc5OS(=O)(=O)C(F)(F)F,Ki,=,2260.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,B,2260.0
1556,CHEMBL283065,COc1cccc(OC)c1c2cccc3C[C@H]4N(C)CCc5cccc(c45)c23,Ki,=,2030.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,B,2030.0
1557,CHEMBL28056,CN1CCc2cccc3c2[C@H]1Cc4cccc(c5c(C)cccc5C#N)c34,Ki,=,2470.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,B,2470.0
1564,CHEMBL26907,CN1CCc2cccc3c2[C@H]1Cc4cccc(c5c(C)cccc5O)c34,Ki,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,B,2500.0
1565,CHEMBL26907,CN1CCc2cccc3c2[C@H]1Cc4cccc(c5c(C)cccc5O)c34,Ki,=,3380.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,B,3380.0
1566,CHEMBL28054,Oc1cc2CC[C@H]3NCc4ccncc4[C@@H]3c2cc1O,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,1300.0
1567,CHEMBL287513,Oc1cc2CC[C@H]3NCc4nc5CCCCc5cc4[C@@H]3c2cc1O,Ki,=,3600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,3600.0
1568,CHEMBL27117,Cc1ccc2[C@H]3[C@@H](CCc4cc(O)c(O)cc34)NCc2n1,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,1400.0
1571,CHEMBL28338,CCCc1cc2[C@H]3[C@@H](CCc4cc(O)c(O)cc34)NCc2s1,EC50,=,3900.0,nM,Dopamine D2 receptor,Homo sapiens,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D2,B,1950.0
1573,CHEMBL27101,Oc1cc2CC[C@H]3NCc4nc(F)ccc4[C@@H]3c2cc1O,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,2200.0
1575,CHEMBL27995,CCCN(CCC)C1COc2cccc(O)c2C1,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,B,3000.0
1578,CHEMBL27251,CN1CCc2ccc3[C@@H](N)c4cccc5C[C@@H]1c2c3c45,Ki,=,2250.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,B,2250.0
1579,CHEMBL27251,CN1CCc2ccc3[C@@H](N)c4cccc5C[C@@H]1c2c3c45,Ki,=,2250.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,2250.0
1580,CHEMBL27251,CN1CCc2ccc3[C@@H](N)c4cccc5C[C@@H]1c2c3c45,Ki,=,2250.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2,B,2250.0
1583,CHEMBL275379,Cc1cnc2CN[C@@H]3CCc4cc(O)c(O)cc4[C@H]3c2c1,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,12000.0
1585,CHEMBL25856,Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O,Ki,=,1520.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,1520.0
1587,CHEMBL25856,Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O,Ki,=,1520.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,B,1520.0
1590,CHEMBL25856,Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,1700.0
1593,CHEMBL25856,Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O,Ki,=,2607.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,2607.0
1599,CHEMBL281932,Oc1cc2CC[C@H]3NCc4ncccc4[C@@H]3c2cc1O,Ki,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,2500.0
1600,CHEMBL284644,Oc1cc2CC[C@H]3NCc4cnccc4[C@@H]3c2cc1O,Ki,=,4400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,4400.0
1611,CHEMBL284959,Cc1cc2[C@H]3[C@@H](CCc4cc(O)c(O)cc34)NCc2nc1C,Ki,=,9100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,9100.0
1612,CHEMBL283247,CCCCc1cnc2CN[C@@H]3CCc4cc(O)c(O)cc4[C@H]3c2c1,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,B,1900.0
1617,CHEMBL282375,CN1CCc2ccc3[C@H](NC(=O)C)c4cccc5C[C@@H]1c2c3c45,Ki,=,3650.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,3650.0
1625,CHEMBL27247,CN1CCc2ccc3[C@@H](NC(=O)C)c4cccc5C[C@@H]1c2c3c45,Ki,=,7980.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human Dopamine receptor D2A,B,7980.0
1644,CHEMBL431298,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N4CCNCC4,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",B,2511.89
1647,CHEMBL29435,COc1c(cc(Br)c2ccccc12)C(=O)NCCN3CCN(CC3)c4cccc(c4)[N+](=O)[O-],Ki,=,1288.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,1288.0
1649,CHEMBL29336,COc1ccc(cc1)N2CCN(CCNC(=O)c3cc(Br)c4ccccc4c3OC)CC2,Ki,=,5692.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,5692.0
1650,CHEMBL29849,COc1cccc(c1)N2CCN(CCNC(=O)c3cc(Br)c4ccccc4c3OC)CC2,Ki,=,1288.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,1288.0
1662,CHEMBL416939,COc1c(cc(Cl)c2ccccc12)C(=O)NCCN3CCN(CC3)c4ccccc4,Ki,=,2529.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,2529.0
1663,CHEMBL282971,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N4CCN5CCC[C@@H]5C4,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",B,1995.26
1664,CHEMBL30208,COc1c(cc(Br)c2ccccc12)C(=O)NCCN3CCN(CC3)c4ccccc4,Ki,=,1892.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,1892.0
1665,CHEMBL29182,COc1c(cc(Br)c2ccccc12)C(=O)NCCN3CCN(CC3)c4cccc(C)c4C,Ki,=,1173.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,1173.0
1666,CHEMBL283034,COc1c(cc(Br)c2ccccc12)C(=O)NCCN3CCN(CC3)c4cccc(C)c4,Ki,=,1207.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,1207.0
1670,CHEMBL29433,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N4CCN5CCC[C@H]5C4,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",B,1584.89
1671,CHEMBL29529,Oc1c(cc(Br)c2ccccc12)C(=O)NCCN3CCN(CC3)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,10000.0
1672,CHEMBL284896,COc1c(ccc2ccccc12)C(=O)NCCN3CCN(CC3)c4ccccc4,Ki,=,7000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,7000.0
1674,CHEMBL30256,Brc1cc(cc2ccccc12)C(=O)NCCN3CCN(CC3)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,10000.0
1675,CHEMBL29649,CCOc1c(cc(Br)c2ccccc12)C(=O)NCCN3CCN(CC3)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,10000.0
1678,CHEMBL287443,COc1c(cc(Br)c2ccccc12)C(=O)NCCN3CCN(CC3)c4ccc(cc4)[N+](=O)[O-],Ki,=,5692.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,B,5692.0
1680,CHEMBL287198,COc1c(cc(Br)c2ccccc12)C(=O)NCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,10000.0
1690,CHEMBL418758,OC(COc1cccc2ccccc12)CN3CCC(Cc4ccccc4)CC3,Ki,=,1438.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,B,1438.0
1691,CHEMBL28902,Cc1nc2cnccc2n1c3ccc(OCc4cccc(\C=C\c5ccc6ccc(Cl)cc6n5)c4)cc3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against Dopamine receptor D2,B,5000.0
1692,CHEMBL28607,COc1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,B,1500.0
1694,CHEMBL27559,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(O)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
1698,CHEMBL286177,OC(COc1cccc2ccccc12)CN3CCC(CC3)Oc4ccccc4,Ki,=,2336.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,B,2336.0
1699,CHEMBL31714,Cc1nc2cnccc2n1c3ccc(OCc4cccc(\C=C\c5nc6cc(F)ccc6s5)c4)cc3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against Dopamine receptor D2,B,5000.0
1707,CHEMBL284716,CCCN(C\C=C\I)C1CCc2cccc(O)c2C1,Ki,=,1072.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against [125I]- NCQ298 binding to dopamine receptor D2 in Sf 9 cells,B,1072.0
1724,CHEMBL30713,CC(N)Cc1c[nH]c2ccccc12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,B,10000.0
1736,CHEMBL35226,CCCN1CCC(COc2nc3ccccc3c4NCCCc24)CC1,IC50,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]YM-0915 from Dopamine receptor D2,B,1700.0
1739,CHEMBL286080,Oc1cc2CCNCC(c3ccccc3)c2cc1O,Ki,=,720000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,720000.0
1746,CHEMBL284092,CC1(C)CC(=O)N(CCCCN2CCN(CC2)c3ncccn3)C(=O)C1,Ki,=,4320.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2 receptor expressed in HEK cells,B,4320.0
1757,CHEMBL34291,COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]2CCN3CCC[C@@H]23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for Dopamine receptor D2 binding,B,10000.0
1758,CHEMBL34291,COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]2CCN3CCC[C@@H]23,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,5000.0
1761,CHEMBL37333,COc1cc(N)c(Cl)cc1C(=O)NC[C@H]2CCN3CCC[C@H]23,IC50,=,3900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,1950.0
1762,CHEMBL38349,Cc1nc(sc1C)N2CCN(CCC3NC(=O)c4ccccc34)CC2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1763,CHEMBL37169,O=C1NC(CCN2CCN(CC2)c3ccc4ccccc4c3)c5ccccc15,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1764,CHEMBL37170,Cc1ccc(cc1C)N2CCN(CC[C@@H]3NC(=O)c4ccccc34)CC2,Ki,=,5882.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5882.0
1765,CHEMBL37604,Cc1ccc(cc1C)C2CCN(CCC3NC(=O)c4ccccc34)CC2,Ki,=,1209.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1209.0
1768,CHEMBL287078,Cc1ccc(cc1)N2CCN(CCC3NC(=O)c4ccccc34)CC2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1771,CHEMBL35114,COc1ccc(cc1)N2CCN(CCC3N(C)C(=O)c4ccccc34)CC2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1772,CHEMBL36337,CN1C(CCN2CCN(CC2)c3ccc(Cl)cc3)c4ccccc4C1=O,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1773,CHEMBL35182,CN1C(CCN2CCN(CC2)c3ccc(C)c(C)c3)c4ccccc4C1=O,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1774,CHEMBL37706,COc1ccc(cc1)N2CCN(CCC3NC(=O)c4ccccc34)CC2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1775,CHEMBL290351,Clc1ccc(cc1)N2CCN(CCC3NC(=O)c4ccccc34)CC2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1776,CHEMBL37638,Cc1ccnc(c1)N2CCN(CCC3NC(=O)c4ccccc34)CC2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,5000.0
1784,CHEMBL38262,Cc1ccc(cc1C)N2CCN(CCC3NC(=O)c4ccccc34)CC2,Ki,=,1842.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1842.0
1785,CHEMBL35093,Cc1ccc(cc1C)N2CCN(CC[C@H]3NC(=O)c4ccccc34)CC2,Ki,=,2748.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,2748.0
1786,CHEMBL808,Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1,IC50,=,12807.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,6403.5
1787,CHEMBL808,Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1,Ki,=,4269.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,4269.0
1821,CHEMBL41200,CCCN(CCC)C1COc2c(C1)cccc2c3ccc(OC)cc3,Ki,=,1090.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,B,1090.0
1827,CHEMBL38656,CCCN(CCC)C1COc2c(C1)cccc2C(=O)c3cocc3,Ki,=,1360.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,B,1360.0
1833,CHEMBL291143,NC[C@@H]1O[C@@H](Cc2c(O)c(O)ccc12)C34CC5CC(CC(C5)C3)C4,Ki,=,1550.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,B,1550.0
1834,CHEMBL291143,NC[C@@H]1O[C@@H](Cc2c(O)c(O)ccc12)C34CC5CC(CC(C5)C3)C4,EC50,>,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D2,B,2000.0
1837,CHEMBL40391,Nc1cccc(n1)c2ccc(CCN3CCN(CC(=O)c4ccccc4)CC3)cc2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound to Dopamine receptor D2,B,5000.0
1845,CHEMBL287770,CCCN(CCC)[C@H]1CCc2cccc(OC)c2[C@H]1C,Ki,=,1050.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,B,1050.0
1866,CHEMBL295559,C1CC(CCN1)c2c([nH]c3ccccc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
1868,CHEMBL40229,CN1CCN(C)C(C1)c2c([nH]c3ccccc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
1869,CHEMBL40284,C1COC(CN1)c2c([nH]c3ccccc23)c4ccccc4,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
1872,CHEMBL295596,O=C1NCCN1CCN2CCCC(C2)c3c([nH]c4ccccc34)c5ccccc5,Ki,>,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1300.0
1875,CHEMBL297784,Cn1ccc2cc3N(CCc3cc12)C(=O)Nc4cccnc4,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 expressed in CHO cells using [125I]iodosulpiride ,B,10000.0
1876,CHEMBL42557,C1CNCC(C1)c2c([nH]c3ccccc23)c4ccccc4,Ki,>,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1300.0
1877,CHEMBL43697,CN1CCCCC1c2c([nH]c3ccccc23)c4ccccc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1700.0
1884,CHEMBL46523,C(N1CCCC(C1)c2c([nH]c3ccccc23)c4ccccc4)c5ccccc5,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
1895,CHEMBL296419,COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1,IC50,=,4521.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,2260.5
1896,CHEMBL296419,COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1,Ki,=,1507.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1507.0
1905,CHEMBL46880,Brc1ccc(OCC2CCN(CC3CC3)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1906,CHEMBL45156,FCCCN1CCC(COc2ccc(Br)cc2)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1907,CHEMBL45305,Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3ccc(F)c(Cl)c3)nc1,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor,B,15000.0
1908,CHEMBL45305,Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3ccc(F)c(Cl)c3)nc1,Ki,=,46000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor,B,46000.0
1910,CHEMBL45168,FCCN1CCC(COc2ccc(I)cc2)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1911,CHEMBL44739,Ic1ccc(OCC2CCN(CC3CC3)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1912,CHEMBL289196,Brc1cccc(OCC2CCN(CC3CC3)CC2)c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1913,CHEMBL46559,Fc1ccc(CN2CCC(COc3ccc(cc3)C#N)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1916,CHEMBL417001,FCCCN1CCC(COc2ccc(cc2)C#N)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1917,CHEMBL46374,OCCN1CCC(COc2ccc(I)cc2)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1918,CHEMBL46596,[O-][N+](=O)c1ccc(OCC2CCN(Cc3ccc(F)cc3)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1919,CHEMBL46519,FCCN1CCC(COc2ccc(cc2)C#N)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1920,CHEMBL274585,I\C=C\CN1CCC(COc2ccc(cc2)C#N)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity for Dopamine receptor D2,B,10000.0
1921,CHEMBL47482,NCC1c2ccccc2Cc3ccccc13,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,10000.0
1932,CHEMBL45244,Cc1cccc(c1)C(=O)NCN2CCN(CC2)c3ccccc3C#N,Ki,=,3740.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,B,3740.0
1933,CHEMBL45244,Cc1cccc(c1)C(=O)NCN2CCN(CC2)c3ccccc3C#N,Ki,=,3740.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2,B,3740.0
1934,CHEMBL45244,Cc1cccc(c1)C(=O)NCN2CCN(CC2)c3ccccc3C#N,Ki,=,2818.38,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,B,2818.38
1936,CHEMBL45244,Cc1cccc(c1)C(=O)NCN2CCN(CC2)c3ccccc3C#N,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
1968,CHEMBL295094,Clc1cccc(c1)C(=O)NCN2CCN(CC2)c3ccccc3Cl,Ki,=,2420.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,B,2420.0
1970,CHEMBL300956,Cc1ccc(cc1)C(=O)NCN2CCN(CC2)c3ccccc3C#N,Ki,=,1150.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,B,1150.0
1975,CHEMBL48819,COc1ccccc1N2CCN(CNC(=O)c3cccc(Cl)c3)CC2,Ki,=,1445.44,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,B,1445.44
1978,CHEMBL298166,Cc1cccc(c1)C(=O)NCN2CCN(CC2)c3ccccc3Cl,Ki,=,1330.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,B,1330.0
1980,CHEMBL298763,Clc1ccccc1N2CCN(CNC(=O)c3ccccc3)CC2,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,B,1500.0
1983,CHEMBL296506,COc1ccccc1N2CCN(CNC(=O)c3cccc(C)c3)CC2,Ki,=,2454.71,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,B,2454.71
1984,CHEMBL423659,O=C(NCN1CCN(CC1)c2ccccc2C#N)c3ccccc3,Ki,=,4180.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,B,4180.0
1985,CHEMBL423659,O=C(NCN1CCN(CC1)c2ccccc2C#N)c3ccccc3,Ki,=,3019.95,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,B,3019.95
1994,CHEMBL49502,Clc1cccc(c1)C(=O)NCN2CCN(CC2)c3ccccc3C#N,Ki,=,2290.87,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,B,2290.87
1997,CHEMBL48807,COc1ccccc1N2CCN(CNC(=O)c3ccccc3)CC2,Ki,=,1880.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,B,1880.0
1998,CHEMBL48807,COc1ccccc1N2CCN(CNC(=O)c3ccccc3)CC2,Ki,=,2454.71,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,B,2454.71
2076,CHEMBL54715,Cc1ccccc1c2ccc(cc2)C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,B,1584.89
2089,CHEMBL294649,Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c4ccccc14,Ki,<,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine D2 receptor,B,100000.0
2094,CHEMBL53510,CN1CCc2cccc3c2[C@H]1Cc4ccc(C)c(O)c34,Ki,=,1070.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,B,1070.0
2095,CHEMBL53510,CN1CCc2cccc3c2[C@H]1Cc4ccc(C)c(O)c34,Ki,=,1070.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,B,1070.0
2096,CHEMBL298612,Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c4ccccc14,Ki,<,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine D2 receptor,B,100000.0
2110,CHEMBL936,OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3,IC50,=,3290.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1645.0
2111,CHEMBL936,OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3,Ki,=,1097.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1097.0
2122,CHEMBL57546,Fc1ccc(cc1)N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2,B,2200.0
2134,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,B,6300.0
2136,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,B,1900.0
2139,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,6300.0
2140,CHEMBL301265,CCCN[C@H]1CCc2nc(N)sc2C1,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,1900.0
2173,CHEMBL56118,N#Cc1c[nH]c(CN2CCN(CC2)c3ccccc3)c1,Ki,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,B,3700.0
2174,CHEMBL56118,N#Cc1c[nH]c(CN2CCN(CC2)c3ccccc3)c1,Ki,=,8000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,B,8000.0
2175,CHEMBL444309,Cc1c(onc1C2CCN(CCc3ccccc3)CC2)c4ccc(Cl)cc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1700.0
2176,CHEMBL444309,Cc1c(onc1C2CCN(CCc3ccccc3)CC2)c4ccc(Cl)cc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,1700.0
2177,CHEMBL444309,Cc1c(onc1C2CCN(CCc3ccccc3)CC2)c4ccc(Cl)cc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,1700.0
2178,CHEMBL444309,Cc1c(onc1C2CCN(CCc3ccccc3)CC2)c4ccc(Cl)cc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,1700.0
2179,CHEMBL293341,Cc1c(onc1c2ccc(Cl)cc2)C3CCN(CCc4ccccc4)CC3,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,B,1700.0
2180,CHEMBL293341,Cc1c(onc1c2ccc(Cl)cc2)C3CCN(CCc4ccccc4)CC3,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,1700.0
2183,CHEMBL61090,COc1cc2ccccc2cc1CC(=O)CC3CCN(Cc4ccccc4)CC3,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,B,1258.93
2184,CHEMBL57478,CC1CCN(Cc2c[nH]c3ccccc23)CC1,Ki,=,5500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,B,5500.0
2185,CHEMBL57535,C(N1CCCCC1)c2c[nH]c3ccccc23,Ki,>,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,B,1300.0
2186,CHEMBL433255,COc1cc2ccccc2cc1OC(=O)CC3CCN(Cc4ccccc4)CC3,Ki,=,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,B,7943.28
2187,CHEMBL294394,C(N1CCN(CC1)c2ccccc2)c3ccc[nH]3,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,B,3100.0
2188,CHEMBL294394,C(N1CCN(CC1)c2ccccc2)c3ccc[nH]3,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,B,3000.0
2197,CHEMBL60518,Ic1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,B,1700.0
2198,CHEMBL299479,Clc1ccc(cc1)C(=O)OCC2CCN(Cc3ccccc3)CC2,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,B,1995.26
2200,CHEMBL59326,COc1cc2ccccc2cc1C(=O)OCC3CCN(Cc4ccccc4)CC3,Ki,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,B,3162.28
2201,CHEMBL59075,COc1cc2ccccc2cc1OCCC3CCN(Cc4ccccc4)CC3,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,B,1584.89
2205,CHEMBL57019,COc1cc2ccccc2cc1C(=O)OCC3CCN(Cc4ccccc4)C3,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,B,10000.0
2217,CHEMBL440120,N#CC(=Cc1[nH]ccc1CN2CCN(CC2)c3ccccc3)C#N,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,4000.0
2218,CHEMBL440120,N#CC(=Cc1[nH]ccc1CN2CCN(CC2)c3ccccc3)C#N,Ki,=,12750.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,12750.0
2219,CHEMBL303538,Clc1ccc(cc1)N2CCN(Cc3ccc(C=C(C#N)C#N)[nH]3)CC2,Ki,=,48500.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,48500.0
2220,CHEMBL303538,Clc1ccc(cc1)N2CCN(Cc3ccc(C=C(C#N)C#N)[nH]3)CC2,Ki,=,59000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,59000.0
2221,CHEMBL294459,N#CC(=Cc1cc(CN2CCN(CC2)c3ccccc3)c[nH]1)C#N,Ki,=,1850.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,1850.0
2223,CHEMBL293956,N#CC(=Cc1ccc(CN2CCN(CC2)c3ccccc3)[nH]1)C#N,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,100000.0
2224,CHEMBL293956,N#CC(=Cc1ccc(CN2CCN(CC2)c3ccccc3)[nH]1)C#N,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,100000.0
2225,CHEMBL294458,Clc1ccc(cc1)N2CCN(Cc3c[nH]c(C=C(C#N)C#N)c3)CC2,Ki,=,7350.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,7350.0
2226,CHEMBL294458,Clc1ccc(cc1)N2CCN(Cc3c[nH]c(C=C(C#N)C#N)c3)CC2,Ki,=,10300.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,10300.0
2229,CHEMBL300553,Clc1ccc(cc1)N2CCN(Cc3cc[nH]c3C=C(C#N)C#N)CC2,Ki,=,8950.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,8950.0
2230,CHEMBL300553,Clc1ccc(cc1)N2CCN(Cc3cc[nH]c3C=C(C#N)C#N)CC2,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,B,15000.0
2250,CHEMBL964,CCN(CC)C(=S)SSC(=S)N(CC)CC,IC50,=,23018.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,11509.0
2251,CHEMBL964,CCN(CC)C(=S)SSC(=S)N(CC)CC,Ki,=,7673.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,7673.0
2273,CHEMBL291439,COc1cc2CCN(CCCCNC(=O)c3cc(Br)cc(OC)c3OC)Cc2cc1OC,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,B,2200.0
2286,CHEMBL64260,COc1cc2CCN(CCNC(=O)c3cc(C)ccc3OC)Cc2cc1OC,Ki,=,2850.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,B,2850.0
2294,CHEMBL61789,COc1c(cc(Br)c2ccccc12)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,3800.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,3800.0
2297,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,3600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,B,3600.0
2298,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,B,2600.0
2299,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,3600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 long,B,3600.0
2302,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,3600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,B,3600.0
2303,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,B,2600.0
2307,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,3600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,B,3600.0
2308,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,B,2600.0
2309,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,3630.78,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,3630.78
2310,CHEMBL59725,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1Cl,Ki,=,3600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,3600.0
2322,CHEMBL303519,C(N1CCN(CC1)c2ncccn2)c3cccc4c3Cc5ccccc45,IC50,=,9800.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,4900.0
2328,CHEMBL304692,C(N1CCN(CC1)c2ncccn2)c3cccc4Cc5ccccc5c34,IC50,=,2300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,B,1150.0
2337,CHEMBL294780,C(N1CCN(CC1)c2ccccc2)c3coc(n3)c4ccccc4,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,3000.0
2338,CHEMBL294780,C(N1CCN(CC1)c2ccccc2)c3coc(n3)c4ccccc4,Ki,=,1750.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,1750.0
2339,CHEMBL64376,C(N1CCN(CC1)c2ccccc2)c3csc(n3)c4ccccc4,Ki,=,2300.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,2300.0
2340,CHEMBL64376,C(N1CCN(CC1)c2ccccc2)c3csc(n3)c4ccccc4,Ki,=,1060.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,1060.0
2341,CHEMBL62703,C(N1CCN(Cc2coc(n2)c3ccccc3)CC1)c4ccccc4,Ki,=,27500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,27500.0
2342,CHEMBL62703,C(N1CCN(Cc2coc(n2)c3ccccc3)CC1)c4ccccc4,Ki,=,21500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,21500.0
2343,CHEMBL64043,C(N1CCN(Cc2csc(n2)c3ccccc3)CC1)c4ccccc4,Ki,=,28000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,28000.0
2344,CHEMBL64043,C(N1CCN(Cc2csc(n2)c3ccccc3)CC1)c4ccccc4,Ki,=,19500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,19500.0
2345,CHEMBL59702,C(NC1CCN(Cc2ccccc2)CC1)c3coc(n3)c4ccccc4,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,14000.0
2346,CHEMBL59702,C(NC1CCN(Cc2ccccc2)CC1)c3coc(n3)c4ccccc4,Ki,=,8650.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,8650.0
2355,CHEMBL64894,[Cl-].CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C,IC50,=,3178.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1589.0
2356,CHEMBL64894,[Cl-].CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C,Ki,=,1059.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1059.0
2357,CHEMBL64752,COc1ccc(Br)cc1c2occ(CN[C@@H]3CCN(Cc4ccccc4)C3)n2,Ki,=,2450.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,2450.0
2358,CHEMBL64752,COc1ccc(Br)cc1c2occ(CN[C@@H]3CCN(Cc4ccccc4)C3)n2,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,2000.0
2359,CHEMBL302186,C(NC1CCN(Cc2ccccc2)CC1)c3csc(n3)c4ccccc4,Ki,=,23000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,23000.0
2360,CHEMBL302186,C(NC1CCN(Cc2ccccc2)CC1)c3csc(n3)c4ccccc4,Ki,=,13500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,13500.0
2362,CHEMBL65641,COc1ccc(Br)cc1c2occ(CNCC[C@@H]3CCN(Cc4ccccc4)C3)n2,Ki,=,1070.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,1070.0
2363,CHEMBL65641,COc1ccc(Br)cc1c2occ(CNCC[C@@H]3CCN(Cc4ccccc4)C3)n2,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,1100.0
2364,CHEMBL64668,COc1ccc(Br)cc1c2occ(CN(C)C[C@@H]3CCN(Cc4ccccc4)C3)n2,Ki,=,3800.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,3800.0
2365,CHEMBL64668,COc1ccc(Br)cc1c2occ(CN(C)C[C@@H]3CCN(Cc4ccccc4)C3)n2,Ki,=,3250.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,3250.0
2366,CHEMBL64566,COc1ccc(Br)cc1c2nc(CNC[C@@H]3CCN(Cc4ccccc4)C3)c[nH]2,Ki,=,6250.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,6250.0
2367,CHEMBL64566,COc1ccc(Br)cc1c2nc(CNC[C@@H]3CCN(Cc4ccccc4)C3)c[nH]2,Ki,=,2750.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,2750.0
2368,CHEMBL59749,C(NCc1csc(n1)c2ccccc2)[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,7900.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,7900.0
2369,CHEMBL59749,C(NCc1csc(n1)c2ccccc2)[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,5050.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,5050.0
2370,CHEMBL59749,C(NCc1csc(n1)c2ccccc2)[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,7950.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,7950.0
2371,CHEMBL59749,C(NCc1csc(n1)c2ccccc2)[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,6400.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,6400.0
2374,CHEMBL62996,Oc1ccc(Br)cc1c2occ(CN3CCN(CC3)c4ccccc4)n2,Ki,=,6650.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,6650.0
2375,CHEMBL62996,Oc1ccc(Br)cc1c2occ(CN3CCN(CC3)c4ccccc4)n2,Ki,=,4400.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,4400.0
2376,CHEMBL64696,COc1ccc(Br)cc1c2occ(CN3CCN(Cc4ccccc4)CC3)n2,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,1500.0
2382,CHEMBL62601,COc1c(cc(Br)c2ccccc12)c3occ(CNC[C@@H]4CCN(Cc5ccccc5)C4)n3,Ki,=,45500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,45500.0
2383,CHEMBL62601,COc1c(cc(Br)c2ccccc12)c3occ(CNC[C@@H]4CCN(Cc5ccccc5)C4)n3,Ki,=,17500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,17500.0
2386,CHEMBL59603,Oc1cc2[C@@H](CNCc2cc1Cl)c3ccccc3,Ki,=,1819.7,nM,Dopamine D2 receptor,Homo sapiens,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,B,1819.7
2387,CHEMBL293158,CN1CCc2cc(Cl)c(O)cc2[C@H]1c3ccccc3,Ki,=,19054.61,nM,Dopamine D2 receptor,Homo sapiens,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,B,19054.61
2390,CHEMBL293828,CCCN1CCc2cc(Cl)c(O)cc2[C@@H]1c3ccccc3,Ki,=,1905.46,nM,Dopamine D2 receptor,Homo sapiens,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,B,1905.46
2391,CHEMBL65397,Oc1cc2[C@@H](NCCc2cc1Cl)c3ccccc3,Ki,=,3715.35,nM,Dopamine D2 receptor,Homo sapiens,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,B,3715.35
2392,CHEMBL303993,CN1CCc2cc(Cl)c(O)cc2[C@@H]1c3ccccc3,Ki,=,1862.09,nM,Dopamine D2 receptor,Homo sapiens,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,B,1862.09
2414,CHEMBL292759,COc1ccc(NS(=O)(=O)c2ccc(Br)cc2)cc1N3CCN(C)CC3,Ki,=,3981.07,nM,Dopamine D2 receptor,Homo sapiens,Compound was tested for its binding affinity against Dopamine receptor D2 in human cloned receptors in CHO cells using [125 I]iodosulpride,B,3981.07
2451,CHEMBL63576,CN1CCN(CC1)C2=Nc3cccnc3Nc4ccc(Cl)cc24,Ki,=,2235.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,B,2235.0
2452,CHEMBL63329,CN1CCN(CC1)C2=Nc3cccnc3Nc4ccc(C)cc24,Ki,=,5940.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,B,5940.0
2454,CHEMBL66227,Fc1ccc(OC[C@@H]2CC[C@H]3CN(CCN3C2)c4ncc(F)cn4)cc1,Ki,>,3310.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,3310.0
2455,CHEMBL66227,Fc1ccc(OC[C@@H]2CC[C@H]3CN(CCN3C2)c4ncc(F)cn4)cc1,Ki,>,3310.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,3310.0
2465,CHEMBL67222,Clc1ccc(CN2CCN(CC2)C3Cc4ccccc4NC3=O)cc1,Ki,=,1373.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,B,1373.0
2467,CHEMBL69759,NS(=O)(=O)c1ccc(cc1)N2CCN(CC[C@@H]3OCCc4ccccc34)CC2,Ki,=,5147.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,5147.0
2472,CHEMBL68131,CCCCN1CCC(COC(=O)c2cc(Cl)c(N)c3OCCOc23)CC1,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Tested against dopamine receptor D2 using cloned human receptor expressed in CHO cells radiolabeled with [125I]iodosulpiride,B,10000.0
2476,CHEMBL63209,CN1C(=O)C(CCc2ccccc12)N3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,7367.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,B,7367.0
2501,CHEMBL67555,COc1cc(N)c(Cl)cc1C(=O)NCC23CC4CN(CC4C2)C3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was selective with respect to binding at the Dopamine receptor D2,B,5000.0
2502,CHEMBL69705,COc1cccc2C[C@@H](CCc12)N(Cc3ccccc3)Cc4ccccc4,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,5000.0
2503,CHEMBL69705,COc1cccc2C[C@@H](CCc12)N(Cc3ccccc3)Cc4ccccc4,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,B,5000.0
2583,CHEMBL65896,COc1cccc2C[C@@H](CCc12)NCc3ccccc3,Ki,=,1310.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,B,1310.0
2584,CHEMBL65896,COc1cccc2C[C@@H](CCc12)NCc3ccccc3,Ki,=,1010.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,B,1010.0
2603,CHEMBL71724,COc1ccc(cc1)N2CCN(CCC3OCCc4ccccc34)CC2,Ki,=,1431.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,B,1431.0
2643,CHEMBL70565,CCCN1CCO[C@H]2[C@H]1COc3ccc(O)cc23,Ki,=,1180.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for antagonist binding affinity by measuring displacement of [3H]spiperone from Human Dopamine receptor D2L expressed in CHO K-1 cells,B,1180.0
2644,CHEMBL70565,CCCN1CCO[C@H]2[C@H]1COc3ccc(O)cc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for antagonist binding affinity by measuring displacement of [3H]spiperone from Human Dopamine receptor D2L expressed in CHO K-1 cells,B,10000.0
2649,CHEMBL71707,Oc1ccc2[nH]cc([C@@H]3C[C@H]4CC[C@@H](C3)N4C[C@@H]5CC[C@@H](CC5)NC(=O)\C=C\c6ccc(Cl)c(Cl)c6)c2c1,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity relative to indolopiperidine (compound 1) for Dopamine receptor D2 was determined,B,1258.93
2666,CHEMBL67750,Clc1cccc(N2CCN(CCCNC(=O)c3ccc4c(Cc5ccccc45)c3)CC2)c1Cl,Ki,=,2570.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,2570.0
2669,CHEMBL69571,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3cccc4Cc5ccccc5c34)CC2)c1Cl,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,10000.0
2691,CHEMBL304605,Clc1cccc(N2CCN(C\C=C\CNC(=O)c3ccc4c(Cc5ccccc45)c3)CC2)c1Cl,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,B,10000.0
2696,CHEMBL68740,Fc1ccc2[nH]c(cc2c1)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,B,5000.0
2701,CHEMBL69259,CN1CCC2(CC1)OC(C)(CC2=O)c3ccccc3.OC(=O)\C=C\C(=O)O,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
2710,CHEMBL71173,C(N1CCC(=CC1)c2nc3ccccc3[nH]2)c4ccccc4,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,B,1400.0
2711,CHEMBL71208,Clc1ccc(CN2CCC(=CC2)c3oc4ccc(Cl)cc4n3)cc1,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,B,1700.0
2712,CHEMBL71209,Clc1ccc2sc(nc2c1)C3=CCN(Cc4ccccc4)CC3,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,B,1600.0
2725,CHEMBL70215,Clc1ccc(CN2CCC(=CC2)c3nc4cc(Cl)ccc4s3)cc1,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,B,2000.0
2729,CHEMBL69356,Clc1ccc2oc(nc2c1)C3=CCN(Cc4ccccc4)CC3,Ki,>,1800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,B,1800.0
2730,CHEMBL67982,Clc1ccccc1CN2CCC(=CC2)c3nc4ccccc4s3,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,B,2000.0
2732,CHEMBL306265,Clc1ccc(CN2CCC(=CC2)c3nc4ccccc4s3)cc1,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,B,1600.0
2753,CHEMBL305706,CCCN(CCC)[C@H]1CCc2ccc(O)cc2C1,Ki,=,4777.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,4777.0
2756,CHEMBL310310,CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccc(Cl)cc4,Ki,=,1740.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,1740.0
2759,CHEMBL73538,CN1CCN(CC1)C2=Nc3ccccc3Nc4ccccc24,Ki,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,B,2500.0
2762,CHEMBL307956,C1CC2(CN1)c3ccccc3Cc4ccccc24,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine receptor D2 using [3H]spiperone as radioligand,B,5000.0
2776,CHEMBL74355,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]-spiperone from CHO cells expressing human Dopamine receptor D2 was determined,B,1300.0
2777,CHEMBL74355,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1300.0
2778,CHEMBL74355,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2,B,1300.0
2779,CHEMBL74355,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,Ki,=,2250.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor by competitive binding experiment,B,2250.0
2787,CHEMBL307444,C(OCC1CCN(Cc2ccccc2)CC1)\C=C/c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2788,CHEMBL77151,Clc1cccc(c1)N2CCN(Cc3nc4ccccc4[nH]3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2789,CHEMBL76982,Clc1ccc(cc1)N2CCN(Cc3nc4ccccc4[nH]3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2792,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,1310.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,B,1310.0
2793,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,B,3400.0
2794,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,B,6300.0
2795,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 long,B,3400.0
2796,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,3388.44,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,3388.44
2797,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,B,3400.0
2798,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,B,6300.0
2799,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 long receptor,B,3400.0
2800,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,2300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,B,2300.0
2801,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,B,3400.0
2802,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,3200.0
2803,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 (short) receptor,B,6300.0
2804,CHEMBL310843,Clc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,>,6000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 (long) receptor (unknown origin),B,6000.0
2805,CHEMBL77563,Clc1ccccc1N2CCN(Cc3nc4ccccc4[nH]3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2811,CHEMBL80469,Clc1ccccc1N2CCN(Cc3nc4ccc[nH]c4n3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2821,CHEMBL76849,C(OCC1CCN(Cc2ccccc2)CC1)\C=C\c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2823,CHEMBL75678,C(CC1CCN(CC2CC2)CC1)OCC#Cc3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2827,CHEMBL77204,C(OCC1CCN(CC2CC2)CC1)\C=C\c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2829,CHEMBL76475,C\C=C\CN1CCC(COC\C=C\c2ccccc2)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2831,CHEMBL76927,Fc1ccc(CCN2CCC(CCOCC#Cc3ccccc3)CC2)cc1,Ki,=,1837.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,1837.0
2836,CHEMBL311508,C(Cc1ccccc1)N2CCC(CC2)OCC#Cc3ccccc3,Ki,=,1356.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,1356.0
2840,CHEMBL80784,C(O\C=C\C=C\c1ccccc1)C2CCN(Cc3ccccc3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2841,CHEMBL430444,FC(F)(F)c1ccc(\C=C\COCC2CCN(Cc3ccccc3)CC2)cc1,Ki,=,4324.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,4324.0
2843,CHEMBL80968,Fc1ccc(\C=C\COCC2CCN(Cc3ccccc3)CC2)cc1,Ki,=,2183.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,2183.0
2847,CHEMBL308098,Fc1ccc(cc1)C#CCOCCC2CCN(CCc3ccccc3)CC2,Ki,=,1062.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,1062.0
2851,CHEMBL440687,C(N1CCN(CC1)c2ccccn2)c3nc4ccccc4[nH]3,Ki,=,51000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity tested on human Dopamine receptor D2 (short) using [3H]spiperone as a radioligand,B,51000.0
2852,CHEMBL440687,C(N1CCN(CC1)c2ccccn2)c3nc4ccccc4[nH]3,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity tested on human Dopamine receptor D2 (long) using [3H]spiperon as a radioligand,B,15000.0
2853,CHEMBL308185,C(OCC1CCN(Cc2ccccc2)CC1)C#Cc3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2857,CHEMBL309015,C(OCC1CCN(Cc2cccc3ccccc23)CC1)\C=C\c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,B,10000.0
2861,CHEMBL75691,Clc1ccc(cc1)c2cc([nH]n2)C3CCNCC3,Ki,>,1800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,1800.0
2875,CHEMBL80722,Cc1c(nc(N)nc1c2ccc(Cl)cc2)C3CCN(CCc4ccccc4)CC3,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,1500.0
2876,CHEMBL310985,C(Cc1ccccc1)N2CCN(CC2)c3cc([nH]n3)c4ccccc4,Ki,>,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,1900.0
2877,CHEMBL309858,OC(=O)\C=C\C(=O)O.C(CCN1CCN(CC1)c2ccccc2)CNC3=Nc4ccccc4OC3,Ki,=,2745.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,B,2745.0
2887,CHEMBL80863,Clc1ccc(cc1)c2cc([nH]n2)C3CCCCN3Cc4ccccc4,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,3400.0
2889,CHEMBL79098,C(Cc1ccccc1)N2CCC(CC2)c3cc([nH]n3)c4ccncc4,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,B,1300.0
2893,CHEMBL80645,OC(=O)\C=C\C(=O)O.C(CCNC1=Nc2ccccc2OC1)CCN3CCN(CC3)c4ncccn4,Ki,=,2540.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,B,2540.0
2895,CHEMBL310311,OC(=O)\C=C\C(=O)O.C(CNC1=Nc2ccccc2OC1)CN3CCN(CC3)c4ccccn4,Ki,>,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,B,4000.0
2896,CHEMBL309843,OC(=O)\C=C\C(=O)O.C(CCN1CCN(CC1)c2ncccn2)CNC3=Nc4ccccc4OC3,Ki,>,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,B,4000.0
2907,CHEMBL80655,OC(=O)\C=C\C(=O)O.C(CNC1=Nc2ccccc2OC1)CN3CCN(CC3)c4ncccn4,Ki,>,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,B,4000.0
2908,CHEMBL412665,OC(=O)\C=C\C(=O)O.C(CNC1=Nc2ccccc2OC1)CN3CCN(CC3)c4ccccc4,Ki,=,2011.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,B,2011.0
2951,CHEMBL311730,CCCN1CCC[C@H](C1)c2cccc(c2)S(=O)(=O)C,Ki,=,3884.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,3884.0
2966,CHEMBL313189,CN(C)CCC1CC2N(O1)c3ccccc3Cc4ccccc24,IC50,=,9549.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human cloned Dopamine receptor D2L,B,4774.965
2991,CHEMBL86060,C([C@H]1COC(=N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,B,1700.0
2992,CHEMBL86060,C([C@H]1COC(=N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,B,1100.0
2995,CHEMBL84819,Clc1cccc(c1)N2CCN(CCCOc3ccc(cc3)c4nc5ccccc5[nH]4)CC2,Ki,=,1403.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,B,1403.0
2996,CHEMBL84819,Clc1cccc(c1)N2CCN(CCCOc3ccc(cc3)c4nc5ccccc5[nH]4)CC2,Ki,=,1403.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,1403.0
3001,CHEMBL313147,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2CCCCn4c(nc5ccccc45)c6ccc(OCCCN(CC)CC)cc6,Ki,=,1495.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,1495.0
3002,CHEMBL316222,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(nc5ccccc45)c6ccc(OCCCN(CC)CC)cc6,Ki,=,2345.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,2345.0
3003,CHEMBL314937,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2C\C=C/Cn4c(nc5ccccc45)c6ccc(OCCCN(CC)CC)cc6,Ki,=,1518.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,1518.0
3004,CHEMBL82527,C([C@H]1CSC(=N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,B,1100.0
3006,CHEMBL82527,C([C@H]1CSC(=N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,B,1500.0
3007,CHEMBL82527,C([C@H]1CSC(=N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,B,1100.0
3008,CHEMBL82564,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(C)nc5ccccc45,Ki,>,3333.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,3333.0
3011,CHEMBL313320,COc1ccc(Br)cc1C2=N[C@@H](CN3CCN(CC3)c4ccccc4)CO2,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,B,2200.0
3013,CHEMBL83306,C[C@@H]1OC(=N[C@H]1CN2CCN(CC2)c3ccccc3)c4ccccc4,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,B,3200.0
3014,CHEMBL83306,C[C@@H]1OC(=N[C@H]1CN2CCN(CC2)c3ccccc3)c4ccccc4,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,B,1900.0
3017,CHEMBL315564,COc1ccc(Br)cc1C2=N[C@@H](CN3CCN(CC3)c4ccccc4)[C@@H](C)O2,Ki,=,21000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,B,21000.0
3018,CHEMBL315564,COc1ccc(Br)cc1C2=N[C@@H](CN3CCN(CC3)c4ccccc4)[C@@H](C)O2,Ki,=,18000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,B,18000.0
3019,CHEMBL315564,COc1ccc(Br)cc1C2=N[C@@H](CN3CCN(CC3)c4ccccc4)[C@@H](C)O2,Ki,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,B,3700.0
3020,CHEMBL315564,COc1ccc(Br)cc1C2=N[C@@H](CN3CCN(CC3)c4ccccc4)[C@@H](C)O2,Ki,=,2400.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,B,2400.0
3021,CHEMBL313692,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2Cc4ccc(Cn5c(nc6ccccc56)c7ccc(OCCCN(CC)CC)cc7)cc4,Ki,=,3438.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,3438.0
3022,CHEMBL85700,CN1CCN(CCCOc2ccc(cc2)c3nc4ccccc4[nH]3)CC1,Ki,>,3333.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,B,3333.0
3023,CHEMBL85700,CN1CCN(CCCOc2ccc(cc2)c3nc4ccccc4[nH]3)CC1,Ki,>,3333.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,3333.0
3027,CHEMBL83722,C(COc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(nc5ccccc45)c6ccc(OCCCN7CCN(CC7)c8ccccc8)cc6)CN9CCN(CC9)c%10ccccc%10,Ki,=,3945.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,3945.0
3029,CHEMBL314439,C(COc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(nc5ccccc45)c6ccc(OCCCN7CCOCC7)cc6)CN8CCOCC8,Ki,>,3333.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,3333.0
3039,CHEMBL87625,CN(C)CCCOc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(nc5ccccc45)c6ccc(OCCCN(C)C)cc6,Ki,=,4985.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,4985.0
3046,CHEMBL313257,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2CCCCCCn4c(nc5ccccc45)c6ccc(OCCCN(CC)CC)cc6,Ki,=,1750.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,1750.0
3047,CHEMBL316014,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(nc5ccccc45)c6ccc(OCCCC7CCCCC7)cc6,Ki,=,1027.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,1027.0
3048,CHEMBL315560,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(nc5ccccc45)c6ccc(OC)cc6,Ki,=,1414.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,1414.0
3049,CHEMBL430242,CCN(CC)CCCOc1ccc(cc1)c2nc3ccccc3n2C\C=C\Cn4c(nc5ccccc45)c6ccccc6,Ki,=,6530.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,B,6530.0
3052,CHEMBL85606,O=C(N[C@@H]1CC[C@@H](CCN2CCc3cc(ccc3C2)C#N)CC1)c4ccnc5ccccc45,Ki,=,1050.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125I]iodosulpiride binding to human Dopamine D2L receptor expressed in CHO cells,B,1050.0
3062,CHEMBL85606,O=C(N[C@@H]1CC[C@@H](CCN2CCc3cc(ccc3C2)C#N)CC1)c4ccnc5ccccc45,Ki,=,5160.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,5160.0
3064,CHEMBL85606,O=C(N[C@@H]1CC[C@@H](CCN2CCc3cc(ccc3C2)C#N)CC1)c4ccnc5ccccc45,Kb,=,6490.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,6490.0
3081,CHEMBL445111,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3CC2)C#N)CC1)c4ccnc5ccccc45,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,B,1258.93
3082,CHEMBL86402,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3CC2)C#N)CC1)c4ccc5ccccc5c4,Ki,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,B,3162.28
3083,CHEMBL85711,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3CC2)C#N)CC1)c4cccc5ccccc45,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,B,1258.93
3084,CHEMBL86127,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3CC2)C#N)CC1)c4cccc5ncccc45,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,B,1995.26
3089,CHEMBL85882,NCC1c2ccccc2Cc3cc(Br)ccc13,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,10000.0
3090,CHEMBL86760,CCCCCCc1ccc2C(CN)c3ccccc3Cc2c1,Ki,=,6280.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,6280.0
3125,CHEMBL91605,COc1cc(F)ccc1N2CCN(CCCNc3c(cnc4c3c(C)nn4C)C(=O)N(C)C)CC2,Log Ki,=,6.4,uM,Dopamine D2 receptor,Homo sapiens,The compound's binding affinity against Dopamine receptor D2,B,2511886431.5095825
3129,CHEMBL88160,CN(C)C(=O)c1cnc2c(c(C)nn2C)c1NCCCN3CCN(CC3)c4ccccc4OCC(F)(F)F,Log Ki,=,8.1,uM,Dopamine D2 receptor,Homo sapiens,The compound's binding affinity against Dopamine receptor D2,B,125892541179.4166
3136,CHEMBL89030,COc1ccccc1N2CCN(CCCNc3cc(C)ccc3C(=O)N(C)C)CC2,Log Ki,=,7.3,uM,Dopamine D2 receptor,Homo sapiens,The compound's binding affinity against Dopamine receptor D2,B,19952623149.68879
3137,CHEMBL329160,COc1ccccc1N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2,Log Ki,=,7.4,uM,Dopamine D2 receptor,Homo sapiens,The compound's binding affinity against Dopamine receptor D2,B,25118864315.095818
3140,CHEMBL90173,COc1cc2OC(=O)C3=C(CCN(Cc4ccc(Cl)cc4)C3)c2cc1OC,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3141,CHEMBL88296,COc1ccc2C3=C(CN(Cc4ccc(cc4)[N+](=O)[O-])CC3)C(=O)Oc2c1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3154,CHEMBL314095,Oc1ccc2C3=C(CN(Cc4ccc(Cl)cc4)CC3)C(=O)Oc2c1,Ki,=,2780.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,2780.0
3175,CHEMBL420620,COc1cc(F)ccc1N2CCN(CCCNc3ncccc3C(=O)N(C)C)CC2,Log Ki,=,6.7,uM,Dopamine D2 receptor,Homo sapiens,The compound's binding affinity against Dopamine receptor D2,B,5011872336.272725
3178,CHEMBL89921,Cc1ccc2C3=C(CN(Cc4ccc(Cl)cc4)CC3)C(=O)Oc2c1,Ki,=,1170.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,1170.0
3184,CHEMBL92373,COc1ccc2C3=C(CN(Cc4ccc(Cl)cc4)CC3)C(=O)Oc2c1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3195,CHEMBL91938,COc1ccc2C3=C(CN(Cc4ccc(cc4)C(F)(F)F)CC3)C(=O)Oc2c1,Ki,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,3700.0
3197,CHEMBL90569,COc1ccc2C3=C(CN(Cc4cccc(Cl)c4)CC3)C(=O)Oc2c1,Ki,=,5500.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5500.0
3198,CHEMBL91067,COc1ccc2C3=C(CN(Cc4ccccc4Cl)CC3)C(=O)Oc2c1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3199,CHEMBL90374,Clc1ccc(cc1)N2CCN(Cc3cccn4nccc34)CC2,Ki,=,16000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,B,16000.0
3200,CHEMBL90374,Clc1ccc(cc1)N2CCN(Cc3cccn4nccc34)CC2,Ki,=,21000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,B,21000.0
3201,CHEMBL91122,COC[C@H]1CCCN1CCc2c([nH]c3ccccc23)c4ccccc4,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,B,3000.0
3205,CHEMBL314285,Cc1ccc2C3=C(CN(Cc4ccc(F)cc4)CC3)C(=O)Oc2c1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3206,CHEMBL91273,COc1ccc2C3=C(CN(Cc4ccc(F)cc4)CC3)C(=O)Oc2c1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3207,CHEMBL328925,OCc1cnn2cccc(CN3CCN(CC3)c4ccc(Cl)cc4)c12,Ki,=,39000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,B,39000.0
3208,CHEMBL328925,OCc1cnn2cccc(CN3CCN(CC3)c4ccc(Cl)cc4)c12,Ki,=,53000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,B,53000.0
3209,CHEMBL440506,COc1ccc2C3=C(CN(CCc4ccccc4)CC3)C(=O)Oc2c1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3210,CHEMBL91362,CCOC(=O)c1cnn2cccc(CN3CCN(CC3)c4ccc(Cl)cc4)c12,Ki,=,37000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,B,37000.0
3211,CHEMBL91362,CCOC(=O)c1cnn2cccc(CN3CCN(CC3)c4ccc(Cl)cc4)c12,Ki,=,45000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,B,45000.0
3212,CHEMBL432059,Clc1ccc(cc1)N2CCN(Cc3ccc4ccnn4c3)CC2,Ki,=,13000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,B,13000.0
3213,CHEMBL432059,Clc1ccc(cc1)N2CCN(Cc3ccc4ccnn4c3)CC2,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,B,15000.0
3214,CHEMBL91658,COc1ccc(CN2CCC3=C(C2)C(=O)Oc4cc(OC)ccc34)cc1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3215,CHEMBL89913,COc1ccc2C3=C(CN(Cc4ccc(Cl)c(Cl)c4)CC3)C(=O)Oc2c1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3216,CHEMBL88937,Clc1ccc(cc1)N2CCN(Cc3cccc4ccnn34)CC2,Ki,=,31000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,B,31000.0
3217,CHEMBL88937,Clc1ccc(cc1)N2CCN(Cc3cccc4ccnn34)CC2,Ki,=,67000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,B,67000.0
3218,CHEMBL88937,Clc1ccc(cc1)N2CCN(Cc3cccc4ccnn34)CC2,Ki,=,31000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2 long,B,31000.0
3219,CHEMBL329126,COc1ccc2C3=C(CN(Cc4ccc(C)cc4)CC3)C(=O)Oc2c1,Ki,=,1170.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,1170.0
3220,CHEMBL91585,COc1ccc2C3=C(CN(Cc4ccncc4)CC3)C(=O)Oc2c1,Ki,>,5800.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,B,5800.0
3238,CHEMBL327339,O=C(NCc1ccccc1)NC2CCN(Cc3ccccc3)CC2,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,1600.0
3249,CHEMBL327310,O=C(NC1CCN(Cc2ccccc2)CC1)NC(=O)c3ccccc3,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,1700.0
3253,CHEMBL90711,CN1CCC(CC1)n2c(C)c(nc2O)c3ccccc3,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,1600.0
3255,CHEMBL93794,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4ncnc(OC)c4C3,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",B,1584.89
3258,CHEMBL92438,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4ncncc4C3,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",B,1258.93
3259,CHEMBL92439,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4nc(ncc4C3)C(C)(C)C,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",B,1584.89
3260,CHEMBL431095,Cc1c(nc(O)n1C2CCN(Cc3cccc(c3)C#N)CC2)c4ccccc4,Ki,>,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,1900.0
3263,CHEMBL93832,Cc1c(nc(O)n1C2CCN(Cc3cccc(Cl)c3)CC2)c4ccccc4,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,1300.0
3265,CHEMBL93970,Cc1c(nc(O)n1C2CCN(Cc3ccccc3Cl)CC2)c4ccccc4,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,B,1500.0
3268,CHEMBL93703,CN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4nc(N)ncc4C3,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",B,1584.89
3269,CHEMBL93336,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4nc(C)ncc4C3,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",B,2511.89
3270,CHEMBL94015,CCCN1COC[C@H]2[C@H]1COc3ccc(O)cc23,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,B,2511.89
3271,CHEMBL94015,CCCN1COC[C@H]2[C@H]1COc3ccc(O)cc23,Ki,=,1183.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,1183.0
3275,CHEMBL90897,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4nc(ncc4C3)N(C)C,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",B,1584.89
3277,CHEMBL91510,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4nc(NC)ncc4C3,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",B,2511.89
3278,CHEMBL328002,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCc4nc(SC)ncc4C3,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",B,1258.93
3290,CHEMBL91228,C#CCN1CCC[C@H](C1)c2cccc(c2)C#N,Ki,=,1178.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,1178.0
3298,CHEMBL90662,CN1CCC[C@H](C1)c2cccc(c2)C#N,Ki,=,1040.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,1040.0
3302,CHEMBL90797,CCCN1CCC[C@H](C1)c2cccc(c2)C(=O)C,Ki,>,1852.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,1852.0
3304,CHEMBL93900,CCCN1CCC[C@H](C1)c2cccc(c2)C(=O)OC,Ki,>,1852.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,1852.0
3353,CHEMBL96726,NC(=O)c1cccc2C3CCN(CC=C)C3CCc12,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,1500.0
3359,CHEMBL92232,CCCN1CCC[C@H](C1)c2cccc(c2)C(=O)N,Ki,>,1852.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",B,1852.0
3369,CHEMBL93403,COc1cccc(c1)C(=O)NCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,1900.0
3371,CHEMBL93403,COc1cccc(c1)C(=O)NCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,1900.0
3373,CHEMBL96462,COc1cccc(CNCCN2CCN(CC2)c3ccc(Cl)cc3)c1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,5000.0
3374,CHEMBL318747,COc1cccc(CCCCN2CCN(CC2)c3ccc(Cl)cc3)c1,Ki,=,2740.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,2740.0
3375,CHEMBL327245,COc1cccc(c1)C(=O)CCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,2550.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,2550.0
3378,CHEMBL315879,COc1cccc(c1)C(=O)NCCCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,2350.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,2350.0
3379,CHEMBL315879,COc1cccc(c1)C(=O)NCCCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,2350.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,2350.0
3384,CHEMBL321557,COc1cccc2C(CCCN3CCN(CC3)c4ccc(Cl)cc4)CCCc12,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,3400.0
3385,CHEMBL96799,COc1cccc2C(=O)N(CCN3CCN(CC3)c4ccc(Cl)cc4)CCc12,Ki,=,3170.0,nM,Dopamine D2 receptor,Homo sapiens,"In vitro binding affinity towards human Dopamine receptor D2L, using [3H]spiroperidol radioligand in Sf9 baculovirus expression.",B,3170.0
3387,CHEMBL330470,COc1ccc2CCN(CCN3CCN(CC3)c4ccc(Cl)cc4)C(=O)c2c1,Ki,=,3960.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,3960.0
3389,CHEMBL92713,COc1cccc(c1)C(=O)NCCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,3950.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,3950.0
3390,CHEMBL92713,COc1cccc(c1)C(=O)NCCCN2CCN(CC2)c3ccc(Cl)cc3,Ki,=,3960.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,3960.0
3397,CHEMBL328476,C(C1NCCc2c1[nH]c3ccccc23)c4ccc5OCOc5c4,Ki,=,4600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,4600.0
3398,CHEMBL319005,COc1cccc(CC2NCCc3c2[nH]c4ccccc34)c1,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,1600.0
3401,CHEMBL323356,Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1,Ki,<,31622.78,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity was measured on Dopamine receptor D2,B,31622.78
3418,CHEMBL92139,CN(C)CCc1cccc2c1ccn2S(=O)(=O)c3ccccc3,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,B,1600.0
3502,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,2500.0
3504,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,2500.0
3506,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,2500.0
3508,CHEMBL1112,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,2500.0
3536,CHEMBL329383,COc1ccc(cc1N2CCNCC2)S(=O)(=O)Nc3cc(Br)cc(F)c3Br,Ki,>,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for binding affinity against Dopamine receptor D2 in CHO cells using [125I]iodosulpiride as the radioligand,B,5011.87
3545,CHEMBL97637,O=S(=O)(Nc1ccc2nccc(N3CCNCC3)c2c1)c4ccc(cc4)c5ccccc5,Ki,<,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned Dopamine receptor D2 in CHO cells using [125I]- iodosulpride as radioligand,B,5011.87
3548,CHEMBL97211,Cc1cc(N2CCNCC2)c3cc(NS(=O)(=O)c4sc5ccc(Cl)cc5c4C)ccc3n1,Ki,<,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned Dopamine receptor D2 in CHO cells using [125I]- iodosulpride as radioligand,B,6309.57
3549,CHEMBL316081,CN1CCN(CC1)c2ccnc3ccc(NS(=O)(=O)c4sc5ccc(Cl)cc5c4C)cc23,Ki,<,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned Dopamine receptor D2 in CHO cells using [125I]- iodosulpride as radioligand,B,7943.28
3550,CHEMBL97596,Clc1cccc2cc(ccc12)S(=O)(=O)Nc3ccc4nccc(N5CCNCC5)c4c3,Ki,<,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned Dopamine receptor D2 in CHO cells using [125I]- iodosulpride as radioligand,B,5011.87
3551,CHEMBL261917,CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccc3nccc(N4CCNCC4)c3c2,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned Dopamine receptor D2 in CHO cells using [125I]- iodosulpride as radioligand,B,10000.0
3552,CHEMBL95823,C[C@H]1CN(CCN1)c2ccnc3ccc(NS(=O)(=O)c4sc5ccc(Cl)cc5c4C)cc23,Ki,<,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned Dopamine receptor D2 in CHO cells using [125I]- iodosulpride as radioligand,B,3162.28
3553,CHEMBL318018,Cc1sc2ccc(Cl)cc2c1S(=O)(=O)Nc3ccc4nccc(N5CCNCC5)c4c3,Ki,<,3981.07,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned Dopamine receptor D2 in CHO cells using [125I]- iodosulpride as radioligand,B,3981.07
3554,CHEMBL97158,Cc1c(sc2ccc(Cl)cc12)S(=O)(=O)Nc3ccc4nccc(N5CCNCC5)c4c3,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned Dopamine receptor D2 in CHO cells using [125I]- iodosulpride as radioligand,B,10000.0
3560,CHEMBL97440,CS(=O)(=O)Oc1ccc2[C@@H]3CCCN(CCCCNC(=O)c4ccc(cc4)c5ccccc5)[C@H]3CCc2c1,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,1995.26
3567,CHEMBL316983,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C=O,Ki,=,6900.0,nM,Dopamine D2 receptor,Homo sapiens,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,B,6900.0
3569,CHEMBL316983,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C=O,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,B,3000.0
3572,CHEMBL316983,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C=O,Ki,=,6900.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity (low) towards human dopamine receptor 2 long against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",B,6900.0
3573,CHEMBL316983,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C=O,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity (low) towards human dopamine receptor 2 short against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",B,3000.0
3580,CHEMBL319355,CS(=O)(=O)Oc1cccc2[C@H]3CCCN(CCCCNC(=O)c4ccc(cc4)c5ccccc5)[C@@H]3CCc12,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,B,1258.93
3588,CHEMBL97424,CCCN1CCO[C@@H]2[C@@H]1COc3ccc(O)cc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for antagonist binding affinity by measuring displacement of [3H]spiperone from Human Dopamine receptor D2L expressed in CHO K-1 cells,B,10000.0
3625,CHEMBL317493,CCCN1CCO[C@H]2[C@@H]1COc3ccc(O)cc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for antagonist binding affinity by measuring displacement of [3H]spiperone from Human Dopamine receptor D2L expressed in CHO K-1 cells,B,10000.0
3629,CHEMBL102162,Cc1sc(C)c2c1CCCc3ncn(C)c23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3633,CHEMBL317597,Cn1ncc2CCCc3ccccc3c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3635,CHEMBL329276,Cc1sc(C)c2c1CCc3c[nH]nc23,Ki,=,4166.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,4166.0
3637,CHEMBL99654,Cc1sc(C)c2c1CC(C)(C)Cc3c[nH]nc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3639,CHEMBL432579,Cc1sc(C)c2c1CCCc3c[nH]nc23,Ki,=,2066.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,2066.0
3644,CHEMBL317825,CC(C)n1ncc2CCCc3c(Cl)sc(Cl)c3c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3647,CHEMBL433012,Clc1sc(Cl)c2c1CCCc3cnn(Cc4ccccc4)c23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3648,CHEMBL99085,CCCn1ncc2CCCc3c(Cl)sc(Cl)c3c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3649,CHEMBL98330,Cn1cc2CCCc3ccccc3c2n1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3650,CHEMBL317051,Cc1sc(C)c2c1CCCc3nnc(C)n23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3651,CHEMBL98331,Cc1sc(C)c2c1CCCc3nncn23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3652,CHEMBL99054,Cc1sc(C)c2c1CCCc3nccn23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3653,CHEMBL317988,Cc1ccc(C)c2c1CCCc3c[nH]nc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3655,CHEMBL316942,Cc1sc(C)c2c1CCCc3cnn(c4ccccc4)c23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards cloned human Dopamine receptor D2 was determined,B,10000.0
3663,CHEMBL415014,Cc1[nH]c(nc1CN2CCN(CC2)c3ncccn3)c4ccccc4,Ki,=,1440.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,B,1440.0
3664,CHEMBL103772,C(N1CCN(CC1)c2ncccn2)c3c[nH]c(n3)c4ccccc4,Ki,=,2250.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,B,2250.0
3665,CHEMBL103772,C(N1CCN(CC1)c2ncccn2)c3c[nH]c(n3)c4ccccc4,Ki,=,2230.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,2230.0
3666,CHEMBL102599,C(N1CCN(CC1)c2ccncn2)c3c[nH]c(n3)c4ccccc4,Ki,>,4130.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,B,4130.0
3674,CHEMBL440511,C(N1CCN(CC1)c2cnccn2)c3c[nH]c(n3)c4ccccc4,Ki,>,4130.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,B,4130.0
3675,CHEMBL317250,C(N1CCN(CC1)c2ccncc2)c3c[nH]c(n3)c4ccccc4,Ki,>,3500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,B,3500.0
3677,CHEMBL100461,Oc1ccc(OCCNCc2ccccc2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,B,10000.0
3681,CHEMBL99967,C(N1CCN(CC1)c2ccccn2)c3c[nH]c(n3)c4ccccc4,Ki,=,2190.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,B,2190.0
3691,CHEMBL323118,CS(=O)(=O)Nc1cc(OCCNCc2ccccc2)ccc1F,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,B,10000.0
3702,CHEMBL102414,Oc1ccc2CCC3C(OCCN3CCc4cccs4)c2c1,Ki,=,3676.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,3676.0
3704,CHEMBL316584,Oc1ccc2CCC3C(OCCN3CCc4ccccc4)c2c1,Ki,>,3676.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,3676.0
3707,CHEMBL103441,CCCN(CCc1ccsc1)CCc2cccs2,Ki,=,1080.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,1080.0
3709,CHEMBL103912,CCCN(CCC)CC1CCc2ccsc2C1,Ki,=,3107.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,3107.0
3710,CHEMBL104135,CCCN(CCC)CC1CCc2sccc2C1,Ki,=,2037.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,2037.0
3711,CHEMBL319051,C1COC2C(CCc3sccc23)N1,Ki,>,4780.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,B,4780.0
3712,CHEMBL104700,C(N1C2CCC1CC2)c3cccnc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
3715,CHEMBL101480,CCCN1CCOC(C1)c2cccc(OC)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
3716,CHEMBL105646,CCCN1CCOC(C1)c2cccc(Cl)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
3725,CHEMBL102463,CCCN1CCOC(C1)c2cccc(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
3756,CHEMBL104155,CC1Cc2ccccc2N1C(=O)CC3CCN(Cc4ccccc4F)CC3,Ki,=,1414.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,1414.0
3765,CHEMBL317266,Fc1ccc2CCN(C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3)c2c1,Ki,=,2552.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,2552.0
3766,CHEMBL321058,Cc1cccc2N(CCc12)C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,3431.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,3431.0
3769,CHEMBL107804,CC1Cc2ccccc2N1C(=O)CN3CCN(Cc4cc(F)cc(F)c4)CC3,Ki,=,3011.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,3011.0
3775,CHEMBL104256,CC1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccccc4C)CC3,Ki,=,1530.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,1530.0
3777,CHEMBL323525,COc1ccc(CN2CCN(CC(=O)N3C(C)Cc4ccccc34)CC2)cc1,Ki,=,2094.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,2094.0
3780,CHEMBL106208,CC1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(OC(F)(F)F)cc4)CC3,Ki,=,3823.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,3823.0
3781,CHEMBL419916,CC1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(cc4)C(C)(C)C)CC3,Ki,=,1918.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,1918.0
3782,CHEMBL320440,CC(C)c1ccc(CN2CCN(CC(=O)N3C(C)Cc4ccccc34)CC2)cc1,Ki,=,1784.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,1784.0
3783,CHEMBL105454,C[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(cc4)C(F)(F)F)CC3,Ki,=,5940.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,5940.0
3786,CHEMBL105354,C[C@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(C)cc4)CC3,Ki,=,2364.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,2364.0
3788,CHEMBL104321,CC1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(cc4)C(F)(F)F)CC3,Ki,=,5287.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,5287.0
3794,CHEMBL322222,C[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc5OCOc5c4)CC3,Ki,=,1434.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,1434.0
3795,CHEMBL104323,C[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4cc(F)c(Cl)cc4F)CC3,Ki,=,2583.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,2583.0
3804,CHEMBL106998,Cc1ccc2N(CCc2c1)C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,1692.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,1692.0
3822,CHEMBL107631,COC(=O)[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,1178.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,1178.0
3823,CHEMBL320721,FC[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,1096.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,1096.0
3824,CHEMBL322567,Clc1ccc(CN2CCN(CCN3C(=O)C(=O)c4ccccc34)CC2)cc1,Ki,=,1225.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,1225.0
3825,CHEMBL106751,CC(N1CCN(CC(=O)N2C(C)Cc3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,1252.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,1252.0
3826,CHEMBL323022,CC1Cc2ccccc2N1C(=O)CN3CCN(CCc4ccc(Cl)cc4)CC3,Ki,=,5247.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,5247.0
3828,CHEMBL105595,Cc1ccc2CCN(C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3)c2c1,Ki,=,6357.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,6357.0
3830,CHEMBL104800,Clc1ccc(CN2CCN(CCN3c4ccccc4CS3(=O)=O)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,10000.0
3834,CHEMBL321201,C[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccccc4Cl)CC3,Ki,=,1149.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,1149.0
3835,CHEMBL107755,Clc1ccc(CN2CCN(CC(=O)N3CCCC4CCCCC34)CC2)cc1,Ki,=,5847.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,5847.0
3836,CHEMBL107338,CC1CC(C)(C)N(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c4cc(C)ccc14,Ki,=,1926.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,1926.0
3837,CHEMBL107391,CC1CCc2cc(F)ccc2N1C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,2220.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,2220.0
3838,CHEMBL108157,Clc1ccc(CN2CCN(CCN3C(=O)Sc4ccccc34)CC2)cc1,Ki,=,1207.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,1207.0
3839,CHEMBL107151,OC[C@@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,3027.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,3027.0
3841,CHEMBL324867,CC(N1CCN(Cc2ccc(Cl)cc2)CC1)C(=O)N3CCc4ccccc34,Ki,>,7000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,7000.0
3843,CHEMBL104063,Clc1ccc(CN2CCN(CCN3C(=O)Oc4ccccc34)CC2)cc1,Ki,=,8053.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,8053.0
3846,CHEMBL106598,Clc1ccc(CN2CCN(CC(=O)N3CCc4c(Cl)cccc34)CC2)cc1,Ki,=,2145.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,2145.0
3847,CHEMBL104399,C[C@@H]1CN(Cc2ccc(Cl)cc2)CCN1CC(=O)N3CCc4ccccc34,Ki,=,5839.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,5839.0
3848,CHEMBL104756,C[C@@H]1CN(CC(=O)N2CCc3ccccc23)C[C@H](C)N1Cc4ccc(Cl)cc4,Ki,=,8620.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,8620.0
3849,CHEMBL104138,C[C@@H]1CN(Cc2ccc(Cl)cc2)CC[N@@+]1(C)CC(=O)N3CCc4ccccc34,Ki,=,4742.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,4742.0
3853,CHEMBL107351,C[C@@H]1CN(CC(=O)N2CCc3ccccc23)[C@@H](C)CN1Cc4ccc(Cl)cc4,Ki,=,6740.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,6740.0
3854,CHEMBL106897,CC1CCc2ccccc2N1C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,4126.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,4126.0
3855,CHEMBL107962,Clc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC35CCCCC5)CC2)cc1,Ki,=,3325.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,3325.0
3861,CHEMBL106119,C[C@H]1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,9395.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,B,9395.0
3863,CHEMBL104196,Clc1ccc(CN2CCN(CC(=O)N3CCOc4ccccc34)CC2)cc1,Ki,=,2610.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,2610.0
3864,CHEMBL323537,Clc1ccc(CN2CCN(CC(=O)N3CCCc4ccccc34)CC2)cc1,Ki,=,2629.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,2629.0
3865,CHEMBL104497,CC1Cc2ccccc2N1C(=O)CC3CCN(Cc4ccc(cc4)[N+](=O)[O-])CC3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,10000.0
3866,CHEMBL104498,Clc1ccc(CN2CCN(CCC(=O)N3CCc4ccccc34)CC2)cc1,Ki,=,5847.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,5847.0
3868,CHEMBL104238,Clc1ccc(CN2CCN(CC(=O)N3CCSc4ccccc34)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,10000.0
3869,CHEMBL106007,Clc1ccc(CN2CCN(CC(=O)N3CCCSc4ccccc34)CC2)cc1,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,5000.0
3876,CHEMBL321871,CC(C)C1Cc2ccccc2N1C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,2524.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,2524.0
3877,CHEMBL320067,CC1CN(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c4ccccc14,Ki,=,4375.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,4375.0
3881,CHEMBL107229,Cc1cccc2CCN(C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3)c12,Ki,=,4623.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,4623.0
3884,CHEMBL106917,CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,3780.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,3780.0
3886,CHEMBL318760,CSc1ccc2N(CCc2c1)C(=O)CN3CCN(Cc4ccc(Cl)cc4)CC3,Ki,=,3780.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,B,3780.0
3890,CHEMBL322326,Clc1ccc(CN2CCN(CCN3C(=O)Cc4ccccc34)CC2)cc1,Ki,=,1642.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,1642.0
3891,CHEMBL104514,Clc1ccc(CN2CCN(CC2)C(=O)CN3CCc4ccccc34)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",B,10000.0
3894,CHEMBL106047,CCCN(CCC)C1CCc2cc(OC)ccc2C1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,B,10000.0
3895,CHEMBL106047,CCCN(CCC)C1CCc2cc(OC)ccc2C1,Ki,=,3940.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,B,3940.0
3896,CHEMBL422959,O=Cc1ccn(c1)C2CCN(Cc3ccccc3)CC2,Ki,=,49000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,49000.0
3897,CHEMBL422959,O=Cc1ccn(c1)C2CCN(Cc3ccccc3)CC2,Ki,=,65000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,65000.0
3902,CHEMBL325104,C#Cc1cccn1C2CCN(Cc3ccccc3)CC2,Ki,=,6600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,6600.0
3903,CHEMBL325104,C#Cc1cccn1C2CCN(Cc3ccccc3)CC2,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,6300.0
3904,CHEMBL108160,C[Si](C)(C)C#Cc1cccn1C2CCN(Cc3ccccc3)CC2,Ki,=,6200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,6200.0
3905,CHEMBL108160,C[Si](C)(C)C#Cc1cccn1C2CCN(Cc3ccccc3)CC2,Ki,=,4900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,4900.0
3906,CHEMBL105509,CCCN(CCC)C1CCc2nc(OC)ccc2C1,Ki,>,3333.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,B,3333.0
3907,CHEMBL105509,CCCN(CCC)C1CCc2nc(OC)ccc2C1,Ki,=,1202.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,B,1202.0
3910,CHEMBL318740,CCCN(CCC)C1CCc2n[nH]cc2C1,Ki,>,3333.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,B,3333.0
3912,CHEMBL326864,N#CC(=Cc1cccn1C2CCN(Cc3ccccc3)CC2)C#N,Ki,=,11000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,11000.0
3913,CHEMBL326864,N#CC(=Cc1cccn1C2CCN(Cc3ccccc3)CC2)C#N,Ki,=,7800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,7800.0
3914,CHEMBL106635,Ic1cccn1C2CCN(Cc3ccccc3)CC2,Ki,=,8500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,8500.0
3915,CHEMBL106635,Ic1cccn1C2CCN(Cc3ccccc3)CC2,Ki,=,5300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,5300.0
3916,CHEMBL104092,C(N1CCC(CC1)n2cccc2C#Cc3ccccc3)c4ccccc4,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,10000.0
3917,CHEMBL104092,C(N1CCC(CC1)n2cccc2C#Cc3ccccc3)c4ccccc4,Ki,=,8300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,8300.0
3922,CHEMBL109173,O=Cc1cccn1C2CCN(Cc3ccccc3)CC2,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,1400.0
3923,CHEMBL109173,O=Cc1cccn1C2CCN(Cc3ccccc3)CC2,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,1500.0
3924,CHEMBL104201,N#CC(=Cc1ccn(c1)C2CCN(Cc3ccccc3)CC2)C#N,Ki,=,13000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,13000.0
3925,CHEMBL104201,N#CC(=Cc1ccn(c1)C2CCN(Cc3ccccc3)CC2)C#N,Ki,=,18000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,18000.0
3928,CHEMBL107529,C(N1CCC(CC1)n2ccc(c2)c3ocnc3)c4ccccc4,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,3400.0
3929,CHEMBL107529,C(N1CCC(CC1)n2ccc(c2)c3ocnc3)c4ccccc4,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,3200.0
3930,CHEMBL326877,C(N1CCC(CC1)n2cccc2)c3ccccc3,Ki,=,8500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,8500.0
3931,CHEMBL326877,C(N1CCC(CC1)n2cccc2)c3ccccc3,Ki,=,9800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,9800.0
3942,CHEMBL110435,Fc1ccc(cc1)C(OCCOC2CC3CCC(C2)N3)c4ccc(F)cc4,Ki,=,1120.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,1120.0
3944,CHEMBL108527,Clc1cccc(N2CCN(CCCNC(=O)c3cccc4c3Cc5ccccc45)CC2)c1Cl,Ki,=,1680.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at human dopamine receptor D2,B,1680.0
3960,CHEMBL110774,Clc1ccc(Cn2c(SCc3ccccc3)nc4ccccc24)cc1,Ki,=,6700.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,6700.0
3961,CHEMBL110431,FC(F)(F)c1ccc(CSc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,2600.0
3963,CHEMBL108678,Fc1ccc(CSc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,>,42000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,42000.0
3966,CHEMBL108297,NS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,1200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,1200.0
3967,CHEMBL321405,CS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,1100.0
3972,CHEMBL111006,Clc1ccc(Cn2c(SCc3ccc(cc3)C#N)nc4ccccc24)cc1,Ki,=,4200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,4200.0
3980,CHEMBL108242,COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,B,1500.0
3981,CHEMBL108243,COC(=O)c1ccc(cc1)c2nc3ccccc3n2Cc4ccc(Cl)cc4,Ki,=,8000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,8000.0
3983,CHEMBL320734,COC(=O)c1ccc(Cc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,6200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,6200.0
3984,CHEMBL320734,COC(=O)c1ccc(Cc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,>,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,B,12000.0
3985,CHEMBL110063,COC(=O)c1ccc(Nc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,1500.0
3986,CHEMBL110063,COC(=O)c1ccc(Nc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,5400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,B,5400.0
3989,CHEMBL108564,COC(=O)c1ccc(CNc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,1100.0
3997,CHEMBL109179,OC(=O)c1ccc(CSc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc1,Ki,=,3500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,3500.0
3998,CHEMBL107988,COC(=O)c1cccc(CSc2nc3ccccc3n2Cc4ccc(Cl)cc4)c1,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,1100.0
4001,CHEMBL107973,CCOC(=O)c1cc(CSc2nc3ccccc3n2Cc4ccc(Cl)cc4)cc(c1)C(=O)OCC,Ki,>,43000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,B,43000.0
4015,CHEMBL324017,CN1CCc2cc(Br)c(O)cc2C(C1)c3ccccc3,Ki,=,1360.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,1360.0
4023,CHEMBL321223,CN1CCc2cc(Br)c(O)cc2C(C1)c3ccc(N\C(=N\c4ccc5c(c4)C(=O)OC56c7ccc(O)cc7Oc8cc(O)ccc68)\S)cc3,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,5000.0
4027,CHEMBL321042,CN1CCc2cc(Br)c(O)cc2C(C1)c3ccc(N)cc3,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,B,1600.0
4068,CHEMBL112831,COc1cc(N)c(Cl)cc1C(=O)N[C@H]2CCCN(Cc3ccccc3)C2,Ki,=,7900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,7900.0
4069,CHEMBL112831,COc1cc(N)c(Cl)cc1C(=O)N[C@H]2CCCN(Cc3ccccc3)C2,Ki,=,4200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,4200.0
4070,CHEMBL112831,COc1cc(N)c(Cl)cc1C(=O)N[C@H]2CCCN(Cc3ccccc3)C2,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,1600.0
4071,CHEMBL112831,COc1cc(N)c(Cl)cc1C(=O)N[C@H]2CCCN(Cc3ccccc3)C2,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,1100.0
4083,CHEMBL113471,COc1c(cc(Br)c2ccccc12)C(=O)NCC[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,2500.0
4084,CHEMBL113471,COc1c(cc(Br)c2ccccc12)C(=O)NCC[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,2800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,2800.0
4085,CHEMBL113471,COc1c(cc(Br)c2ccccc12)C(=O)NCC[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,2000.0
4086,CHEMBL113471,COc1c(cc(Br)c2ccccc12)C(=O)NCC[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,1900.0
4097,CHEMBL325818,COc1c(cc(Br)c2ccccc12)C(=O)NC[C@@H]3CCN(Cc4ccccc4)C3,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,1300.0
4101,CHEMBL109472,COc1c(cc(C#Cc2ccccc2)c3ccccc13)C(=O)N[C@@H]4CCN(Cc5ccccc5)C4,Ki,=,7700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,7700.0
4102,CHEMBL109472,COc1c(cc(C#Cc2ccccc2)c3ccccc13)C(=O)N[C@@H]4CCN(Cc5ccccc5)C4,Ki,=,5500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,5500.0
4103,CHEMBL109472,COc1c(cc(C#Cc2ccccc2)c3ccccc13)C(=O)N[C@@H]4CCN(Cc5ccccc5)C4,Ki,=,6400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,B,6400.0
4104,CHEMBL109472,COc1c(cc(C#Cc2ccccc2)c3ccccc13)C(=O)N[C@@H]4CCN(Cc5ccccc5)C4,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,B,4000.0
4109,CHEMBL113142,Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
4110,CHEMBL113142,Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
4112,CHEMBL325060,CCS(=O)(=O)c1ccc(OC)c(c1)c2ccc(CN3CCCCCC3c4ccccc4C)[nH]2,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",B,1258.93
4116,CHEMBL111909,OC(=O)\C=C\C(=O)O.C(NC1CCN(Cc2ccccc2)CC1)\C=C\c3ccccc3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,5000.0
4117,CHEMBL112413,CN(C\C=C\c1ccccc1)C2CCN(Cc3ccccc3)CC2.OC(=O)\C=C\C(=O)O,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,5000.0
4118,CHEMBL320801,OC(=O)\C=C\C(=O)O.C(\C=C\c1ccccc1)N(C\C=C\c2ccccc2)C3CCN(Cc4ccccc4)CC3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,5000.0
4119,CHEMBL112957,CN(CC#Cc1ccccc1)C2CCN(Cc3ccccc3)CC2.OC(=O)\C=C\C(=O)O,IC50,=,4100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,2050.0
4121,CHEMBL111964,CN(C1CCN(Cc2ccccc2)CC1)C(=O)C#Cc3ccccc3.OC(=O)\C=C\C(=O)O,IC50,=,4900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,2450.0
4122,CHEMBL113449,OC(=O)\C=C\C(=O)O.O=C(NC1CCN(Cc2ccccc2)CC1)C#Cc3ccccc3,IC50,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,1250.0
4127,CHEMBL116233,OC(=O)\C=C\C(=O)O.O=C(NC1CCN(Cc2ccccc2)CC1)\C=C\c3ccccc3,IC50,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,2350.0
4128,CHEMBL115506,OC(=O)\C=C\C(=O)O.C(\C=C\c1ccccc1)N(C2CCN(Cc3ccccc3)CC2)c4ccccc4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,5000.0
4129,CHEMBL115934,OC(=O)\C=C\C(=O)O.C(NC1CCN(Cc2ccccc2)CC1)C#Cc3ccccc3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,5000.0
4130,CHEMBL112457,OC(=O)\C=C\C(=O)O.O=C(\C=C\c1ccccc1)N(C2CCN(Cc3ccccc3)CC2)c4ccccc4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,5000.0
4131,CHEMBL325063,CN(C1CCN(Cc2ccccc2)CC1)C(=O)\C=C\c3ccccc3.OC(=O)\C=C\C(=O)O,IC50,=,7100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from dopamine D2 receptor,B,3550.0
4140,CHEMBL115222,CNC(=O)CN1CN(c2ccccc2)C3(CCN(Cc4cc5OCOc5cc4Cl)CC3)C1=O,IC50,=,2120.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine receptor D2,B,1060.0
4144,CHEMBL326263,Fc1ccc(cc1)C(CCCN2CCN(CC2)C(=O)OCCc3ccc(cc3)C#N)c4ccc(F)cc4,IC50,=,2240.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine receptor D2,B,1120.0
4147,CHEMBL113956,CCOc1ccc(CCNC(=O)N2CCN(CCCC(c3ccc(F)cc3)c4ccc(F)cc4)CC2)cc1,IC50,=,2890.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine receptor D2,B,1445.0
4150,CHEMBL325516,Fc1ccc(CCOC(=O)N2CCN(CCCC(c3ccc(F)cc3)c4ccc(F)cc4)CC2)cc1,IC50,=,2620.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine receptor D2,B,1310.0
4162,CHEMBL117730,COc1c(C)ccc2C[C@H]3NCCc4cccc(c34)c12,Ki,=,4710.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,B,4710.0
4165,CHEMBL116367,Cc1ccc2C[C@H]3NCCc4cccc(c34)c2c1O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,B,10000.0
4166,CHEMBL334116,COc1c(OS(=O)(=O)C(F)(F)F)ccc2C[C@H]3N(C)CCc4cccc(c34)c12,Ki,=,1040.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,B,1040.0
4176,CHEMBL119223,COc1c(C)ccc2C[C@H]3N(Cc4ccccc4)CCc5cccc(c35)c12,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,B,5000.0
4177,CHEMBL331100,COc1c(C=C)ccc2C[C@H]3N(C)CCc4cccc(c34)c12,Ki,=,1750.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,B,1750.0
4181,CHEMBL324372,COc1c(ccc2C[C@H]3N(C)CCc4cccc(c34)c12)C(=O)C,Ki,=,2980.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,B,2980.0
4184,CHEMBL326159,CN1CCc2cccc3c2[C@H]1Cc4ccc(C(=O)C)c(O)c34,Ki,=,2760.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,B,2760.0
4185,CHEMBL115524,CCc1ccc2C[C@H]3N(C)CCc4cccc(c34)c2c1O,Ki,=,2050.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,B,2050.0
4195,CHEMBL333725,CC(C)N1CCc2cccc3c2[C@H]1Cc4cccc(O)c34,Ki,=,1010.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,B,1010.0
4196,CHEMBL324073,CN1CCc2cccc3c2[C@H]1Cc4cccc(C(=O)N)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,B,10000.0
4198,CHEMBL333085,COc1ccccc1c2cccc3C[C@H]4N(C)CCc5cccc(c45)c23,Ki,=,1330.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,B,1330.0
4206,CHEMBL332677,CCCN(CCC)C1COc2c(C1)ccc3sc(N)nc23,Ki,=,3510.0,nM,Dopamine D2 receptor,Homo sapiens,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]spiperone as radioligand.,B,3510.0
4211,CHEMBL118637,CCCNC1Cc2cc3nc(N)sc3cc2C1,Ki,=,1350.0,nM,Dopamine D2 receptor,Homo sapiens,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]NPA as radioligand.,B,1350.0
4223,CHEMBL116372,CCCN(CCC)C1COc2ccc3nc(N)sc3c2C1,Ki,=,5920.0,nM,Dopamine D2 receptor,Homo sapiens,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]spiperone as radioligand.,B,5920.0
4225,CHEMBL120055,Cc1ccccc1N2CCN(CC2)C(=O)COc3ccc4[nH]cc(CCN)c4c3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was tested for its affinity towards dopaminergic (D2) receptor,B,5000.0
4234,CHEMBL123937,OC(CC(=O)O)C(=O)O.O=C1c2ccccc2CCC13CCN(Cc4ccc5ccccc5c4)CC3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,10000.0
4235,CHEMBL123488,OC(CC(=O)O)C(=O)O.FC(F)(F)c1ccc(CN2CCC3(CC2)CCc4ccccc4C3=O)cc1,Ki,=,2192.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,2192.0
4236,CHEMBL122761,Clc1ccc2C(=O)C3(CCN(CCc4ccccc4)CC3)CCc2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,10000.0
4237,CHEMBL122761,Clc1ccc2C(=O)C3(CCN(CCc4ccccc4)CC3)CCc2c1,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1100.0
4240,CHEMBL331172,O=C1CCc2ccccc2C13CCN(CCc4ccccc4)CC3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,10000.0
4241,CHEMBL122758,OC1CCc2ccccc2C13CCN(CCc4ccccc4)CC3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,10000.0
4244,CHEMBL120927,CN1CCc2ccc3cnc4cccc5C[C@@H]1c2c3c45,Ki,=,1330.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,B,1330.0
4251,CHEMBL339960,Clc1ccc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)c(Cl)c1,Ki,>,23890.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,B,23890.0
4269,CHEMBL419792,CN[C@H]1CN2C(=O)Nc3cccc(C1)c23,Ki,=,16300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,16300.0
4284,CHEMBL127257,Cc1ccc(cc1C)N2CCN(Cc3nc4ccccc4[nH]3)CC2,Ki,>,6000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 (long) receptor (unknown origin),B,6000.0
4309,CHEMBL125745,NCCc1cccc2c1ccn2S(=O)(=O)c3ccccc3,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,B,1700.0
4315,CHEMBL263700,CN(C)CCc1cn(C(=O)c2ccccc2)c3ccc(O)cc13,Ki,>,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,B,2200.0
4318,CHEMBL127411,CN(C)[C@H]1Cc2cn(c3cccc([C@@H]1O)c23)S(=O)(=O)c4ccc(C)cc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,B,1700.0
4379,CHEMBL129263,O[C@@H](CCCN1CCN(CC1)c2ncc(F)cn2)c3ccc(F)cc3,Ki,=,3346.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,B,3346.0
4382,CHEMBL129768,O[C@H](CCCN1CCN(CC1)c2ncc(F)cn2)c3ccc(F)cc3,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,B,5000.0
4399,CHEMBL128276,COc1ccc(OCCNCCCOc2ccccc2)cc1,Ki,=,1950.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,1950.0
4400,CHEMBL128276,COc1ccc(OCCNCCCOc2ccccc2)cc1,Ki,=,1949.84,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,B,1949.84
4416,CHEMBL128222,Clc1ccc(OCCNCCCOc2ccc(Br)cc2)cc1,Ki,>,5880.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,5880.0
4417,CHEMBL131484,Cc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1,Ki,=,1320.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,1320.0
4418,CHEMBL131484,Cc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1,Ki,=,1318.26,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,B,1318.26
4421,CHEMBL132455,[O-][N+](=O)c1ccc(OCCNCCCOc2ccccc2)cc1,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,1400.0
4422,CHEMBL132455,[O-][N+](=O)c1ccc(OCCNCCCOc2ccccc2)cc1,Ki,=,1412.54,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,B,1412.54
4427,CHEMBL341225,Cc1ccc(OCCNCCCOc2ccc(Br)cc2)cc1,Ki,=,5730.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,B,5730.0
4428,CHEMBL341225,Cc1ccc(OCCNCCCOc2ccc(Br)cc2)cc1,Ki,=,5754.4,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,B,5754.4
4454,CHEMBL338938,CCCN(CCC)C1CCc2cc(CN(C(=O)N)c3ccc(OC)cc3)ccc2C1,Ki,=,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,B,6309.57
4470,CHEMBL129997,CCCN(CCC)[C@@H]1CCc2c(C1)ccc(C(O)Cc3ccc(Cl)cc3)c2OC,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,B,1258.93
4504,CHEMBL133938,CCCN(CCc1cccs1)[C@H]2CCc3ccc(OC)cc3C2,Ki,=,1241.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,1241.0
4508,CHEMBL441092,NC1CCc2c(O)cccc2C1,Ki,=,1492.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,1492.0
4510,CHEMBL132261,CCCN(CCc1cccs1)C2CCc3c(C2)cccc3OC4CCCC4,Ki,=,1046.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,1046.0
4526,CHEMBL135944,CCCN(CCC)[C@H]1CCc2ccc(OC)cc2C1,Ki,=,3351.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,3351.0
4528,CHEMBL134326,CCCN(CCC)[C@@H]1CCc2ccc(OC)cc2C1,Ki,=,5882.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,5882.0
4537,CHEMBL336962,CCCN[C@H]1CCc2ccc(OC)cc2C1,Ki,=,3206.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,3206.0
4539,CHEMBL422274,COc1ccc2CCC(N)Cc2c1,Ki,=,5825.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,5825.0
4562,CHEMBL335971,CCCN[C@@H]1CCc2ccc(OC)cc2C1,Ki,=,58882.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,B,58882.0
4610,CHEMBL138015,CCCN(C\C=C\I)C1COc2ccc(O)cc2C1,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,B,5000.0
4657,CHEMBL141537,Fc1cccc2C[C@@H](CCc12)NCc3ccccc3,Ki,=,2830.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]raclopride binding to Dopamine receptor D2,B,2830.0
4666,CHEMBL342630,CC(C)N[C@@H]1CCc2c(F)cccc2C1,Ki,=,2450.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from Dopamine receptor D2,B,2450.0
4667,CHEMBL342630,CC(C)N[C@@H]1CCc2c(F)cccc2C1,Ki,=,5940.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]raclopride binding to Dopamine receptor D2,B,5940.0
4676,CHEMBL345087,CCCN(C(C)C)[C@@H]1CCc2c(F)cccc2C1,Ki,=,1530.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]quinpirole from Dopamine receptor D2,B,1530.0
4677,CHEMBL345087,CCCN(C(C)C)[C@@H]1CCc2c(F)cccc2C1,Ki,=,4720.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]raclopride binding to Dopamine receptor D2,B,4720.0
4691,CHEMBL141343,Cc1c(C)c2OC(C)(CN3CCN(CC3)c4cc(nc(n4)N5CCCC5)N6CCCC6)CCc2c(C)c1O,IC50,=,16760.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,8380.0
4692,CHEMBL141343,Cc1c(C)c2OC(C)(CN3CCN(CC3)c4cc(nc(n4)N5CCCC5)N6CCCC6)CCc2c(C)c1O,Ki,=,5587.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,5587.0
4703,CHEMBL142217,N#Cc1ccc2[nH]cc(CN3CCN(CC3)c4ccccc4)c2c1,Ki,=,34000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,34000.0
4704,CHEMBL142217,N#Cc1ccc2[nH]cc(CN3CCN(CC3)c4ccccc4)c2c1,Ki,=,3500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,3500.0
4705,CHEMBL140594,Clc1ccc(cc1)N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,7900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,7900.0
4706,CHEMBL140594,Clc1ccc(cc1)N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,7600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,7600.0
4717,CHEMBL140006,Clc1ccc(cc1Cl)N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,43000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,43000.0
4718,CHEMBL140006,Clc1ccc(cc1Cl)N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,36000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,36000.0
4719,CHEMBL344602,Clc1ccc(cc1Cl)N2CCN(Cc3cc4ccc(cc4[nH]3)C#N)CC2,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,2000.0
4720,CHEMBL344602,Clc1ccc(cc1Cl)N2CCN(Cc3cc4ccc(cc4[nH]3)C#N)CC2,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,1400.0
4721,CHEMBL141035,Clc1ccccc1N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,2300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,2300.0
4723,CHEMBL140099,N#Cc1ccc2[nH]c(CN3CCN(CC3)c4ccccc4)cc2c1,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,3100.0
4726,CHEMBL140099,N#Cc1ccc2[nH]c(CN3CCN(CC3)c4ccccc4)cc2c1,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,3100.0
4727,CHEMBL343880,N#Cc1ccc2cc(CN3CCN(CC3)c4ccccc4)[nH]c2c1,Ki,=,5600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,5600.0
4728,CHEMBL343880,N#Cc1ccc2cc(CN3CCN(CC3)c4ccccc4)[nH]c2c1,Ki,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,2500.0
4729,CHEMBL143761,Fc1ccc(cc1)N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,28000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,28000.0
4730,CHEMBL143761,Fc1ccc(cc1)N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,19000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,19000.0
4731,CHEMBL143761,Fc1ccc(cc1)N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,19000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,19000.0
4732,CHEMBL143761,Fc1ccc(cc1)N2CCN(Cc3cc4cc(ccc4[nH]3)C#N)CC2,Ki,=,28000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,28000.0
4733,CHEMBL342001,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ccc(cc34)C#N)CC2,Ki,=,4300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,4300.0
4734,CHEMBL342001,Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ccc(cc34)C#N)CC2,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,2600.0
4735,CHEMBL140165,Fc1ccc(cc1)N2CCN(Cc3c[nH]c4ccc(cc34)C#N)CC2,Ki,=,2400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,2400.0
4736,CHEMBL140165,Fc1ccc(cc1)N2CCN(Cc3c[nH]c4ccc(cc34)C#N)CC2,Ki,=,1800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,B,1800.0
4737,CHEMBL143355,Clc1ccccc1N2CCN(Cc3c[nH]c4ccc(cc34)C#N)CC2,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,B,1400.0
4829,CHEMBL145584,NCCc1cccc(O)c1,Ki,=,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,20000.0
4834,CHEMBL357448,COc1cccc(c1)C(=O)NCCCN2CCN(CC2)c3ccccc3OC,Ki,=,2990.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,2990.0
4846,CHEMBL1263,OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2,Ki,=,32000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,32000.0
4857,CHEMBL146620,Fc1ccc(cc1)C(=O)CN2CCC(CC2)S(=O)(=O)c3ccccc3,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4861,CHEMBL358075,Fc1ccc(cc1)S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4862,CHEMBL358075,Fc1ccc(cc1)S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2,B,1500.0
4864,CHEMBL149429,Fc1ccc(CCN2CCC(CC2)S(=O)(=O)c3ccc(Cl)cc3)c(F)c1,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1100.0
4865,CHEMBL146144,OC1c2ccccc2CCC13CCN(CCc4ccccc4)CC3,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1700.0
4875,CHEMBL343411,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)S(=O)(=O)c3ccccc3,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1100.0
4877,CHEMBL147048,Fc1ccc(CCN2CCC(CC2)S(=O)(=O)c3cccc(c3)C#N)c(F)c1,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4879,CHEMBL146595,Fc1ccc(CCN2CCC3(CC2)CCc4ccccc4S3(=O)=O)c(F)c1,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4880,CHEMBL146448,O=C1NCCN1CCN2CCC(CC2)S(=O)(=O)c3ccccc3,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4882,CHEMBL148280,O=S(=O)(C1CCN(CCc2ccccc2)CC1)c3ccccc3,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4883,CHEMBL145939,Fc1ccc(CCN2CCC(CC2)S(=O)(=O)c3ccccc3)c(F)c1,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1400.0
4884,CHEMBL145939,Fc1ccc(CCN2CCC(CC2)S(=O)(=O)c3ccccc3)c(F)c1,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2,B,1500.0
4888,CHEMBL148565,O=S(=O)(C1CCN(CCCc2ccccc2)CC1)c3ccccc3,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4889,CHEMBL358839,O=S(=O)(C1CCN(Cc2ccccc2)CC1)c3ccccc3,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4891,CHEMBL423206,Fc1ccc2OC3(CCN(CC3)C4CCc5ccccc5C4)CCc2c1,Ki,=,1800.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1800.0
4892,CHEMBL150220,Fc1ccc(CCN2CCC(CC2)S(=O)(=O)c3ccc(cc3)C#N)c(F)c1,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
4893,CHEMBL149510,OC(CCc1ccccc1)CN2CCC3(CC2)CCc4cc(F)ccc4O3,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1100.0
4895,CHEMBL148626,CN(CCCC(O)c1ccc(Cl)cc1)CCCC(=O)c2ccc(F)cc2,Log Ki,=,7.58,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,38018939.63205613
4896,CHEMBL148627,Fc1ccc(cc1)C(=O)CCCN2CCC(C2)c3ccc(Cl)cc3,Log Ki,=,7.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,64565422.9034655
4897,CHEMBL150161,OC1(CCN(CCCC(=O)c2ccc(F)cc2)C1)c3ccc(Cl)cc3,Log Ki,=,7.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,30199517.20402019
4903,CHEMBL148794,OC1(CCCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Log Ki,=,8.96,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,912010839.3559117
4904,CHEMBL358190,OCCC1(CCN(CCCC(=O)c2ccc(F)cc2)C1)c3ccc(Cl)cc3,Log Ki,=,7.64,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,43651583.22401656
4905,CHEMBL149877,OCC1(CCN(CCCC(=O)c2ccc(F)cc2)C1)c3ccc(Cl)cc3,Log Ki,=,7.36,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,22908676.52767775
4906,CHEMBL357956,OC(C1CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Log Ki,=,7.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,41686938.34703355
4907,CHEMBL149721,OCC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3,Log Ki,=,7.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,64565422.9034655
4908,CHEMBL1269,Fc1ccc(cc1)C(=O)CCC[n+]2ccc(cc2)c3ccc(Cl)cc3,Log Ki,<,6.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,1000000.0
4909,CHEMBL147829,OC1(Cc2ccc(Cl)cc2)CCN(CCCC(=O)c3ccc(F)cc3)CC1,Log Ki,=,8.1,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,125892541.1794166
4910,CHEMBL147830,Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)c3ccc(Cl)cc3,Log Ki,=,7.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human Dopamine receptor D2,B,64565422.9034655
4913,CHEMBL148042,CN1CCCN(CC1)C2=Nc3cccnc3Nc4ccc(Cl)cc24,Ki,=,19117.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,B,19117.0
4929,CHEMBL356149,CN1CCC(CC1)NC2=Nc3cccnc3Nc4ccc(Cl)cc24,Ki,=,1099.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,B,1099.0
4942,CHEMBL347959,CN1CCC(CC1)NC2=Nc3cccnc3Nc4ccc(C)cc24,Ki,=,2596.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,B,2596.0
4944,CHEMBL146856,Clc1ccc2Nc3ncccc3N=C(N4CCN(Cc5ccccc5)CC4)c2c1,Ki,=,9943.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,B,9943.0
4950,CHEMBL147130,O=C1COc2ccc(CN3CCN(CC3)c4ccccc4)cc2N1,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,B,2200.0
4952,CHEMBL147011,Clc1ccc(cc1)N2CCN(Cc3ccc4OCC(=O)Nc4c3)CC2,Ki,>,5880.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,B,5880.0
4953,CHEMBL348435,COc1ccc(cc1)N2CCN(Cc3ccc4OCC(=O)Nc4c3)CC2,Ki,=,5590.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,B,5590.0
4954,CHEMBL150181,Cc1ccc(cc1C)N2CCN(Cc3ccc4OCC(=O)Nc4c3)CC2,Ki,=,2340.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,B,2340.0
4958,CHEMBL150173,Cc1ccc(cc1)N2CCN(Cc3ccc4NC(=O)COc4c3)CC2,Ki,=,2980.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,B,2980.0
4960,CHEMBL149497,COc1ccc(cc1)C2CCN(Cc3ccc4NC(=O)COc4c3)CC2,Ki,=,1130.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,B,1130.0
4962,CHEMBL150129,COc1ccc(cc1)N2CCN(Cc3ccc4NC(=O)COc4c3)CC2,Ki,>,5880.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,B,5880.0
4981,CHEMBL347290,COc1cccc(c1)C(=O)NCCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,1560.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,1560.0
4982,CHEMBL152576,COc1cccc(c1)C(=O)NCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,1130.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,1130.0
4983,CHEMBL152391,COc1cccc(c1)C(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,1410.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,1410.0
4988,CHEMBL156845,COc1cccc(c1)C(=O)NCCN2CCN(CC2)c3ccc(C)cc3,Ki,=,7460.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,7460.0
5002,CHEMBL157222,COc1cccc(c1)C(=O)NCCN2CCN(CC2)c3ccccc3,Ki,>,8300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,8300.0
5004,CHEMBL156599,COc1cccc(c1)C(=O)NCCN2CCN(CC2)c3cccc(Cl)c3Cl,Ki,=,3680.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,3680.0
5008,CHEMBL346692,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,Ki,=,3090.3,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,3090.3
5017,CHEMBL154508,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1Cl,Ki,=,5200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,5200.0
5018,CHEMBL154508,Clc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1Cl,Ki,=,1149.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,1149.0
5023,CHEMBL154274,COc1ccc(cc1N2CCNCC2)S(=O)(=O)Nc3cc(Br)ccc3Br,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for binding affinity against Dopamine receptor D2 in CHO cells using [125I]iodosulpiride as the radioligand,B,10000.0
5024,CHEMBL157910,COc1ccc(cc1N2CCNCC2)S(=O)(=O)Nc3cc(Cl)cc(Cl)c3Cl,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for binding affinity against Dopamine receptor D2 in CHO cells using [125I]iodosulpiride as the radioligand,B,10000.0
5025,CHEMBL414628,COc1ccc(cc1N2CCNCC2)S(=O)(=O)N3CCc4ccc(I)cc34,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Compound was evaluated for binding affinity against Dopamine receptor D2 in CHO cells using [125I]iodosulpiride as the radioligand,B,2511.89
5030,CHEMBL348617,COc1ccc2C(=O)CC(CN3CCN(CC3)c4ccccn4)Cc2c1,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine receptor D2,B,10000.0
5033,CHEMBL155207,C(Cc1ccccc1)C2CCN(Cc3c[nH]c4ncccc34)CC2,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,B,1100.0
5045,CHEMBL154482,C(Cc1cc2ccc[nH]c2n1)N3CCC(=CC3)\C=C\c4ccccc4,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,B,1300.0
5062,CHEMBL154244,COc1cc2CC(CN3CCN(CC3)c4ccccn4)CC(=O)c2cc1OC,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine receptor D2,B,10000.0
5095,CHEMBL423247,Cc1cccc2c(CN3CCN(CC3)c4ccc(Cl)cc4)cnn12,Ki,=,4900.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,4900.0
5096,CHEMBL423247,Cc1cccc2c(CN3CCN(CC3)c4ccc(Cl)cc4)cnn12,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,5000.0
5097,CHEMBL423247,Cc1cccc2c(CN3CCN(CC3)c4ccc(Cl)cc4)cnn12,Ki,=,4897.79,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,4897.79
5118,CHEMBL346805,Clc1ccc(cc1)N2CCN(Cc3cnn4c(C=O)cccc34)CC2,Ki,=,9500.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,9500.0
5119,CHEMBL346805,Clc1ccc(cc1)N2CCN(Cc3cnn4c(C=O)cccc34)CC2,Ki,=,9200.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,9200.0
5120,CHEMBL160932,Cc1nn2c(cccc2c1CN3CCN(CC3)c4ccc(Cl)cc4)C#N,Ki,=,59000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound was tested in vitro for its ability to compete with [3H]spiperone radioligand at cloned human Dopamine receptor D2L stably expressed in CHO cells,B,59000.0
5121,CHEMBL160932,Cc1nn2c(cccc2c1CN3CCN(CC3)c4ccc(Cl)cc4)C#N,Ki,=,58000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,58000.0
5122,CHEMBL160626,Clc1ccc(cc1)N2CCN(Cc3cnn4c(cccc34)C#N)CC2,Ki,=,44000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity of compound was tested in vitro for its ability to compete with [3H]spiperone radioligand at cloned human Dopamine receptor D2L stably expressed in CHO cells,B,44000.0
5123,CHEMBL160626,Clc1ccc(cc1)N2CCN(Cc3cnn4c(cccc34)C#N)CC2,Ki,=,45000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,45000.0
5128,CHEMBL156851,Cc1nn2c(cccc2c1CN3CCN(CC3)c4ccc(Cl)cc4)C#C,Ki,=,21000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,21000.0
5129,CHEMBL156851,Cc1nn2c(cccc2c1CN3CCN(CC3)c4ccc(Cl)cc4)C#C,Ki,=,25000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,25000.0
5130,CHEMBL155913,Clc1ccc(cc1)N2CCN(Cc3cnn4c(cccc34)c5ccccc5)CC2,Ki,=,5400.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,5400.0
5131,CHEMBL155913,Clc1ccc(cc1)N2CCN(Cc3cnn4c(cccc34)c5ccccc5)CC2,Ki,=,2800.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,2800.0
5132,CHEMBL351550,Cc1nn2c(cccc2c1CN3CCN(CC3)c4ccc(Cl)cc4)c5ccccc5,Ki,=,28000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,28000.0
5133,CHEMBL351550,Cc1nn2c(cccc2c1CN3CCN(CC3)c4ccc(Cl)cc4)c5ccccc5,Ki,=,24000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,24000.0
5134,CHEMBL160749,Cc1nn2c(cccc2c1CN3CCN(CC3)c4ccc(Cl)cc4)c5ccc(F)cc5,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,14000.0
5135,CHEMBL160749,Cc1nn2c(cccc2c1CN3CCN(CC3)c4ccc(Cl)cc4)c5ccc(F)cc5,Ki,=,16000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,16000.0
5136,CHEMBL156198,Fc1ccc(cc1)c2cccc3c(CN4CCN(CC4)c5ccc(Cl)cc5)cnn23,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,15000.0
5137,CHEMBL156198,Fc1ccc(cc1)c2cccc3c(CN4CCN(CC4)c5ccc(Cl)cc5)cnn23,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,15000.0
5158,CHEMBL160952,Clc1ccc(cc1)N2CCN(Cc3cnn4c(cccc34)C#C)CC2,Ki,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,3700.0
5159,CHEMBL160952,Clc1ccc(cc1)N2CCN(Cc3cnn4c(cccc34)C#C)CC2,Ki,=,6200.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,6200.0
5160,CHEMBL160952,Clc1ccc(cc1)N2CCN(Cc3cnn4c(cccc34)C#C)CC2,Ki,=,3715.35,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,3715.35
5161,CHEMBL345357,OCc1ccc2c(CN3CCN(CC3)c4ccc(Cl)cc4)cnn2c1,Ki,=,28000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,28000.0
5162,CHEMBL345357,OCc1ccc2c(CN3CCN(CC3)c4ccc(Cl)cc4)cnn2c1,Ki,=,22000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,22000.0
5163,CHEMBL345357,OCc1ccc2c(CN3CCN(CC3)c4ccc(Cl)cc4)cnn2c1,Ki,=,27542.29,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,27542.29
5164,CHEMBL156369,Cc1cccn2ncc(CN3CCN(CC3)c4ccc(Cl)cc4)c12,Ki,=,13000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,13000.0
5165,CHEMBL156369,Cc1cccn2ncc(CN3CCN(CC3)c4ccc(Cl)cc4)c12,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,12000.0
5166,CHEMBL160396,OCc1cccn2ncc(CN3CCN(CC3)c4ccc(Cl)cc4)c12,Ki,=,56000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,56000.0
5167,CHEMBL160396,OCc1cccn2ncc(CN3CCN(CC3)c4ccc(Cl)cc4)c12,Ki,=,79000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,79000.0
5168,CHEMBL160454,C[Si](C)(C)c1cccc2c(CN3CCN(CC3)c4ccc(Cl)cc4)cnn12,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,B,3100.0
5169,CHEMBL160454,C[Si](C)(C)c1cccc2c(CN3CCN(CC3)c4ccc(Cl)cc4)cnn12,Ki,=,2800.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,B,2800.0
5182,CHEMBL434665,CCCN[C@@H]1Cc2cccc3nc(O)n(C1)c23,Ki,=,2430.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,2430.0
5196,CHEMBL345458,CN(C)[C@@H]1Cc2cccc3ncn(C1)c23,Ki,=,1281.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,B,1281.0
5199,CHEMBL345349,C1CCN2CCc3c([nH]c4ccccc34)C2C1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5253,CHEMBL160998,O=C(N[C@@H]1CC[C@@H](CCN2Cc3ccc(cc3C2)C#N)CC1)c4cc5ccccc5[nH]4,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,B,2511.89
5256,CHEMBL158402,CN(C)CCSc1cccc(n1)C2CCCCC2,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,B,1300.0
5263,CHEMBL351722,O=C(N[C@@H]1CC[C@@H](CCN2Cc3ccc(cc3C2)C#N)CC1)c4ccnc5ccccc45,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,B,2511.89
5270,CHEMBL161507,CCCN[C@@H]1CCc2c(cccc2C(=O)OC)[C@@H]1C,Ki,=,2328.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),B,2328.0
5272,CHEMBL349843,CCCN[C@@H]1CCc2c(OS(=O)(=O)C(F)(F)F)cccc2[C@@H]1C,Ki,=,2557.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),B,2557.0
5276,CHEMBL355149,CN1C2CCC1CC(C2)NC(=O)c3cnn4ccccc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for binding affinity for Dopamine D2 receptor,B,5000.0
5280,CHEMBL350972,CN1C2CCC1CC(C2)OC(=O)c3cnn4ccccc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Tested for binding affinity for Dopamine D2 receptors,B,5000.0
5294,CHEMBL349904,CC(C)(C)c1ccc(OC[C@@H]2CC[C@H]3CN(CCN3C2)c4ncccn4)cc1,Ki,=,1720.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,1720.0
5296,CHEMBL159903,Fc1ccc(OC[C@@H]2CC[C@H]3CN(CCN3C2)c4ncccn4)cc1,Ki,=,1196.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,1196.0
5299,CHEMBL166269,C(Oc1ccccc1)[C@@H]2CC[C@H]3CN(CCN3C2)c4ncccn4,Ki,=,1140.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,1140.0
5303,CHEMBL161982,Fc1ccc(OC[C@@H]2CC[C@H]3CN(CCN3C2)c4ccc(Cl)cn4)cc1,Ki,=,1880.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,B,1880.0
5310,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on low Affinity Site of Dopamine receptor D2L,B,20000.0
5311,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity of Compound of Dopamine receptor D2S,B,20000.0
5314,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2L,B,20000.0
5315,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2S,B,20000.0
5316,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Dissociation constant of compound on one-site model Dopamine receptor D2L,B,20000.0
5317,CHEMBL163087,CCCN(CCC)C1CCC(=CC1)C#C[Si](C)(C)C,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Dissociation constant of compound on one-site model Dopamine receptor D2S,B,20000.0
5322,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on low Affinity Site of Dopamine receptor D2L,B,14000.0
5323,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity of Compound of Dopamine receptor D2S,B,12000.0
5326,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,19000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2L,B,19000.0
5327,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,17000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2S,B,17000.0
5328,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,2800.0,nM,Dopamine D2 receptor,Homo sapiens,Dissociation constant of compound on one-site model Dopamine receptor D2L,B,2800.0
5329,CHEMBL162762,CCCN(CCC)C1CCC(=CC1)C#C,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Dissociation constant of compound on one-site model Dopamine receptor D2S,B,2900.0
5332,CHEMBL164631,CCCN(CCC)C1CCC(=CC1)C#N,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on High Affinity Site of Dopamine receptor D2L,B,20000.0
5333,CHEMBL164631,CCCN(CCC)C1CCC(=CC1)C#N,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity on High Affinity Site of Dopamine receptor D2S,B,20000.0
5334,CHEMBL350161,CCCN(CCC)C1CCC(=CC#N)CC1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on High Affinity Site of Dopamine receptor D2L,B,20000.0
5335,CHEMBL350161,CCCN(CCC)C1CCC(=CC#N)CC1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity on High Affinity Site of Dopamine receptor D2S,B,20000.0
5336,CHEMBL164950,CCCN(CCC)C1CCC(=C(C#N)C#N)CC1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on High Affinity Site of Dopamine receptor D2L,B,20000.0
5337,CHEMBL164950,CCCN(CCC)C1CCC(=C(C#N)C#N)CC1,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity on High Affinity Site of Dopamine receptor D2S,B,15000.0
5346,CHEMBL165171,CCCN(CCC)C1CCC(=C(C#Cc2ccccc2)C#Cc3ccccc3)CC1,Ki,=,5200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on High Affinity Site of Dopamine receptor D2L,B,5200.0
5347,CHEMBL165171,CCCN(CCC)C1CCC(=C(C#Cc2ccccc2)C#Cc3ccccc3)CC1,Ki,=,7300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity on High Affinity Site of Dopamine receptor D2S,B,7300.0
5348,CHEMBL164736,CCCN(CCC)C1CCC(=C(C#C[Si](C)(C)C)C#C[Si](C)(C)C)CC1,Ki,=,11000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on High Affinity Site of Dopamine receptor D2L,B,11000.0
5349,CHEMBL164736,CCCN(CCC)C1CCC(=C(C#C[Si](C)(C)C)C#C[Si](C)(C)C)CC1,Ki,=,13000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity on High Affinity Site of Dopamine receptor D2S,B,13000.0
5354,CHEMBL165022,CCCN(CCC)C1CCC(=C(C#C)C#C)CC1,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity on High Affinity Site of Dopamine receptor D2L,B,12000.0
5355,CHEMBL165022,CCCN(CCC)C1CCC(=C(C#C)C#C)CC1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity on High Affinity Site of Dopamine receptor D2S,B,20000.0
5356,CHEMBL166325,CCCN(CCC)C1CCC(=CC1)C#Cc2ccccc2,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on High Affinity Site of Dopamine receptor D2L,B,15000.0
5357,CHEMBL166325,CCCN(CCC)C1CCC(=CC1)C#Cc2ccccc2,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding Affinity was tested on High Affinity Site of Dopamine receptor D2S,B,15000.0
5387,CHEMBL165381,CCCN(CCC)CC[C@@H]1CC[C@H](CC1)Nc2ncccn2,Ki,=,2400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,2400.0
5407,CHEMBL166151,C(CN1CCN(CC1)c2ccncc2)[C@@H]3CC[C@H](CC3)Nc4ncccn4,Ki,=,4800.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,B,4800.0
5422,CHEMBL167414,COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,1400.0
5426,CHEMBL169631,COc1cc(N(C)C(=O)C)c(Cl)cc1C(=O)NC[C@H]2CCN(Cc3ccccc3)C2,Ki,=,38000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,38000.0
5427,CHEMBL169631,COc1cc(N(C)C(=O)C)c(Cl)cc1C(=O)NC[C@H]2CCN(Cc3ccccc3)C2,Ki,=,28000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,28000.0
5428,CHEMBL353087,COc1cc(NC(=O)C)c(Cl)cc1C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2,Ki,=,19000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,19000.0
5429,CHEMBL353087,COc1cc(NC(=O)C)c(Cl)cc1C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2,Ki,=,21000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,21000.0
5430,CHEMBL423440,COc1ccc(Br)cc1C(=O)NC[C@H]2CCN(Cc3ccccc3)C2,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,2000.0
5431,CHEMBL423440,COc1ccc(Br)cc1C(=O)NC[C@H]2CCN(Cc3ccccc3)C2,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,1500.0
5444,CHEMBL353090,COc1ccc(Br)cc1C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,3100.0
5445,CHEMBL353090,COc1ccc(Br)cc1C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,1600.0
5448,CHEMBL167032,COc1cc(NC(=O)C)c(Cl)cc1C(=O)NC[C@H]2CCN(Cc3ccccc3)C2,Ki,=,27000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,27000.0
5449,CHEMBL167032,COc1cc(NC(=O)C)c(Cl)cc1C(=O)NC[C@H]2CCN(Cc3ccccc3)C2,Ki,=,25000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,25000.0
5452,CHEMBL168372,COc1cc(N(C)C(=O)C)c(Cl)cc1C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2,Ki,=,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,B,30000.0
5453,CHEMBL168372,COc1cc(N(C)C(=O)C)c(Cl)cc1C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2,Ki,=,19000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,B,19000.0
5456,CHEMBL352925,C([C@H]1CCN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,25000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to displace [3H]spiperone from the cloned human dopamine D2 long receptor expressed in CHO cells,B,25000.0
5457,CHEMBL352925,C([C@H]1CCN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,32000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to displace [3H]spiperone from the cloned human dopamine D2 short receptor expressed in CHO cells,B,32000.0
5458,CHEMBL169889,COc1ccc(Br)cc1C2=NCC[C@H](CN3CCN(CC3)c4ccccc4)N2,Ki,=,44000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,B,44000.0
5459,CHEMBL169889,COc1ccc(Br)cc1C2=NCC[C@H](CN3CCN(CC3)c4ccccc4)N2,Ki,=,43000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,B,43000.0
5460,CHEMBL168541,O=C1C[C@@H](CN2CCN(CC2)c3ccccc3)N=C(N1)c4ccccc4,Ki,=,18000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,B,18000.0
5461,CHEMBL168541,O=C1C[C@@H](CN2CCN(CC2)c3ccccc3)N=C(N1)c4ccccc4,Ki,=,6400.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,B,6400.0
5462,CHEMBL168571,O=C1C[C@H](CN2CCN(CC2)c3ccccc3)N=C(N1)c4ccccc4,Ki,=,7300.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,B,7300.0
5463,CHEMBL168571,O=C1C[C@H](CN2CCN(CC2)c3ccccc3)N=C(N1)c4ccccc4,Ki,=,2800.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,B,2800.0
5464,CHEMBL353220,COc1ccc(Br)cc1C2=NCC[C@@H](CN3CCN(CC3)c4ccccc4)N2,Ki,=,16000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,B,16000.0
5465,CHEMBL353220,COc1ccc(Br)cc1C2=NCC[C@@H](CN3CCN(CC3)c4ccccc4)N2,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,B,14000.0
5466,CHEMBL169459,C([C@@H]1CCN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,29000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,B,29000.0
5467,CHEMBL169459,C([C@@H]1CCN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,30000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 short in CHO cells,B,30000.0
5468,CHEMBL169562,C1C[C@H](CN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,B,10000.0
5469,CHEMBL169562,C1C[C@H](CN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,4200.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,B,4200.0
5470,CHEMBL354748,C1C[C@@H](CN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,19000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,B,19000.0
5471,CHEMBL354748,C1C[C@@H](CN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,B,14000.0
5472,CHEMBL354845,CCCN1CCO[C@@H]2[C@H]1COc3cc4CCOc4cc23,Ki,<,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,B,100000.0
5473,CHEMBL169322,CC(C)CN1CCO[C@H]2[C@H]1CCc3cc4CCOc4cc23,Ki,=,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,B,5011.87
5477,CHEMBL171672,C(C1CC1)N2CCO[C@H]3[C@H]2CCc4cc5CCOc5cc34,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,B,2511.89
5478,CHEMBL173803,CCCN1CCO[C@@H]2[C@H]1CCc3cc4CCOc4cc23,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,B,10000.0
5479,CHEMBL435272,C(Cc1ccccc1)N2CCO[C@H]3[C@H]2CCc4cc5CCOc5cc34,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,B,10000.0
5480,CHEMBL355065,C(N1CCO[C@H]2[C@H]1CCc3cc4CCOc4cc23)c5ccccc5,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,B,10000.0
5482,CHEMBL170923,CCCN1CCO[C@H]2[C@H]1COc3cc4CCOc4cc23,Ki,=,12589.25,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,B,12589.25
5483,CHEMBL1346,NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5,IC50,=,25118.86,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,12559.43
5484,CHEMBL1346,NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c4ccccc4)c5ccccc5,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase in GTPgamma35S binding by scintillation proximity assay,B,5000.0
5491,CHEMBL177807,Fc1ccc(C(=O)CN2CCC(CC2)S(=O)(=O)c3ccccc3)c(F)c1,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2,B,1500.0
5492,CHEMBL176109,Fc1ccc(CCN2CCC(F)(CC2)S(=O)(=O)c3ccc(cc3)N4CCC4)c(F)c1,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2,B,2000.0
5496,CHEMBL178055,Fc1ccc(CCN2CCC(F)(CC2)S(=O)(=O)c3ccc(cc3)n4cccn4)c(F)c1,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2,B,2000.0
5497,CHEMBL174049,Fc1ccc(CCN2CCC(F)(CC2)S(=O)(=O)c3ccc(cc3)n4ccnn4)c(F)c1,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human Dopamine receptor D2,B,2000.0
5546,CHEMBL555146,C[C@@H]1CCCN1CCc2oc3ccc(cc3c2)C(=O)c4ccc(F)cc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human recombinant Dopamine D2 receptor,B,10000.0
5549,CHEMBL362487,Clc1ccccc1S(=O)(=O)n2cc(C3=CCNCC3)c4ccccc24,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human cloned Dopamine receptor D2 stably expressed in CHO-K1 cells using [3H]spiperone,B,2000.0
5550,CHEMBL180606,Fc1ccccc1S(=O)(=O)n2cc(C3=CCNCC3)c4ccccc24,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against human cloned Dopamine receptor D2 stably expressed in CHO-K1 cells using [3H]spiperone,B,2000.0
5561,CHEMBL183460,Cc1ccc2c(OCCN3CCC(Cc4ccc5OCC(=O)Nc5c4)CC3)cccc2n1,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,B,1258.93
5585,CHEMBL184383,Clc1cccc(N2CCN(CCCCNC(=O)c3oc4ccc(I)cc4c3)CC2)c1Cl,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,B,3200.0
5597,CHEMBL1363,COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1,Ki,=,13000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,13000.0
5601,CHEMBL366043,Clc1ccc(cc1)c2ccc(cc2)C(=O)NC3CCN(Cc4ccccc4)C3,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,2600.0
5602,CHEMBL184551,O=Cc1ccccc1c2ccc(cc2)C(=O)NC3CCN(Cc4ccccc4)C3,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,3100.0
5604,CHEMBL183160,Fc1cccc(c1)c2ccc(cc2)C(=O)NC3CCN(Cc4ccccc4)C3,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,4000.0
5605,CHEMBL187122,O=C(NC1CCN(Cc2ccccc2)C1)c3ccc(cc3)c4ccsc4,Ki,=,1200.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,1200.0
5606,CHEMBL186558,O=C(N[C@@H]1CCN(Cc2ccccc2)C1)c3ccc(cc3)c4cccs4,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,1500.0
5609,CHEMBL427522,O=Cc1ccc(cc1)c2ccc(cc2)C(=O)NC3CCN(Cc4ccccc4)C3,Ki,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,3700.0
5614,CHEMBL182075,CSc1ccc(cc1)c2ccc(cc2)C(=O)NC3CCN(Cc4ccccc4)C3,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,4000.0
5615,CHEMBL187804,FC(F)(F)c1ccc(cc1)c2ccc(cc2)C(=O)NC3CCN(Cc4ccccc4)C3,Ki,=,8000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,8000.0
5618,CHEMBL424808,Nc1cccc(c1)c2ccc(cc2)C(=O)NC3CCN(Cc4ccccc4)C3,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,B,5000.0
5622,CHEMBL185271,COCC1=C([C@@H](N(C(=O)NCCCN2CCC(CC2)c3cccc(NC(=O)C)c3)C(=O)N1)c4ccc(F)c(F)c4)C(=O)OC,Ki,=,2800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,B,2800.0
5623,CHEMBL184724,CC1CN(CCOc2ccccc2Cc3ccccc3)CCO1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,10000.0
5624,CHEMBL184073,C(CN1CCN(CC1)c2ccccc2)Oc3ccccc3Cc4ccccc4,Ki,=,4188.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,4188.0
5625,CHEMBL187367,C(COc1ccccc1Cc2ccccc2)CN3CCCC3,Ki,=,1006.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,1006.0
5626,CHEMBL187420,C(CN1CCCC1)Nc2ccccc2Cc3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,10000.0
5628,CHEMBL361875,CCCN(CCC)[C@H]1CCc2c(C1)cccc2c3c(OC)cccc3OC,Ki,=,1210.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]raclopride binding to human dopamine D2A receptor expressed in Ltk cells,B,1210.0
5629,CHEMBL186720,CN(C)CCOc1ccccc1Cc2ccccc2,Ki,=,2740.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,2740.0
5630,CHEMBL364565,C(CN1CCCCC1)Oc2ccccc2Cc3ccccc3,Ki,=,1015.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,1015.0
5631,CHEMBL365697,C(CN1CCOCC1)Oc2ccccc2Cc3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,10000.0
5633,CHEMBL364586,O=C(c1ccccc1)c2ccccc2OCCN3CCCC3,Ki,=,5317.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,5317.0
5634,CHEMBL185875,OC(c1ccccc1)c2ccccc2OCCN3CCCC3,Ki,=,6280.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,6280.0
5635,CHEMBL366265,CCN(CC)CCOc1ccccc1Cc2ccccc2,Ki,=,2024.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,2024.0
5636,CHEMBL435505,C(CN1CCCC1)Oc2ccccc2Cc3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human recombinant dopamine receptor D2L,B,10000.0
5649,CHEMBL187928,OC(=O)C(F)(F)F.O=C(\C=C\c1ccccc1)N(Cc2ccc(cc2)c3ccc(CNCCc4ccccc4)cc3)Cc5cccnc5,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 expressed in CHO cells using the radioligand [125I]iodosulpiride,B,1258.93
5650,CHEMBL191460,CN(C)CCN(Cc1ccc(cc1)c2ccc(CNCCc3ccccc3)cc2)C(=O)CCC4CCCC4.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor D2 expressed in CHO cells using the radioligand [125I]iodosulpiride,B,1258.93
5661,CHEMBL372222,Cc1ccc(cc1)c2cc3NC(=O)N(CCN4CCN(CC4)c5ccccc5Cl)C(=O)c3[nH]2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,10000.0
5665,CHEMBL372020,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C#N,Ki,=,6500.0,nM,Dopamine D2 receptor,Homo sapiens,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,B,6500.0
5667,CHEMBL372020,CCCN(CCC)[C@H]1CCn2c(C1)ccc2C#N,Ki,=,5100.0,nM,Dopamine D2 receptor,Homo sapiens,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,B,5100.0
5668,CHEMBL192099,Fc1ccc(cc1F)N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2,B,2200.0
5671,CHEMBL425190,Cc1ccc2c(OCCN3CCN(Cc4cccc5cccnc45)CC3)cccc2n1,Ki,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human dopamine receptor D2,B,3162.28
5704,CHEMBL372453,COc1ccc(NC(=O)N2CCN(CC2)c3ccc(Cl)cc3)cc1N4CCN(C)CC4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5705,CHEMBL194206,COc1ccc(NC(=O)N2CCN(CC2)c3ccc(F)cc3)cc1N4CCN(C)CC4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5706,CHEMBL197408,COc1ccc(NC(=O)N2CCN(CC2)c3ccc(cc3)c4ccccc4)cc1N5CCN(C)CC5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5707,CHEMBL196598,COc1ccc(NC(=O)N2CCN(CC2)c3ccc(cc3)C(F)(F)F)cc1N4CCN(C)CC4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5708,CHEMBL197796,COc1ccc(NC(=O)N2CCN(CC2)c3ccc(SC)cc3)cc1N4CCN(C)CC4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5709,CHEMBL195927,COc1ccccc1N2CCC(CC2)C(=O)Nc3ccc(OC)c(c3)N4CCN(C)CC4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5740,CHEMBL196928,CCCN(CCC)C1CCn2nccc2C1,Ki,=,18000.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,18000.0
5741,CHEMBL196928,CCCN(CCC)C1CCn2nccc2C1,Ki,=,8500.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,8500.0
5742,CHEMBL197159,CCCN(CCC)[C@@H]1CCn2nccc2C1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,20000.0
5743,CHEMBL197159,CCCN(CCC)[C@@H]1CCn2nccc2C1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,20000.0
5744,CHEMBL197159,CCCN(CCC)[C@@H]1CCn2nccc2C1,Ki,=,55000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,B,55000.0
5745,CHEMBL197159,CCCN(CCC)[C@@H]1CCn2nccc2C1,Ki,=,53000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,B,53000.0
5746,CHEMBL197159,CCCN(CCC)[C@@H]1CCn2nccc2C1,Ki,=,57000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,B,57000.0
5749,CHEMBL193337,CCCN(CCC)[C@H]1CCn2nccc2C1,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,15000.0
5750,CHEMBL193337,CCCN(CCC)[C@H]1CCn2nccc2C1,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,10000.0
5758,CHEMBL194099,CCCN(CCC)C1CCn2ncc(Cl)c2C1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,20000.0
5759,CHEMBL194099,CCCN(CCC)C1CCn2ncc(Cl)c2C1,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,12000.0
5760,CHEMBL383805,CCCNC1CCn2ncc(C(=O)OC)c2C1,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,100000.0
5761,CHEMBL383805,CCCNC1CCn2ncc(C(=O)OC)c2C1,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,100000.0
5762,CHEMBL198303,CCCN(CCC)C1CCn2ncc(C(=O)OC)c2C1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,20000.0
5763,CHEMBL198303,CCCN(CCC)C1CCn2ncc(C(=O)OC)c2C1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,20000.0
5764,CHEMBL198125,CCCN(CCC)C1CCn2ncc(CO)c2C1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,20000.0
5765,CHEMBL198125,CCCN(CCC)C1CCn2ncc(CO)c2C1,Ki,>,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,20000.0
5766,CHEMBL198174,CCCN(CCC)C1CCn2ncc(C=O)c2C1,Ki,=,5900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,5900.0
5767,CHEMBL198174,CCCN(CCC)C1CCn2ncc(C=O)c2C1,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,B,4000.0
5805,CHEMBL196370,COc1ccccc1N2CCN(CC2)C(=O)Nc3ccc(OC)c(c3)N4CCN(C)CC4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5806,CHEMBL370128,COc1ccc(NC(=O)N2CCN(CC2)c3ccccc3Cl)cc1N4CCN(C)CC4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5807,CHEMBL196169,COc1ccc(NC(=O)N2CCN(CC2)c3ccccc3F)cc1N4CCN(C)CC4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards cloned Dopamine receptor D2,B,10000.0
5842,CHEMBL196866,Fc1ccccc1CN2CC[C@@H](C2)NC(=O)c3ccc(cc3)c4cccs4,Ki,=,38000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,38000.0
5843,CHEMBL370823,Fc1ccc(CN2CC[C@@H](C2)NC(=O)c3ccc(cc3)c4cccs4)cc1,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,1500.0
5848,CHEMBL199186,Clc1ccc(CN2CC[C@@H](C2)NC(=O)c3ccc(cc3)c4cccs4)cc1Cl,Ki,=,29000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,29000.0
5849,CHEMBL198580,Fc1ccc(CN2CC[C@@H](C2)NC(=O)c3ccc(cc3)c4cccs4)cc1F,Ki,=,18000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,18000.0
5850,CHEMBL427555,COc1cccc(CN2CC[C@@H](C2)NC(=O)c3ccc(cc3)c4cccs4)c1,Ki,=,4460.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,4460.0
5853,CHEMBL370652,FC(F)(F)c1ccc(CN2CC[C@@H](C2)NC(=O)c3cccc(c3)c4cccs4)cc1,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,1300.0
5855,CHEMBL197225,O=C(N[C@H]1CCN(Cc2ccc3OCOc3c2)C1)c4ccc(cc4)c5cccs5,Ki,=,1800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,B,1800.0
5869,CHEMBL370364,Cc1ccc(cc1)c2cc3C(=O)N(CCN4CCN(CC4)c5ccccc5Cl)C(=O)Nc3[nH]2,Ki,=,1720.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,1720.0
5871,CHEMBL199876,Clc1ccc(cc1)c2cc3C(=O)N(CCN4CCN(CC4)c5ccccc5Cl)C(=O)Nc3[nH]2,Ki,=,2370.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2370.0
5891,CHEMBL201326,COc1cccc2cc(oc12)C(=O)NCCCCN3CCN(CC3)c4cccc5nccnc45,Ki,=,1246.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,B,1246.0
5911,CHEMBL201010,C[N+]12CCCC(C1c3[nH]c4ccccc4c3CC2)c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5913,CHEMBL381472,O=C(CCC(=O)c1ccccc1)NCCc2c[nH]c3ccccc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5915,CHEMBL382642,C1CCC2(N(C1)CCc3c2[nH]c4ccccc34)c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5917,CHEMBL201577,O=C(CCCC(=O)c1ccccc1)NCCc2c[nH]c3ccccc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5919,CHEMBL201788,COc1cc2CCN(CCc3ccccc3)CCc4ccccc4Cc2cc1OC,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5921,CHEMBL201241,C1CC(C2N(C1)CCc3c2[nH]c4ccccc34)c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5923,CHEMBL378358,CN1CCc2c(Cc3ccn(C)c3CC1)[nH]c4ccccc24,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5925,CHEMBL201444,CCOC(=O)C(CBr)c1ccccc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5927,CHEMBL201748,C1Cc2c([nH]c3ccccc23)C4CC(CN14)c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5929,CHEMBL440390,CCOC(=O)CCCC(Br)c1ccccc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5931,CHEMBL381102,O=C1CCCC(O1)c2ccccc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5933,CHEMBL201142,C=CCN1CCc2ccccc2Cc3ccsc3CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5935,CHEMBL201287,COc1cc2CCN(CC=C)CCc3ccccc3Cc2cc1OC,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5937,CHEMBL383102,C1CC2N(CCc3c2[nH]c4ccccc34)C1c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5939,CHEMBL1398,O=C1OCCC1c2ccccc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5941,CHEMBL201739,C1Cc2c([nH]c3ccccc23)C4N1Cc5ccccc45,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5943,CHEMBL201393,C1CN2CCc3c([nH]c4ccccc34)C2C1c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5945,CHEMBL380124,O=C1CC(CO1)c2ccccc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5949,CHEMBL202924,COc1cc2CCN(C)CCc3ccccc3Cc2cc1OC,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,B,5000.0
5950,CHEMBL379450,C(Cc1ccccc1)N2CCc3ccccc3Cc4[nH]c5ccccc5c4CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5952,CHEMBL201432,C(C1CC1)N2CCc3ccccc3Cc4[nH]c5ccccc5c4CC2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,B,5000.0
5959,CHEMBL379673,CN1CCCCc2[nH]c3ccccc3c2CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5963,CHEMBL201288,CCN1CCc2c(Cc3ccccc3C1)[nH]c4ccccc24,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5965,CHEMBL201598,O=C1CCCC(N1CCC2=CCc3ccccc23)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5967,CHEMBL201375,CN1CCc2c(CCC(C1)c3ccccc3)[nH]c4ccccc24,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5969,CHEMBL201177,CN1CCCC(c2ccccc2)c3[nH]c4ccccc4c3CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5971,CHEMBL381325,OC(CCCC(=O)NCCC1=CCc2ccccc12)c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5973,CHEMBL201561,CN1CCCCCc2[nH]c3ccccc3c2CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5975,CHEMBL437888,C(C1CC1)N2CCCCCc3[nH]c4ccccc4c3CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5980,CHEMBL381912,C1CC(N2CCc3c([nH]c4ccccc34)C2C1)c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5982,CHEMBL201086,O=C1OCCCC1c2ccccc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5990,CHEMBL201575,CCOC(=O)C(CCCBr)c1ccccc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5992,CHEMBL382780,O=C1C(CCCN1CCc2c[nH]c3ccccc23)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5994,CHEMBL381573,CN1CCCC(Cc2[nH]c3ccccc3c2CC1)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
5996,CHEMBL426662,CN1CCCCC(c2ccccc2)c3[nH]c4ccccc4c3CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,F,10000.0
6026,CHEMBL201019,CCOc1cc(N)c(Cl)cc1C(=O)NC[C@@H]2CCN3CCC[C@@H]23,IC50,=,5300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,2650.0
6027,CHEMBL201621,COc1cc(N)c(Cl)cc1C(=O)OC[C@@H]2CCN3CCC[C@@H]23,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,5000.0
6036,CHEMBL383577,Cn1nc(C(=O)OC[C@@H]2CCN3CCC[C@@H]23)c4ccccc14,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,5000.0
6037,CHEMBL201946,O=C(OC[C@@H]1CCN2CCC[C@@H]12)c3c[nH]c4ccccc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,5000.0
6038,CHEMBL201878,O=C(OC[C@@H]1CCN2CCC[C@@H]12)c3[nH]nc4ccccc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,5000.0
6039,CHEMBL202434,Clc1cc(C(=O)NC[C@@H]2CCN3CCC[C@@H]23)c4nccn4c1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,5000.0
6055,CHEMBL369997,CCCC(N1CCCC1)C(=O)c2ccc(cc2)c3cccs3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6056,CHEMBL202420,CCCC(N1CCCC1)C(=O)c2ccc(Br)cc2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6057,CHEMBL372312,CCC[C@H](N1CCCC1)C(=O)c2ccc(C)cc2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6058,CHEMBL379679,CCCC(N1CCCC1)C(=O)c2ccc(NC(=O)C)cc2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6059,CHEMBL204490,CCCC(N1CCCC1)C(=O)c2ccc(cc2)C(F)(F)F,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6060,CHEMBL203403,CCCC(N1CCCC1)C(=O)c2ccccc2C,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6061,CHEMBL202939,CCC(CC(=O)c1ccc(C)cc1)N2CCCC2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6062,CHEMBL377498,CCC(CC(=O)c1ccc(Cl)c(Cl)c1)N2CCCC2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6063,CHEMBL203563,CCCC(N1CCCC1)C(=O)c2ccc(O)cc2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6064,CHEMBL379446,CCCC(N1CCCC1)C(=O)c2ccc(cc2)[N+](=O)[O-],IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6065,CHEMBL204759,CCCC(N1CCCC1)C(=O)c2ccc3ccccc3c2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6066,CHEMBL204254,CCCC(N1CCCC1)C(=O)c2cccc(C)c2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6067,CHEMBL381127,CCCC(N1CCCC1)C(=O)c2ccc(OC)cc2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory activity against dopamine D2,B,5000.0
6071,CHEMBL379238,CC(C)(CCCN1CCCC(C1)c2ocnc2)S(=O)(=O)c3ccccc3,Ki,=,1500.0,/nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,B,1500.0
6139,CHEMBL426317,COc1cccc(c1)N2CCN(CCCCN3N=CC(=O)N(C)C3=O)CC2,Ki,=,2575.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 dopamine receptor by radioligand binding assay,B,2575.0
6150,CHEMBL209821,CC(=O)Nc1cccc(c1)N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor by radioligand binding assay,B,2000.0
6151,CHEMBL379984,CC(C)CS(=O)(=O)NCCCCN1CCN(CC1)c2cccc(NC(=O)C)c2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor by radioligand binding assay,B,5000.0
6183,CHEMBL209832,C(N1CCN(CC1)c2ncccn2)c3cnn(c3)c4ccccc4,Ki,=,6000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,6000.0
6184,CHEMBL209832,C(N1CCN(CC1)c2ncccn2)c3cnn(c3)c4ccccc4,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,14000.0
6192,CHEMBL211026,C(N1CCN(CC1)c2ccccc2)c3cn(nn3)c4ccccc4,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,1500.0
6218,CHEMBL210318,C(N1CCN(CC1)c2ccccc2)c3ccc(cc3)n4cccn4,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,3000.0
6219,CHEMBL210318,C(N1CCN(CC1)c2ccccc2)c3ccc(cc3)n4cccn4,Ki,=,2400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,2400.0
6235,CHEMBL210955,Clc1ccc(cc1)N2CCN(Cc3cnn(c3)c4ccccc4)CC2,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,B,2900.0
6236,CHEMBL210955,Clc1ccc(cc1)N2CCN(Cc3cnn(c3)c4ccccc4)CC2,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,B,1900.0
6237,CHEMBL210955,Clc1ccc(cc1)N2CCN(Cc3cnn(c3)c4ccccc4)CC2,Ki,=,2884.03,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,2884.03
6238,CHEMBL211135,Clc1ccc(cc1)N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2,Ki,=,8200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,8200.0
6239,CHEMBL211135,Clc1ccc(cc1)N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,12000.0
6242,CHEMBL377542,Fc1ccc(cc1)N2CCN(Cc3cn4ccncc4n3)CC2,Ki,=,68000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,68000.0
6243,CHEMBL377542,Fc1ccc(cc1)N2CCN(Cc3cn4ccncc4n3)CC2,Ki,=,64000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,64000.0
6244,CHEMBL425064,Fc1ccc(cc1)N2CCN(Cc3cn4cccnc4n3)CC2,Ki,=,49000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,49000.0
6245,CHEMBL425064,Fc1ccc(cc1)N2CCN(Cc3cn4cccnc4n3)CC2,Ki,=,55000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,55000.0
6249,CHEMBL207543,Clc1ccc(cc1Cl)N2CCN(Cc3cn4nc(ccc4n3)N5CCCCC5)CC2,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,1100.0
6250,CHEMBL380054,Fc1ccc(cc1)N2CCN(Cc3cn4ccccc4n3)CC2,Ki,=,19000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,19000.0
6251,CHEMBL380054,Fc1ccc(cc1)N2CCN(Cc3cn4ccccc4n3)CC2,Ki,=,21000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,21000.0
6252,CHEMBL378680,Clc1ccc(cc1Cl)N2CCN(Cc3cn4ccccc4n3)CC2,Ki,=,2700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,2700.0
6253,CHEMBL378680,Clc1ccc(cc1Cl)N2CCN(Cc3cn4ccccc4n3)CC2,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,3200.0
6259,CHEMBL212370,Clc1ccc(cc1)N2CCN(Cc3cn4ccccc4n3)CC2,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,15000.0
6260,CHEMBL212370,Clc1ccc(cc1)N2CCN(Cc3cn4ccccc4n3)CC2,Ki,=,16000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,16000.0
6261,CHEMBL207488,Fc1ccc(cc1)N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2,Ki,=,9900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,9900.0
6262,CHEMBL207488,Fc1ccc(cc1)N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,12000.0
6266,CHEMBL209034,Clc1ccc2nc(CN3CCN(CC3)c4ccc(Cl)c(Cl)c4)cn2n1,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,1100.0
6271,CHEMBL210341,Clc1ccc(cc1Cl)N2CCN(Cc3cn4cc(Br)ccc4n3)CC2,Ki,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,3700.0
6272,CHEMBL210341,Clc1ccc(cc1Cl)N2CCN(Cc3cn4cc(Br)ccc4n3)CC2,Ki,=,3500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,3500.0
6273,CHEMBL380287,CN1CCN(CC1)c2ccc3nc(CN4CCN(CC4)c5ccc(Cl)c(Cl)c5)cn3n2,Ki,=,7800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,7800.0
6274,CHEMBL380287,CN1CCN(CC1)c2ccc3nc(CN4CCN(CC4)c5ccc(Cl)c(Cl)c5)cn3n2,Ki,=,8000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,8000.0
6275,CHEMBL210283,COc1ccccc1N2CCN(Cc3cn4cc(C)cc(C#N)c4n3)CC2,Ki,=,2700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,B,2700.0
6276,CHEMBL210283,COc1ccccc1N2CCN(Cc3cn4cc(C)cc(C#N)c4n3)CC2,Ki,=,4200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,B,4200.0
6292,CHEMBL441529,CO\N=C(/C(O)CN1CCN(CC1)c2ccccn2)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6295,CHEMBL211360,CO\N=C(/C(COC(C)C)CN1CCN(CC1)c2ccccn2)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6297,CHEMBL215705,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cc(F)cc(F)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6300,CHEMBL214197,CO\N=C(\CCN1CCN(CC1C)c2ccccn2)/c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6302,CHEMBL212595,CO\N=C(\CN1CCN(CC1)c2ccccn2)/c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6304,CHEMBL378427,O\N=C(/CN1CCN(CC1)c2ccccn2)\c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6306,CHEMBL213208,CO\N=C(\C(CN1CCN(CC1)c2ccccn2)OC)/c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6308,CHEMBL378302,CO\N=C(/C(O)CN1CCN(CC1)c2ccccn2)\c3cccnc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6310,CHEMBL377794,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cc(C)cc(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6312,CHEMBL212393,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cc(C)cc(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6314,CHEMBL212891,CO\N=C(/CN1CCN(CC1)c2ccccn2)\c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6315,CHEMBL212891,CO\N=C(/CN1CCN(CC1)c2ccccn2)\c3ccc(F)cc3,Ki,=,2530.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,2530.0
6317,CHEMBL212490,CO\N=C(/C(CN1CCN(CC1)c2ccccn2)OC)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6319,CHEMBL209759,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(Cl)cc3Cl,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6321,CHEMBL211829,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(Cl)cc3Cl,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6323,CHEMBL209447,O\N=C(/CCCN1CCN(CC1)c2ccccn2)\c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6325,CHEMBL211415,O\N=C(\CCCN1CCN(CC1)c2ccccn2)/c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6327,CHEMBL211463,Cc1cccc(c1)\C(=N/O)\C(O)CN2CCN(CC2)c3ccccn3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6329,CHEMBL378576,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(F)c(Cl)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6332,CHEMBL211902,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(F)c(Cl)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6334,CHEMBL378324,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(Cl)c(Cl)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6337,CHEMBL215723,Cc1cccc(c1)\C(=N\O)\C(O)CN2CCN(CC2)c3ccccn3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6339,CHEMBL211836,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cccc(c3)C#N,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6342,CHEMBL210101,CO\N=C(/CCN1CCC(CC1)c2ccccn2)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6345,CHEMBL211623,COC(CN1CCN(CC1)c2ccccn2)\C(=N\O)\c3cccc(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6347,CHEMBL212969,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6350,CHEMBL427048,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6353,CHEMBL437532,CO\N=C(\CCN1CCC(CC1)c2ccccn2)/c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6356,CHEMBL213097,CO\N=C(/CCN1CCC(CC1)c2cccc[n+]2[O-])\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6358,CHEMBL212028,COC(CN1CCN(CC1)c2ccccn2)\C(=N/O)\c3cccc(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6360,CHEMBL212235,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6363,CHEMBL212236,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6365,CHEMBL379546,CO\N=C(\CCN1CCC(CC1)c2cccc[n+]2[O-])/c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6368,CHEMBL213004,CO\N=C(/C(C)CN1CCN(CC1)c2ccccn2)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6370,CHEMBL377585,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(Br)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6372,CHEMBL212872,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(Br)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6374,CHEMBL211831,CO\N=C(/CCN1CCCC(C1)c2ccccn2)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6376,CHEMBL213828,CO\N=C(/CCCN1CCN(CC1)c2ccccn2)\c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6378,CHEMBL211732,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cc(F)cc(F)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6381,CHEMBL209472,O\N=C(\CN1CCN(CC1)c2ccccn2)/c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6386,CHEMBL213558,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(Cl)c(Cl)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6388,CHEMBL215569,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(Cl)c(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6390,CHEMBL215450,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(Cl)c(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6393,CHEMBL212444,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(C)c(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6396,CHEMBL215678,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccc(C)c(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6398,CHEMBL212291,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cccnc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6399,CHEMBL212291,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cccnc3,Ki,=,1820.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,B,1820.0
6401,CHEMBL212292,CO\N=C(/CCN1CCN(CC1C)c2ccccn2)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6404,CHEMBL213518,O\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cc(F)cc(F)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6406,CHEMBL214247,CO\N=C(\C(O)CN1CCN(CC1)c2ccccn2)/c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6409,CHEMBL212288,CONCC(CN1CCN(CC1)c2ccccn2)\C(=N/OC)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6412,CHEMBL212075,Cc1ccc(OCc2ccccc2)c(c1)\C(=N\O)\CCN3CCN(CC3)c4ccccn4,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6414,CHEMBL213106,Cc1ccc(O)c(c1)\C(=N\O)\CCN2CCN(CC2)c3ccccn3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6416,CHEMBL376955,N#CCO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6419,CHEMBL215670,O\N=C(/CCN1CCN(CC1)c2ncccc2C#N)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6421,CHEMBL215704,CCO\N=C(/CCN1CCN(CC1)c2cccc(OCC)c2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6423,CHEMBL377050,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6426,CHEMBL385826,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6428,CHEMBL438961,O\N=C(\CCN1CCN(CC1)c2ncccc2C#N)/c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6430,CHEMBL211972,O\N=C(/CCN1CCN(CC1)c2ncccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6432,CHEMBL212804,O\N=C(\CCN1CCN(CC1)c2ncccn2)/c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6434,CHEMBL212901,CCO\N=C\1/C(CN2CCN(CC2)c3ccccn3)CCc4ccccc14,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6436,CHEMBL212782,CCO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6439,CHEMBL213572,CCO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6441,CHEMBL213486,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccccc3C,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6443,CHEMBL426510,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(F)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6446,CHEMBL212188,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(F)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6448,CHEMBL212189,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(Cl)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6450,CHEMBL212298,Cc1cccc(c1)\C(=N\O)\CCN2CCN(CC2)c3ccccn3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6452,CHEMBL212831,CCCO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6454,CHEMBL213164,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cccc(F)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6457,CHEMBL212784,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(Cl)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6460,CHEMBL212847,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(c3)C#N,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6462,CHEMBL212902,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6464,CHEMBL211930,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cccc(Cl)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6466,CHEMBL212861,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6469,CHEMBL384529,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(Cl)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6471,CHEMBL214343,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cc(F)cc(F)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6473,CHEMBL212903,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3cccc(C)c3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6476,CHEMBL437493,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3cccc(c3)C#N,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6478,CHEMBL211985,Cc1cc(C)cc(c1)\C(=N\O)\CCN2CCN(CC2)c3ccccn3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6480,CHEMBL214314,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6483,CHEMBL385350,O\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6485,CHEMBL214954,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3Cl,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6487,CHEMBL385230,O\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccccc3Cl,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6489,CHEMBL215849,Cc1ccccc1\C(=N\O)\CCN2CCN(CC2)c3ccccn3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6491,CHEMBL214440,Cc1ccccc1\C(=N/O)\CCN2CCN(CC2)c3ccccn3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6493,CHEMBL213398,CCO\N=C(/CCN1CCN(CC1)c2ncccc2C#N)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6495,CHEMBL379597,CCO\N=C(/CCN1CCN(CC1)c2ncccc2C)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6497,CHEMBL377023,CCO\N=C(/CCN1CCN(CC1)c2ncccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6499,CHEMBL377388,CCO\N=C(/CCN1CCN(CC1)c2nccs2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6502,CHEMBL212073,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3Cl,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6504,CHEMBL212290,CO\N=C(\CCN1CCN(CC1)c2ccccn2)/c3ccccc3Cl,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6506,CHEMBL437687,CO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3C,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6509,CHEMBL212545,O\N=C(/CCN1CCN(CC1)c2nccs2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6511,CHEMBL213246,CCO\N=C(/CCN1CCN(CC1)c2ccccc2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6513,CHEMBL261957,CCCCO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6515,CHEMBL386867,CCO\N=C(/CCN1CCN(CC1)c2ccccc2C#N)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6517,CHEMBL212607,CCO\N=C(/CCN1CCN(CC1)c2ccccc2OC)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6519,CHEMBL214190,O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccc(F)cc3F,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6521,CHEMBL376639,CC(C)O\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6523,CHEMBL213700,C=CCO\N=C(/CCN1CCN(CC1)c2ccccn2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6525,CHEMBL411545,CCO\N=C(/CCN1CCN(CC1)c2cccc(OC)c2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6527,CHEMBL214203,CCO\N=C(/CCN1CCN(CC1)c2ccc(OC)cc2)\c3ccccc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
6528,CHEMBL405751,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4cnn(c5ccccc5)c4C(F)(F)F)c6ccccc26,Ki,=,2084.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,2084.0
6529,CHEMBL215885,COc1ccc(cc1)C(=O)NN2c3ccc(Cl)cc3N=C(N4CCN(C)CC4)c5ccccc25,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,3000.0
6530,CHEMBL215885,COc1ccc(cc1)C(=O)NN2c3ccc(Cl)cc3N=C(N4CCN(C)CC4)c5ccccc25,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6532,CHEMBL211461,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCC4CCCC4)c5ccccc25,Ki,=,1950.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1950.0
6535,CHEMBL386424,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)\C=C\c4ccccc4)c5ccccc25,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1600.0
6540,CHEMBL212486,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)C(F)(F)F)c4ccccc24,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1900.0
6543,CHEMBL214016,COc1cccc(c1)C(=O)NN2c3ccc(Cl)cc3N=C(N4CCN(C)CC4)c5ccccc25,Ki,=,1126.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1126.0
6546,CHEMBL213388,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)C4CCCCC4)c5ccccc25,Ki,=,1776.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1776.0
6548,CHEMBL212608,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4)c5ccccc25,Ki,=,1150.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1150.0
6549,CHEMBL212608,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4)c5ccccc25,Ki,=,1150.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1150.0
6550,CHEMBL213775,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccc(Br)cc4)c5ccccc25,Ki,=,2386.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,2386.0
6551,CHEMBL214142,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccc(Cl)cc4)c5ccccc25,Ki,=,9251.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,9251.0
6552,CHEMBL213795,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccc(C)cc4)c5ccccc25,Ki,=,1521.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1521.0
6556,CHEMBL212905,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4cccc(c4)C#N)c5ccccc25,Ki,=,3648.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3648.0
6557,CHEMBL380236,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4cccc(c4)C(F)(F)F)c5ccccc25,Ki,=,1362.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1362.0
6563,CHEMBL212186,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4NC5CCCCC5)c6ccccc26,Ki,=,3818.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,3818.0
6564,CHEMBL378543,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)c4ccccc4C)c5ccccc25,Ki,=,4927.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,4927.0
6571,CHEMBL213882,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccc5ccccc5c4)c6ccccc26,Ki,=,1314.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1314.0
6577,CHEMBL213238,CN1CCN(CC1)C2=Nc3ccccc3N(NC(=O)c4cccc(c4)C#N)c5ccc(Cl)cc25,Ki,=,1186.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1186.0
6578,CHEMBL213239,COc1cccc(c1)C(=O)NN2c3ccccc3N=C(N4CCN(C)CC4)c5cc(Cl)ccc25,Ki,=,1379.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1379.0
6581,CHEMBL210016,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4N5CCN(C)CC5)c6ccccc26,Ki,=,3772.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,3772.0
6582,CHEMBL379560,COc1ccccc1C(=O)NN2c3ccc(Cl)cc3N=C(N4CCN(C)CC4)c5ccccc25,Ki,=,1126.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1126.0
6584,CHEMBL377564,Fc1ccc(CN2CCN(CC2)C3=Nc4cc(Cl)ccc4N(NC(=O)c5ccccc5Cl)c6ccccc36)c(F)c1,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6585,CHEMBL377043,Clc1ccc2N(NC(=O)c3ccccc3Cl)c4ccccc4C(=Nc2c1)N5CCN(Cc6cccc7OCOc67)CC5,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,2000.0
6588,CHEMBL379874,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4cccs4)c5ccccc25,Ki,=,1474.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1474.0
6589,CHEMBL212896,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccsc4)c5ccccc25,Ki,=,2997.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,2997.0
6591,CHEMBL212334,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccc(cc4)C#N)c5ccccc25,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,2000.0
6594,CHEMBL386336,Cc1ccc(CN2CCN(CC2)C3=Nc4cc(Cl)ccc4N(NC(=O)c5ccccc5Cl)c6ccccc36)c(C)c1,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6595,CHEMBL379286,Clc1ccc2N(NC(=O)c3ccccc3Cl)c4ccccc4C(=Nc2c1)N5CCN(Cc6ccc7OCCOc7c6)CC5,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,2000.0
6596,CHEMBL379862,FC1(F)Oc2cccc(CN3CCN(CC3)C4=Nc5cc(Cl)ccc5N(NC(=O)c6ccccc6Cl)c7ccccc47)c2O1,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6597,CHEMBL378893,FC(F)(F)Oc1cccc(CN2CCN(CC2)C3=Nc4cc(Cl)ccc4N(NC(=O)c5ccccc5Cl)c6ccccc36)c1,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6598,CHEMBL213472,CN1CCN(CC1)C2=Nc3ccccc3N(NC(=O)c4ccc5OCOc5c4)c6ccc(Cl)cc26,Ki,=,1261.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1261.0
6599,CHEMBL377420,COc1cc(cc(OC)c1OC)C(=O)NN2c3ccccc3N=C(N4CCN(C)CC4)c5cc(Cl)ccc25,Ki,=,3230.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3230.0
6616,CHEMBL212077,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccc(Cl)c(Cl)c4)c5ccccc25,Ki,=,6394.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,6394.0
6617,CHEMBL213424,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4c(C)cccc4N)c5ccccc25,Ki,=,1015.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1015.0
6618,CHEMBL213424,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4c(C)cccc4N)c5ccccc25,Ki,=,1015.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,1015.0
6623,CHEMBL212384,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)Nc4cc(Cl)cc(Cl)c4)c5ccccc25,Ki,=,3896.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3896.0
6625,CHEMBL213201,CN1CCN(CC1)C2=Nc3ccccc3N(NC(=O)c4ccc(cc4)C#N)c5ccc(Cl)cc25,Ki,=,1969.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1969.0
6627,CHEMBL212950,CC(C)CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4Cl)c5ccccc25,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6628,CHEMBL385590,CC(C)(C)CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4Cl)c5ccccc25,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6630,CHEMBL212966,CCC(CC)CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4Cl)c5ccccc25,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6633,CHEMBL215997,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4cccnc4)c5ccccc25,Ki,=,12710.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,12710.0
6634,CHEMBL216047,Clc1ccc2N(NC(=O)c3ccccc3Cl)c4ccccc4C(=Nc2c1)N5CCN(CC6CCCCC6)CC5,Ki,>,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,3000.0
6635,CHEMBL385295,CN1CCN(CC1)C2=Nc3ccccc3N(NC(=O)c4ccccc4C)c5ccc(Cl)cc25,Ki,=,1571.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1571.0
6636,CHEMBL437917,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccc(F)cc4C(F)(F)F)c5ccccc25,Ki,=,1616.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1616.0
6637,CHEMBL384248,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccncc4)c5ccccc25,Ki,=,28425.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,28425.0
6639,CHEMBL215641,Fc1ccccc1CN2CCN(CC2)C3=Nc4cc(Cl)ccc4N(NC(=O)c5ccccc5Cl)c6ccccc36,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,2000.0
6642,CHEMBL379875,COc1cc(cc(OC)c1OC)C(=O)NN2c3ccc(Cl)cc3N=C(N4CCN(C)CC4)c5ccccc25,Ki,=,5561.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,5561.0
6648,CHEMBL212844,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4ccccc4n5ccnc5)c6ccccc26,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,3000.0
6649,CHEMBL212438,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)c4cc(F)c(F)c(F)c4F)c5ccccc25,Ki,=,1280.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,B,1280.0
6651,CHEMBL215581,CCCC(CCC)C(=O)NN1c2ccc(Cl)cc2N=C(N3CCN(C)CC3)c4ccccc14,Ki,=,1850.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,B,1850.0
6654,CHEMBL216198,C(Cc1ccccc1OCc2ccccn2)c3ccccc3,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
6657,CHEMBL387052,COc1cccc(CCc2ccccc2OCc3ccccn3)c1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
6660,CHEMBL217425,C(Cc1ccccc1OCc2cccnc2)c3ccccc3,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
6661,CHEMBL217281,COc1cccc(CCc2ccccc2OCc3cccnc3)c1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
6662,CHEMBL215010,C(Cc1ccccc1OCc2ccccc2)c3ccccc3,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
6663,CHEMBL214739,COc1cccc(CCc2ccccc2OCc3ccccc3)c1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
6664,CHEMBL217886,COc1cccc(CCc2ccccc2OCc3cccc(OC)c3)c1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
6672,CHEMBL217299,Oc1cc2OCC3NCc4ccccc4C3c2cc1O,Ki,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,B,3700.0
6673,CHEMBL217299,Oc1cc2OCC3NCc4ccccc4C3c2cc1O,Ki,=,1910.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2 receptor,B,1910.0
6674,CHEMBL387250,Oc1cc2OC[C@H]3NCc4ccccc4[C@@H]3c2cc1O,Ki,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,B,2500.0
6675,CHEMBL384046,Oc1cc2OC[C@@H]3NCc4ccccc4[C@H]3c2cc1O,Ki,=,6800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,B,6800.0
6676,CHEMBL384538,CCCC[C@H]1[C@H](C[C@@H](C)[C@H]2CC[C@H]3\C(=C\C=C/4\C[C@@H](O)[C@H](C)[C@H](O)C4=C)\CCC[C@]23C)OC(=O)C1=C,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
6677,CHEMBL216228,Cc1nc(nc2ccc(NC(=O)COc3ccc(Cl)cc3)cc12)N4CCCC4,IC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2(L),B,50000.0
6687,CHEMBL376092,COc1ccccc1C2CCN(CNC(=O)c3cccc(C)c3)CC2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor in HEK293 cells coexpressing G-alpha-qo5 by FLIPR,F,5000.0
6688,CHEMBL216794,Cc1cccc(c1)C(=O)NCN2CCC(CC2)c3ccccn3,Ki,=,3500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,B,3500.0
6689,CHEMBL216794,Cc1cccc(c1)C(=O)NCN2CCC(CC2)c3ccccn3,Ki,=,3500.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2 receptor in HEK293 cells coexpressing G-alpha-qo5 by FLIPR,F,3500.0
6692,CHEMBL219179,Oc1ccc(nc1)N2CCN(Cc3nc4ccccc4[nH]3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,B,10000.0
6693,CHEMBL219179,Oc1ccc(nc1)N2CCN(Cc3nc4ccccc4[nH]3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human D2S receptor,B,10000.0
6696,CHEMBL219261,Cc1cc(F)ccc1NC(=O)CN2CCC(CC2)c3cccc[n+]3[O-],Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,B,10000.0
6697,CHEMBL219261,Cc1cc(F)ccc1NC(=O)CN2CCC(CC2)c3cccc[n+]3[O-],Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human D2S receptor,B,10000.0
6698,CHEMBL375596,Cc1cccc(NC(=O)CN2CCC(CC2)c3ccccn3)c1,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,B,2900.0
6703,CHEMBL219182,Cc1cccc(c1)C(=O)NCN2CCC(CC2)c3cccc[n+]3[O-],Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,B,10000.0
6704,CHEMBL219182,Cc1cccc(c1)C(=O)NCN2CCC(CC2)c3cccc[n+]3[O-],Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human D2S receptor,B,10000.0
6707,CHEMBL219185,Cc1cccc(NC(=O)CN2CCC(CC2)c3cccc[n+]3[O-])c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,B,10000.0
6708,CHEMBL219185,Cc1cccc(NC(=O)CN2CCC(CC2)c3cccc[n+]3[O-])c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human D2S receptor,B,10000.0
6729,CHEMBL218150,Clc1cccc(N2CCN(CCCCNC(=O)c3cc4cc(Br)ccc4[nH]3)CC2)c1Cl,Ki,=,2290.87,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,2290.87
6737,CHEMBL218787,Clc1ccc(cc1)N2CCN(Cc3cnn4c(I)cccc34)CC2,Ki,=,7585.78,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,7585.78
6741,CHEMBL376445,Clc1cccc(N2CCN(CCCCNC(=O)c3oc4ccc(Br)cc4c3)CC2)c1Cl,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10000.0
6817,CHEMBL1437,NC[C@H](O)c1ccc(O)c(O)c1,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,1300.0
6863,CHEMBL388509,CC(C)[C@H](NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34)C(=O)N[C@@H](Cc5ccc(F)cc5)C(=O)N6CCC[C@H]6C(=O)N,Kd,=,16000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM 09151-2 from dopamine D2 receptor in lamb striatum membrane after 2 hrs,B,16000.0
6882,CHEMBL225368,CC(C)[C@H](NC(=O)[C@H](Cc1ccc(cc1)[N+](=O)[O-])NC(=O)[C@H]2CN(C)[C@@H]3Cc4c[nH]c5cccc(C3=C2)c45)C(=O)N6[C@@H](Cc7ccccc67)C(=O)N,Kd,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM 09151-2 from dopamine D2 receptor in lamb striatum membrane after 2 hrs,B,2000.0
6885,CHEMBL229429,FCc1nc(cs1)C#Cc2cc(F)cc(c2)C#N,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from dopamine D2 receptor,B,10000.0
6917,CHEMBL231350,CC(C)Nc1cc2CCN(C)CCc2cc1NS(=O)(=O)c3ccc(cc3)c4ccc(Cl)cc4,EC50,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor by [35S]GTPgammaS binding assay,F,5000.0
6990,CHEMBL243794,CC(=O)Nc1cccc(c1)C2CCN(CCCC(=O)c3ccc(Cl)cc3)CC2,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,B,1400.0
6993,CHEMBL244004,CC(=O)Nc1cccc(c1)C2CCN(CCCC(=O)c3ccc(C)c(C)c3)CC2,Ki,=,6100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,B,6100.0
7012,CHEMBL244374,CC(C)C(=O)Nc1cccc(c1)C2CCN(Cc3cccc(Oc4ccc(C)cc4)c3)CC2,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,B,1300.0
7025,CHEMBL245229,COc1ccc(Oc2ccc(CN3CCC(CC3)c4cccc(NC(=O)C(C)C)c4)cc2)cc1,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,B,1400.0
7026,CHEMBL389129,CC(C)C(=O)Nc1cccc(c1)C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,B,2900.0
7029,CHEMBL242004,CC(C)C(=O)Nc1ccc(C)c(c1)C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2,Ki,=,7400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,B,7400.0
7048,CHEMBL244775,[O-][N+]1(C\C=C\CNC(=O)c2ccc(cc2)c3ccccn3)CCN(CC1)c4cccc(Cl)c4Cl,Ki,=,1160.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,1160.0
7063,CHEMBL242644,COc1ccccc1N2CCN(CC(O)CCNC(=O)c3ccc(cc3)c4ccccn4)CC2,Ki,=,1090.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,B,1090.0
7076,CHEMBL394863,Clc1cccc(N2CCN(C[C@@H]3C[C@@H]3CNC(=O)c4ccc(cc4)c5ccccn5)CC2)c1Cl,Ki,=,1050.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,B,1050.0
7102,CHEMBL443843,COc1ccc2C3N(CCCc4ccccc34)CCCc2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,10000.0
7104,CHEMBL397180,COc1ccc(CCN2CCCc3ccccc3C2)cc1Cl,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,10000.0
7105,CHEMBL394777,COc1cc2C3N(CCCc4ccccc34)CCc2cc1Cl,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,10000.0
7106,CHEMBL231374,COc1ccc2CCN(C)CCCc3ccccc3Cc2c1,Ki,=,1396.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,1396.0
7108,CHEMBL397207,COc1cc2CCN(C)CCCc3ccccc3Cc2cc1OC,Ki,=,1028.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,B,1028.0
7118,CHEMBL244277,Cc1oc(nc1)c2ccc3CCN(CCCSc4nnc(c5cccn5C)n4C)CCc3c2,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,1258.93
7120,CHEMBL395741,Cc1onc(c1)c2ccc3CCN(CCCSc4nnc(c5ccc6nc(C)ccc6c5)n4C)CCc3c2,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,1995.26
7121,CHEMBL243708,Cc1onc(c1)c2ccc3CCN(CCCSc4nnc(c5ccc6nc(C)c(C)nc6c5)n4C)CCc3c2,Ki,=,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,6309.57
7126,CHEMBL243898,Cc1onc(c1)c2ccc3CCN(CCCSc4nnc(c5ccccn5)n4C)CCc3c2,Ki,>,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,1584.89
7134,CHEMBL244280,Cc1onc(c1)c2ccc3CCN(CCCSc4nnc(c5cccc(F)c5)n4C)CCc3c2,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,1258.93
7135,CHEMBL243899,Cc1onc(c1)c2ccc3CCN(CCCSc4nnc(C)n4C)CCc3c2,Ki,>,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,1258.93
7141,CHEMBL242598,Cc1onc(c1)c2ccc3CCN(CCCSc4nnc(C5CCOCC5)n4C)CCc3c2,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,1258.93
7145,CHEMBL244945,COc1ccc(cn1)c2nnc(SCCCN3CCc4ccc(cc4CC3)c5cc(C)on5)n2C,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,F,1258.93
7147,CHEMBL244946,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CCc5ccc(cc5CC4)c6cc(C)nn6C)n3C,Ki,=,9549.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human recombinant dopamine D2,B,9549.93
7308,CHEMBL399203,Oc1cc(cc2c1NC(=NS2(=O)=O)Nc3ccccc3Oc4ccccc4)[N+](=O)[O-],IC50,>,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,1600.0
7326,CHEMBL238915,Clc1ccc(cc1)N2CCN(CCCCN3C(=O)c4ccccc4S3(=O)=O)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,10000.0
7330,CHEMBL238916,FC(F)(F)c1cccc(c1)N2CCN(CCCCN3C(=O)c4ccccc4S3(=O)=O)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,10000.0
7338,CHEMBL238717,O=C1N(CCCCN2CCN(CC2)c3ccccc3)C=Nc4ccccc14,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,10000.0
7342,CHEMBL238718,Clc1ccc(cc1)N2CCN(CCCCN3C=Nc4ccccc4C3=O)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,10000.0
7346,CHEMBL398813,FC(F)(F)c1cccc(c1)N2CCN(CCCCN3C=Nc4ccccc4C3=O)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,10000.0
7356,CHEMBL239917,Clc1ccc(cc1)N2CCN(CCCCN3C(=O)Cc4ccccc34)CC2,Ki,=,1747.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,B,1747.0
7374,CHEMBL240995,Clc1ccc(cc1)N2CCN(CCCCN3Cc4ccccc4C3=O)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,F,10000.0
7389,CHEMBL241210,Clc1cccc(N2CCN(CCNC(=O)c3ccc(cc3)C#Cc4ccccc4)CC2)c1Cl,Ki,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,4700.0
7390,CHEMBL241210,Clc1cccc(N2CCN(CCNC(=O)c3ccc(cc3)C#Cc4ccccc4)CC2)c1Cl,Ki,=,9900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,9900.0
7397,CHEMBL241211,Clc1cccc(N2CCN(CCNC(=O)c3cccc(c3)C#Cc4ccccc4)CC2)c1Cl,Ki,=,1200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,1200.0
7398,CHEMBL241211,Clc1cccc(N2CCN(CCNC(=O)c3cccc(c3)C#Cc4ccccc4)CC2)c1Cl,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,B,1400.0
7405,CHEMBL241424,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)C#Cc4ccccc4)CC2,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,1400.0
7413,CHEMBL391257,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc(c3)C#Cc4ccccc4)CC2,Ki,=,1200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,B,1200.0
7461,CHEMBL240379,O=C1N(CCCCN2CCCN(CC2)C(c3ccccc3)c4ccccc4)C(=O)c5ccccc15,Ki,=,1180.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,1180.0
7482,CHEMBL238859,O=C(NCCCCN1CCN2C(C1)c3ccccc3Cc4ccccc24)c5ccc6ccccc6c5,Ki,=,1324.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,1324.0
7484,CHEMBL393774,O=C(NCCCCN1CCN2C(C1)c3ccccc3Cc4ccccc24)c5cc6ccccc6s5,Ki,=,4925.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,4925.0
7487,CHEMBL393775,O=C1Cc2ccccc2C(=C3CCN(CCCCN4C(=O)c5ccccc5C4=O)CC3)c6ccsc16,Ki,=,1149.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,1149.0
7493,CHEMBL392579,O=C(NCCCCN1CCC(CC1)N(Cc2ccccc2)c3ccccc3)c4cc5ccccc5s4,Ki,=,1570.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,1570.0
7494,CHEMBL238875,COc1ccccc1N(C2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)C(=O)C,Ki,=,13350.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,13350.0
7496,CHEMBL241018,COc1ccccc1N(C2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)C(=O)c5ccccc5,Ki,=,4620.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,4620.0
7497,CHEMBL392791,COc1ccccc1NC2CCN(CCCCN3C(=O)c4ccccc4C3=O)CC2,Ki,=,2288.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,2288.0
7500,CHEMBL240589,O=C(NCCCCN1CCc2ccccc2C1)\C=C\c3ccccc3,Ki,=,1272.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,B,1272.0
7504,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,31000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells; Low binding affinity,B,31000.0
7506,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells; Low binding affinity,B,4000.0
7509,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,2570.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,2570.0
7515,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,B,3100.0
7517,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,B,3000.0
7519,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity (low) towards human dopamine receptor 2 (long) against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",B,3100.0
7520,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity (low) towards human dopamine receptor 2 short against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",B,3000.0
7539,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,1185.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,B,1185.0
7553,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,2300.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2S receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1150.0
7554,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,2700.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1350.0
7555,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,EC50,=,2800.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1400.0
7562,CHEMBL240773,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@@H]12,Ki,=,2950.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,2950.0
7630,CHEMBL392823,Oc1ccc(cc1)C2(O)CCN(Cc3c[nH]c4ccccc34)CC2,Ki,=,5360.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,5360.0
7640,CHEMBL245815,OC1(Cc2ccc(Cl)cc2)CCN(Cc3c[nH]c4ccccc34)CC1,Ki,=,2890.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,2890.0
7642,CHEMBL245816,OC1(CCCN(Cc2c[nH]c3ccccc23)C1)c4ccc(Cl)cc4,Ki,=,4265.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,4265.0
7658,CHEMBL246232,NCC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,10000.0
7660,CHEMBL399601,CC(=O)NCC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,2000.0
7662,CHEMBL246437,OCC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4,Ki,=,2370.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,2370.0
7684,CHEMBL246856,OC1(CCN(Cc2cc3ccccc3[nH]2)CC1)c4ccc(Cl)cc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,10000.0
7693,CHEMBL393539,Cc1ccc2c(OCCN3CCC(Cc4ccc5OCC(=O)Nc5c4F)CC3)cc(F)cc2n1,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,B,1258.93
7694,CHEMBL238519,Cc1ccc2c(OCCN3CCC(Cc4ccc5OCC(=O)Nc5c4F)CC3)cc(Cl)cc2n1,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,B,1258.93
7695,CHEMBL238520,Cc1ccc2c(OCCN3CCC(Cc4cc5NC(=O)COc5cc4F)CC3)cc(F)cc2n1,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,B,1995.26
7696,CHEMBL391661,Cc1ccc2c(OCCN3CCC(Cc4cc5NC(=O)COc5cc4F)CC3)cc(Cl)cc2n1,Ki,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,B,3162.28
7697,CHEMBL238730,Cc1ccc2c(OCCN3CCC(Cc4cc(F)c5OCC(=O)Nc5c4)CC3)cc(F)cc2n1,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,B,10000.0
7698,CHEMBL238732,Cc1ccc2c(OCCN3CCC(Cc4cc(F)c5OCC(=O)Nc5c4)CC3)cc(Cl)cc2n1,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,B,2511.89
7706,CHEMBL240665,Fc1ccccc1\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3F,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7707,CHEMBL240863,Fc1cccc(\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3F)c1,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7708,CHEMBL240864,Fc1ccccc1S(=O)(=O)c2ccc(\C=C\c3ccncc3)nc2,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7710,CHEMBL397112,Fc1ccc(\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3F)c(Cl)c1,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7711,CHEMBL240680,Cc1cc(F)ccc1\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3F,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7712,CHEMBL395458,Fc1ccc(\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3F)c(c1)C#N,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7713,CHEMBL240876,Oc1cc(F)ccc1\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3F,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7714,CHEMBL240877,Oc1ccccc1\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3F,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7715,CHEMBL240878,COc1cc(F)ccc1\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3F,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7716,CHEMBL395459,[O-][S+](c1ccc(\C=C\c2ccc(F)cc2)nc1)c3ccccc3F,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7717,CHEMBL238760,[O-][S+](c1ccc(\C=C\c2ccc(F)cc2F)nc1)c3ccccc3F,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7718,CHEMBL240886,[O-][S+](c1ccccc1)c2ccc(\C=C\c3ccc(F)cc3)nc2,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7719,CHEMBL240887,[O-][S+](c1ccccc1)c2ccc(\C=C\c3ccc(F)cc3F)nc2,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7720,CHEMBL240887,[O-][S+](c1ccccc1)c2ccc(\C=C\c3ccc(F)cc3F)nc2,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7721,CHEMBL240887,[O-][S+](c1ccccc1)c2ccc(\C=C\c3ccc(F)cc3F)nc2,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
7722,CHEMBL240888,COc1cccc(c1)C2=NCCc3c2[nH]c4ccccc34,Ki,=,31000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,31000.0
7723,CHEMBL392401,Oc1cccc(c1)C2NCCc3c2[nH]c4ccccc34,Ki,=,88000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,88000.0
7724,CHEMBL241082,COc1cccc(c1)C2=NCCc3c2[nH]c4ccc(OC)cc34,Ki,=,25000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,25000.0
7725,CHEMBL241083,C1Cc2c([nH]c3ccccc23)C(N1)c4ccccc4,Ki,>,300000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,300000.0
7727,CHEMBL241099,COc1ccc2[nH]c3C(=NCCc3c2c1)c4cc(cn4C)[N+](=O)[O-],Ki,=,200000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,200000.0
7728,CHEMBL393275,COc1cccc(CC2NCCc3c2[nH]c4ccc(OC)cc34)c1,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,1500.0
7729,CHEMBL391190,COc1ccc2[nH]c3C(Cc4ccc5OCOc5c4)NCCc3c2c1,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,1900.0
7734,CHEMBL241281,CC(=O)OC1CCCc2ccc(cc12)\N=C\N3CCc4ccccc4C3,Ki,=,2400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,2400.0
7735,CHEMBL240021,COc1cc2CCN(Cc2cc1OC)\C=N\c3ccc4CCN(C(=O)OC(C)(C)C)c4c3,Ki,=,54000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,54000.0
7736,CHEMBL240022,COc1cc2CCN(Cc2cc1OC)\C=N\c3ccc4CCCC(OC(=O)C)c4c3,Ki,=,11000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,11000.0
7737,CHEMBL392970,COc1cc2CCN(Cc2cc1OC)\C=N\c3ccc4CCCCC(OC(=O)C)c4c3,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,14000.0
7738,CHEMBL240023,CCCOC1CCCc2ccc(cc12)\N=C\N3CCc4cc(OC)c(OC)cc4C3,Ki,=,42000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,42000.0
7739,CHEMBL241101,COC(=O)N1CCc2ccc(cc12)\N=C\N3CCc4cc(OC)c(OC)cc4C3,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,14000.0
7740,CHEMBL391192,COc1cc2CCN(Cc2cc1OC)\C=N\c3ccc4CCC(O)c4c3,Ki,>,300000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,300000.0
7741,CHEMBL442093,OC1CCc2ccc(cc12)\N=C\N3CCc4ccccc4C3,Ki,>,300000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,300000.0
7742,CHEMBL241102,COc1cc2CCN(Cc2cc1OC)\C=N\c3ccc4CCC(OC(=O)C)c4c3,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,12000.0
7743,CHEMBL241103,CC(=O)OC1CCc2ccc(cc12)\N=C\N3CCc4ccccc4C3,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,1700.0
7744,CHEMBL241282,COc1cc2CCN(Cc2cc1OC)\C=N\c3ccc4CCC5SCCSC5c4c3,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,100000.0
7745,CHEMBL241283,CCCCSC1=CCc2ccc(cc12)\N=C\N3CCc4cc(OC)c(OC)cc4C3,Ki,=,8200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,8200.0
7746,CHEMBL429644,CCCCSC1CCc2ccc(cc12)\N=C\N3CCc4cc(OC)c(OC)cc4C3,Ki,=,3100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,3100.0
7747,CHEMBL392887,COc1cc2CCN(Cc2cc1OC)\C=N\c3ccc4CCCCC(O)c4c3,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,1700.0
7748,CHEMBL240024,COc1cc2CCN(Cc2cc1OC)\C=N\c3ccc4CC5SCCSC5c4c3,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,100000.0
7749,CHEMBL240025,CN(Cc1ccccc1)\C=N\c2ccc3CCC(OC(=O)C)c3c2,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,1600.0
7750,CHEMBL392888,CN(Cc1ccccc1)\C=N\c2ccc3CCC(O)c3c2,Ki,=,59000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,59000.0
7766,CHEMBL437007,Cn1ncc2C(=O)CC(CN3CCC(CC3)C(=O)c4ccc(F)cc4)Cc12,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone human cloned dopamine D2 receptor,B,10000.0
7768,CHEMBL246488,Cn1ncc2C(=O)CC(CN3CCC(CC3)c4noc5cc(F)ccc45)Cc12,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone human cloned dopamine D2 receptor,B,10000.0
7770,CHEMBL391984,Cc1noc2CC(CN3CCC(CC3)C(=O)c4ccc(F)cc4)CC(=O)c12,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone human cloned dopamine D2 receptor,B,10000.0
7771,CHEMBL391984,Cc1noc2CC(CN3CCC(CC3)C(=O)c4ccc(F)cc4)CC(=O)c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,B,10000.0
7774,CHEMBL401328,Oc1cccc(c1)C2CNCCO2,EC50,=,7200.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,3600.0
7775,CHEMBL251215,CCN1CCOC(C1)c2cccc(O)c2,EC50,>,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,15000.0
7776,CHEMBL398480,Oc1cccc(c1)C2CN(CC=C)CCO2,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,50000.0
7777,CHEMBL251216,CC(=O)NCCCCN1CCOC(C1)c2cccc(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7778,CHEMBL398694,COCCN1CCOC(C1)c2cccc(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7779,CHEMBL250632,CCCN1CCOC(C1)c2ccccc2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7781,CHEMBL400766,CCCN1CCOC(C1)c2cccc(SC)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7782,CHEMBL250634,CCCN1CCOC(C1)c2cccc(c2)S(=O)(=O)C,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7784,CHEMBL250636,CCCN1CCOC(C1)c2cccc(c2)C(=O)O,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7791,CHEMBL400988,CCCN1CCOC(C1)c2cccc(c2)c3ncc[nH]3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7792,CHEMBL250002,CCCN1CCO[C@@H](C1)c2ccc(F)c(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7793,CHEMBL401125,CCCN1CCO[C@H](C1)c2ccc(F)c(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7794,CHEMBL250003,CCCN1CCO[C@@H](C1)c2cc(O)cc(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7795,CHEMBL401126,CCCN1CCO[C@H](C1)c2cc(O)cc(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7796,CHEMBL250403,CCCN1CCO[C@@H](C1)c2cccc(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7797,CHEMBL248595,CCCN1CCO[C@H](C1)c2cccc(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation,F,5000.0
7850,CHEMBL250699,COc1cc(NC(=O)c2oc(cc2)c3ccc(Cl)cc3)cc(OC)c1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor,B,5000.0
7870,CHEMBL254298,CC1(C(=O)Nc2cc(Cl)cc(Cl)c2C1=O)c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,10000.0
7871,CHEMBL404352,CC1(C(=O)Nc2cc(Cl)cc(Cl)c2C1=O)c3cccc(O)c3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,10000.0
7872,CHEMBL253708,CC1(C(=O)Nc2cc(Cl)cc(Cl)c2C1=O)c3ccc(O)cc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,10000.0
7873,CHEMBL253096,CC1(C(=O)Nc2cc(Cl)cc(Cl)c2C1=O)c3cccc(OCc4ccccc4)c3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,10000.0
7903,CHEMBL403550,CCCCC(=O)Oc1cccc2C[C@H]3N(CCC)CCc4cccc(c34)c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
7904,CHEMBL253318,CN1CCc2ccc3NC(=O)c4cccc5C[C@@H]1c2c3c45,Ki,=,6110.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,B,6110.0
7929,CHEMBL259776,COc1ccccc1N2CCN(CCCC(=O)NCC3=Nc4ccc(F)cc4C(=O)N3c5ccccc5)CC2,IC50,=,5300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,2650.0
7931,CHEMBL261434,Cc1cccc(N2CCN(CCCC(=O)NCC3=Nc4ccc(F)cc4C(=O)N3c5ccccc5)CC2)c1C,IC50,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,2000.0
7933,CHEMBL261019,Fc1ccc2C(=O)N(C(=Nc2c1)CNC(=O)CCCN3CCN(CC3)c4cccc(c4)C(F)(F)F)c5ccccc5,IC50,=,6600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,3300.0
7934,CHEMBL259415,Cc1cccc(N2CCN(CCCC(=O)NCC3=Nc4ccccc4C(=O)N3c5ccccc5)CC2)c1C,IC50,=,6900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,3450.0
7946,CHEMBL271844,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CCc5cc6ocnc6cc5CC4)n3C,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,2511.89
7954,CHEMBL255618,CC(CCSc1nnc(c2cccc3nc(C)ccc23)n1C)N4CCc5cc6nc(oc6c(Br)c5CC4)C(F)(F)F,Ki,>,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1584.89
7958,CHEMBL255621,Cc1ncoc1c2nnc(SCCCN3CCc4cc5ocnc5cc4CC3)n2C,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,2511.89
7959,CHEMBL255827,Cc1oc2cc3CCN(CCCSc4nnc(c5ocnc5C)n4C)CCc3cc2n1,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,2511.89
7961,CHEMBL273165,CC(CCSc1nnc(c2cccc3nc(C)ccc23)n1C)N4CCc5cc6nc(C)oc6c(Br)c5CC4,Ki,>,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1584.89
7964,CHEMBL269959,Cc1oc2cc3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3cc2n1,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,2511.89
7965,CHEMBL269959,Cc1oc2cc3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3cc2n1,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,2511.89
7966,CHEMBL269959,Cc1oc2cc3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3cc2n1,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,2511.89
7973,CHEMBL256475,Cc1ncoc1c2nnc(SCCCN3CCc4cc5onc(C)c5cc4CC3)n2C,Ki,>,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1258.93
7980,CHEMBL408169,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CCc5cc6NCCOc6cc5CC4)n3C,Ki,>,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1258.93
7983,CHEMBL257900,Cc1ccc2c(cccc2n1)c3nnc(SCCN4CCc5cc6nc(oc6c(C)c5CC4)C(F)(F)F)n3C,Ki,>,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1584.89
7987,CHEMBL272702,CC(=O)N1CCOc2cc3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3cc12,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,2511.89
7991,CHEMBL272379,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CCc5cc6OCCN(c6cc5CC4)S(=O)(=O)C)n3C,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,2511.89
7998,CHEMBL256652,CN1C(=O)COc2cc3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3cc12,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,2511.89
8000,CHEMBL257536,Cc1ncoc1c2nnc(SCCCN3CCc4cc5NC(=O)COc5cc4CC3)n2C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,10000.0
8006,CHEMBL271066,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CCc5cc6NC(=O)COc6cc5CC4)n3C,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,2511.89
8019,CHEMBL406678,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CCc5nc6ccccn6c5CC4)n3C,Ki,<,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1258.93
8029,CHEMBL256658,Cc1ccc2nc3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3n2c1,Ki,<,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1258.93
8030,CHEMBL257716,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CCc5nc6ccc(Cl)cn6c5CC4)n3C,Ki,<,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1258.93
8031,CHEMBL257717,Cc1ccn2c3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3nc2c1,Ki,<,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1258.93
8044,CHEMBL272478,CC(C)N1Cc2cc3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3cc2C1=O,Ki,>,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1584.89
8056,CHEMBL256015,CC(C)c1oc2cc3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCc3cc2n1,Ki,>,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1258.93
8060,CHEMBL404363,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CCc5ccc6nc(oc6c5CC4)C(F)(F)F)n3C,Ki,<,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1584.89
8061,CHEMBL256659,Cc1ncoc1c2nnc(SCCCN3CCc4ccc5nc(oc5c4CC3)C(F)(F)F)n2C,Ki,<,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,1584.89
8064,CHEMBL272073,FCCOc1ccc(CN2CCN(CC2)c3ccc(Cl)cc3)cc1,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 long receptor,B,1100.0
8066,CHEMBL404888,COc1cc(CN2CCN(CC2)c3ccc(Cl)cc3)ccc1OCCF,Ki,=,21000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 long receptor,B,21000.0
8088,CHEMBL402143,COc1c(OCCF)cccc1C(O)C2CCN(CCc3ccc(F)cc3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,B,10000.0
8113,CHEMBL270595,C(Cc1ccccn1)N2CCCC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
8118,CHEMBL272602,Oc1ccccc1N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,4500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,B,4500.0
8119,CHEMBL272602,Oc1ccccc1N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,B,4700.0
8120,CHEMBL407818,Oc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,6100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,B,6100.0
8121,CHEMBL407818,Oc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,87000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,B,87000.0
8124,CHEMBL272853,FCCOc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,B,30000.0
8125,CHEMBL272853,FCCOc1ccc(cc1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,50000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,B,50000.0
8126,CHEMBL272873,FCCOc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,66000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,B,66000.0
8127,CHEMBL272873,FCCOc1ccc(cc1)N2CCN(Cc3cnn4ccccc34)CC2,Ki,=,79000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,B,79000.0
8132,CHEMBL405292,Fc1cccc(n1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,B,3400.0
8133,CHEMBL405292,Fc1cccc(n1)N2CCN(Cc3cc4ccccn4n3)CC2,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,B,1700.0
8142,CHEMBL487182,COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,B,5000.0
8144,CHEMBL487182,COc1cc2CCN3Cc4c(C[C@H]3c2cc1OC)ccc(OC)c4OC,Ki,=,1125.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human FLAG-tagged dopamine D2 receptor expressed in HEK293 cells after 1 hr,B,1125.0
8165,CHEMBL1557,Cl.NCCc1ccc(O)c(O)c1,IC50,=,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,50000.0
8168,CHEMBL1557,Cl.NCCc1ccc(O)c(O)c1,Ki,=,11600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,11600.0
8171,CHEMBL1557,Cl.NCCc1ccc(O)c(O)c1,Ki,=,5623.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,B,5623.41
8187,CHEMBL461571,C[C@@H](Oc1cccc(Cn2c(C)c(C(=O)c3ccc(Cl)cc3)c4ccc(OC(F)(F)F)cc24)c1)C(=O)O,IC50,=,3550.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radioligand from dopamine D2S receptor,B,1775.0
8241,CHEMBL480127,Cc1ccc2[nH]cc(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c2c1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,5000.0
8242,CHEMBL480699,COc1ccc2[nH]cc(C(=O)Nc3ccc(Oc4cccnc4C)nc3)c2c1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,5000.0
8243,CHEMBL519103,Cc1ccc2c(c[nH]c2c1)C(=O)Nc3ccc(Oc4cccnc4C)nc3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,5000.0
8244,CHEMBL516452,Clc1ncccc1Oc2ccc(NC(=O)c3c[nH]c4ccccc34)cn2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,5000.0
8245,CHEMBL479952,O=C(Nc1ccc(Oc2cccnc2)nc1)c3c[nH]c4ccccc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,5000.0
8290,CHEMBL493069,COC(=O)c1coc2CC(CN3CCC(CC3)C(=O)c4ccc(F)cc4)CC(=O)c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,10000.0
8291,CHEMBL494701,Fc1ccc(cc1)C(=O)C2CCN(CC3CC(=O)c4cc(oc4C3)c5ccccc5)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,10000.0
8292,CHEMBL494702,CCOC(=O)c1oc2CC(CN3CCC(CC3)C(=O)c4ccc(F)cc4)CC(=O)c2c1C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,10000.0
8296,CHEMBL516944,Fc1ccc(cc1)C(=O)N2CCN(CC3CC(=O)c4ccoc4C3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,B,10000.0
8302,CHEMBL449920,CCCN1CCN(CC1)c2ccc(OC)cc2,Ki,=,6400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,6400.0
8303,CHEMBL449920,CCCN1CCN(CC1)c2ccc(OC)cc2,Ki,=,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,6309.57
8314,CHEMBL508112,S(Sc1nc2ccccc2s1)c3nc4ccccc4s3,IC50,=,5866.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,2933.0
8315,CHEMBL508112,S(Sc1nc2ccccc2s1)c3nc4ccccc4s3,Ki,=,1955.0,nM,Dopamine D2 receptor,Homo sapiens,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,1955.0
8330,CHEMBL493384,COc1ccc(CCN(C)CCN2CCCCC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8331,CHEMBL493369,CN(CCN1CCCC1)CCc2ccc(OC(F)(F)F)cc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8332,CHEMBL498566,CCN(CCN1CCCC1)CCc2ccc(OC(F)(F)F)cc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8333,CHEMBL498564,CN(CCN1CCCCC1)CCc2ccc(OC(F)(F)F)cc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8334,CHEMBL526849,CCN(CCN1CCCCC1)CCc2ccc(OC(F)(F)F)cc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8341,CHEMBL498775,CN(CCN1CCCC1)CCc2cccc(OC(F)(F)F)c2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8342,CHEMBL497340,CCN(CCN1CCCC1)CCc2cccc(OC(F)(F)F)c2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8343,CHEMBL497549,CN(CCN1CCCCC1)CCc2cccc(OC(F)(F)F)c2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8344,CHEMBL497550,CCN(CCN1CCCCC1)CCc2cccc(OC(F)(F)F)c2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity at dopamine D2 receptor,B,10000.0
8351,CHEMBL468176,Fc1ccc(c(Cl)c1)c2noc(n2)C3CCN(CC3)c4cnc5ccc(Cl)cc5c4,IC50,>,50000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,25000.0
8352,CHEMBL468176,Fc1ccc(c(Cl)c1)c2noc(n2)C3CCN(CC3)c4cnc5ccc(Cl)cc5c4,EC50,>,50000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor,F,25000.0
8363,CHEMBL477820,C[C@@H]([C@H]1C[C@]1(C)c2ccccc2)N3CCN(CC3)c4ccc(C)cc4C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,B,10000.0
8364,CHEMBL515187,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OC(=O)CC)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
8367,CHEMBL477821,Clc1ccccc1CN2CCC(CC2)N3CCC(CC3)N4C(=O)Nc5ccccc45,IC50,=,2060.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,1030.0
8372,CHEMBL478671,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OC(=O)CCC)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
8374,CHEMBL515342,CCCCCC(=O)Oc1cccc2C[C@H]3N(CCC)CCc4cccc(c34)c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
8375,CHEMBL516580,CCCCCCC(=O)Oc1cccc2C[C@H]3N(CCC)CCc4cccc(c34)c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
8376,CHEMBL478043,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OC(=O)CNC(=O)OCc5ccccc5)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
8377,CHEMBL455318,CCCN1CCc2cccc3c4cc(OC(=O)CCC(=O)Oc5cccc6C[C@H]7N(CCC)CCc8cccc(c78)c56)ccc4C[C@@H]1c23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
8378,CHEMBL509451,CCCN1CCc2cccc3c4cc(OC(=O)CCCC(=O)Oc5cccc6C[C@H]7N(CCC)CCc8cccc(c78)c56)ccc4C[C@@H]1c23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]ketanserin from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
8382,CHEMBL522460,Cc1ccccc1CN2CCC(CC2)N3CCC(CC3)N4C(=O)Nc5ccccc45,IC50,=,2650.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,1325.0
8384,CHEMBL491209,CCOC(=O)N1CCC(CC1)N2CCC(CC2)N3C(=O)Nc4ccccc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,5000.0
8386,CHEMBL490598,Cc1ccccc1CN2CCC(CC2)N3CCC(CC3)N4C(=O)Nc5c(F)cccc45,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,5000.0
8388,CHEMBL490797,Cc1ccccc1CN2CCC(CC2)N3CCC(CC3)N4C(=O)Nc5ccc(F)cc45,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,5000.0
8389,CHEMBL521914,Fc1cccc2N(C3CCN(CC3)C4CCN(Cc5ccccc5C(F)(F)F)CC4)C(=O)Nc12,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,5000.0
8390,CHEMBL489576,Fc1ccc2N(C3CCN(CC3)C4CCN(Cc5ccccc5C(F)(F)F)CC4)C(=O)Nc2c1,IC50,=,2690.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,1345.0
8391,CHEMBL491818,Fc1ccc2NC(=O)N(C3CCN(CC3)C4CCN(Cc5ccccc5C(F)(F)F)CC4)c2c1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,5000.0
8394,CHEMBL492034,Cc1ccc(N2CCN(C[C@H]3C[C@]3(C)c4ccccc4)CC2)c(C)c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,B,10000.0
8395,CHEMBL523994,C[C@H]([C@H]1C[C@]1(C)c2ccccc2)N3CCN(CC3)c4ccc(C)cc4C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,B,10000.0
8396,CHEMBL521582,Cl.CCCN(CCC)CCc1ccc(OC)c(OCCc2ccccc2)c1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,B,5000.0
8401,CHEMBL458001,ClC1=C(C=NN(Cc2cccc(NC(=O)c3ccc(cc3)c4ccccc4)c2)C1=O)N5CCNCC5,Ki,=,5248.07,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,B,5248.07
8402,CHEMBL458002,Cc1ccc(CN2N=CC(=C(Cl)C2=O)N3CCNCC3)cc1NC(=O)c4ccc(cc4)c5ccccc5,Ki,=,4897.79,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,B,4897.79
8403,CHEMBL458220,Cc1c(CN2N=CC(=C(Cl)C2=O)N3CCNCC3)cccc1NC(=O)c4ccc(cc4)c5ccccc5,Ki,=,5128.61,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,B,5128.61
8433,CHEMBL476642,COc1ccc(cc1)N2CCN(CCCN3CCCc4ccccc4C3=O)CC2,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,100000.0
8442,CHEMBL515472,COc1c(OCCF)cccc1[C@H](O)C2CCN(CCc3ccc(F)cc3)CC2,Ki,=,2686.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,B,2686.0
8443,CHEMBL516088,COc1c(OCCF)cccc1C(=O)C2CCN(CCc3ccc(F)cc3)CC2,Ki,=,3828.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,B,3828.0
8444,CHEMBL476839,COc1c(OCCF)cccc1C(O)C2CCN(CCc3ccc(C)cc3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,B,10000.0
8445,CHEMBL490632,COc1c(OCCF)cccc1C(=O)C2CCN(CCc3ccc(C)cc3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,B,10000.0
8473,CHEMBL484357,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCC(=CC3)C#Cc4ccccc4,Ki,=,5500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,5500.0
8474,CHEMBL484357,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCC(=CC3)C#Cc4ccccc4,Ki,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,4700.0
8483,CHEMBL484203,CCCN(CCCCn1cc(C)nn1)C2CCC(=CC2)C#CC,Ki,=,4100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,4100.0
8484,CHEMBL484203,CCCN(CCCCn1cc(C)nn1)C2CCC(=CC2)C#CC,Ki,=,2100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,2100.0
8485,CHEMBL444128,CCCNCCCCNC(=O)c1ccc(cc1)c2ccccc2,Ki,=,21000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,21000.0
8486,CHEMBL444128,CCCNCCCCNC(=O)c1ccc(cc1)c2ccccc2,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,100000.0
8487,CHEMBL484204,CCCN(CCC)CCCCNC(=O)c1ccc(cc1)c2ccccc2,Ki,=,9700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,9700.0
8488,CHEMBL484204,CCCN(CCC)CCCCNC(=O)c1ccc(cc1)c2ccccc2,Ki,=,8800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,8800.0
8489,CHEMBL485227,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCCCC3,Ki,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,4700.0
8490,CHEMBL485227,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCCCC3,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,6300.0
8492,CHEMBL503958,Br.Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,B,10000.0
8513,CHEMBL515853,COc1cccc(CCc2ccccc2OCCN3CCN(CC3)c4cccc(Cl)c4)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8515,CHEMBL458792,COc1cccc(CCc2ccccc2OCCCN3CCN(CC3)c4cccc(Cl)c4)c1,Ki,=,298000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,298000.0
8516,CHEMBL457889,COc1cccc(CCc2ccccc2OCCCCN3CCN(CC3)c4cccc(Cl)c4)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8518,CHEMBL457890,COc1cccc(CCc2ccccc2OCCCCCN3CCN(CC3)c4cccc(Cl)c4)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8520,CHEMBL457891,COc1cccc(CCc2ccccc2OCCN3CCN(CC3)c4cccc(c4)C(F)(F)F)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8522,CHEMBL457899,COc1cccc(CCc2ccccc2OCCCN3CCN(CC3)c4cccc(c4)C(F)(F)F)c1,Ki,=,1412000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1412000.0
8523,CHEMBL459158,COc1cccc(CCc2ccccc2OCCCCN3CCN(CC3)c4cccc(c4)C(F)(F)F)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8525,CHEMBL514286,COc1cccc(CCc2ccccc2OCCN3CCN(CC3)c4ccccc4OC)c1,Ki,=,427000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,427000.0
8526,CHEMBL456647,COc1cccc(CCc2ccccc2OCCCN3CCN(CC3)c4ccccc4OC)c1,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,6300.0
8527,CHEMBL516334,COc1cccc(CCc2ccccc2OCCCCN3CCN(CC3)c4ccccc4OC)c1,Ki,=,67000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,67000.0
8528,CHEMBL458991,COc1cccc(CCc2ccccc2OCCCCCN3CCN(CC3)c4ccccc4OC)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8530,CHEMBL458992,COc1cccc(CCc2ccccc2OCCN3CCN(CC3)c4ccc(F)cc4)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8532,CHEMBL457921,COc1cccc(CCc2ccccc2OCCCN3CCN(CC3)c4ccc(F)cc4)c1,Ki,=,655000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,655000.0
8533,CHEMBL456673,COc1cccc(CCc2ccccc2OCCCCN3CCN(CC3)c4ccc(F)cc4)c1,Ki,=,1324000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1324000.0
8534,CHEMBL514098,COc1cccc(CCc2ccccc2OCCCCCN3CCN(CC3)c4ccc(F)cc4)c1,Ki,=,847000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,847000.0
8535,CHEMBL456674,COc1cccc(CCc2ccccc2OCCN3CCN(CC3)c4ncccn4)c1,Ki,=,629000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,629000.0
8536,CHEMBL456675,COc1cccc(CCc2ccccc2OCCCN3CCN(CC3)c4ncccn4)c1,Ki,=,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,20000.0
8538,CHEMBL458354,COc1cc(F)cc(c1)N2CCN(CCCCNC(=O)c3ccc4nonc4c3)CC2,Ki,=,1341.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,B,1341.0
8541,CHEMBL487760,COc1cccc(CCc2ccccc2OCCCCN3CCN(CC3)c4ncccn4)c1,Ki,=,854000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,854000.0
8542,CHEMBL487761,COc1cccc(CCc2ccccc2OCCCCCN3CCN(CC3)c4ncccn4)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8544,CHEMBL487960,COc1cccc(CCc2ccccc2OCCN3CCN(C)CC3)c1,Ki,=,178000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,178000.0
8545,CHEMBL518931,COc1cccc(CCc2ccccc2OCCCN3CCN(C)CC3)c1,Ki,=,565000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,565000.0
8546,CHEMBL486534,COc1cccc(CCc2ccccc2OCCCCN3CCN(C)CC3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8548,CHEMBL485719,COc1cccc(CCc2ccccc2OCCCCCN3CCN(C)CC3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8550,CHEMBL521025,COc1cccc(CCc2ccccc2OCCN3CCc4ccccc4C3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8552,CHEMBL485720,COc1cccc(CCc2ccccc2OCCCN3CCc4ccccc4C3)c1,Ki,=,114000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,114000.0
8553,CHEMBL485918,COc1cccc(CCc2ccccc2OCCCCN3CCc4ccccc4C3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8555,CHEMBL519228,COc1cccc(CCc2ccccc2OCCCCCN3CCc4ccccc4C3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8557,CHEMBL486336,COc1cccc(CCc2ccccc2OCCN3CCc4cc(OC)c(OC)cc4C3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8559,CHEMBL486337,COc1cccc(CCc2ccccc2OCCCN3CCc4cc(OC)c(OC)cc4C3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8561,CHEMBL485727,COc1cccc(CCc2ccccc2OCCCCN3CCc4cc(OC)c(OC)cc4C3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8563,CHEMBL519547,COc1cccc(CCc2ccccc2OCCCCCN3CCc4cc(OC)c(OC)cc4C3)c1,Ki,>,1000000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,B,1000000.0
8584,CHEMBL460644,C(N1CCN(CC1)c2ncccn2)c3c[nH]c4ncccc34,Ki,=,1170.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,1170.0
8590,CHEMBL456429,OC1(CC2CCC(C1)N2CC(=O)c3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,1231.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,1231.0
8591,CHEMBL456430,OC1(CC2CCC(C1)N2Cc3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,1050.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,1050.0
8593,CHEMBL458342,Clc1ccc(cc1)N2CCC3CCC(C2)N3Cc4c[nH]c5ncccc45,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,10000.0
8609,CHEMBL484599,CCCN1CCO[C@H]2[C@H]1CCc3ccc(cc23)C(=O)N,Ki,=,1202.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,1202.26
8610,CHEMBL500627,CCCN1CCO[C@@H]2[C@@H]1CCc3ccc(cc23)C(=O)N,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,10000.0
8611,CHEMBL484345,NCCC(=O)Nc1cccc2c1cnn2S(=O)(=O)c3cccc4ccccc34,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2000.0
8614,CHEMBL482977,CCCN1CCO[C@H]2[C@H]1CCc3ccc(cc23)C(=O)O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,10000.0
8615,CHEMBL482978,CCCN1CCO[C@H]2[C@H]1CCc3ccc(cc23)C(=O)C,Ki,=,3090.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,3090.3
8616,CHEMBL485017,CCCN1CCO[C@H]2[C@H]1CCc3ccc(cc23)c4nnn[nH]4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,10000.0
8618,CHEMBL484170,CCCN1CCO[C@H]2[C@H]1CCc3ccc(cc23)C(=O)NC,Ki,=,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,7943.28
8619,CHEMBL485029,CCCN1CCO[C@H]2[C@H]1CCc3ccc(cc23)C(=O)N(C)C,Ki,=,1862.09,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,1862.09
8620,CHEMBL519688,CCCCNC(=O)c1ccc2CC[C@@H]3[C@H](OCCN3CCC)c2c1,Ki,=,4570.88,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,4570.88
8621,CHEMBL485027,CCCN1CCO[C@H]2[C@H]1CCc3ccc(cc23)C(=O)NCc4ccc(OC)cc4,Ki,=,3388.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,3388.44
8622,CHEMBL485028,CCCN1CCO[C@H]2[C@H]1CCc3ccc(cc23)C(=O)Nc4ccc(OC)cc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,10000.0
8623,CHEMBL482562,O=C(Nc1ccc2cnn(c2c1)S(=O)(=O)c3cccc4ccccc34)C5CCNCC5,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2000.0
8624,CHEMBL520129,O=C(Nc1ccc2cnn(c2c1)S(=O)(=O)c3cccc4ccccc34)C5CCCNC5,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2000.0
8626,CHEMBL485128,CCCN1CCO[C@H]2[C@H]1CCc3cc4COC(=O)c4cc23,Ki,=,2041.74,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,2041.74
8627,CHEMBL519201,CCCN1CCO[C@H]2[C@H]1CCc3cc4CN(C)C(=O)c4cc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,10000.0
8628,CHEMBL485325,CCCN1CCO[C@H]2[C@H]1CCc3cc4CCOC(=O)c4cc23,Ki,=,1479.11,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,1479.11
8631,CHEMBL482556,CCCN1CCO[C@H]2[C@H]1CCc3cc4C=CNC(=O)c4cc23,Ki,=,1202.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,B,1202.26
8641,CHEMBL497877,F[C@@H]1CCNC[C@H]1c2c([nH]c3ccccc23)c4ccccc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1700.0
8642,CHEMBL497878,F[C@@H]1CCNC[C@H]1c2c([nH]c3ccc(F)cc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8643,CHEMBL496852,F[C@@H]1CCNC[C@H]1c2c([nH]c3ccc(Cl)cc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8644,CHEMBL504699,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(F)ccc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8645,CHEMBL504699,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(F)ccc23)c4ccccc4,Ki,>,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,B,1500.0
8646,CHEMBL498048,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(Cl)ccc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8647,CHEMBL498729,F[C@@H]1CCNC[C@H]1c2c([nH]c3c(F)cccc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8648,CHEMBL523585,F[C@@H]1CCNC[C@H]1c2c([nH]c3c(Cl)cccc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8649,CHEMBL496687,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(F)ccc23)c4cccc5ccccc45,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1400.0
8651,CHEMBL523760,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(F)ccc23)c4cccnc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8652,CHEMBL497054,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(F)ccc23)c4ccsc4,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8653,CHEMBL507898,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(F)ccc23)C4CCCCC4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8654,CHEMBL507727,COC(=O)c1[nH]c2cc(F)ccc2c1[C@@H]3CNCC[C@H]3F,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8655,CHEMBL497064,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(F)ccc23)C(=O)Nc4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
8661,CHEMBL554897,Cl.COc1ccc(cc1OC)c2cc(CCCCN3CCN(CC3)c4ccccc4F)on2,Ki,=,5148.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,5148.0
8662,CHEMBL544451,Cl.Cc1ccccc1N2CCN(CCCCc3onc(c3)c4cccs4)CC2,Ki,=,2108.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,2108.0
8663,CHEMBL544689,Cl.COc1ccccc1N2CCN(CCCCc3onc(c3)c4ccccc4)CC2,Ki,=,1727.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,1727.0
8664,CHEMBL544925,Cl.COc1ccc(c(OC)c1)c2cc(CCCCN3CCN(CC3)C(c4ccccc4)c5ccccc5)on2,Ki,=,3828.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,3828.0
8665,CHEMBL553810,Cl.[O-][N+](=O)c1cccc(c1)c2cc(CCCCN3CCN(CC3)C(c4ccccc4)c5ccccc5)on2,Ki,=,1522.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,1522.0
8666,CHEMBL542324,Cl.C(CCc1onc(c1)c2cccs2)CN3CCN(CC3)c4ccccc4,Ki,=,4136.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,4136.0
8668,CHEMBL542571,Cl.COc1ccc(cc1OC)c2cc(CCCCN3CCN(CC3)C(c4ccccc4)c5ccccc5)on2,Ki,=,2618.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,2618.0
8669,CHEMBL542573,Cl.COc1ccc(c(OC)c1)c2cc(CCCCN3CCN(CC3)c4ccccc4)on2,Ki,=,2196.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,2196.0
8673,CHEMBL543277,Cl.C(CCc1onc(\C=C\c2ccccc2)c1)CN3CCN(CC3)c4ccccc4,Ki,=,9724.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,9724.0
8678,CHEMBL542139,Cl.COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N4CCNCC4,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Compound was tested for its binding affinity against Dopamine receptor D2 in human cloned receptors in CHO cells using [125 I]iodosulpride,B,2511.89
8679,CHEMBL545222,Cl.O=C1C=C(OC12CCN(CCc3ccccc3)CC2)c4ccccc4,Ki,=,7180.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,7180.0
8680,CHEMBL555614,Cl.C=CCN1CCC2(CC1)OC=C(C2=O)c3ccccc3,Ki,=,4870.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,4870.0
8681,CHEMBL545454,Cl.CN(C)CCC1(OC=C(C1=O)c2ccccc2)c3ccccc3,Ki,=,2690.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,2690.0
8682,CHEMBL556035,Cl.COc1ccc(cc1)C2=COC3(CCN(CCc4ccccc4)CC3)C2=O,Ki,=,2070.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,2070.0
8684,CHEMBL545695,Cl.Fc1ccc(CN2CCC3(CC2)OC=C(C3=O)c4ccc(F)cc4)cc1,Ki,=,1656.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,1656.0
8685,CHEMBL554415,Cl.Fc1ccc(cc1)C2=COC3(CCN(Cc4ccccc4)CC3)C2=O,Ki,=,1420.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,1420.0
8686,CHEMBL542148,Cl.CN(C)CC1(C)OC=C(C1=O)c2ccccc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8687,CHEMBL542395,Cl.Fc1ccc(CN2CCC3(CC2)OC=C(C3=O)c4ccccc4)cc1,Ki,=,2420.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,2420.0
8688,CHEMBL553500,Cl.O=C1C=C(OC12CCN(Cc3ccccc3)CC2)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8690,CHEMBL542877,Cl.O=C1C(=COC12CCN(Cc3ccccc3)C2)c4ccccc4,Ki,=,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,20000.0
8691,CHEMBL553288,Cl.O=C1C(=COC12CCCNC2)c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8692,CHEMBL543109,Cl.O=C1C=C(OC12CN3CCC2CC3)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8693,CHEMBL543111,Cl.O=C1C=C(OC12CCNCC2)c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8694,CHEMBL543343,Cl.O=C1C(=COC12CCN(CCc3ccccc3)CC2)c4ccc5ccccc5c4,Ki,=,3130.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,3130.0
8695,CHEMBL553082,Cl.Cc1cc(CN2CCC3(CC2)OC=C(C3=O)c4ccccc4)on1,Ki,=,32000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,32000.0
8698,CHEMBL543587,Cl.CCN(CC)CCCC1(C)OC=C(C1=O)c2ccccc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8699,CHEMBL552631,Cl.CN1CCC2(CC1)OC=C(C2=O)c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8700,CHEMBL543822,Cl.Fc1ccc(cc1)C2=COC3(CCN(CCc4ccccc4)CC3)CC2=O,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,2900.0
8701,CHEMBL543823,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c4cccs4,Ki,=,1080.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,1080.0
8702,CHEMBL553784,Cl.Fc1ccc(cc1)C2=CC(=O)C3(CCN(CCc4ccccc4)CC3)O2,Ki,=,5320.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,5320.0
8703,CHEMBL544055,Cl.CN1CCC2(CC1)CC(=O)C(=CO2)c3ccc(F)cc3,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,100000.0
8704,CHEMBL552687,Cl.O=C1C(=COC12CCN(Cc3ccccc3)CC2)c4ccccc4,Ki,=,2370.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,2370.0
8705,CHEMBL544761,Cl.O=C1C=C(OC12CCCN(Cc3ccccc3)C2)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8708,CHEMBL545457,Cl.O=C1C=C(OC12CCCNC2)c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8709,CHEMBL545697,Cl.COc1ccc(cc1)C2=COC3(CCN(CCc4ccccc4)CC3)CC2=O,Ki,=,1496.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,1496.0
8710,CHEMBL542399,Cl.CCN(CC)CCCC1(C)CC(=O)C(=CO1)c2ccccc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,10000.0
8711,CHEMBL542400,Cl.Fc1ccccc1C2=COC3(CCN(CCc4ccccc4)CC3)CC2=O,Ki,=,2330.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,2330.0
8712,CHEMBL542646,Cl.CN1C2CCC1CC3(C2)CC(=O)C(=CO3)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,10000.0
8713,CHEMBL542647,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OC(=C1)c4occc4,Ki,=,7600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,7600.0
8714,CHEMBL552858,Cl.CN(C)CC1(C)CC(=O)C(=CO1)c2ccccc2,Ki,=,4100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,4100.0
8715,CHEMBL543591,Cl.COc1ccc(cc1)C2=CC(=O)C3(CCN(CCc4ccccc4)CC3)O2,Ki,=,8400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,8400.0
8717,CHEMBL554009,Br.CN1CCc2c(Br)c(O)c(O)cc2C(C1)c3ccccc3,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,B,4000.0
8718,CHEMBL544532,Cl.O=C1CC2(CN3CCC2CC3)OC=C1c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,10000.0
8719,CHEMBL544533,Cl.O=C1CC2(CCN(Cc3ccccc3)CC2)OC=C1c4ccccc4,Ki,=,1460.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,1460.0
8720,CHEMBL545000,Cl.CN1CCc2cc(O)c(O)cc2C(C1)c3ccccc3,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,B,1900.0
8722,CHEMBL553503,Br.Oc1cc2C(CNCCc2c(Cl)c1O)c3ccccc3,Ki,=,8000.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,B,8000.0
8725,CHEMBL543398,Br.CN1CCc2c(Cl)c(O)c(O)cc2C(C1)c3ccccc3,Ki,=,2700.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,B,2700.0
8727,CHEMBL544114,Br.Oc1cc2C(CN(CC=C)CCc2c(Br)c1O)c3ccccc3,Ki,=,21000.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,B,21000.0
8729,CHEMBL542700,Cl.Oc1cc2CCNCC(c3ccccc3)c2cc1O,Ki,=,8800.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state,B,8800.0
8730,CHEMBL552611,Cl.Oc1cc2CCN(CC=C)CC(c3ccccc3)c2cc1O,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Dopamine receptor D2 agonist activity was determined for inhibition of the constrictor response to electrical stimulation in an isolated perfused rabbit ear artery preparation,F,5000.0
8732,CHEMBL544115,Br.Oc1cc2C(CN(CC=C)CCc2c(Cl)c1O)c3ccccc3,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state,B,1300.0
8733,CHEMBL544118,Cl.CN1CCc2c(Cl)c(O)c(O)c(Cl)c2C(C1)c3ccccc3,Ki,=,810000.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,B,810000.0
8734,CHEMBL544814,Cl.CCCc1cc2[C@@H]3[C@H](CCc4cc(O)c(O)cc34)NCc2s1,Ki,=,4020.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,B,4020.0
8735,CHEMBL544814,Cl.CCCc1cc2[C@@H]3[C@H](CCc4cc(O)c(O)cc34)NCc2s1,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D2,B,5000.0
8737,CHEMBL544123,Cl.[O-][N+](=O)c1ccc(CN2CCC3(CC2)CCc4ccccc4C3=O)cc1,Ki,=,1969.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,1969.0
8738,CHEMBL545285,Cl.Fc1ccc(CN2CCC3(CC2)CCc4ccccc4C3=O)cc1,Ki,=,1137.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,1137.0
8743,CHEMBL542709,Cl.COc1ccc(CN2CCC3(CC2)CCc4ccccc4C3=O)cc1,Ki,=,1417.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,1417.0
8744,CHEMBL542942,Cl.OC1c2ccccc2CCC13CCN(CCc4ccccc4)CC3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,10000.0
8745,CHEMBL554437,Cl.O=C1c2ccccc2CCC13CCN(CC4CCCCC4)CC3,Ki,=,1168.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,1168.0
8746,CHEMBL543176,Br.O=C1C(CCc2ccccc12)C3CCN(CC4CC4)CC3,Ki,=,1079.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,1079.0
8747,CHEMBL554873,Cl.O=C1c2ccccc2CCC13CCN(CCc4ccccc4)CC3,Ki,=,2189.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,2189.0
8748,CHEMBL543412,Br.Fc1ccc(cc1)C(=O)CC2CCN(CC3CC3)CC2,Ki,=,1630.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,1630.0
8749,CHEMBL554874,Cl.O=C1c2ccccc2CCC13CCN(Cc4ccccc4)CC3,Ki,=,3506.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,3506.0
8754,CHEMBL542946,Cl.CN1CCC2(CC1)CCc3ccccc3C2=O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,B,10000.0
8761,CHEMBL543472,Cl.Oc1ccc2CCNCC(c3ccccc3)c2c1,Ki,=,4408.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2,B,4408.0
8768,CHEMBL557799,Br.Oc1cc2C(CNCCc2cc1Br)c3ccccc3,Ki,=,5760.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2,B,5760.0
8769,CHEMBL556361,Cl.OC1(CC2CCC(C1)N2CC(=O)c3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,1231.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,1231.0
8771,CHEMBL537183,Cl.OC1(CC2CCC(C1)N2Cc3ccc(F)cc3)c4ccc(Cl)cc4,Ki,=,1050.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine D2 receptor,B,1050.0
8777,CHEMBL538977,Cl.[O-][N+](=O)c1cccc(c1)c2cc(CCCCN3CCN(CC3)c4ccccc4)on2,Ki,=,1470.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,1470.0
8779,CHEMBL539999,Cl.Fc1ccc(cc1)c2cc(CCCCN3CCN(CC3)C(c4ccccc4)c5ccccc5)on2,Ki,=,1461.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,1461.0
8785,CHEMBL538474,Cl.C(CCc1onc(c1)c2ccccc2)CN3CCN(CC3)c4ccccc4,Ki,=,3366.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,3366.0
8787,CHEMBL539235,Cl.Fc1ccc(cc1)c2cc(CCCCN3CCN(CC3)c4ccccc4)on2,Ki,=,2530.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,2530.0
8788,CHEMBL557409,Cl.COc1ccc(cc1OC)c2cc(CCCCN3CCN(CC3)c4ccccc4)on2,Ki,=,3388.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,3388.0
8789,CHEMBL541791,Cl.COc1ccc(cc1OC)c2cc(CCCCN3CCN(CC3)c4ccccc4C)on2,Ki,=,1401.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,1401.0
8790,CHEMBL538248,Cl.Clc1cccc(CN2CCC3(CC2)OC=C(C3=O)c4ccccc4)c1,Ki,=,2110.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,2110.0
8791,CHEMBL556133,Cl.CN1CCC2(CC1)OC(=CC2=O)c3ccccc3,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,2900.0
8792,CHEMBL539518,Cl.CN1CCC2(CC1)CC(=O)C(=CO2)c3ccccc3,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,100000.0
8793,CHEMBL553666,Cl.O=C1C(=COC12CCN(CC#C)CC2)c3ccccc3,Ki,=,24000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,24000.0
8794,CHEMBL540028,Cl.O=C1C(=COC12CCCN(Cc3ccccc3)C2)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8795,CHEMBL558226,Cl.COc1cc(N)c(Cl)cc1C(=O)NC2C3CC4CN(C3)CC24,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Compound was tested for inhibitory activity against Dopamine D2 receptor,B,5000.0
8796,CHEMBL540285,Cl.CCN(CC)CCC1(C)OC(=CC1=O)c2ccccc2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8797,CHEMBL540538,Cl.CCN(CC)CCC1(C)OC=C(C1=O)c2ccccc2,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8798,CHEMBL559021,Cl.O=C1C(=COC12CCN(Cc3occc3)CC2)c4ccccc4,Ki,=,7630.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,7630.0
8800,CHEMBL541817,Cl.O=C1C(=COC12CCNCC2)c3ccccc3,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8801,CHEMBL553864,Cl.Fc1ccc(cc1)C2=COC3(CCCN(Cc4ccccc4)C3)CC2=O,Ki,=,8780.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,8780.0
8802,CHEMBL538755,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c4ccccc4,Ki,=,2030.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,2030.0
8803,CHEMBL539007,Cl.Fc1ccc(cc1)C2COC3(CCN(CCc4ccccc4)CC3)CC2=O,Ki,=,1530.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,1530.0
8805,CHEMBL540033,Cl.CN(C)CCC1(OC=CC1=O)c2ccccc2,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8806,CHEMBL541055,Cl.CN1C2CCC1CC3(C2)OC=C(C3=O)c4ccccc4,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,10000.0
8809,CHEMBL541559,Br.Oc1cc2C(CNCCc2c(Br)c1O)c3ccccc3,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state.,B,2000.0
8810,CHEMBL539526,Cl.O=C1CC2(CCN(CCc3ccccc3)CC2)OC(=C1)c4ccccc4,Ki,=,4200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,4200.0
8812,CHEMBL540039,Cl.C([C@H]1CN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,B,14000.0
8813,CHEMBL540039,Cl.C([C@H]1CN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,B,10000.0
8814,CHEMBL540039,Cl.C([C@H]1CN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human Dopamine receptor D2L expressed in CHO cells,B,10000.0
8815,CHEMBL540039,Cl.C([C@H]1CN=C(N1)c2ccccc2)N3CCN(CC3)c4ccccc4,Ki,=,11000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,B,11000.0
8818,CHEMBL538785,Cl.Cc1c(O)c(O)cc2C(CN(CC=C)CCc12)c3ccc(O)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Dopamine receptor D2 agonist activity was determined for inhibition of the constrictor response to electrical stimulation in an isolated perfused rabbit ear artery preparation,F,5000.0
8830,CHEMBL540857,Br.Oc1cc2C(CNCCc2cc1Cl)c3ccccc3,Ki,=,1374.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2 from pig anterior pituitary tissue,B,1374.0
8837,CHEMBL558036,Cl.Cc1ccccc1N2CCN(CCCCc3onc(c3)c4ccccc4)CC2,Ki,=,6512.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,B,6512.0
8838,CHEMBL555900,Cl.CN1CCC2(CC1)OC=C(C2=O)c3ccc(F)cc3,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,B,2600.0
8843,CHEMBL560650,Clc1ccc(CN2CCN(CCN3Cc4ccccc4C3)C2=O)cc1Cl,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
8844,CHEMBL553238,Clc1ccc(CN2CCN(CCN3Cc4ccccc4C3)C2=O)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
8847,CHEMBL561262,COc1ccccc1N2CCN(Cc3c(C)nc4cc(C)ncn34)CC2,Ki,=,40000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,40000.0
8848,CHEMBL561262,COc1ccccc1N2CCN(Cc3c(C)nc4cc(C)ncn34)CC2,Ki,=,53000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,53000.0
8851,CHEMBL559868,Clc1nccc2c(CN3CCN(CC3)c4ccccc4)c[nH]c12,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,2600.0
8852,CHEMBL559868,Clc1nccc2c(CN3CCN(CC3)c4ccccc4)c[nH]c12,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,2900.0
8872,CHEMBL564477,Cc1ccc(cn1)N2CCN(CCN3Cc4ccccc4C3)C2=O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
8883,CHEMBL561123,CN1C(=O)c2[nH]cc(CN3CCN(CC3)c4ccccc4)c2N=C1N5CCOCC5,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,1100.0
8891,CHEMBL564347,CN(CCN1CCN(C1=O)c2ccc3OCOc3c2)C[C@@]45CC[C@@H](CC4)C5(C)C,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,F,1584.89
8905,CHEMBL559780,Cc1nc2cc(ccc2s1)N3CCN(CCN4Cc5ccccc5C4)C3=O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
8915,CHEMBL562384,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccccn4)n2c(C)n1,Ki,=,17000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,17000.0
8916,CHEMBL562384,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccccn4)n2c(C)n1,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,10000.0
8934,CHEMBL550392,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccccc4)n2c(C)n1,Ki,=,8600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,8600.0
8935,CHEMBL550392,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccccc4)n2c(C)n1,Ki,=,11000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,11000.0
8946,CHEMBL550849,Fc1c(Cl)cccc1N2CCN(CCN3CCC(CC3)C(F)(F)F)C2=O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
8955,CHEMBL549638,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccc(F)cc4)n2c(C)n1,Ki,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,4700.0
8956,CHEMBL549638,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccc(F)cc4)n2c(C)n1,Ki,=,3500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,3500.0
8976,CHEMBL550920,COc1ccc(cc1)N2CCN(Cc3c(C)nc4cc(C)ncn34)CC2,Ki,=,9100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,9100.0
8977,CHEMBL550920,COc1ccc(cc1)N2CCN(Cc3c(C)nc4cc(C)ncn34)CC2,Ki,=,13000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,13000.0
8981,CHEMBL554692,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccc(Cl)cc4)n2c(C)n1,Ki,=,26000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,26000.0
8982,CHEMBL554692,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccc(Cl)cc4)n2c(C)n1,Ki,=,57000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,57000.0
8991,CHEMBL551964,Cc1ccc2c3O[C@@H](CN4CCN(CC4)c5ccc6cc(ccc6n5)C#N)COc3ccc2n1,Ki,=,1306.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,1306.0
8992,CHEMBL549759,CC(=O)n1ccc2cc(ccc12)N3CCN(CCN4Cc5ccccc5C4)C3=O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
8993,CHEMBL554914,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
8996,CHEMBL564741,CC(N1CCN(CCN2Cc3ccccc3C2)C1=O)c4cccc(c4)C(F)(F)F,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
9002,CHEMBL570998,CC(C)N1CCN(CCN2CCN(C2=O)c3cccc(Cl)c3F)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
9003,CHEMBL550358,COc1cccc(c1)N2CCN(CCN3CCN(CC3)C(C)C)C2=O,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,2511.89
9006,CHEMBL558838,COc1ccccc1N2CCN(Cc3c(C)[nH]c4nc(ncc34)N(C)C)CC2,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,2900.0
9007,CHEMBL558838,COc1ccccc1N2CCN(Cc3c(C)[nH]c4nc(ncc34)N(C)C)CC2,Ki,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,2600.0
9009,CHEMBL563614,COc1ccccc1N2CCN(Cc3c(C)nc4cc(C)nc(C)n34)CC2,Ki,=,2300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,2300.0
9010,CHEMBL563614,COc1ccccc1N2CCN(Cc3c(C)nc4cc(C)nc(C)n34)CC2,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,2900.0
9014,CHEMBL563109,COc1ccccc1N2CCN(Cc3cnc4cc(C)nc(C)n34)CC2,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,1300.0
9029,CHEMBL563247,O=C1N(CCN2Cc3ccccc3C2)CCN1c4csc5ccccc45,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,1258.93
9030,CHEMBL556895,O=C1N(CCN2Cc3ccccc3C2)CCN1c4cscc4c5ccccn5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
9032,CHEMBL564108,CC(C)N1CCN(CCN2CCN(C2=O)c3ccc(F)c(c3)C#N)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,F,10000.0
9035,CHEMBL563078,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccc(Cl)c(Cl)c4)n2c(C)n1,Ki,=,3300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,B,3300.0
9036,CHEMBL563078,Cc1cc2nc(C)c(CN3CCN(CC3)c4ccc(Cl)c(Cl)c4)n2c(C)n1,Ki,=,5500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,B,5500.0
9080,CHEMBL574030,COc1ccc(cc1)n2cc(nn2)C(=O)NCCCCN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,B,1700.0
9101,CHEMBL574569,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc(c3)c4cn(Cc5ccc(cc5)c6ccc(Cn7cc(nn7)c8cccc(c8)C(=O)NCCCCN9CCN(CC9)c%10ccccc%10OC)cc6)nn4)CC2,Ki,=,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2long receptor expressed in CHO cells,B,15000.0
9102,CHEMBL574569,COc1ccccc1N2CCN(CCCCNC(=O)c3cccc(c3)c4cn(Cc5ccc(cc5)c6ccc(Cn7cc(nn7)c8cccc(c8)C(=O)NCCCCN9CCN(CC9)c%10ccccc%10OC)cc6)nn4)CC2,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2short receptor expressed in CHO cells,B,10000.0
9103,CHEMBL574534,COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4cn(Cc5ccc(cc5)c6ccc(Cn7cc(nn7)c8ccc(cc8)C(=O)NCCCCN9CCN(CC9)c%10ccccc%10OC)cc6)nn4)CC2,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2long receptor expressed in CHO cells,B,2000.0
9116,CHEMBL565552,CN(C)CCn1cc(c2cccnc12)S(=O)(=O)c3cccc4ccccc34,IC50,<,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,2500.0
9117,CHEMBL584046,CN(C)CCn1cc(c2cccnc12)S(=O)(=O)c3cccc(Cl)c3,IC50,<,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,2500.0
9118,CHEMBL565745,NCCn1cc(c2cccnc12)S(=O)(=O)c3cccc(Cl)c3,IC50,<,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,2500.0
9119,CHEMBL576315,NCCn1cc(c2cccnc12)S(=O)(=O)c3ccccc3,IC50,<,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,2500.0
9120,CHEMBL571858,CN(C)CCn1cc(c2cccnc12)S(=O)(=O)c3cccc(F)c3,IC50,<,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in CHO-K1 cells,B,2500.0
9145,CHEMBL569270,CNc1cc(ncn1)c2csc(n2)N(C)C(=O)c3ccc(F)cc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor by PDSP assay,B,10000.0
9181,CHEMBL572270,CC1=NC2C=C3CCN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)CCC3=CC2O1,Ki,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,2511.89
9184,CHEMBL567919,CN(CCN1CCN(C2COOC2)C1=O)C[C@@]34CC[C@@H](CC3)C4(C)C,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,B,1584.89
9208,CHEMBL596271,Cn1c(CN2CCN(CC2)c3ccc(Cl)cc3)nc4ccccc14,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,10000.0
9209,CHEMBL605836,Cn1c(CN2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F)nc4ccccc14,Ki,=,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,5011.87
9210,CHEMBL595759,Cn1c(CN2CCN(CC2)c3ncc(Cl)cn3)nc4ccccc14,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,10000.0
9211,CHEMBL595608,Cn1c(CN2CCN(CC2)c3ccc(cc3)C(F)(F)F)nc4ccccc14,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,10000.0
9212,CHEMBL595609,Cn1c(CN2CCN(CC2)c3nc4ccccc4s3)nc5ccccc15,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,10000.0
9213,CHEMBL595151,Cn1c(CN2CCN(CC2)c3ccc(cn3)C(F)(F)F)nc4ccccc14,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,10000.0
9217,CHEMBL604467,Cn1c(CN2CCC(CC2)c3ccccc3C(F)(F)F)nc4ccccc14,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,F,3162.28
9224,CHEMBL595449,CN(C)Cc1nc(c2ccc(cc2)C(C)(C)C)n(n1)c3cccc(O)c3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,5000.0
9225,CHEMBL610449,CN1CCCc2cc3OCOc3cc2c4ccccc4CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9228,CHEMBL610449,CN1CCCc2cc3OCOc3cc2c4ccccc4CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9231,CHEMBL594798,CN1CCc2cc(O)ccc2C1Cc3ccccc3C,Ki,=,2724.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,2724.0
9234,CHEMBL594799,CCc1cc(OC)ccc1C2Cc3ccccc3CN2C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9240,CHEMBL594127,COc1ccc2C(Cc3ccccc3C)N(C)CCc2c1,Ki,=,7371.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,7371.0
9243,CHEMBL593394,COc1ccc2CCc3ccccc3CN(C)CCc2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9246,CHEMBL593395,COc1ccc2C3N(CCc4ccccc34)CCc2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9249,CHEMBL593626,Oc1ccc2C3N(CCc4ccccc34)CCc2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9257,CHEMBL595720,CN1CCc2cc(O)ccc2CCc3ccccc3C1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9261,CHEMBL594557,COc1ccc2C3N(CCCc2c1)Cc4ccccc34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9264,CHEMBL594789,COc1ccc2Cc3ccccc3CN(C)CCCc2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9268,CHEMBL596179,CN1CCCc2cc(O)ccc2Cc3ccccc3C1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,B,10000.0
9275,CHEMBL592618,CCCN1CCC(CC1)c2cccc(O)c2,Ki,=,2570.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,2570.0
9279,CHEMBL597413,CS(=O)(=O)c1cccc(c1)N2CCN(Cc3ccccc3)CC2,Ki,=,1923.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,1923.0
9287,CHEMBL596801,CCCN1CCN(CC1)c2cccc(c2)S(=O)(=O)C,Ki,=,1211.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,1211.0
9291,CHEMBL596802,CCCN1CCC(CC1)c2cccc(c2)S(=O)(=O)C,Ki,=,17550.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,B,17550.0
9292,CHEMBL596802,CCCN1CCC(CC1)c2cccc(c2)S(=O)(=O)C,Ki,=,7521.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,B,7521.0
9295,CHEMBL604102,N[C@@H]1CCN(C1)c2ccc3[nH]nc(c3c2)S(=O)(=O)c4cccc5ccccc45,Ki,=,2910.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2910.0
9301,CHEMBL598759,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OCC=C)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9302,CHEMBL598760,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OCC(=C)C)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9303,CHEMBL599080,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OCC=C(C)C)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9304,CHEMBL596865,CCCN1CCc2cccc3c2[C@H]1Cc4ccc(CC=C)c(O)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9305,CHEMBL596866,CCCN1CCc2cccc3c2[C@H]1Cc4ccc(CC(=C)C)c(O)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9306,CHEMBL611973,CCCN1CCc2cccc3c2[C@H]1Cc4ccc5CC(C)(C)Oc5c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9307,CHEMBL603542,CCCN1CCc2cccc3c2[C@H]1Cc4c(CC=C(C)C)ccc(O)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9308,CHEMBL591448,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OCC#C)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9309,CHEMBL596678,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OCC#CC)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9310,CHEMBL597881,CCCN1CCc2cccc3c2[C@H]1Cc4ccc5cc(C)oc5c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9311,CHEMBL597882,CCCN1CCc2cccc3c2[C@H]1Cc4ccc5c(C)c(C)oc5c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9312,CHEMBL608728,CN1CCc2cccc3c2[C@H]1Cc4cccc(OCC=C)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9313,CHEMBL596884,CN1CCc2cccc3c2[C@H]1Cc4ccc(CC=C)c(O)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9314,CHEMBL596885,CN1CCc2cccc3c2[C@H]1Cc4cccc(OCC#C)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9315,CHEMBL607559,CN1CCc2cccc3c2[C@H]1Cc4ccc5cc(C)oc5c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9316,CHEMBL596886,COc1cc2CCN(C)[C@@H]3Cc4cccc(OCC=C)c4c(c1)c23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9317,CHEMBL603752,COc1cc2CCN(C)[C@@H]3Cc4ccc(CC=C)c(O)c4c(c1)c23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9318,CHEMBL609317,CC1Cc2ccc3C[C@H]4N(C)CCc5cccc(c45)c3c2O1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9319,CHEMBL609611,C[C@H]1Cc2ccc3C[C@H]4N(C)CCc5cccc(c45)c3c2O1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9320,CHEMBL597094,C[C@@H]1Cc2ccc3C[C@H]4N(C)CCc5cccc(c45)c3c2O1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,B,10000.0
9321,CHEMBL596622,CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c3ccc(CNC4CCC4)cc3,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2000.0
9323,CHEMBL599282,CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c3ccc(CN(C4CCC4)S(=O)(=O)C)cc3,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2000.0
9324,CHEMBL603901,CN(Cc1ccc(cc1)[C@H]2CN(C)CCc3cc(Cl)c(O)cc23)S(=O)(=O)C,Ki,=,6000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,6000.0
9326,CHEMBL604108,CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c3ccc(CNc4ccccc4)cc3,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2000.0
9328,CHEMBL598515,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4cc(N)ccc34,Ki,=,5400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,5400.0
9329,CHEMBL598516,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4cc(NC(=O)C5CC5)ccc34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,10000.0
9330,CHEMBL597909,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4cc(NS(=O)(=O)C)ccc34,Ki,=,3000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,3000.0
9331,CHEMBL600986,CCS(=O)(=O)Nc1ccc2[C@H]3[C@H](CCc2c1)N(C)CCc4cc(Cl)c(O)cc34,Ki,=,3300.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,3300.0
9332,CHEMBL600987,CCNC(=O)Nc1ccc2[C@H]3[C@H](CCc2c1)N(C)CCc4cc(Cl)c(O)cc34,Ki,=,6000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,6000.0
9333,CHEMBL599977,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4cc(NC(=O)Nc5c(Cl)cccc5Cl)ccc34,Ki,=,1093.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,1093.0
9334,CHEMBL603485,CCOC(=O)Nc1ccc2[C@H]3[C@H](CCc2c1)N(C)CCc4cc(Cl)c(O)cc34,Ki,=,3900.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,3900.0
9335,CHEMBL591685,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c(N)cccc34,Ki,=,2100.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2100.0
9336,CHEMBL602659,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c(NC(=O)C5CC5)cccc34,Ki,=,2137.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,2137.0
9340,CHEMBL604127,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c(cccc34)C#N,Ki,=,1328.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,1328.0
9348,CHEMBL600083,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c(Br)cccc34,Ki,=,1693.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,1693.0
9349,CHEMBL604316,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c(C=O)cccc34,Ki,=,1371.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,1371.0
9350,CHEMBL599116,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c(CO)cccc34,Ki,=,1647.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,1647.0
9351,CHEMBL598949,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@@H]1CCc4c3cccc4N5CCCC5=O,Ki,=,1370.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,1370.0
9361,CHEMBL604383,CN1CCc2cc(Cl)c(O)cc2[C@@H]3[C@H]1CCc4c3cccc4c5cccc(OC(F)(F)F)c5,Ki,=,1612.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,B,1612.0
9403,CHEMBL611207,CN1CCCC[C@@H]1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-],Ki,=,1545.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,B,1545.0
9409,CHEMBL611207,CN1CCCC[C@@H]1CCN2c3ccccc3Sc4ccc(cc24)[S+](C)[O-],Ki,=,1841.0,nM,Dopamine D2 receptor,Homo sapiens,Low binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,B,1841.0
9415,CHEMBL609742,Clc1ccccc1S(=O)(=O)Nc2ccc3[nH]cc(C[C@H]4CCCN4)c3c2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human dopamine receptor D2 expressed in CHO-K1 cells,B,5000.0
9417,CHEMBL606547,CN1CCC[C@@H]1Cc2c[nH]c3ccc(NS(=O)(=O)c4ccccc4Cl)cc23,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human dopamine receptor D2 expressed in CHO-K1 cells,B,2000.0
9418,CHEMBL606556,CN1CCC[C@@H]1Cc2c[nH]c3ccc(NS(=O)(=O)c4cccc(Cl)c4)cc23,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human dopamine receptor D2 expressed in CHO-K1 cells,B,2000.0
9457,CHEMBL1082106,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5ccc(Br)cc5)n2C,Ki,>,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,1258.93
9460,CHEMBL1079837,COc1ccc(cc1)C23CC2CN(CCCSc4nnc(c5ocnc5C)n4C)C3,Ki,>,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,1584.89
9481,CHEMBL1081237,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CC5CC5(C4)c6ccc(Cl)c(Cl)c6)n3C,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,1258.93
9482,CHEMBL1081237,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CC5CC5(C4)c6ccc(Cl)c(Cl)c6)n3C,Ki,=,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,5011.87
9489,CHEMBL1080846,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5ccc(Cl)c(Cl)c5)n2C,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,1584.89
9492,CHEMBL1081203,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CC5CC5(C4)c6ccccc6)n3C,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,3162.28
9497,CHEMBL1081401,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CC5CC5(C4)c6ccc(cc6)C(C)(C)C)n3C,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,1995.26
9503,CHEMBL1079497,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CC5CC5(C4)c6ccc(Br)cc6)n3C,Ki,=,3981.07,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,3981.07
9509,CHEMBL1079577,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CC5CC5(C4)c6ccc(cc6)C#N)n3C,Ki,=,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,6309.57
9510,CHEMBL1079578,COc1ccc(cc1)C23CC2CN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)C3,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,1258.93
9512,CHEMBL1079578,COc1ccc(cc1)C23CC2CN(CCCSc4nnc(c5cccc6nc(C)ccc56)n4C)C3,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,1258.93
9522,CHEMBL1080293,Cc1ccc2c(cccc2n1)c3nnc(SCCCN4CC5CC5(C4)c6ccc(cc6)C(F)(F)F)n3C,Ki,>,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,F,1258.93
9525,CHEMBL1076586,O=C(N1CCN(CC1)C(=O)c2ccc3cc[nH]c3c2)c4ccc(cc4)c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9526,CHEMBL1081648,COc1cccc(c1)c2ccc(cc2)C(=O)N3CCN([C@@H](C)C3)C(=O)c4ccc5cc[nH]c5c4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9527,CHEMBL1081649,COc1cccc(c1)c2ccc(cc2)C(=O)N3CCN([C@H](C)C3)C(=O)c4ccc5cc[nH]c5c4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9528,CHEMBL1080155,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5cccc(OC(F)(F)F)c5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9529,CHEMBL1082209,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5cccc(c5)C(F)(F)F,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9530,CHEMBL1082210,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5cccc(F)c5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9531,CHEMBL1082211,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5ccccc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9532,CHEMBL1081212,COc1ccccc1c2ccc(cc2)C(=O)N3CCN([C@@H](C)C3)C(=O)c4ccc5cc[nH]c5c4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9534,CHEMBL1080389,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5ccccc5F,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9535,CHEMBL1080556,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5ccccc5Cl,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9536,CHEMBL1080735,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5ccccc5C(F)(F)F,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9537,CHEMBL1080907,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5ccccc5C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9538,CHEMBL1081254,COc1ccc(cc1)c2ccc(cc2)C(=O)N3CCN([C@@H](C)C3)C(=O)c4ccc5cc[nH]c5c4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9539,CHEMBL1080755,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5ccc(OC(F)(F)F)cc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9540,CHEMBL1080926,C[C@H]1CN(CCN1C(=O)c2ccc3cc[nH]c3c2)C(=O)c4ccc(cc4)c5ccc(F)cc5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,10000.0
9542,CHEMBL1086754,Cc1c(cc(c2ccccc2)n1C)C(=O)NCCCN3CCN(CC3)c4cccc(Cl)c4Cl,IC50,=,2542.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,1271.0
9543,CHEMBL1086756,CCCn1c(C)c(cc1c2ccccc2)C(=O)NCCCN3CCN(CC3)c4cccc(Cl)c4Cl,IC50,=,3736.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor,B,1868.0
9550,CHEMBL1083815,O=C1N(CCN2CCCCCC2)CCN1c3ccncc3,EC50,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,1581.14
9558,CHEMBL1086395,Clc1cccc(c1)N2C=CN(CCCN3CCCCCC3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9568,CHEMBL1085673,Clc1cccc(c1)N2CCN(CC3CCCNC3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9570,CHEMBL1085674,Clc1cccc(c1)N2CCN(CC3CCNCC3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9572,CHEMBL1085903,FC(F)(F)c1cccc(c1)N2CCN(CC3CCCCN3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9578,CHEMBL1077189,C1Cc2ccccc2C3N1Cc4cccc5[nH]cc3c45,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,B,10000.0
9580,CHEMBL1086789,C1Cc2ccccc2C3N1CCc4[nH]c5ccccc5c34,Ki,=,1476.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,B,1476.0
9582,CHEMBL1086790,C1Cc2ccccc2C3N1CCc4cccc5[nH]cc3c45,Ki,=,4458.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,B,4458.0
9584,CHEMBL1088073,CN1CCc2ccccc2Cc3c[nH]c4cccc(C1)c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,B,10000.0
9594,CHEMBL1081309,Clc1cc(Cl)cc(c1)N2CCN(CCN3CCCCCC3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9596,CHEMBL1081310,Cc1ccccc1N2CCN(CCN3CCCCCC3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9601,CHEMBL1077348,Cc1ccc(cc1)N2CCN(CCN3CCCCCC3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9603,CHEMBL1081487,COc1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9605,CHEMBL1081488,FC(F)(F)c1cccc(c1)N2CCN(CCN3CCCCCC3)C2=O,EC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,F,3971.64
9622,CHEMBL1078595,O=S(=O)(Nc1ccc2CCN(Cc3cc[nH]n3)CCc2c1)c4ccc(nc4)N5CCOCC5,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor,F,3162.28
9624,CHEMBL1092929,FC(F)(F)c1cccc(c1)C(=O)NCC(=O)N[C@@H]2CCN(CCC3CCN(CC3)C(=O)c4ccccc4)C2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 (receptor),B,5000.0
9625,CHEMBL1089881,Fc1ccccc1C(=O)N2CCC(CCN3CC[C@H](C3)NC(=O)CNC(=O)c4cccc(c4)C(F)(F)F)CC2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 (receptor),B,5000.0
9626,CHEMBL1092921,Fc1ccc(F)c(c1)C(=O)N2CCC(CCN3CC[C@H](C3)NC(=O)CNC(=O)c4cccc(c4)C(F)(F)F)CC2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 (receptor),B,5000.0
9627,CHEMBL1088874,FC(F)(F)c1cccc(c1)C(=O)NCC(=O)N[C@@H]2CCN(CCC3CCN(CC3)C(=O)c4ccccc4Cl)C2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 (receptor),B,5000.0
9628,CHEMBL1093469,FC(F)(F)c1cccc(c1)C(=O)NCC(=O)N[C@@H]2CCN(CCN3CCN(CC3)C(=O)c4ccccc4)C2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 (receptor),B,5000.0
9629,CHEMBL1092238,FC(F)(F)c1cccc(c1)C(=O)NCC(=O)N[C@@H]2CCN(CCN3CCN(CC3)C(=O)c4ccccc4Cl)C2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 (receptor),B,5000.0
9630,CHEMBL1093802,Fc1ccccc1C(=O)N2CCN(CCN3CC[C@H](C3)NC(=O)CNC(=O)c4cccc(c4)C(F)(F)F)CC2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 (receptor),B,5000.0
9631,CHEMBL1089793,Fc1ccc(F)c(c1)C(=O)N2CCN(CCN3CC[C@H](C3)NC(=O)CNC(=O)c4cccc(c4)C(F)(F)F)CC2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 (receptor),B,5000.0
9632,CHEMBL1095777,CCc1cc2CC(Cc2cc1CC)NC[C@H](O)c3ccc(O)c4NC(=O)C=Cc34,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Activity at human D2R expressed in CHO cells by radiolabelled [35S]GTPgammaS assay,F,5000.0
9665,CHEMBL1082723,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]4(N1)C(=O)Nc5ccc(Cl)cc45,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human recombinant dopamine D2 receptor,B,5000.0
9669,CHEMBL1160787,Oc1cc2[C@H](CNCCc2c(Cl)c1O)c3ccccc3,Ki,=,8000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards Dopamine receptor D2,B,8000.0
9670,CHEMBL1162962,Fc1ccc(\C=C\c2ccc(cn2)S(=O)(=O)c3ccccc3)c(F)c1,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,B,2000.0
9696,CHEMBL1173363,COc1ccc2[nH]cc(CN3CCC(O)(CC3)c4ccccc4)c2c1.OC(=O)C(=O)O,Ki,=,1396.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,1396.0
9713,CHEMBL1195032,C[C@@H]1NCCc2cc(O)c(O)cc12,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at dopamine D2 receptor (unknown origin),B,5000.0
9774,CHEMBL1201192,NC(=O)C[S@@+]([O-])C(c1ccccc1)c2ccccc2,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,B,100000.0
9797,CHEMBL1202203,Br.C([C@H]1C[C@@H]1c2ccccc2)N3CCN(CC3)c4cccnc4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,5000.0
9801,CHEMBL1202207,Br.C([C@H]1C[C@@H]1c2ccccc2)N3CCN(CC3)c4ccncc4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",B,5000.0
9821,CHEMBL1202298,Br.CN1CCc2ccccc2Cc3cc(O)c(O)cc3CC1,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,B,5000.0
9822,CHEMBL1202783,Cl.C(Oc1cccc2C=C(CN3CCOCC3)COc12)[C@@H]4CNCCO4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 from cell LtkhD2A membranes using [3H]raclopride as the radioligand.,B,10000.0
9837,CHEMBL1210154,C\C(=N/OC(=O)Nc1ccccc1)\c2cccc(c2)c3cccs3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2S receptor expressed in HEK293 cells,B,5000.0
9842,CHEMBL1210614,Cc1ncoc1c2nnc(SCCCN3CC4CC4(C3)c5cccc(c5)S(F)(F)(F)(F)F)n2C,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by FLIPR assay,F,3162.28
9846,CHEMBL1214829,C(N1CCN(Cc2ccccc2)CC1)c3oc4ccccc4c3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10000.0
9847,CHEMBL1214830,COc1ccc(CN2CCN(Cc3oc4ccccc4c3)CC2)cc1,Ki,=,2700.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,2700.0
9848,CHEMBL1214831,CCOc1ccc(CN2CCN(Cc3oc4ccccc4c3)CC2)cc1,Ki,=,4868.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,4868.0
9849,CHEMBL1214891,FC(F)CCOc1ccc(CN2CCN(Cc3oc4ccccc4c3)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10000.0
9850,CHEMBL1214892,CCCOc1ccc(CN2CCN(Cc3oc4ccccc4c3)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10000.0
9851,CHEMBL1214893,FCCCOc1ccc(CN2CCN(Cc3oc4ccccc4c3)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10000.0
9852,CHEMBL1214894,COc1cccc(CN2CCN(Cc3oc4ccccc4c3)CC2)c1,Ki,=,5728.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,5728.0
9853,CHEMBL1214895,CCOc1cccc(CN2CCN(Cc3oc4ccccc4c3)CC2)c1,Ki,=,4542.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,4542.0
9854,CHEMBL1214958,FCCOc1cccc(CN2CCN(Cc3oc4ccccc4c3)CC2)c1,Ki,=,2281.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,2281.0
9855,CHEMBL1214959,CCCOc1cccc(CN2CCN(Cc3oc4ccccc4c3)CC2)c1,Ki,=,2977.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,2977.0
9856,CHEMBL1214960,FCCCOc1cccc(CN2CCN(Cc3oc4ccccc4c3)CC2)c1,Ki,=,2920.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,2920.0
9857,CHEMBL1214961,COc1ccccc1CN2CCN(Cc3oc4ccccc4c3)CC2,Ki,=,5122.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,5122.0
9858,CHEMBL1214962,CCOc1ccccc1CN2CCN(Cc3oc4ccccc4c3)CC2,Ki,=,6005.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,6005.0
9859,CHEMBL1215036,FCCOc1ccccc1CN2CCN(Cc3oc4ccccc4c3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10000.0
9860,CHEMBL1215037,CCCOc1ccccc1CN2CCN(Cc3oc4ccccc4c3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10000.0
9861,CHEMBL1215038,FCCCOc1ccccc1CN2CCN(Cc3oc4ccccc4c3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,10000.0
9862,CHEMBL1221449,CN1CCN(CC1)c2cccc(c2)N(CC3CC3)S(=O)(=O)c4ccc5ccccc5c4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9863,CHEMBL1221452,CN1CCN(CC1)c2cccc(c2)N(Cc3ccccc3)S(=O)(=O)c4ccc5ccccc5c4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9864,CHEMBL1221497,CN1CCN(CC1)c2cccc(NS(=O)(=O)c3ccc4ccccc4c3)c2,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9875,CHEMBL1221681,O[C@@H](CN[C@H]1CCC[C@@H]1OCc2ccccc2)c3ccc(O)c4NC(=O)Sc34,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Activity at human D2R expressed in CHO cells by radiolabelled [35S]GTPgammaS assay,F,5000.0
9876,CHEMBL1222134,CC(C)N(c1cccc(c1)N2CCN(C)CC2)S(=O)(=O)c3ccc4ccccc4c3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9877,CHEMBL1222138,CC(C)N(c1cccc(c1)N2CCN(C)CC2)S(=O)(=O)c3ccccc3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9878,CHEMBL1222234,CC(C)N(c1cccc(c1)N2CCN(C)CC2)S(=O)(=O)c3cccc4ccccc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9879,CHEMBL1222362,CN(c1cccc(c1)N2CCN(C)CC2)S(=O)(=O)c3ccc4ccccc4c3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9880,CHEMBL1222363,CCCN(c1cccc(c1)N2CCN(C)CC2)S(=O)(=O)c3ccc4ccccc4c3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9881,CHEMBL1222364,CCN(c1cccc(c1)N2CCN(C)CC2)S(=O)(=O)c3ccc4ccccc4c3,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 expressed in CHOKI cells,B,5000.0
9884,CHEMBL1223600,CC(C)c1ccc(CS(=O)(=O)c2ccc(cc2)[C@]34CNC[C@H]3C4)cc1,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,3162.28
9909,CHEMBL1224527,Oc1ccc2[C@@H]3CNCC[C@H]3[C@@H](Cc2c1O)c4ccccc4,Ki,=,750000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,750000.0
9916,CHEMBL1224700,FC(F)(F)c1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)[C@]34CNC[C@H]3C4,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,F,3162.28
9942,CHEMBL1242923,O=C(Cc1ccccc1)NC2CCN(CCCN3C(=O)COc4ccccc34)CC2,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,5000.0
9946,CHEMBL1242923,O=C(Cc1ccccc1)NC2CCN(CCCN3C(=O)COc4ccccc34)CC2,Kb,=,2091.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in F1pIn CHO cells assessed as inhibition of ERK1/2 phosphorylation incubated for 5 mins by AlphaScreen assay,B,2091.0
9959,CHEMBL1255966,Br.CCCN(CCC)C1CCc2ccc(O)cc2C1,Ki,=,1430.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,B,1430.0
9968,CHEMBL1256786,COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,5000.0
10005,CHEMBL1257337,Cc1ncoc1c2nnc(SCCCN3[C@@H]4CC[C@H]3C[C@H](C4)c5cccc(c5)C(F)(F)F)n2C,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,3162.28
10018,CHEMBL1257448,Cc1ncoc1c2nnc(SCCCN3[C@@H]4CC[C@H]3C[C@H](C4)c5ccc(cc5F)C(F)(F)F)n2C,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,3162.28
10031,CHEMBL1257565,Cc1ncoc1c2nnc(SCCCN3CCC4(CC4C3)c5ccccc5)n2C,Ki,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,3162.28
10061,CHEMBL1257808,Cc1ncoc1c2nnc(SCCCN3CCC4(CC4C3)c5cccc(c5)C(F)(F)F)n2C,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,2511.89
10093,CHEMBL1258035,Cc1ncoc1c2nnc(SCCCN[C@@H]3CC[C@@]4(CC34)c5ccc(cc5)C(F)(F)F)n2C,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,3162.28
10108,CHEMBL1258153,Cc1ncoc1c2nnc(SCCCN[C@H]3CC[C@@]4(CC34)c5ccc(cc5)C(F)(F)F)n2C,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,3162.28
10119,CHEMBL1258269,Cl.Cc1ncoc1c2nnc(SCCCN[C@@H]3CC4C[C@@]4(C3)c5ccc(cc5F)C(F)(F)F)n2C,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,3162.28
10164,CHEMBL1258606,Cc1ncoc1c2nnc(SCCCN3CCC4(CCOc5ccccc45)C3)n2C,Ki,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,F,3162.28
10207,CHEMBL1258999,Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3coc4ccccc34)nc1,Ki,=,27000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor,B,27000.0
10208,CHEMBL1258999,Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3coc4ccccc34)nc1,Ki,=,28000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor,B,28000.0
10217,CHEMBL1259071,Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3cc(Br)cs3)nc1,Ki,=,73000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor,B,73000.0
10218,CHEMBL1259071,Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3cc(Br)cs3)nc1,Ki,=,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor,B,100000.0
10246,CHEMBL1259241,Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3csc4ccccc34)nc1,Ki,=,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 long receptor,B,20000.0
10247,CHEMBL1259241,Cc1ccc(CNCC2(F)CCN(CC2)C(=O)c3csc4ccccc34)nc1,Ki,=,54000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]Spiperone from human dopamine D2 short receptor,B,54000.0
10248,CHEMBL1275709,CN(C)[C@@H]1CC[C@@H](C1)c2c[nH]c3ccc(cc23)C#N,IC50,>,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,15000.0
10249,CHEMBL1275791,CN(C)[C@H]1CC[C@H](C1)c2c[nH]c3ccc(F)cc23,IC50,>,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2,B,15000.0
10306,CHEMBL1277105,O=S(=O)(c1cccc2ccccc12)c3n[nH]c4ccc(cc34)N5CCNCC5,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,B,5000.0
10307,CHEMBL1277565,Cn1nc(c2cc(ccc12)N3CCNCC3)S(=O)(=O)c4cccc5ccccc45,Ki,=,2243.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,B,2243.0
10308,CHEMBL1277837,CC(C)n1nc(c2cc(ccc12)N3CCNCC3)S(=O)(=O)c4cccc5ccccc45,Ki,=,2036.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,B,2036.0
10310,CHEMBL1275630,CC(C)Cn1nc(c2cc(ccc12)N3CCNCC3)S(=O)(=O)c4cccc5ccccc45,Ki,=,1903.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,B,1903.0
10346,CHEMBL1424807,Clc1cccc(N2CCNCC2)c1Cl,Ki,=,1160.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,1160.0
10347,CHEMBL1424807,Clc1cccc(N2CCNCC2)c1Cl,Ki,=,1148.15,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,1148.15
10356,CHEMBL1478530,CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2NC(=O)C=Cc12,Ki,=,86000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,86000.0
10393,CHEMBL1627305,OC(CCNC(=O)c1cc2ccccc2[nH]1)CN3CCN(CC3)c4cccc(Cl)c4Cl,IC50,=,4400.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,B,2200.0
10416,CHEMBL1632158,COC(=O)CCCCCN1CCC(CNC(=O)c2c3OCCCn3c4ccccc24)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,10000.0
10417,CHEMBL1632174,OC(=O)CCCCCN1CCC(CNC(=O)c2c3OCCCn3c4ccccc24)CC1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,10000.0
10424,CHEMBL1642116,CN1CCN(CC1)c2ccc3C(=O)CCN(c3c2)S(=O)(=O)c4ccc5ccccc5c4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,5000.0
10425,CHEMBL1642117,CN1CCN(CC1)c2cccc3N(CCC(=O)c23)S(=O)(=O)c4ccc5ccccc5c4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,5000.0
10427,CHEMBL1642123,CC1CC(=O)c2c(cccc2N1S(=O)(=O)c3ccc4ccccc4c3)N5CCN(C)CC5,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,B,5000.0
10430,CHEMBL1642851,Cl.O=S(=O)(c1cccc2ccccc12)c3n[nH]c4ccc(NC5CCNCC5)cc34,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,5000.0
10431,CHEMBL1642865,Cl.NCCC(=O)Nc1ccc2[nH]nc(c2c1)S(=O)(=O)c3cccc4ccccc34,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,5000.0
10432,CHEMBL1642866,Cl.O=C(Nc1ccc2[nH]nc(c2c1)S(=O)(=O)c3cccc4ccccc34)C5CCNCC5,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,5000.0
10433,CHEMBL1642882,Cl.Clc1cccc(c1)S(=O)(=O)c2n[nH]c3ccc(NC4CCNCC4)cc23,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,5000.0
10434,CHEMBL1642886,Cl.CC(C)c1ccc(cc1)S(=O)(=O)c2n[nH]c3ccc(NC4CCNCC4)cc23,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,5000.0
10435,CHEMBL1642889,Cl.O=S(=O)(c1ccc2ccccc2c1)c3n[nH]c4ccc(NC5CCNCC5)cc34,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,5000.0
10454,CHEMBL1672288,Fc1cc(cc(c1)C#Cc2csc(F)n2)C#N,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,10000.0
10460,CHEMBL1684023,CCCN1CCc2cccc3c2C1Cc4cccc(OCc5cn(CCCN6CCN(CC6)c7ccccc7OC)nn5)c34,Ki,=,1203.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,B,1203.0
10468,CHEMBL1684125,CCCN1CCc2cccc3c2C1Cc4cccc(OCCCn5cc(CCN6CCN(CC6)c7ccccc7OC)nn5)c34,Ki,=,7384.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,B,7384.0
10526,CHEMBL1742470,CCCN(C(C)C)[C@H]1COc2cccc(C(=O)NC(C)C)c2C1,Ki,>,50000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]raclopride from D2A receptor expressed in mouse fibroblast (LtK-) cells,B,50000.0
10533,CHEMBL1744087,CS(=O)(=O)O.C(Oc1cccc2C=C(CN3CCOCC3)COc12)[C@H]4CNCCO4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against Dopamine receptor D2 from cell LtkhD2A membranes using [3H]raclopride as the radioligand.,B,10000.0
10543,CHEMBL1765631,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCn4ncc(C=O)c4C3,Ki,=,8400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,B,8400.0
10544,CHEMBL1765631,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)C3CCn4ncc(C=O)c4C3,Ki,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,B,4700.0
10646,CHEMBL1774386,FC(CCNC(=O)c1oc2ccccc2c1)CN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,9163.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from wild type human dopamine D2 receptor expressed in HEK293 cells,B,9163.0
10648,CHEMBL1774386,FC(CCNC(=O)c1oc2ccccc2c1)CN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,14600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,14600.0
10659,CHEMBL1774536,COc1ccccc1N2CCN(CC(F)CCNC(=O)c3ccc4c(Cc5ccccc45)c3)CC2,Ki,=,2890.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,2890.0
10661,CHEMBL1774537,FC(CCNC(=O)c1ccc2c(Cc3ccccc23)c1)CN4CCN(CC4)c5cccc(Cl)c5Cl,Ki,=,4260.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,4260.0
10678,CHEMBL1774549,OC(CCNCc1ccc2c(Cc3ccccc23)c1)CN4CCN(CC4)c5cccc(Cl)c5Cl,Ki,=,2090.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,2090.0
10679,CHEMBL1774550,FC(CCNCc1ccc2c(Cc3ccccc23)c1)CN4CCN(CC4)c5cccc(Cl)c5Cl,Ki,=,5270.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,5270.0
10682,CHEMBL1773087,CN(CCC(F)CN1CCN(CC1)c2cccc(Cl)c2Cl)Cc3ccc4c(Cc5ccccc45)c3,Ki,=,2060.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,B,2060.0
10686,CHEMBL1779058,OC12C3C4CC5C6C4C1C6C(C35)N2CCCC(=O)c7ccc(F)cc7,Ki,=,1724.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,B,1724.0
10688,CHEMBL1779059,COc1ccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C46)cc1OCCc8ccccc8,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,B,10000.0
10690,CHEMBL1779060,COc1ccc(C)cc1C(=O)NCCN2C3C4C5CC6C7C5C3C7C2(O)C46,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,B,10000.0
10703,CHEMBL1788325,CCCN[C@H]1CCc2ccc3[nH]c(cc3c2C1)C(=O)N,Ki,>,1667.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,B,1667.0
10706,CHEMBL1794855,CCN(C)C1CCCc2ccncc12.OC(=O)\C=C/C(=O)O.OC(=O)\C=C/C(=O)O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Affinity towards human dopamine receptor D2,B,10000.0
10758,CHEMBL1806867,CCCN1CCc2cccc3c2C1Cc4cccc(OC(=O)NC(C)(C)C)c34,Ki,=,2800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,B,2800.0
10760,CHEMBL1806869,CCCN1CCc2cccc3c2C1Cc4cccc(OC(=O)Nc5cccc6ccccc56)c34,Ki,=,2005.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,B,2005.0
10761,CHEMBL1806870,CCCN1CCc2cccc3c2C1Cc4cccc(OC(=O)NCc5ccccc5)c34,Ki,=,4300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,B,4300.0
10762,CHEMBL1806871,CCCN1CCc2cccc3c2[C@H]1Cc4cccc(OC(=O)NCc5ccccc5)c34,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,B,2200.0
10783,CHEMBL1807823,O[C@@H](CNCCSCCCNCCc1ccccc1)c2ccc(O)c3NC(=O)Sc23,IC50,=,3981.07,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,1990.535
10784,CHEMBL1807824,CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3NC(=O)Sc23)cc1,IC50,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,1255.945
10785,CHEMBL1807825,CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3NC(=O)Sc23)cc1,IC50,=,3981.07,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,1990.535
10790,CHEMBL1807830,O[C@@H](CNCC[S+]([O-])CCCNCCc1cccc(Cl)c1)c2ccc(O)c3NC(=O)Sc23,IC50,>,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,1581.14
10792,CHEMBL1807832,O[C@@H](CNCCOCCCNCCc1cccc(Cl)c1)c2ccc(O)c3NC(=O)Sc23,IC50,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,1581.14
10796,CHEMBL1807872,O[C@@H](CNCCCOCCNCCc1cccc(Cl)c1)c2ccc(O)c3NC(=O)Sc23,IC50,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,1255.945
10798,CHEMBL1807874,CN(CCOCCCNC[C@H](O)c1ccc(O)c2NC(=O)Sc12)CCc3ccccc3,IC50,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor,B,1255.945
10807,CHEMBL1813586,OC(=O)C(=O)O.OC1(CCN(CCCCOc2ccc3CCC(=O)Nc3c2)CC1)c4ccc(Cl)cc4,Ki,=,2604.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,B,2604.0
10825,CHEMBL1822386,O[C@H]1CN(Cc2ccc(F)cc2)CC[C@@H]1N3CCC(CC3)C(=O)c4ccc(F)cc4,Ki,=,1350.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,1350.0
10826,CHEMBL1822390,COc1ccc(cc1)C(=O)C2CCN(CC2)[C@H]3CCN(Cc4ccc(F)cc4)C[C@@H]3O,Ki,=,1489.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,B,1489.0
10838,CHEMBL1834252,COc1ccccc1CCN2CCN(Cc3oc4ccccc4c3)CC2,Ki,=,1648.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,B,1648.0
10841,CHEMBL1834255,C(CN1CCN(Cc2oc3ccccc3c2)CC1)Cc4ccccc4,Ki,=,1025.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,B,1025.0
10842,CHEMBL1834256,COc1ccccc1CCCN2CCN(Cc3oc4ccccc4c3)CC2,Ki,=,5866.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,B,5866.0
10844,CHEMBL1833977,COc1ccc(CCCN2CCN(Cc3oc4ccccc4c3)CC2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,B,10000.0
10849,CHEMBL1834261,COc1ccc(CCCCN2CCN(Cc3oc4ccccc4c3)CC2)cc1,Ki,=,5791.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,B,5791.0
10915,CHEMBL1923292,Fc1ccc(CN2CCN(CC2)c3ccc4OCCOc4c3)cc1,Ki,=,7600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,7600.0
10916,CHEMBL1923292,Fc1ccc(CN2CCN(CC2)c3ccc4OCCOc4c3)cc1,Ki,=,5700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,5700.0
10917,CHEMBL1923293,COc1cc(CN2CCN(CC2)c3ccc4OCCOc4c3)ccc1F,Ki,=,17000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,17000.0
10918,CHEMBL1923293,COc1cc(CN2CCN(CC2)c3ccc4OCCOc4c3)ccc1F,Ki,=,16000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,16000.0
10919,CHEMBL1923415,Oc1cc(CN2CCN(CC2)c3ccc4OCCOc4c3)ccc1F,Ki,=,9000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,9000.0
10920,CHEMBL1923415,Oc1cc(CN2CCN(CC2)c3ccc4OCCOc4c3)ccc1F,Ki,=,6100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,6100.0
10921,CHEMBL1923416,Fc1ccc(CN2CCN(CC2)c3ccc4OCCOc4c3)cn1,Ki,=,29000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,B,29000.0
10922,CHEMBL1923416,Fc1ccc(CN2CCN(CC2)c3ccc4OCCOc4c3)cn1,Ki,=,45000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,B,45000.0
10967,CHEMBL1928247,CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1,Ki,=,19000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,B,19000.0
10968,CHEMBL1928247,CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1,Ki,=,9700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,B,9700.0
10988,CHEMBL1940410,Fc1ccc(SCCCN2CCN(CC2)c3ccc(cc3)C(F)(F)F)cc1,Ki,=,4753.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,4753.0
11018,CHEMBL1945034,O[C@@H](CNCCc1ccc(CNCCc2ccccn2)cc1)c3ccc(O)c4NC(=O)Sc34,IC50,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,1255.945
11020,CHEMBL1945036,CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3NC(=O)Sc23)cc1)c4ccccc4,IC50,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,1255.945
11022,CHEMBL1945038,O[C@@H](CNCCc1cccc(CNCCCc2ccccn2)c1)c3ccc(O)c4NC(=O)Sc34,IC50,>,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,1255.945
11026,CHEMBL1945040,COc1ccccc1CNCc2ccc(CCNC[C@H](O)c3ccc(O)c4NC(=O)Sc34)cc2,IC50,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,1255.945
11029,CHEMBL1945043,O[C@@H](CNCCc1cccc(CNCc2ccccn2)c1)c3ccc(O)c4NC(=O)Sc34,IC50,=,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,2505.935
11035,CHEMBL1945293,COCCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3NC(=O)Sc23)cc1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,5000.0
11036,CHEMBL1945294,O[C@@H](CNCCc1cccc(CN2CCCC2)c1)c3ccc(O)c4NC(=O)Sc34,IC50,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,1581.14
11042,CHEMBL1945300,OCc1cc(ccc1O)[C@@H](O)CNCCc2ccc(CNCCc3ccccc3)cc2,IC50,>,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,3971.64
11043,CHEMBL1945503,O[C@@H](CNCCc1cccc(CNCCc2ccccn2)c1)c3ccc(O)c4NC(=O)C=Cc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of radiolabeled spiperone from dopamine D2 receptor,B,5000.0
11047,CHEMBL1946124,Fc1ccc2C(=O)C(CCN3CCCN(CC3)c4ccc(Cl)cc4)Cc2c1,Ki,=,1021.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,B,1021.0
11056,CHEMBL1946257,Clc1ccc(cc1)N2CCCN(CCCCC(=O)c3nc4ccccc4s3)CC2,Ki,=,1983.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,B,1983.0
11057,CHEMBL1946257,Clc1ccc(cc1)N2CCCN(CCCCC(=O)c3nc4ccccc4s3)CC2,Ki,=,1983.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,1983.0
11065,CHEMBL1949726,C[C@@H]1Cc2c(Cc3ccccc3CCN1C)[nH]c4ccccc24,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,B,10000.0
11067,CHEMBL1949727,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3CC1C(=O)O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,B,10000.0
11071,CHEMBL1949729,CN1CCc2ccccc2Cc3[nH]c4ccccc4c3C[C@H]1CO,Ki,=,2923.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,B,2923.0
11074,CHEMBL1950491,Cl.COc1cc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2cc1O,EC50,=,56000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor,F,28000.0
11075,CHEMBL1950492,Cl.COc1cc2C[C@H]3N(CCc4cc(OC)c(O)cc34)Cc2cc1O,EC50,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor,F,7000.0
11081,CHEMBL2016608,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,=,2662.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1331.0
11083,CHEMBL2016609,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11084,CHEMBL2016609,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11085,CHEMBL2016610,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11086,CHEMBL2016610,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11087,CHEMBL2016611,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11088,CHEMBL2016611,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11089,CHEMBL2016612,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11090,CHEMBL2016612,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11091,CHEMBL2016613,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11092,CHEMBL2016613,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCCCCCCCCCCCCCC(=O)N4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11093,CHEMBL2016614,CCCCCCCCCC(=O)NN1c2ccc(Cl)cc2N=C(N3CCN(C)CC3)c4ccccc14,IC50,=,8939.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,4469.5
11094,CHEMBL2016614,CCCCCCCCCC(=O)NN1c2ccc(Cl)cc2N=C(N3CCN(C)CC3)c4ccccc14,IC50,=,8912.51,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,4456.255
11095,CHEMBL2016615,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,=,2078.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1039.0
11096,CHEMBL2016615,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,=,2041.74,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1020.87
11097,CHEMBL2016616,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,=,2440.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1220.0
11098,CHEMBL2016616,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,=,2454.71,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1227.355
11099,CHEMBL2016617,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11100,CHEMBL2016617,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11101,CHEMBL2016618,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11102,CHEMBL2016618,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11103,CHEMBL2016619,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11104,CHEMBL2016619,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11105,CHEMBL2016620,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11106,CHEMBL2016620,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11107,CHEMBL2016621,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11108,CHEMBL2016621,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCCCCCCCCCCCCCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11111,CHEMBL2016623,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCC(=O)N4CCN(CC4)C(=O)CCCC(=O)N5CCN(CC5)C(=O)CCCC(=O)NN6c7ccc(Cl)cc7N=C(N8CCN(C)CC8)c9ccccc69)c%10ccccc2%10,IC50,=,2630.27,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1315.135
11112,CHEMBL2016623,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCCC(=O)N4CCN(CC4)C(=O)CCCC(=O)N5CCN(CC5)C(=O)CCCC(=O)NN6c7ccc(Cl)cc7N=C(N8CCN(C)CC8)c9ccccc69)c%10ccccc2%10,IC50,=,2633.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1316.5
11113,CHEMBL2016624,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)OCCOC(=O)CCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,=,2398.83,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1199.415
11114,CHEMBL2016624,CN1CCN(CC1)C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)OCCOC(=O)CCC(=O)NN4c5ccc(Cl)cc5N=C(N6CCN(C)CC6)c7ccccc47)c8ccccc28,IC50,=,2412.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,1206.0
11137,CHEMBL2016630,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,10715.19,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5357.595
11138,CHEMBL2016630,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,11000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5500.0
11140,CHEMBL2016631,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCCCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,7762.47,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,3881.235
11141,CHEMBL2016631,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCCCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,=,7800.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,3900.0
11143,CHEMBL2016632,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11144,CHEMBL2016632,Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCN(CCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCN5CCN(CC5)C6=Nc7cc(Cl)ccc7Nc8ccccc68)CC4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,B,5000.0
11147,CHEMBL2021525,Cl.CCCN[C@@H]1CCc2c(CS(=O)(=O)C(F)(F)F)cccc2C1,Ki,>,3800.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,B,3800.0
11183,CHEMBL2029915,O=C(Cc1ccccc1)Nc2ccc(CCN3CCN(CC3)c4ccccc4)cc2,Ki,=,4189.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,4189.0
11191,CHEMBL2029923,O=C(Cc1ccccc1)Nc2cccc(CCN3CCN(CC3)c4ccccc4)c2,Ki,=,3575.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,3575.0
11195,CHEMBL2029927,O=C(Nc1ccccc1)Nc2cccc(CCN3CCN(CC3)c4ccccc4)c2,Ki,=,3250.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,B,3250.0
11200,CHEMBL2030622,C(N1C2CCC1CC2)c3ccccc3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
11201,CHEMBL2030623,Fc1cccc(CN2C3CCC2CC3)c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
11202,CHEMBL2030624,COc1ccc(CN2C3CCC2CC3)cc1OC,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
11206,CHEMBL2030628,Fc1cccc(CCN2C3CCC2CC3)c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
11207,CHEMBL2030629,C(Cc1ccccn1)N2C3CCC2CC3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
11208,CHEMBL2030630,Fc1cccc(CCCN2C3CCC2CC3)c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
11214,CHEMBL2030636,Fc1cccc(CCN2CCCC2)c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,10000.0
11215,CHEMBL2030637,Fc1cccc(CCCN2CCCC2)c1,Ki,=,9914.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 dopamine receptor,B,9914.0
11216,CHEMBL2031737,C[C@@H]1CCCN1CCc2oc3ccc(cc3c2)C(=O)c4ccc(cc4)[N+](=O)[O-],Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human recombinant Dopamine D2 receptor,B,10000.0
11217,CHEMBL2031873,O=C(NC1CCCC1)c2ccc(cc2)c3ccc4C(=O)N(CCN5CCCC5)CCc4c3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,10000.0
11218,CHEMBL2031874,CN(C)C(=O)c1ccc(cc1)c2ccc3C(=O)N(CCN4CCCC4)CCc3c2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,10000.0
11219,CHEMBL2031876,C[C@@H]1CCCN1C(=O)c2ccc(cc2)c3ccc4C(=O)N(CCN5CCCC5)CCc4c3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,10000.0
11220,CHEMBL2031877,C[C@H]1CCCN1C(=O)c2ccc(cc2)c3ccc4C(=O)N(CCN5CCCC5)CCc4c3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,10000.0
11221,CHEMBL2031884,CCNC(=O)c1ccc(cc1)c2ccc3C(=O)N(CCN4CCC[C@H]4C)CCc3c2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,10000.0
11222,CHEMBL2031885,C[C@@H]1CCCN1CCN2CCc3cc(ccc3C2=O)c4ccc(cc4)C(=O)N5CCCC5,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,10000.0
11223,CHEMBL2032049,C[C@@H]1[C@H]2CN(CCC3(CCCCC3)C(=O)O)CC[C@@H]2Cc4[nH]c5ccc(cc5c14)C(F)(F)F,Ki,=,3160.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,3160.0
11224,CHEMBL2037430,Clc1ccc(cc1)N2CCN(CCCc3nc4ccccc4s3)CC2,Ki,=,2321.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,2321.0
11225,CHEMBL2037430,Clc1ccc(cc1)N2CCN(CCCc3nc4ccccc4s3)CC2,Ki,=,2321.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,2321.0
11232,CHEMBL2037519,O=C(CCCN1CCN(CC1)c2ncccn2)c3nc4ccccc4s3,Ki,=,1522.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,1522.0
11240,CHEMBL2037524,Clc1ccc(cc1)N2CCN(CCCC(=O)c3nc4ccccc4s3)CC2,Ki,=,8355.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,8355.0
11241,CHEMBL2037525,O=C(CCCN1CCN(CC1)c2ccccc2)c3nc4ccccc4s3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,10000.0
11245,CHEMBL2037527,O=C(CCCCN1Cc2ccccc2C1)c3nc4ccccc4s3,Ki,=,2931.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,2931.0
11246,CHEMBL2037528,Clc1ccc(cc1)N2CCN(CCCCC(=O)c3nc4ccccc4s3)CC2,Ki,=,4793.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,B,4793.0
11261,CHEMBL2048230,CCCN1CCC(CC1)c2ccc(OC)cc2,Ki,=,23000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,23000.0
11262,CHEMBL2048230,CCCN1CCC(CC1)c2ccc(OC)cc2,Ki,=,25118.86,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,25118.86
11286,CHEMBL2057451,COc1cc2CCN3Cc4c(C)cc(C)cc4C[C@H]3c2cc1OC,EC50,=,16190.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity Assay: Each medicament was dissolved in serum-free F12 culture medium containing 100 M of IBMX. CHO cells which can stably express D2 receptor were pre-incubated at 37 C. for 10 min, and then 10 M Forskoline and 10 M Dopanie were added at the same time to react for 10 min. 100 L, of pre-cooled 1 M of HClO4 was added and the reaction was terminated at 4 C. for 1 hour. 20 L of 2 M K2CO3 was added to neutralize the reaction. The resulting mixture was centrifugated at 3000 rpm for 15 min, and the precipitate KClO4 was discarded. A certain amount of the supernatant was taken for cAMP detection. Spiperone and Quinpirole were used as positive control.",B,8095.0
11288,CHEMBL2057452,COc1cc2CCN3Cc4c(C)cc(C)cc4CC3c2cc1OC,EC50,=,15610.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity Assay: Each medicament was dissolved in serum-free F12 culture medium containing 100 M of IBMX. CHO cells which can stably express D2 receptor were pre-incubated at 37 C. for 10 min, and then 10 M Forskoline and 10 M Dopanie were added at the same time to react for 10 min. 100 L, of pre-cooled 1 M of HClO4 was added and the reaction was terminated at 4 C. for 1 hour. 20 L of 2 M K2CO3 was added to neutralize the reaction. The resulting mixture was centrifugated at 3000 rpm for 15 min, and the precipitate KClO4 was discarded. A certain amount of the supernatant was taken for cAMP detection. Spiperone and Quinpirole were used as positive control.",B,7805.0
11311,CHEMBL2059307,O=C1CCc2ncccc2N1CCCN3CCC(CC3)N4C(=O)Nc5ccccc45,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,2200.0
11312,CHEMBL2059308,O=C1CCc2cnccc2N1CCCN3CCC(CC3)N4C(=O)Nc5ccccc45,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,1100.0
11317,CHEMBL2059313,O=C1COc2ccccc2N1CCCN3CCC(CC3)N4C(=O)Nc5cccnc45,Ki,=,1250.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,1250.0
11318,CHEMBL2059314,O=C1COc2ccccc2N1CCCN3CCC(CC3)N4C(=O)Nc5ccncc45,Ki,>,9500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,9500.0
11319,CHEMBL2059315,O=C1COc2ccccc2N1CCCN3CCC(CC3)N4C(=O)Nc5cnccc45,Ki,=,1350.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,B,1350.0
11329,CHEMBL2062848,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@@H]([C@@H]12)c4ccccc4,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,12000.0
11330,CHEMBL2062849,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@H]([C@H]12)c4ccccc4,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,1700.0
11331,CHEMBL2062850,OC[C@H]1[C@H]2CN(Cc3ccccc3)[C@@H]([C@H]2[C@@H]1N4CCCC4)c5ccccc5,Ki,=,7400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,7400.0
11333,CHEMBL2062852,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](C)[C@@H]12,Ki,=,38000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,38000.0
11334,CHEMBL2062853,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](C)[C@H]12,Ki,=,3900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,3900.0
11335,CHEMBL2062854,C[C@@H]1[C@@H]2[C@H](CN1Cc3ccccc3)[C@H](CO)[C@H]2N4CCCC4,Ki,=,66000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,66000.0
11336,CHEMBL2062855,C[C@H]1[C@H]2[C@@H](CN1Cc3ccccc3)[C@@H](CO)[C@@H]2N4CCCC4,Ki,=,16000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,16000.0
11337,CHEMBL2062856,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@@H]([C@@H]12)c4ccc(Br)cc4,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,5000.0
11338,CHEMBL2062857,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@H]([C@H]12)c4ccc(Br)cc4,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,2000.0
11339,CHEMBL2062858,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@@H]([C@@H]12)c4ccccn4,Ki,=,42000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,42000.0
11340,CHEMBL2062859,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@H]([C@H]12)c4ccccn4,Ki,=,12000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,12000.0
11341,CHEMBL2062860,OC[C@H]1[C@H]2CN(Cc3ccccc3)[C@@H]([C@H]2[C@@H]1N4CCCCC4)c5ccccc5,Ki,=,7000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,7000.0
11342,CHEMBL2062861,OC[C@@H]1[C@@H]2CN(Cc3ccccc3)[C@H]([C@@H]2[C@H]1N4CCCCC4)c5ccccc5,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,B,2000.0
11346,CHEMBL2088198,CCc1cc2CC(Cc2cc1CC)NCCc3ccc(O)c4NC(=O)C=Cc34,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as increase in GTPgamma35S binding by scintillation proximity assay,B,5000.0
11350,CHEMBL2093001,COc1ccc(cc1c2ccc(CN3CCCCC[C@H]3c4ccccc4)[nH]2)S(=O)(=O)N(C)c5ccccc5,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",B,1584.89
11379,CHEMBL2111526,COc1ccc(Br)cc1c2occ(CNC3CCN(Cc4ccccc4)C3)n2,Ki,=,8250.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,B,8250.0
11380,CHEMBL2111526,COc1ccc(Br)cc1c2occ(CNC3CCN(Cc4ccccc4)C3)n2,Ki,=,6600.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,B,6600.0
11387,CHEMBL2111582,CCCN(C(C)C)[C@@H]1COc2cccc(C(=O)NC(C)C)c2C1,Ki,>,50000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]raclopride from D2A receptor expressed in mouse fibroblast (LtK-) cells,B,50000.0
11394,CHEMBL2112375,Cl.Cl.COc1cccc2C(CCCc12)NCCN3CCN(CC3)c4ccc(Cl)cc4,Ki,=,3180.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,B,3180.0
11404,CHEMBL2112911,Cl.Clc1cccc(N2CCN(CCCCNC(=O)c3oc4ccccc4c3)CC2)c1Cl,Ki,=,5740.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,B,5740.0
11407,CHEMBL2112936,N[C@H]1CCCC[C@@H]1NC(=O)c2c3N[C@@H]4CCCC[C@H]4Nc3c5C(=O)c6ccccc6c7ncnc2c57,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity against dopamine D2 receptor,B,3200.0
11408,CHEMBL2113241,Cc1coc2ccc(cc12)N3C[C@@]4(CN5CCC4CC5)OC3=O,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 receptor,B,5000.0
11410,CHEMBL2113243,CO\N=C(/CCN1CCN(CC1)c2ccccc2OC(C)C)\c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
11412,CHEMBL2113244,CO\N=C(\CCN1CCN(CC1)c2ccccc2OC(C)C)/c3ccc(F)cc3,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human recombinant D2 receptor expressed in HEK293 cells by FLIPR assay,F,5000.0
11414,CHEMBL2113348,Cl.O=C(N[C@@H]1CC[C@@H](CCN2CCc3cc(ccc3C2)C#N)CC1)c4ccc5ccccc5c4,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,B,1584.89
11424,CHEMBL2113386,Ic1ccccc1CS(=O)(=O)Nc2ccc3[nH]cc(C[C@H]4CCCN4)c3c2,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of [3H]spiperone binding to human dopamine receptor D2 expressed in CHO-K1 cells,B,2000.0
11426,CHEMBL2113718,N#Cc1cc(CN2CCN(CC2)c3ccccc3)c[nH]1,Ki,=,2400.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,B,2400.0
11427,CHEMBL2113718,N#Cc1cc(CN2CCN(CC2)c3ccccc3)c[nH]1,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,B,3400.0
11430,CHEMBL2115519,O=C1C[C@@]2(CC[C@@H](CC2)OCc3ccccc3)OC=C1c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,10000.0
11431,CHEMBL2115560,O=C1C[C@@]2(CC[C@H](CC2)OCc3ccccc3)OC=C1c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,B,10000.0
11432,CHEMBL2146597,O=C1Nc2ccccc2N1C3CCN(CC3)C4CCCCC4,Ki,>,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,1258.93
11447,CHEMBL2159456,Fc1cccc(OCCN2CCC(CNS(=O)(=O)c3cccs3)CC2)c1,Ki,=,1059.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,B,1059.0
11490,CHEMBL2164434,CCCCNC(=O)c1cc2ccccc2[nH]1,Ki,=,13570.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,B,13570.0
11583,CHEMBL2165126,Clc1cccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293T cell membranes coexpressing Galphao1 assessed as induction of nucleotide exchange preincubated for 30 mins followed by addition of [35S]GTPgammaS measured after 30 mins by [35S]GTPgammaS binding assay,B,2500.0
11601,CHEMBL2165129,Clc1cccc(N2CCN(CC#CCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,1004.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,B,1004.0
11602,CHEMBL2165129,Clc1cccc(N2CCN(CC#CCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,Ki,=,1004.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100 C.), and Melitilex-A (Wallac) scintillant was applied.",B,1004.0
11631,CHEMBL2165133,Clc1cccc(N2CCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,1850.0
11707,CHEMBL2179222,COc1ccc(cc1NC2CCN(C)CC2)S(=O)(=O)n3cc(C)c4cc(Cl)cnc34,Ki,=,1812.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor,B,1812.0
11711,CHEMBL2180637,CCCCCN(CCc1ccccc1)CCc2cccc(O)c2,Ki,=,1420.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,B,1420.0
11716,CHEMBL2180639,Oc1cccc(CCN(CCc2ccccc2)CC3CCC3)c1,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as stimulation of mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,F,5000.0
11718,CHEMBL2180640,CCCCN(CCc1ccccc1)CCc2cccc(O)c2,Ki,=,1233.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,B,1233.0
11720,CHEMBL2180641,CCCCCCN(CCc1ccccc1)CCc2cccc(O)c2,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as stimulation of mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,F,5000.0
11722,CHEMBL2203406,CCCN(CC[C@@]1(O)C[C@H](C1)NC(=O)c2ccc3ccccc3c2)[C@H]4CCc5nc(N)sc5C4,Ki,>,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]YM-09151-2 from human cloned dopamine D2 receptor expressed in CHOp cells after 60 mins by scintillation counter,B,4000.0
11751,CHEMBL2205831,OC12C3C4CC5C6C4C1C6C(C35)N2CC7CCCCC7,Ki,=,2830.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 dopamine receptor,B,2830.0
11752,CHEMBL2205831,OC12C3C4CC5C6C4C1C6C(C35)N2CC7CCCCC7,Ki,=,2830.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,B,2830.0
11780,CHEMBL2207488,CCCN1CCC(CC1)c2coc3ccccc23,Ki,=,2717.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,2717.0
11784,CHEMBL2207490,CCCN1CCC(CC1)c2n[nH]c3ccccc23,Ki,=,1066.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,1066.0
11786,CHEMBL2207491,CCCN1CCC(CC1)n2ccc3ccccc23,Ki,=,1136.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,1136.0
11787,CHEMBL2207492,CCCN1CCC(CC1)n2cnc3ccccc23,Ki,=,10820.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,10820.0
11788,CHEMBL2207492,CCCN1CCC(CC1)n2cnc3ccccc23,IC50,>,580000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,290000.0
11791,CHEMBL2207494,CCCN1CCC(CC1)N2C(=O)N(C)c3cc(Cl)ccc23,Ki,=,5182.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,5182.0
11792,CHEMBL2207494,CCCN1CCC(CC1)N2C(=O)N(C)c3cc(Cl)ccc23,Ki,=,2002.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,2002.0
11793,CHEMBL2207495,CCCN1CCC(CC1)N2C(=O)C(=O)c3ccccc23,Ki,=,12830.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,12830.0
11794,CHEMBL2207495,CCCN1CCC(CC1)N2C(=O)C(=O)c3ccccc23,Ki,=,12160.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,12160.0
11797,CHEMBL2207497,CCCN1CCC(CC1)c2ccc3ccccc3c2,Ki,=,1535.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,B,1535.0
11798,CHEMBL2207497,CCCN1CCC(CC1)c2ccc3ccccc3c2,Ki,=,2870.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,2870.0
11800,CHEMBL2207498,CCCN1CCC(CC1)c2cc3ccccc3s2,Ki,=,2325.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,B,2325.0
11831,CHEMBL2219578,O=C(N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1)c4cc5ccccc5[nH]4,Kb,=,2510.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,2510.0
11875,CHEMBL2303762,OC[C@H]1O[C@H](Oc2ccc(CC3NCCc4cc(O)c(O)cc34)cc2)[C@H](O)[C@H](O)[C@H]1O,Ki,=,11400.0,nM,Dopamine D2 receptor,Homo sapiens,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,B,11400.0
11876,CHEMBL2303762,OC[C@H]1O[C@H](Oc2ccc(CC3NCCc4cc(O)c(O)cc34)cc2)[C@H](O)[C@H](O)[C@H]1O,IC50,=,2420.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibitory concentration against binding of [3H]spiperone to human D2 dopaminergic receptor,B,1210.0
11884,CHEMBL2314732,COc1ccc2C[C@@H]3N(CCc4cc5OCOc5cc34)Cc2c1O,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,B,5000.0
11890,CHEMBL2323582,CC1=CC(=[N+]2C1=C(c3ccc(OCCCN4CCCCC4)cc3)c5c(C)cc(C)n5[B-]2(F)F)C,Ki,=,1971.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO-K1 cells,B,1971.0
11896,CHEMBL2325929,CN1CCC(CC1)c2cn(c3ccncc3)c4ccc(cc24)c5cnn(C)c5,Ki,=,6400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,B,6400.0
11902,CHEMBL2325933,CN1CCC(CC1)c2cn(c3ccncc3)c4ccc(cc24)c5cccnc5,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,B,1100.0
11921,CHEMBL2326471,Nc1nc2cc3CCN(Cc4nocn4)CCc3cc2s1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,5000.0
11934,CHEMBL2326475,Nc1nc2cc3CCN(CCc3cc2s1)C(=O)c4ccccc4,Ki,=,4300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,4300.0
11958,CHEMBL2326483,Nc1nc2cc3CCN(Cc4ccccn4)CCc3cc2s1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,5000.0
11970,CHEMBL2326487,Nc1nc2cc3CCNCCc3cc2s1,Ki,=,3900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,3900.0
11973,CHEMBL2326488,CN1CCc2cc3nc(N)sc3cc2CC1,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,1500.0
11976,CHEMBL2326489,CCN1CCc2cc3nc(N)sc3cc2CC1,Ki,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,2500.0
11979,CHEMBL2326490,Nc1nc2cc3CCN(CCc3cc2s1)C4CC4,Ki,=,1100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,1100.0
11982,CHEMBL2326491,Nc1nc2cc3CCN(CC(F)(F)F)CCc3cc2s1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,5000.0
11985,CHEMBL2326492,CN(C)C(=O)CN1CCc2cc3nc(N)sc3cc2CC1,Ki,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,B,5000.0
12003,CHEMBL2334887,COc1cc2[C@@H]3Cc4ccc(OC)c(O)c4CN3CCc2cc1O,Ki,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,B,5000.0
12032,CHEMBL2335739,COc1ccc2[C@H]3C[C@@](O)(CCN3CCc2c1)c4ccc(Cl)cc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,B,10000.0
12046,CHEMBL2336284,CCCN1CCC(CC1)c2cccc(OC)c2,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,1500.0
12047,CHEMBL2336284,CCCN1CCC(CC1)c2cccc(OC)c2,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,1584.89
12053,CHEMBL2336289,CCCN1CCC(CC1)c2cccc(c2)S(=O)(=O)C3CCCC3,Ki,=,3800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,3800.0
12054,CHEMBL2336289,CCCN1CCC(CC1)c2cccc(c2)S(=O)(=O)C3CCCC3,Ki,=,3981.07,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,B,3981.07
12084,CHEMBL2368733,F[C@H]1CCNC[C@@H]1c2c([nH]c3ccccc23)c4ccccc4,Ki,>,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1700.0
12085,CHEMBL2368734,F[C@@H]1CCNC[C@H]1c2c([nH]c3cc(F)ccc23)c4cocc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
12086,CHEMBL2368748,O[C@@H]1CCNC[C@H]1c2c([nH]c3ccccc23)c4ccccc4,Ki,>,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,B,1600.0
12157,CHEMBL2391541,COc1ccc2[nH]cc(CCN(CC=C)CC=C)c2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,B,10000.0
12158,CHEMBL2391541,COc1ccc2[nH]cc(CCN(CC=C)CC=C)c2c1,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,B,10000.0
12199,CHEMBL2397389,CCCN(CCCCNC(=O)c1ccc(cc1)c2ccccc2)[C@@H]3CCC(=CC3)C#C,EC50,=,2400.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2S receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1200.0
12310,CHEMBL2413154,COc1ccccc1N2CCN(CCCCN3N=CC(=O)N(C)C3=O)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine 2 receptor (unknown origin),B,10000.0
12312,CHEMBL2420769,C(N1CCN(CC1)c2ccccc2)c3cccs3,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,10000.0
12313,CHEMBL2420770,Fc1ccccc1N2CCN(Cc3cccs3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,10000.0
12314,CHEMBL2420771,Clc1ccccc1N2CCN(Cc3cccs3)CC2,Ki,=,2179.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,2179.0
12315,CHEMBL2420772,Clc1cccc(N2CCN(Cc3cccs3)CC2)c1Cl,Ki,=,1545.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,1545.0
12317,CHEMBL2420774,Oc1ccccc1N2CCN(Cc3cccs3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,10000.0
12318,CHEMBL2420775,Fc1ccc(cc1)N2CCN(Cc3cccs3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,10000.0
12319,CHEMBL2420776,Clc1ccc(cc1)N2CCN(Cc3cccs3)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,10000.0
12320,CHEMBL2420777,Clc1ccc(cc1Cl)N2CCN(Cc3cccs3)CC2,Ki,=,1593.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,1593.0
12321,CHEMBL2420778,Oc1ccc(cc1)N2CCN(Cc3cccs3)CC2,Ki,=,2167.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2 receptor,B,2167.0
12342,CHEMBL2432039,C(N[C@H]1C2C3CC4C5C3CC2C5C14)C67C8C9C%10C(C6C8%10)C79,Ki,=,5675.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,B,5675.0
12350,CHEMBL2432047,C(N[C@H]1C2C3CC4C5C3CC2C5C14)c6cccnc6,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,B,10000.0
12351,CHEMBL2432048,C(Cc1ccccc1)N[C@H]2C3C4CC5C6C4CC3C6C25,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,B,10000.0
12352,CHEMBL2432049,C(Cc1ccccn1)N[C@H]2C3C4CC5C6C4CC3C6C25,Ki,=,9906.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,B,9906.0
12353,CHEMBL2432050,Fc1cccc(CCCN[C@H]2C3C4CC5C6C4CC3C6C25)c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,B,10000.0
12361,CHEMBL2432058,CN(CCc1ccccc1)[C@H]2C3C4CC5C6C4CC3C6C25,Ki,=,5096.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,B,5096.0
12380,CHEMBL2436555,Cl.NC1=Nc2ccc(Cl)cc2CN1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [[3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in human fibroblasts after 90 mins by scintillation counting analysis,B,10000.0
12388,CHEMBL2443000,COc1ccccc1N2CCN(Cc3cn(CCOCCOCCF)nn3)CC2,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,3400.0
12389,CHEMBL2443000,COc1ccccc1N2CCN(Cc3cn(CCOCCOCCF)nn3)CC2,Ki,=,7700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,7700.0
12390,CHEMBL2443001,COc1ccccc1N2CCN(Cc3cn(CCOCCOCCOCCF)nn3)CC2,Ki,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,4700.0
12391,CHEMBL2443001,COc1ccccc1N2CCN(Cc3cn(CCOCCOCCOCCF)nn3)CC2,Ki,=,8300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,8300.0
12392,CHEMBL2443002,COc1ccccc1N2CCN(Cc3cn(nn3)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)CC2,Ki,=,42000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,42000.0
12393,CHEMBL2443002,COc1ccccc1N2CCN(Cc3cn(nn3)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)CC2,Ki,=,23000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,23000.0
12394,CHEMBL2443003,COc1ccccc1N2CCN(Cc3cn(nn3)[C@@H]4O[C@H](CF)[C@@H](O)[C@H](O)[C@H]4O)CC2,Ki,=,51000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,51000.0
12395,CHEMBL2443003,COc1ccccc1N2CCN(Cc3cn(nn3)[C@@H]4O[C@H](CF)[C@@H](O)[C@H](O)[C@H]4O)CC2,Ki,=,24000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,24000.0
12396,CHEMBL2443004,COc1ccccc1N2CCN(Cc3cn(nn3)c4ccc(OCCF)cc4)CC2,Ki,=,18000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,18000.0
12397,CHEMBL2443004,COc1ccccc1N2CCN(Cc3cn(nn3)c4ccc(OCCF)cc4)CC2,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,1600.0
12400,CHEMBL2443006,COc1ccccc1N2CCN(Cc3cn(nn3)c4ccc(OCCOCCOCCF)cc4)CC2,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,2900.0
12401,CHEMBL2443006,COc1ccccc1N2CCN(Cc3cn(nn3)c4ccc(OCCOCCOCCF)cc4)CC2,Ki,=,2700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,2700.0
12404,CHEMBL2443008,COc1ccccc1N2CCN(Cc3cn(nn3)c4ccc(OCCCOC5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5F)cc4)CC2,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,B,1500.0
12405,CHEMBL2443008,COc1ccccc1N2CCN(Cc3cn(nn3)c4ccc(OCCCOC5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5F)cc4)CC2,Ki,=,4100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,4100.0
12409,CHEMBL2443010,COc1ccccc1N2CCN(Cc3cn(CCOCCF)nn3)CC2,Ki,=,1600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,B,1600.0
12410,CHEMBL2448165,COc1cc(N)c(Cl)cc1C(=O)N[C@@H]2C3CC4CN(C3)CC24,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine receptor D2,B,5000.0
12422,CHEMBL3084507,COc1ccccc1[C@]2(O)C[C@H]3CC[C@@H](C2)N3Cc4c[nH]c5ccccc45,Ki,=,2070.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,B,2070.0
12461,CHEMBL3085215,CCCN(C(C)C)[C@@H]1COc2cccc(C(=O)C)c2C1,Ki,=,30100.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2A by measuring its ability to displace [3H]raclopride from D2A receptor expressed in mouse fibroblast (LtK-) cells,B,30100.0
12462,CHEMBL3085216,CCCN(C(C)C)[C@H]1COc2cccc(C(=O)N)c2C1,Ki,>,50000.0,nM,Dopamine D2 receptor,Homo sapiens,In vitro binding affinity at human cloned Dopamine receptor D2A measured by ability to displace [3H]raclopride from D2A receptor expressed in mouse fibroblast (LtK-) cells,B,50000.0
12471,CHEMBL3085813,CC(C)(C)OC(=O)NC[C@@H]1CC[C@@H](CN2CCc3ccccc3C2)CC1,Ki,=,1148.15,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,1148.15
12474,CHEMBL3085814,CC(C)(C)OC(=O)N[C@@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,Ki,=,1071.52,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,1071.52
12480,CHEMBL3085816,CN(C)C(=O)N[C@@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,Ki,=,13489.63,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,13489.63
12486,CHEMBL3085818,CC(C)(C)OC(=O)N[C@@H]1CC[C@@H](CCN2CCc3ccc(cc3C2)C#N)CC1,Ki,=,2238.72,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,2238.72
12516,CHEMBL3088210,CC(=O)N[C@@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1,Ki,=,6025.6,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,6025.6
12519,CHEMBL3088211,CCOC(=O)N[C@@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1,Ki,=,2691.53,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,2691.53
12522,CHEMBL3088212,CC(C)OC(=O)N[C@@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1,Ki,=,1479.11,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,1479.11
12525,CHEMBL3088213,CC(C)COC(=O)N[C@@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1,Ki,=,5248.07,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,B,5248.07
12536,CHEMBL3092753,NC(=NC(=O)c1ccc2c(Cc3ccccc23)c1)N,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,1400.0
12582,CHEMBL3099716,CC1(C)OC(=O)N([C@@H]2CC[C@H](CC2)c3cnc(N)c(c3)c4ncccn4)[C@H]1c5ccccc5,IC50,>,48500.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,24250.0
12586,CHEMBL3104092,CN1CCc2c(C1)c3cccc4Cc5ccccc5Cn2c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),B,10000.0
12587,CHEMBL3104093,CN1CCc2c(C1)c3cccc4c5ccccc5CCn2c34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),B,10000.0
12593,CHEMBL3104518,Fc1ccc(cc1)C(=O)C2CCN(CC3CC(=O)c4ccc(cc4C3)c5ccccc5)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2 receptor,B,10000.0
12605,CHEMBL3113639,CCCNCC1=Cc2ccccc2OC1=O,IC50,>,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,15000.0
12606,CHEMBL3113641,[O-][N+](=O)c1ccc2OC(=O)C(=Cc2c1)CN3CCCC3,IC50,>,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,15000.0
12607,CHEMBL3113642,FC(F)(F)c1ccc2OC(=O)C(=Cc2c1)CN3CCCC3,IC50,>,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,15000.0
12608,CHEMBL3113643,FC(F)(F)Oc1ccc2OC(=O)C(=Cc2c1)CN3CCCC3,IC50,>,26000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,13000.0
12609,CHEMBL3113644,Nc1ccc2OC(=O)C(=Cc2c1)CN3CCCC3,IC50,=,16280.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,8140.0
12610,CHEMBL3113646,COc1ccc2OC(=O)C(=Cc2c1)CN3CCCC3,IC50,>,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,B,15000.0
12708,CHEMBL3134063,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCCCCNC(=O)OC(C)(C)C)c(O)c34,IC50,=,6540.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,3270.0
12712,CHEMBL3134064,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCC(=O)NCCCOc5ccc6C[C@H]7N(C)CCc8cccc(c78)c6c5O)c(O)c34,IC50,=,4360.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,2180.0
12716,CHEMBL3134065,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCCCC(=O)NCCCOc5ccc6C[C@H]7N(C)CCc8cccc(c78)c6c5O)c(O)c34,IC50,=,5320.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,2660.0
12720,CHEMBL3134066,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCCCCCC(=O)NCCCOc5ccc6C[C@H]7N(C)CCc8cccc(c78)c6c5O)c(O)c34,IC50,=,3600.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,1800.0
12736,CHEMBL3134070,CN1CCc2cccc3c2[C@H]1Cc4ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCC(=O)NCCCOc5ccc6C[C@H]7N(C)CCc8cccc(c78)c6c5O)c(O)c34,IC50,=,2680.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,B,1340.0
12842,CHEMBL3234545,CN1C(=O)c2ccccc2[S@@+]([O-])c3ccc(cc13)C(=O)NCCc4cccs4,Ki,>,50000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,B,50000.0
12858,CHEMBL3265065,CCCN(CC[C@@]1(O)C[C@@H](C1)NC(=O)c2ccc3ccccc3c2)[C@H]4C[C@@H]4c5cccc(Cl)c5,Ki,=,1220.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,B,1220.0
12877,CHEMBL3286567,C1CN2C(CN1)Cc3c[nH]c4cccc2c34,Ki,=,2100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,2100.0
12878,CHEMBL3286567,C1CN2C(CN1)Cc3c[nH]c4cccc2c34,Ki,=,2089.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,B,2089.3
12917,CHEMBL3287280,F[C@@H](CCNC(=O)c1oc2ccccc2c1)CN3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,2500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,B,2500.0
12918,CHEMBL3287281,FCC(CCNC(=O)c1oc2ccccc2c1)N3CCN(CC3)c4cccc(Cl)c4Cl,Ki,=,7400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,B,7400.0
13025,CHEMBL3287898,CCc1ccccc1NC(=O)N2C[C@@H](C)Oc3cc(ccc23)c4ccc(cc4)[C@@H]5CC[C@@H](CC(=O)O)CC5,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of D2 receptor (unknown origin),B,5000.0
13029,CHEMBL3289642,Fc1ccc2C(=O)C(CCN3CCN(CC3)c4ccc(Cl)cc4)Cc2c1,Ki,=,1543.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1543.0
13030,CHEMBL3289642,Fc1ccc2C(=O)C(CCN3CCN(CC3)c4ccc(Cl)cc4)Cc2c1,Ki,=,1548.82,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1548.82
13031,CHEMBL3289643,Clc1ccc(cc1)N2CCN(CCC3Cc4ccccc4C3=O)CC2,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,10000.0
13032,CHEMBL3289644,Fc1ccc2CC(CCN3CCN(CC3)c4ccc(Cl)cc4)Cc2c1,Ki,=,1417.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1417.0
13033,CHEMBL3289645,FC(F)(F)c1ccc(OCCCN2CCN(CC2)c3ccccn3)cc1,Ki,=,1092.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1092.0
13034,CHEMBL3289645,FC(F)(F)c1ccc(OCCCN2CCN(CC2)c3ccccn3)cc1,Ki,=,1096.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1096.48
13035,CHEMBL3289646,Cc1ccc(nc1)N2CCN(CCCOc3ccc(F)cc3)CC2,Ki,=,1046.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1046.0
13036,CHEMBL3289646,Cc1ccc(nc1)N2CCN(CCCOc3ccc(F)cc3)CC2,Ki,=,1047.13,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1047.13
13037,CHEMBL3289647,Cc1ccc(nc1)N2CCN(CCCSc3ccc(F)cc3)CC2,Ki,=,1106.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1106.0
13039,CHEMBL3289648,Cc1ccc(nc1)N2CCN(CCCCc3ccc(F)cc3)CC2,Ki,=,1861.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1861.0
13040,CHEMBL3289648,Cc1ccc(nc1)N2CCN(CCCCc3ccc(F)cc3)CC2,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1995.26
13041,CHEMBL3289649,Clc1ccc(cc1)N2CCN(CCCCCc3oc4ccccc4n3)CC2,Ki,=,3108.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,3108.0
13043,CHEMBL3286429,Clc1ccc(cc1)N2CCN(CCCc3oc4ccccc4n3)CC2,Ki,=,3962.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,3962.0
13046,CHEMBL3289653,Clc1ccc(cc1)N2CCN(CCCc3oc4ccccc4c3)CC2,Ki,=,1979.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1979.0
13048,CHEMBL3289655,Clc1ccc(cc1)N2CCCN(CCCc3oc4ccccc4c3)CC2,Ki,=,2507.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,2507.0
13078,CHEMBL3289967,Cc1cccc(c1)S(=O)(=O)NCCCN2CCN(CC2)c3noc4ccccc34,Ki,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,2000.0
13080,CHEMBL3289969,Clc1ccc(cc1Cl)S(=O)(=O)NCCCN2CCN(CC2)c3noc4ccccc34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,10000.0
13082,CHEMBL3289971,Fc1ccc(cc1Cl)S(=O)(=O)NCCCN2CCN(CC2)c3noc4ccccc34,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,10000.0
13088,CHEMBL3289977,O=S(=O)(NCCCN1CCN(CC1)c2noc3ccccc23)c4ccc5ccccc5c4,Ki,=,7200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,7200.0
13092,CHEMBL3289979,Clc1ccc2cc(ccc2c1)S(=O)(=O)NCCCN3CCN(CC3)c4noc5ccccc45,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,10000.0
13095,CHEMBL3289982,O=S(=O)(NCCCCN1CCN(CC1)c2noc3ccccc23)c4cc5ccccc5s4,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,1300.0
13098,CHEMBL3289985,Cc1c(sc2ccc(F)cc12)S(=O)(=O)NCCCN3CCN(CC3)c4noc5ccccc45,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,10000.0
13101,CHEMBL3289988,O=S(=O)(NCCCN1CCN(CC1)c2noc3ccccc23)c4cccc5scnc45,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,B,10000.0
13157,CHEMBL3298200,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCCN3CCC(O)(CC3)c4ccc(Cl)cc4,Ki,=,2250.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,2250.0
13158,CHEMBL3298200,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCCN3CCC(O)(CC3)c4ccc(Cl)cc4,Ki,=,2238.72,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,2238.72
13161,CHEMBL3298685,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCCCN3CCC(O)(CC3)c4ccc(Cl)cc4,Ki,=,1980.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,1980.0
13162,CHEMBL3298685,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCCCN3CCC(O)(CC3)c4ccc(Cl)cc4,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,1995.26
13165,CHEMBL3298755,OC1(CCNCC1)c2ccc(Cl)cc2,Ki,=,9090.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,9090.0
13166,CHEMBL3298755,OC1(CCNCC1)c2ccc(Cl)cc2,Ki,=,9120.11,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,9120.11
13167,CHEMBL3298756,CC(C)(C)OC(=O)NCCN1CCC(O)(CC1)c2ccc(Cl)cc2,Ki,=,2750.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,2750.0
13168,CHEMBL3298756,CC(C)(C)OC(=O)NCCN1CCC(O)(CC1)c2ccc(Cl)cc2,Ki,=,2754.23,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,2754.23
13170,CHEMBL3298757,CC(C)(C)OC(=O)NCCCN1CCC(O)(CC1)c2ccc(Cl)cc2,Ki,=,1350.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,1350.0
13171,CHEMBL3298757,CC(C)(C)OC(=O)NCCCN1CCC(O)(CC1)c2ccc(Cl)cc2,Ki,=,1348.96,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,1348.96
13181,CHEMBL3298825,CC(C)(C)OC(=O)NCCCCN1CCC(O)(CC1)c2ccc(Cl)cc2,Ki,=,2110.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,2110.0
13182,CHEMBL3298825,CC(C)(C)OC(=O)NCCCCN1CCC(O)(CC1)c2ccc(Cl)cc2,Ki,=,2089.3,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,2089.3
13249,CHEMBL3299091,CC(C)(C)OC(=O)NCCCCCN1CCC(O)(CC1)c2ccc(Cl)cc2,Ki,=,2050.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,2050.0
13250,CHEMBL3299091,CC(C)(C)OC(=O)NCCCCCN1CCC(O)(CC1)c2ccc(Cl)cc2,Ki,=,2041.74,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,2041.74
13292,CHEMBL3299099,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCN3CCC(O)(CC3)c4ccc(Cl)cc4,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,1700.0
13293,CHEMBL3299099,Cc1cc(C)c2c(N)c(sc2n1)C(=O)NCCCN3CCC(O)(CC3)c4ccc(Cl)cc4,Ki,=,1698.24,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,B,1698.24
13298,CHEMBL3311308,COc1ccc(cc1)S(=O)(=O)Nc2c(C)cc(C)cc2C,IC50,>,31622.78,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor by GTPgS SPA/summary (Abse5) assay,B,15811.39
13299,CHEMBL3311308,COc1ccc(cc1)S(=O)(=O)Nc2c(C)cc(C)cc2C,IC50,>,30199.52,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor by GTPgS SPA assay,B,15099.76
13376,CHEMBL3322997,CC(C)(C)c1cc(cc(c1)C(C)(C)C)N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,Ki,=,1303.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,1303.0
13384,CHEMBL3322999,FC(F)(F)c1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c5ccccc5n1,Ki,=,13567.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,13567.0
13385,CHEMBL3323000,FC(F)(F)c1ccc2c(ccnc2c1)N3CCN(CCCCNC(=O)c4cn5ccccc5n4)CC3,Ki,=,4983.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,4983.0
13386,CHEMBL3323001,Clc1ccc2c(ccnc2c1)N3CCN(CCCCNC(=O)c4cn5ccccc5n4)CC3,Ki,=,1883.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,1883.0
13387,CHEMBL3323002,O=C(NCCCCN1CCN(CC1)c2ccc3ccccc3n2)c4cn5ccccc5n4,Ki,=,1563.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,1563.0
13388,CHEMBL3323003,O=C(NCCCCN1CCN(CC1)c2ncnc3ccccc23)c4cn5ccccc5n4,Ki,=,1133.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,1133.0
13395,CHEMBL3323004,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c5ccccc5n1,Ki,=,1452.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,1452.0
13396,CHEMBL3323005,Cc1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,Ki,=,24938.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,24938.0
13397,CHEMBL3323006,Cc1cc(nc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,Ki,=,3646.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,3646.0
13398,CHEMBL3323007,Cc1nc(cc(n1)C(C)(C)C)N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,Ki,=,4604.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,4604.0
13405,CHEMBL3323011,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2,IC50,=,2300.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,B,1150.0
13469,CHEMBL3323117,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)[C@@H]3CC[C@H](CC3)c4ccccc4)CC2,Ki,=,1510.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,B,1510.0
13505,CHEMBL3335535,C(Cc1ccccc1)C2CN(Cc3nc4ccccc4[nH]3)CCO2,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,100000.0
13506,CHEMBL3335535,C(Cc1ccccc1)C2CN(Cc3nc4ccccc4[nH]3)CCO2,IC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,50000.0
13507,CHEMBL3335536,C(Cc1ccccc1)[C@H]2CN(Cc3nc4ccccc4[nH]3)CCO2,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,100000.0
13508,CHEMBL3335536,C(Cc1ccccc1)[C@H]2CN(Cc3nc4ccccc4[nH]3)CCO2,IC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,50000.0
13509,CHEMBL3335537,C(Cc1ccccc1)[C@@H]2CN(Cc3nc4ccccc4[nH]3)CCO2,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,100000.0
13510,CHEMBL3335537,C(Cc1ccccc1)[C@@H]2CN(Cc3nc4ccccc4[nH]3)CCO2,IC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,50000.0
13511,CHEMBL3335537,C(Cc1ccccc1)[C@@H]2CN(Cc3nc4ccccc4[nH]3)CCO2,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,100000.0
13513,CHEMBL3335538,FC(F)(F)Oc1ccc(CN2CCOC(CCc3ccccc3)C2)cc1,Ki,=,5500.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor,B,5500.0
13515,CHEMBL3335539,COc1ccc(CN2CCOC(CCc3ccccc3)C2)cc1,IC50,=,16500.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor,B,8250.0
13519,CHEMBL3335554,FC(F)(F)Oc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1,Ki,=,5500.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor,B,5500.0
13521,CHEMBL3335555,Oc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1,IC50,=,16500.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2L receptor,B,8250.0
13596,CHEMBL3354073,OCCCCCC1CCN(CCCN2C(=O)CCc3ccccc23)CC1,Ki,=,1174.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,A,1174.9
13599,CHEMBL3357315,FC1CN(CCNC(=O)c2ccc(F)c(F)c2)CCC1N3C(=O)Nc4ccccc34,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of dopamine D2 receptor (unknown origin),B,5000.0
13600,CHEMBL3358098,O=C(NCCCCN1CCN(CC1)c2ccccn2)c3cc4ccccc4cn3,Ki,=,5596.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,5596.0
13624,CHEMBL3358506,Cc1cccc(c1)N2CCN(CCCCNC(=O)[C@H]3CCc4ccccc4N3)CC2,Ki,=,3412.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to dopamine D2 receptor (unknown origin),B,3412.0
13660,CHEMBL3394260,COC(=O)CCCCCCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(nc3n2)c4occc4)cc1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13661,CHEMBL3394260,COC(=O)CCCCCCCCCCCNC(=O)CCCOc1ccc(CCNc2nc(N)n3nc(nc3n2)c4occc4)cc1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13663,CHEMBL3394261,Nc1nc(NCCc2ccc(Oc3nc(Cl)nc(n3)N4CCOCC4)cc2)nc5nc(nn15)c6occc6,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13664,CHEMBL3394261,Nc1nc(NCCc2ccc(Oc3nc(Cl)nc(n3)N4CCOCC4)cc2)nc5nc(nn15)c6occc6,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13669,CHEMBL3394263,CCCN(CCc1cccc2NC(=O)Cc12)c3nc(N)n4nc(nc4n3)c5occc5,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13670,CHEMBL3394263,CCCN(CCc1cccc2NC(=O)Cc12)c3nc(N)n4nc(nc4n3)c5occc5,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13687,CHEMBL3394269,CC(C)(C)NC(=O)OC1CCN(CCc2cccc3NC(=O)Cc23)CC1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13688,CHEMBL3394269,CC(C)(C)NC(=O)OC1CCN(CCc2cccc3NC(=O)Cc23)CC1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13690,CHEMBL3394270,NC1CCN(CCc2cccc3NC(=O)Cc23)CC1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13691,CHEMBL3394270,NC1CCN(CCc2cccc3NC(=O)Cc23)CC1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13693,CHEMBL3394271,Nc1nc(NC2CCN(CCc3cccc4NC(=O)Cc34)CC2)nc5nc(nn15)c6occc6,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13694,CHEMBL3394271,Nc1nc(NC2CCN(CCc3cccc4NC(=O)Cc34)CC2)nc5nc(nn15)c6occc6,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13696,CHEMBL3394272,CC(C)(C)OC(=O)N1CCN(CCc2cccc3NC(=O)Cc23)CC1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13697,CHEMBL3394272,CC(C)(C)OC(=O)N1CCN(CCc2cccc3NC(=O)Cc23)CC1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13699,CHEMBL3394273,CC(C)(C)OC(=O)N1CCCN(CCc2cccc3NC(=O)Cc23)CC1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13700,CHEMBL3394273,CC(C)(C)OC(=O)N1CCCN(CCc2cccc3NC(=O)Cc23)CC1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13702,CHEMBL3394274,O=C1Cc2c(CCN3CCNCC3)cccc2N1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13703,CHEMBL3394274,O=C1Cc2c(CCN3CCNCC3)cccc2N1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13705,CHEMBL3394275,[O-]C(=O)C(F)(F)F.O=C1Cc2c(CCN3CCC[NH2+]CC3)cccc2N1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13706,CHEMBL3394275,[O-]C(=O)C(F)(F)F.O=C1Cc2c(CCN3CCC[NH2+]CC3)cccc2N1,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13708,CHEMBL3394276,Nc1nc(nc2nc(nn12)c3occc3)N4CCN(CCc5cccc6NC(=O)Cc56)CC4,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13709,CHEMBL3394276,Nc1nc(nc2nc(nn12)c3occc3)N4CCN(CCc5cccc6NC(=O)Cc56)CC4,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13711,CHEMBL3394277,Nc1nc(nc2nc(nn12)c3occc3)N4CCC[NH+](CCc5cccc6NC(=O)Cc56)CC4.[O-]C(=O)C(F)(F)F,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13712,CHEMBL3394277,Nc1nc(nc2nc(nn12)c3occc3)N4CCC[NH+](CCc5cccc6NC(=O)Cc56)CC4.[O-]C(=O)C(F)(F)F,EC50,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes incubated for 1 hr by [35S]GTPgammaS binding assay,F,50000.0
13829,CHEMBL3423400,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2N(CCc3c2[nH]c4ccccc34)C1)C(=O)N[C@@H](Cc5ccc(F)cc5)C(=O)N6C[C@@H](N)C[C@H]6C(=O)N,Kd,=,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,B,5000.0
13830,CHEMBL3423401,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2N(CCc3c2[nH]c4ccccc34)C1)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N[C@@H](CCCCN)C(=O)N,Kd,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,B,6300.0
13831,CHEMBL3423402,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]3CCCN3C(=O)CCCCCNC(=O)[C@H]4CC[C@H]5N(CCc6c5[nH]c7ccccc67)C4)C(=O)N,Kd,=,7000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,B,7000.0
13834,CHEMBL3423403,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@@H]2CCCN2C(=O)CCCCCNC(=O)[C@H]3CC[C@H]4N(CCc5c4[nH]c6ccccc56)C3)C(=O)N,Kd,=,9000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,B,9000.0
13835,CHEMBL3423404,CCCC[C@H](NC(=O)[C@H]1CC[C@H]2N(CCc3c2[nH]c4ccccc34)C1)C(=O)N[C@@H](Cc5ccc(O)cc5)C(=O)N[C@@H](CCCCN)C(=O)N,Kd,=,4700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,B,4700.0
13837,CHEMBL3423405,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@H]2N(CCc3c2[nH]c4ccccc34)C1)C(=O)N[C@@H](Cc5c[nH]c6ccccc56)C(=O)N7C[C@@H](N)C[C@H]7C(=O)N,Kd,=,20000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,B,20000.0
13839,CHEMBL3423406,CCCC[C@H](NC(=O)[C@H]1CC[C@H]2N(CCc3c2[nH]c4ccccc34)C1)C(=O)N[C@@H](Cc5c[nH]c6ccccc56)C(=O)N[C@@H](CCCCN)C(=O)N,Kd,=,16000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,B,16000.0
13841,CHEMBL3423407,CCCC[C@H](NC(=O)[C@H]1CC[C@H]2N(CCc3c2[nH]c4ccccc34)C1)C(=O)N[C@@H](Cc5ccc(F)c(F)c5)C(=O)N[C@@H](CCCCN)C(=O)N,Kd,=,8000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,B,8000.0
13843,CHEMBL3423408,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@H]2N(CCc3c2[nH]c4ccccc34)C1)C(=O)N[C@@H](Cc5ccc(F)cc5)C(=O)N6C[C@@H](N)C[C@H]6C(=O)N,Kd,=,13000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,B,13000.0
13844,CHEMBL3423409,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@H]2N(CCc3c2[nH]c4ccccc34)C1)C(=O)N[C@@H](Cc5ccc(F)cc5)C(=O)N[C@@H](CCCCN)C(=O)N,Kd,=,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 2 hrs by scintillation counting analysis,B,2000.0
13846,CHEMBL3423410,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]2CCCN2C(=O)CCCCCNC(=O)[C@H]3CC[C@H]4N(CCc5c4[nH]c6ccccc56)C3)C(=O)N,Kd,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,B,4000.0
13853,CHEMBL3423411,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]2CCCN2C(=O)CCCCCNC(=O)[C@@H]3CC[C@@H]4N(CCc5c4[nH]c6ccccc56)C3)C(=O)N,Kd,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-YM09151-2 from dopamine D2 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 2 hrs by scintillation counting analysis,B,14000.0
13877,CHEMBL3577343,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)[C@@H]3COC(=CC3)C#C)nn1,EC50,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2S receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1450.0
13891,CHEMBL3577344,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)CCc3ccc(O)c4NC(=O)C=Cc34)nn1,EC50,=,3800.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galpha0i assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,1900.0
13893,CHEMBL3577344,CCCCn1cc(CCCOc2ccc(cc2OC)C(=O)NCCCCN(CCC)CCc3ccc(O)c4NC(=O)C=Cc34)nn1,EC50,=,7300.0,nM,Dopamine D2 receptor,Homo sapiens,Intrinsic activity at human dopamine D2L receptor expressed in HEK293 cells co-transfected with Galphai2 assessed as [35S]GTPgammaS binding after 30 mins by [35S]GTPgammaS incorporation assay,B,3650.0
13928,CHEMBL3581320,Fc1ccc2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cc5ccccc5[nH]4)Cc2c1,Kb,=,1047.0,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,1047.0
13932,CHEMBL3581321,Clc1ccc2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)c4cc5ccccc5[nH]4)Cc2c1,Kb,=,2090.0,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,2090.0
13943,CHEMBL3581324,O=C(N[C@@H]1CC[C@@H](CCN2CCCc3ccccc3C2)CC1)c4cc5ccccc5[nH]4,Kb,=,2510.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as equilibrium dissociation constant after 3 hrs by MicroBeta counting analysis,B,2510.0
13944,CHEMBL3581324,O=C(N[C@@H]1CC[C@@H](CCN2CCCc3ccccc3C2)CC1)c4cc5ccccc5[nH]4,Kb,=,2570.0,nM,Dopamine D2 receptor,Homo sapiens,Negative allosteric modulator activity at wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as ERK1/2 phosphorylation measured as equilibrium dissociation constant after 30 mins,B,2570.0
13947,CHEMBL3581325,O=C(N[C@@H]1CC[C@@H](CCN2CCc3sccc3C2)CC1)c4cc5ccccc5[nH]4,Kb,=,2240.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from wild type human dopamine D2L receptor expressed in FlpIn CHO cell membrane assessed as equilibrium dissociation constant after 3 hrs by MicroBeta counting analysis,B,2240.0
14046,CHEMBL3585373,CCCN(CCCNC(=O)CCC(=O)O)CCc1cccc2NC(=O)Cc12,EC50,=,4677.35,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,2338.675
14048,CHEMBL3585373,CCCN(CCCNC(=O)CCC(=O)O)CCc1cccc2NC(=O)Cc12,EC50,=,4677.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2L receptor expressed in CHO cell membranes after 1 hr by [35S]-GTPgammaS binding assay,B,2338.5
14066,CHEMBL3588988,Clc1cccc(N2CCN(CCCCn3cc(nn3)c4ccc(cc4)c5ccccc5)CC2)c1Cl,Ki,=,2590.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,2590.0
14069,CHEMBL3588991,COc1ccccc1N2CCN(CC(O)CCn3cc(nn3)c4ccccc4)CC2,Ki,=,1210.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,1210.0
14070,CHEMBL3588992,COc1ccccc1N2CCN(CC(O)CCn3cc(nn3)c4ccccc4OC)CC2,Ki,=,1020.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,1020.0
14073,CHEMBL3588995,OC(CCn1cc(nn1)c2ccc3ccccc3c2)CN4CCN(CC4)c5cccc(Cl)c5Cl,Ki,=,18800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,18800.0
14074,CHEMBL3588996,OC(CCn1cc(nn1)c2ccc(cc2)c3ccccc3)CN4CCN(CC4)c5cccc(Cl)c5Cl,Ki,=,15100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,15100.0
14107,CHEMBL3590085,Cc1ncoc1c2nnc(SCCCN3C[C@@H]4C[C@@]4(C3)c5ccc(cc5F)C(F)(F)F)n2C,Ki,=,2110.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,B,2110.0
14123,CHEMBL3597637,COc1c(Cl)cccc1N2CCN(CCCCNC(=O)c3cnc4ccccc4c3)CC2,EC50,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as stimulation of quinpirole-stimulated mitogenesis,B,5000.0
14149,CHEMBL3597654,COc1ccccc1N2CCN(CC(O)CCNC(=O)c3ccc4cccnc4c3)CC2,Ki,=,1030.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,B,1030.0
14151,CHEMBL3605327,Cl.Clc1ccc(N2CCN(CCCCC(=O)Nc3nc4ccccc4s3)CC2)c(Cl)c1,Ki,=,5586.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,B,5586.0
14237,CHEMBL3613876,Clc1cccc(N2CCN(CCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2)c1Cl,EC50,=,3548.13,nM,Dopamine D2 receptor,Homo sapiens,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphai2 by [35S]GTPgammaS binding assay,B,1774.065
14244,CHEMBL3613877,COc1ccccc1N2CCN(CCc3cn(nn3)c4ccn5ncc(C=O)c5c4)CC2,EC50,=,4365.16,nM,Dopamine D2 receptor,Homo sapiens,Activity at dopamine D2S receptor (unknown origin) expressed in HEK293 cell membranes co-expressing Galpha protein subunit Galphai2 by [35S]GTPgammaS binding assay,B,2182.58
14268,CHEMBL3622092,COc1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,Ki,=,7500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,7500.0
14280,CHEMBL3622100,COc1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,4000.0
14281,CHEMBL3622101,Brc1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,Ki,=,5200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,5200.0
14282,CHEMBL3622102,CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)Cc4ccc(OC)cc4,Ki,=,4100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,B,4100.0
14295,CHEMBL3642681,O[C@@H]1CC[C@@H](CC(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5occc45)CC2)CC1,Ki,=,1538.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1538.0
14297,CHEMBL3642683,COCCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4occc34)CC1,Ki,=,1347.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1347.0
14299,CHEMBL3642685,OCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4occc34)CC1,Ki,=,1360.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1360.0
14300,CHEMBL3642686,COCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4occc34)CC1,Ki,=,1158.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1158.0
14301,CHEMBL3642687,CO[C@@H]1CC[C@@H](CC(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5occc45)CC2)CC1,Ki,=,1463.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1463.0
14327,CHEMBL3642712,COCCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1488.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1488.0
14329,CHEMBL3642714,O=C(CC1COCCO1)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2,Ki,=,1471.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1471.4
14330,CHEMBL3642715,COCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1545.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1545.4
14331,CHEMBL3642716,CS(=O)(=O)CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1018.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1018.3
14332,CHEMBL3642717,OCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1568.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1568.0
14335,CHEMBL3642720,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1)C5CCCO5,Ki,=,1044.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1044.0
14340,CHEMBL3642725,CS(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1269.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1269.5
14341,CHEMBL3642726,CCS(=O)(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1093.5,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1093.5
14348,CHEMBL3642733,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1)c5ccc(cc5)N6CCCCC6,Ki,=,5340.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,5340.0
14353,CHEMBL3642738,O=C(C[C@@H]1COCCO1)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2,Ki,=,1124.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1124.0
14356,CHEMBL3642741,O=C(CC1CCCO1)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2,Ki,=,1262.8,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1262.8
14357,CHEMBL3642742,CO[C@@H]1CC[C@@H](CC(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2)CC1,Ki,=,2451.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2451.9
14359,CHEMBL3642744,O=C(C[C@H]1COCCO1)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2,Ki,=,1461.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1461.0
14376,CHEMBL3642761,Cc1cc(CC(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2)on1,Ki,=,1304.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1304.6
14378,CHEMBL3642763,CN(C)C(=O)CCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,2562.7,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2562.7
14382,CHEMBL3642767,CO[C@H]1CC[C@H](CC(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2)C1,Ki,=,1291.7,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1291.7
14385,CHEMBL3642770,CC(C)CCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1277.1,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1277.1
14386,CHEMBL3642771,CCCCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1143.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1143.6
14387,CHEMBL3642772,FC(F)(F)CCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1253.7,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1253.7
14393,CHEMBL3642778,Cc1cc2OCCc2c(n1)N3CCN(CC[C@@H]4CC[C@H](CC4)NC(=O)C5CCOCC5)CC3,Ki,=,1950.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1950.0
14394,CHEMBL3639416,Cc1cc2OCCc2c(n1)N3CCN(CC[C@@H]4CC[C@H](CC4)NC(=O)CC5CCOCC5)CC3,Ki,=,1935.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1935.0
14395,CHEMBL3642779,COCCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nc(C)cc4OCCc34)CC1,Ki,=,1486.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1486.0
14396,CHEMBL3642780,CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ncc(C)c4occc34)CC1,Ki,=,1461.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1461.0
14397,CHEMBL3642781,Cc1cnc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCOCC4)CC2)c5ccoc15,Ki,=,1126.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1126.0
14398,CHEMBL3642782,Cc1cnc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)CC4CCOCC4)CC2)c5ccoc15,Ki,=,2718.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2718.0
14399,CHEMBL3642783,COCCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ncc(C)c4occc34)CC1,Ki,=,2471.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2471.0
14400,CHEMBL3642784,CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ncc(C)c4OCCc34)CC1,Ki,=,2308.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2308.0
14401,CHEMBL3642785,Cc1cnc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)C4CCOCC4)CC2)c5CCOc15,Ki,=,4510.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,4510.0
14402,CHEMBL3642786,Cc1cnc(N2CCN(CC[C@@H]3CC[C@H](CC3)NC(=O)CC4CCOCC4)CC2)c5CCOc15,Ki,=,2951.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2951.0
14403,CHEMBL3642787,COCCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3ncc(C)c4OCCc34)CC1,Ki,=,3564.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,3564.0
14405,CHEMBL3642789,COC(CC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1)OC,Ki,=,1384.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1384.9
14406,CHEMBL3642790,COC(CCC(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1)OC,Ki,=,2365.4,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2365.4
14413,CHEMBL3642797,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1)c5ccc6OCOc6c5,Ki,=,3372.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,3372.0
14414,CHEMBL3642798,O=C(Cc1ccc2OCOc2c1)N[C@@H]3CC[C@@H](CCN4CCN(CC4)c5nccc6OCCc56)CC3,Ki,=,3042.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,3042.0
14416,CHEMBL3642800,CC(C)(O)C(=O)N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1,Ki,=,1265.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1265.0
14419,CHEMBL3642803,Cc1onc(n1)c2cccc(c2)C(=O)N[C@@H]3CC[C@@H](CCN4CCN(CC4)c5nccc6OCCc56)CC3,Ki,=,2147.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2147.0
14421,CHEMBL3642805,O=C(Cc1noc2ccccc12)N[C@@H]3CC[C@@H](CCN4CCN(CC4)c5nccc6OCCc56)CC3,Ki,=,1308.9,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1308.9
14423,CHEMBL3642807,CC(C)(C)c1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2,Ki,=,1663.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1663.0
14426,CHEMBL3642810,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nccc4OCCc34)CC1)c5ccc(cc5)c6ccccc6,Ki,=,1132.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1132.0
14428,CHEMBL3642812,CC(C)(C)Oc1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCN(CC3)c4nccc5OCCc45)CC2,Ki,=,3161.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,3161.0
14546,CHEMBL3664872,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCOc34)CC1)C5COc6ccccc6C5,Ki,=,1047.58,nM,Dopamine D2 receptor,Homo sapiens,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,1047.58
14563,CHEMBL3664889,Clc1ccc(NC(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4cccc5OCOc45)CC2)cc1,Ki,=,2707.02,nM,Dopamine D2 receptor,Homo sapiens,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",B,2707.02
14625,CHEMBL3676905,CC(C)(C)c1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4coc5ccccc45)CC2,Ki,=,1111.22,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,1111.22
14708,CHEMBL3695409,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1)c5ccc(cc5)N6CCCCC6,Ki,=,2272.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,2272.3
14709,CHEMBL3695410,FC(F)(F)c1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4cccc5OCCc45)CC2,Ki,=,1461.2,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,1461.2
14714,CHEMBL3695415,CCC(C)C(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1,Ki,=,1201.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,1201.3
14715,CHEMBL3695416,CN(C)C(=O)CCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1,Ki,=,1063.3,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,1063.3
14720,CHEMBL3695421,O=C(N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1)c5ccc(cc5)n6cccn6,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,1700.0
14721,CHEMBL3695422,Cc1onc(n1)c2ccc(cc2)C(=O)N[C@@H]3CC[C@@H](CCN4CCC(CC4)c5cccc6OCCc56)CC3,Ki,=,3728.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,3728.0
14723,CHEMBL3695424,CC(C)(C)c1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4cccc5OCCc45)CC2,Ki,>,10000000.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,10000000.0
14727,CHEMBL3695428,CC(C)CCC(=O)N[C@@H]1CC[C@@H](CCN2CCC(CC2)c3cccc4OCCc34)CC1,Ki,=,1067.6,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,1067.6
14739,CHEMBL3695441,CC(C)(C)Oc1ccc(cc1)C(=O)N[C@@H]2CC[C@@H](CCN3CCC(CC3)c4cccc5OCCc45)CC2,Ki,>,10000000.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,10000000.0
14791,CHEMBL3697995,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1)c5ccc(cc5)N6CCOCC6,Ki,=,1510.24,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 g protein/well (D2, D3) and 15 g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 M-0.1 nM for 1 h at RT.",B,1510.24
14795,CHEMBL3697999,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3cccc4OCOc34)CC1)c5ccc6OCCOc6c5,Ki,=,4818.65,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 g protein/well (D2, D3) and 15 g protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 l with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 M-0.1 nM for 1 h at RT.",B,4818.65
14824,CHEMBL3735756,COc1ccc(CCN(CCCc2ccccc2)CCc3ccc4OCOc4c3)cc1OC,Ki,=,1729.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in stable fibroblast after 90 mins by scintillation counting method,B,1729.0
14825,CHEMBL3736433,CB1Nc2c(OCC(O)CN(C)C)cccc2C=C1,IC50,>,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as dopamine-induced cAMP by HTRF assay,B,2505.935
14826,CHEMBL3736433,CB1Nc2c(OCC(O)CN(C)C)cccc2C=C1,EC50,>,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as cAMP level by HTRF assay,B,2505.935
14827,CHEMBL3736156,CB1Nc2cccc(OCC(O)CN(C)C)c2C=C1,IC50,>,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as dopamine-induced cAMP by HTRF assay,B,2505.935
14828,CHEMBL3736156,CB1Nc2cccc(OCC(O)CN(C)C)c2C=C1,EC50,>,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as cAMP level by HTRF assay,B,2505.935
14834,CHEMBL3740360,Clc1ccc(N2CCN(CCCCNc3noc(n3)c4ccccc4)CC2)c(Cl)c1,Ki,=,6230.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,B,6230.0
14836,CHEMBL3740498,Cl.Clc1ccc(N2CCN(CCCCNc3noc(n3)c4ccccc4)CC2)c(Cl)c1,Ki,=,1290.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,B,1290.0
14840,CHEMBL3739820,Cl.Clc1ccc(cc1)N2CCN(CCCCNc3noc(n3)c4ccccc4)CC2,Ki,=,79630.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,B,79630.0
14871,CHEMBL3740778,Nc1nc2CC[C@@H](Cc2s1)N(CCN3CCN(CC3)c4ccc5[nH]ccc5c4Cl)CC#N.OC(=O)C(F)(F)F,EC50,=,3930.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity against human D2 receptor expressed in CHO cells assessed as dopamine EC50 at 300 nM by [35S]GTPgammaS binding assay (Rvb = 225 +/- 45 nM),B,1965.0
14906,CHEMBL3752576,C=CCN(CCc1c[nH]c2ccccc12)CC=C,Ki,<,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,B,10000.0
14907,CHEMBL3754496,Fc1ccc2[nH]cc(CCN(CC=C)CC=C)c2c1,Ki,=,2454.71,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,B,2454.71
14908,CHEMBL3752900,Clc1ccc2[nH]cc(CCN(CC=C)CC=C)c2c1,Ki,=,1862.09,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,B,1862.09
14909,CHEMBL3754166,Brc1ccc2[nH]cc(CCN(CC=C)CC=C)c2c1,Ki,=,4365.16,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,B,4365.16
14910,CHEMBL3753318,Cc1ccc2[nH]cc(CCN(CC=C)CC=C)c2c1,Ki,=,5128.61,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,B,5128.61
14924,CHEMBL3758330,Oc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,5031.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,5031.0
14926,CHEMBL3759513,Clc1cccc(c1)N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,3323.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,3323.0
14927,CHEMBL3758920,Clc1ccc(cc1)N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,12143.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,12143.0
14929,CHEMBL3758711,FC(F)(F)c1cccc(c1)N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2,Ki,=,1553.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,1553.0
14937,CHEMBL3759312,COc1ccccc1N2CCN(CCCCNC(=O)N(C)c3ccccc3)CC2,Ki,=,1549.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,B,1549.0
14945,CHEMBL3765285,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)c5ocnn5,Ki,=,12589.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,12589.25
14946,CHEMBL3764251,Cn1cncc1c2nnc(SCCCN3CCOC(C3)c4ccc(cc4)C(F)(F)F)n2C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14947,CHEMBL3764739,Cn1cccc1c2nnc(SCCCN3CCOC(C3)c4ccc(cc4)C(F)(F)F)n2C,Ki,=,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,6309.57
14948,CHEMBL3765266,Cc1onc(n1)c2ccc(cc2)c3nnc(SCCCN4CCOC(C4)c5ccc(cc5)C(F)(F)F)n3C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14949,CHEMBL3764246,Cc1ccc(cc1)C2CN(CCCSc3nnc(c4ccc(cc4)c5noc(C)n5)n3C)CCO2,Ki,=,25118.86,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,25118.86
14950,CHEMBL3764245,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1C4CCCCC4,Ki,=,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,7943.28
14951,CHEMBL3763200,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccncc4,Ki,=,12589.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,12589.25
14952,CHEMBL3764612,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4cccnc4,Ki,=,15848.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,15848.93
14953,CHEMBL3765169,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4cnccn4,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14954,CHEMBL3764306,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(nc4)C(=O)N,Ki,=,25118.86,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,25118.86
14955,CHEMBL3765422,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4cncc(c4)C(=O)N,Ki,=,15848.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,15848.93
14956,CHEMBL3765426,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)C(=O)N,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14957,CHEMBL3765426,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)C(=O)N,Ki,=,12589.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,12589.25
14958,CHEMBL3764212,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4cccc(c4)C(=O)N,Ki,=,15848.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,15848.93
14959,CHEMBL3765267,CC(=O)c1ccc(cc1)c2nnc(SCCCN3CCOC(C3)c4ccc(cc4)C(F)(F)F)n2C,Ki,=,19952.62,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,19952.62
14960,CHEMBL3764830,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)S(=O)(=O)N,Ki,>,31622.78,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,31622.78
14961,CHEMBL3764639,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)C#N,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14962,CHEMBL3764597,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3F)C(F)(F)F)nnc1c4ccc(cc4)C(=O)N,Ki,=,15848.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,15848.93
14963,CHEMBL3764143,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)c5occn5,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,1584.89
14964,CHEMBL3764143,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)c5occn5,Ki,=,15848.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,15848.93
14965,CHEMBL3764143,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)c5occn5,Ki,=,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,5011.87
14966,CHEMBL3765072,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccc(cc4)n5cnnc5,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14967,CHEMBL3764884,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4nccs4,Ki,=,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,7943.28
14968,CHEMBL3765754,Cc1ncoc1c2nnc(SCCCN3CCOC(C3)c4ccc(F)cc4)n2C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14969,CHEMBL3765754,Cc1ncoc1c2nnc(SCCCN3CCOC(C3)c4ccc(F)cc4)n2C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14971,CHEMBL3764557,Cc1ncoc1c2nnc(SCCCN3CCOC(C3)c4ccc(cc4)C(F)(F)F)n2C,Ki,=,12589.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,12589.25
14972,CHEMBL3763418,Cc1ncoc1c2nnc(SCCCCN3CCOC(C3)c4ccc(cc4)C(F)(F)F)n2C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14973,CHEMBL3763418,Cc1ncoc1c2nnc(SCCCCN3CCOC(C3)c4ccc(cc4)C(F)(F)F)n2C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14974,CHEMBL3764586,Cc1ncoc1c2nnc(SCCCN3CCOC(C3)c4ccc(cc4F)C(F)(F)F)n2C,Ki,=,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,10000.0
14976,CHEMBL3764833,Cc1ncoc1c2nnc(SCCCN3CCOC(C3)c4ccc(Br)cc4)n2C,Ki,=,15848.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,15848.93
14977,CHEMBL3764191,Cn1c(SCCCN2CCOC(C2)c3ccc(cc3)C(F)(F)F)nnc1c4ccsc4,Ki,=,7943.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,B,7943.28
14978,CHEMBL3769968,Cl.NCC1CC1c2cc(F)c(F)cc2OCC=C,Ki,=,4897.79,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor by radioligand binding assay,B,4897.79
14979,CHEMBL3769968,Cl.NCC1CC1c2cc(F)c(F)cc2OCC=C,Ki,=,4898.0,nM,Dopamine D2 receptor,Homo sapiens,Binding affinity to human dopamine D2 receptor by radioligand binding assay,B,4898.0
14982,CHEMBL3769836,CC1(NC(=O)N(CC(O)CN2CCN(CC2)c3ccccc3)C1=O)c4ccc(F)cc4,Ki,=,2906.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,2906.0
14983,CHEMBL3769441,COc1cccc(c1)N2CCN(CC(O)CN3C(=O)NC(C)(C3=O)c4ccc(F)cc4)CC2,Ki,=,5187.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,5187.0
14984,CHEMBL3770473,CC1(NC(=O)N(CC(O)CN2CCN(CC2)c3ccccc3F)C1=O)c4ccc(F)cc4,Ki,=,1709.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,1709.0
14989,CHEMBL3769612,Cc1ccc(C)c(c1)N2CCN(CC(O)CN3C(=O)NC(C)(C3=O)c4ccc(F)cc4)CC2,Ki,=,1814.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,1814.0
14990,CHEMBL3770293,CC1(NC(=O)N(CC(O)CN2CCN(CC2)c3ccc(F)cc3)C1=O)c4ccc(F)cc4,Ki,=,5641.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,5641.0
14991,CHEMBL3770522,CC1(NC(=O)N(CC(O)CN2CCN(CC2)c3ccc(Cl)cc3)C1=O)c4ccc(F)cc4,Ki,=,4255.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,4255.0
14992,CHEMBL3769536,CC1(NC(=O)N(CC(O)CN2CCN(CC2)c3ccc(F)cc3F)C1=O)c4ccc(F)cc4,Ki,=,6790.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,6790.0
14993,CHEMBL3770581,CC1(NC(=O)N(CC(O)CN2CCN(CC2)c3ccc(Cl)c(Cl)c3)C1=O)c4ccc(F)cc4,Ki,=,1976.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,1976.0
14994,CHEMBL3770110,Cc1ccc(cc1C)N2CCN(CC(O)CN3C(=O)NC(C)(C3=O)c4ccc(F)cc4)CC2,Ki,=,2261.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,B,2261.0
15006,CHEMBL3775226,Cc1ncoc1c2nnc(SCCCN3CC4CCN(C4C3)c5ccc(cc5F)C(F)(F)F)n2C,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,1584.89
15033,CHEMBL3774927,Cc1ccccc1N2CCC3CN(CCCSc4nnc(c5cnccn5)n4C)CC23,Ki,=,3162.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,3162.28
15034,CHEMBL3775023,COc1ccc(cc1)N2CCC3CN(CCCSc4nnc(c5cnccn5)n4C)CC23,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,1584.89
15040,CHEMBL3775097,Cn1c(SCCCN2CC3CCN(C3C2)c4ccc(cc4)C#N)nnc1c5cnccn5,Ki,=,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,6309.57
15044,CHEMBL3775598,CC(C)Oc1ccccc1N2CCC3CN(CCCSc4nnc(c5cnccn5)n4C)CC23,Ki,=,5011.87,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,5011.87
15050,CHEMBL3774911,Cn1c(SCCCN2CC3CCN(C3C2)c4ccc(F)cc4C(F)(F)F)nnc1c5cnccn5,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,1258.93
15054,CHEMBL3775572,Cn1c(SCCCN2CC3CCN(C3C2)c4ccc(cc4)C(F)(F)F)nnc1c5cncnc5,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,1258.93
15066,CHEMBL3775197,Cn1c(SCCCN2CC3CCN(C3C2)c4ccccc4C(F)(F)F)nnc1c5cccnc5,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,1258.93
15070,CHEMBL3774411,Cn1c(SCCCN2CC3CCN(C3C2)c4ccc(cc4)C(F)(F)F)nnc1C5=CC(=O)NC=C5,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,1995.26
15074,CHEMBL3774769,CN1C=C(C=CC1=O)c2nnc(SCCCN3CC4CCN(C4C3)c5ccc(cc5)C(F)(F)F)n2C,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,1584.89
15078,CHEMBL3775350,CN1C=CC(=CC1=O)c2nnc(SCCCN3CC4CCN(C4C3)c5c(F)cc(F)cc5F)n2C,Ki,=,1258.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,1258.93
15080,CHEMBL3775350,CN1C=CC(=CC1=O)c2nnc(SCCCN3CC4CCN(C4C3)c5c(F)cc(F)cc5F)n2C,Ki,=,3981.07,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,3981.07
15093,CHEMBL3774463,Cn1c(SCCCN2CC3CCN(C3C2)c4ccc(cc4)C(F)(F)F)nnc1C5CCCCC5,Ki,=,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,B,6309.57
15114,CHEMBL3780975,COc1cc2CCN(Cc3cccc(O)c3OC)C(C)c2cc1O,Ki,=,1095.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,1095.0
15115,CHEMBL3780438,COc1cc(CCN(C)Cc2cccc(O)c2OC)ccc1O,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,10000.0
15116,CHEMBL3780812,CCN(CCc1ccc(O)c(OC)c1)Cc2cccc(O)c2OC,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,B,10000.0
15142,CHEMBL3792751,Fc1ccc2c(CN3CCO[C@H](COc4cccc(Cl)n4)C3)c[nH]c2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human recombinant dopamine D2L receptor expressed in CHO cells,B,10000.0
15143,CHEMBL3792751,Fc1ccc2c(CN3CCO[C@H](COc4cccc(Cl)n4)C3)c[nH]c2c1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,B,10000.0
15147,CHEMBL3792731,Clc1ccc(CN2CCO[C@H](CSc3ccccc3)C2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human recombinant dopamine D2L receptor expressed in CHO cells,B,10000.0
15148,CHEMBL3792731,Clc1ccc(CN2CCO[C@H](CSc3ccccc3)C2)cc1,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,B,10000.0
15150,CHEMBL3794079,Cc1ccc(CN2CCO[C@H](CSc3ccccc3)C2)cc1C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human recombinant dopamine D2L receptor expressed in CHO cells,B,10000.0
15151,CHEMBL3794079,Cc1ccc(CN2CCO[C@H](CSc3ccccc3)C2)cc1C,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,B,10000.0
15153,CHEMBL3799271,N[C@H]1CN2C(=O)Nc3cccc(C1)c23,Ki,=,12100.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,12100.0
15158,CHEMBL3798018,CN[C@H]1CN2C(=O)Nc3cc(cc(C1)c23)C#N,Ki,=,5120.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,5120.0
15167,CHEMBL3797740,CCCN(C)[C@H]1CN2C(=O)Nc3cccc(C1)c23,Ki,=,1180.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,1180.0
15205,CHEMBL3800633,CN(CCCCNC(=O)c1oc2ccccc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,Ki,=,14700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,14700.0
15219,CHEMBL3798179,CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,Ki,=,4230.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,4230.0
15233,CHEMBL3799626,CN(CCCCNC(=O)c1ccc2c(Cc3ccccc23)c1)[C@H]4CN5C(=O)Nc6cccc(C4)c56,Ki,=,3700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,B,3700.0
15238,CHEMBL3799147,Cl.Cc1ccccc1N2CCN(CCCCNC(=O)Oc3cccc4ccccc34)CC2,EC50,=,5300.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,B,2650.0
15240,CHEMBL3798334,COc1ccccc1N2CCN(CCCNC(=O)Oc3cccc4ccccc34)CC2,EC50,=,4100.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,B,2050.0
15242,CHEMBL3798943,Cl.Cc1ccccc1N2CCN(CCCNC(=O)Oc3cccc4ccccc34)CC2,EC50,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,B,7000.0
15246,CHEMBL3798211,Cl.NC(=O)c1ccc(OC(=O)NCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c4ccccc14,EC50,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,B,1300.0
15250,CHEMBL3798372,Cl.Clc1cccc(N2CCN(CCCCNC(=O)Oc3cccc4OCCOc34)CC2)c1Cl,EC50,=,3500.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,B,1750.0
15252,CHEMBL3800421,Clc1cccc(N2CCN(CCCCNC(=O)Oc3cccc4[nH]ccc34)CC2)c1Cl,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,B,5000.0
15254,CHEMBL3798331,Cl.Clc1cccc(N2CCN(CCCCNC(=O)Oc3cccc4[nH]cnc34)CC2)c1Cl,EC50,=,9900.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor short isoform transfected in HEK293 cells measured for 10 mins by spectroscopic analysis,B,4950.0
15265,CHEMBL3799430,CC(C)CS(=O)(=O)n1ccc2c(cc(nc12)N3CCN(C)CC3)c4ccc(cc4)C(=O)N(C)C,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,2000.0
15267,CHEMBL3797293,CC(C)CS(=O)(=O)n1ccc2c(cc(nc12)N3CCN(C)CC3)c4cccnc4,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,2000.0
15268,CHEMBL3800442,CC(C)CS(=O)(=O)n1ccc2c(cc(nc12)N3CCN(C)CC3)C4=CNC(=O)C=C4,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,2000.0
15269,CHEMBL3800576,CC(C)CS(=O)(=O)n1ccc2c(cc(nc12)N3CCN(C)CC3)c4cnn(C)c4,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,2000.0
15271,CHEMBL3800055,CC(C)CS(=O)(=O)n1ccc2c(cc(nc12)N3CCN(C)CC3)c4c(C)onc4C,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,2000.0
15272,CHEMBL3800153,CN1CCN(CC1)c2cc(c3ccc(cc3)C(F)(F)F)c4ccn(c4n2)S(=O)(=O)C,Ki,=,1231.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,1231.0
15274,CHEMBL3799330,CN1CCN(CC1)c2cc(c3ccc(cc3)C(F)(F)F)c4ccn(c4n2)S(=O)(=O)C5CCCCC5,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,2000.0
15275,CHEMBL3799448,CN1CCN(CC1)c2cc(c3ccc(cc3)C(F)(F)F)c4ccn(c4n2)S(=O)(=O)C5CCOCC5,Ki,>,2000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,2000.0
15277,CHEMBL3799529,CC(C)CS(=O)(=O)n1ccc2c(cc(nc12)N3CCNCC3)c4ccc(cc4)C(F)(F)F,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,B,1700.0
15279,CHEMBL3800400,COc1cc(CCNC[C@H](O)c2ccc(O)c3NC(=O)C=Cc23)ccc1OCCCc4ccccc4,Ki,=,5700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,5700.0
15280,CHEMBL3800400,COc1cc(CCNC[C@H](O)c2ccc(O)c3NC(=O)C=Cc23)ccc1OCCCc4ccccc4,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,3200.0
15285,CHEMBL3800468,COc1cc(CCNC[C@@H](O)c2ccc(O)c3NC(=O)C=Cc23)ccc1OCCCc4ccccc4,Ki,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,2900.0
15286,CHEMBL3800468,COc1cc(CCNC[C@@H](O)c2ccc(O)c3NC(=O)C=Cc23)ccc1OCCCc4ccccc4,Ki,=,2300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,2300.0
15302,CHEMBL3799427,COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc3ccccc3,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,B,1900.0
15303,CHEMBL3799427,COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc3ccccc3,Ki,=,1700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,B,1700.0
15312,CHEMBL3800636,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc3ccccc3,EC50,=,2600.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,B,1300.0
15318,CHEMBL3798748,COc1cc(CCNC[C@H](O)c2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,EC50,=,13000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,B,6500.0
15324,CHEMBL3797205,COc1cc(CCNC[C@@H](O)c2ccc(O)c3NC(=O)COc23)ccc1OCCCc4ccccc4,EC50,=,8800.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at ARMS2-PK-tagged D2S receptor (unknown origin) transfected in HEK293 cells after 5 hrs by beta-arrestin assay,B,4400.0
15358,CHEMBL3806091,CNC(=O)c1cccc(OCCCCN2CCN(CC2)c3cccc(Cl)c3Cl)c1C,IC50,=,3600.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,B,1800.0
15405,CHEMBL3817911,O=C1N(CCCCN2CCC3CCCCC3C2)C(=O)c4ccccc14,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,B,10000.0
15409,CHEMBL3819082,Cl.Fc1ccc2CC(CCN3CCc4ccccc4C3)Cc2c1,Ki,=,1150.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,B,1150.0
15421,CHEMBL3818200,O=C(CCCN1CCc2ccccc2C1)c3ccc(cc3)C#N,Ki,=,1456.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,B,1456.0
15422,CHEMBL3818200,O=C(CCCN1CCc2ccccc2C1)c3ccc(cc3)C#N,Ki,=,1445.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,B,1445.44
15444,CHEMBL3890882,CN[C@H]1[C@H](CCO)c2cc3c(ccn3S(=O)(=O)c4ccccc4)cc12,Ki,=,15848.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,15848.93
15450,CHEMBL3894257,Cc1ncsc1c2nnc(SCCCN3CC[C@]4(C[C@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1230.27,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1230.27
15454,CHEMBL3894853,CN1C=CC(=CC1=O)c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,2238.72,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,2238.72
15455,CHEMBL3894853,CN1C=CC(=CC1=O)c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1862.09,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,1862.09
15457,CHEMBL3895173,CN[C@@H]1[C@H](CCO)c2ccc3c(ccn3S(=O)(=O)c4ccccc4)c12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,10000.0
15467,CHEMBL3897499,CCCN1CC[C@@H]2[C@@H]3[C@H](CCC[C@@H]13)[C@@H](CC)c4nc5cc(ccc5cc24)C(F)(F)F,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,B,10000.0
15468,CHEMBL3897772,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1C5=CC=NC(=O)C5,Ki,=,1445.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1445.44
15470,CHEMBL3897805,COc1ccc(OC)c2CN3CCc4cc5OCOc5cc4[C@@H]3Cc12,IC50,=,2508.05,nM,Dopamine D2 receptor,Homo sapiens,"Reception Binding Assay: Different concentrations (10^5 M-10^11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30 C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 L liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",B,1254.025
15471,CHEMBL3897805,COc1ccc(OC)c2CN3CCc4cc5OCOc5cc4[C@@H]3Cc12,EC50,=,9740.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity Assay: Each medicament was dissolved in serum-free F12 culture medium containing 100 M of IBMX. CHO cells which can stably express D2 receptor were pre-incubated at 37 C. for 10 min, and then 10 M Forskoline and 10 M Dopanie were added at the same time to react for 10 min. 100 L, of pre-cooled 1 M of HClO4 was added and the reaction was terminated at 4 C. for 1 hour. 20 L of 2 M K2CO3 was added to neutralize the reaction. The resulting mixture was centrifugated at 3000 rpm for 15 min, and the precipitate KClO4 was discarded. A certain amount of the supernatant was taken for cAMP detection. Spiperone and Quinpirole were used as positive control.",B,4870.0
15482,CHEMBL3899169,Cc1ccc2N=C(N3CCN(CC(C)(C)C(=O)O)CC3)c4cc(Cl)sc4Oc2c1,Ki,=,2780.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay or Functional Activity Assay: Further, the compounds of the invention may be tested in binding assays and functional activity assays by well known methods for other physiologically important receptors such as, but not limited to, the hERG channel, other serotonin receptors (specifically 5-HT1B, 5-HT1D, receptors, lack of agonist activity at 5-HT2B receptors, 5-HT2C, 5-HT5, 5-HT6, and 5-HT7 receptors), dopaminergic receptors (specifically D1, D2, and D3), GABAA receptors, adrenergic receptors and monoamine transporters.",B,2780.0
15483,CHEMBL3899169,Cc1ccc2N=C(N3CCN(CC(C)(C)C(=O)O)CC3)c4cc(Cl)sc4Oc2c1,Ki,>,4570.0,nM,Dopamine D2 receptor,Homo sapiens,"Binding Assay or Functional Activity Assay: Further, the compounds of the invention may be tested in binding assays and functional activity assays by well known methods for other physiologically important receptors such as, but not limited to, the hERG channel, other serotonin receptors (specifically 5-HT1B, 5-HT1D, receptors, lack of agonist activity at 5-HT2B receptors, 5-HT2C, 5-HT5, 5-HT6, and 5-HT7 receptors), dopaminergic receptors (specifically D1, D2, and D3), GABAA receptors, adrenergic receptors and monoamine transporters.",B,4570.0
15497,CHEMBL3903542,Clc1cccc(N2CCN(CC3CCC(COc4ccc5CCC(=O)Nc5c4)CC3)CC2)c1Cl,EC50,=,46000.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,23000.0
15498,CHEMBL3903542,Clc1cccc(N2CCN(CC3CCC(COc4ccc5CCC(=O)Nc5c4)CC3)CC2)c1Cl,EC50,=,2100.0,nM,Dopamine D2 receptor,Homo sapiens,"Beta-Arrestin Recruitment (Tango) Assay: Recruitment of -arrestin to agonist-stimulated D2 receptors was performed using a previously described Tango-type assay (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). Briefly, HTLA cells stably expressing -arrestin-TEV protease and a tetracycline transactivator-driven luciferase were plated in 15-cm dishes in DMEM containing 10% fetal bovine serum and transfected (via calcium phosphate) with 20 g of a D2V2-TCS-tTA construct (Barnea et al., Proc. Natl. Acad. Sci. USA 105:64 (2008)). The next day, cells were plated in white, clear-bottom, 384-well plates (Greiner, 10,000 cells/well, 50 l/well) in DMEM containing 1% dialyzed fetal bovine serum. The following day, the cells were challenged with 10 l/well of reference agonist (6 M) or D2 test ligand (6 M)reference agonist prepared in HBS, 20 mM HEPES, pH 7.4, 18% DMSO (final ligand concentrations were 1 M, final DMSO concentration was 3%).",B,1050.0
15503,CHEMBL3905196,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccccc5C(F)(F)F)C3)n2C,Ki,=,1584.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1584.89
15521,CHEMBL3908862,Cc1ncoc1c2nnc(SCCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1348.96,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,1348.96
15522,CHEMBL3908870,CC1(C)CC(=O)N(CCCCN2Cc3ccccc3C2)C(=O)C1,Ki,=,2933.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,2933.0
15523,CHEMBL3908870,CC1(C)CC(=O)N(CCCCN2Cc3ccccc3C2)C(=O)C1,Ki,=,2951.21,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,2951.21
15524,CHEMBL3908917,CN[C@H]1[C@@H](CCO)c2c1ccc3c2ccn3S(=O)(=O)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,10000.0
15529,CHEMBL3910730,Fc1ccc(N2CCN(CCCCCC(=O)NCc3ccc(cc3)C#N)CC2)c(c1)c4ccc(cc4)C#N,Ki,=,1385.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,1385.0
15536,CHEMBL3912897,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c4ccccc4)C2)nnc1c5cccnc5,Ki,=,3311.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,3311.31
15538,CHEMBL3913062,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccccc5)C3)n2C,Ki,=,16982.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,16982.44
15539,CHEMBL3913100,O=C(CCOCCN1CCN(CC1)c2cccnc2c3ccccc3)NCc4ccc(cc4)C#N,Ki,=,4346.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,4346.0
15540,CHEMBL3913542,Cc1ccc(c(C)n1)c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1230.27,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1230.27
15544,CHEMBL3913849,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1C5CCNC(=O)C5,Ki,=,1348.96,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1348.96
15557,CHEMBL3916231,CC(O)CN1CCN(CCSC(c2ccc(F)cc2)c3ccc(F)cc3)CC1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,5000.0
15558,CHEMBL3916787,CN(C)[C@@H]1[C@H](CCO)c2cc3c(ccn3S(=O)(=O)c4ccccc4)cc12,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,10000.0
15563,CHEMBL3918282,OC(CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c3ccc(F)cc3)CC1)Cc4ccccc4,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,5000.0
15571,CHEMBL3920167,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1c5cccc(c5)c6occn6,Ki,=,1174.9,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,1174.9
15581,CHEMBL3922143,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(F)cc5)C3)n2C,Ki,=,8128.31,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,8128.31
15585,CHEMBL3923145,O=C(CCOCCN1CCN(CC1)c2ccccc2c3ccccc3)NCc4ccncc4,Ki,=,2450.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,2450.0
15587,CHEMBL3923578,Cc1ncsc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1621.81,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1621.81
15589,CHEMBL3924565,Cl.Clc1ccc(cc1)C(=O)CCCN2CCCc3ccccc3C2,Ki,=,3578.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,3578.0
15590,CHEMBL3924565,Cl.Clc1ccc(cc1)C(=O)CCCN2CCCc3ccccc3C2,Ki,=,3548.13,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,3548.13
15593,CHEMBL3927835,COc1ccc(OC)c2CN3CCc4cc(OC)c(OC)cc4C3Cc12,EC50,=,3300.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity Assay: Each medicament was dissolved in serum-free F12 culture medium containing 100 M of IBMX. CHO cells which can stably express D2 receptor were pre-incubated at 37 C. for 10 min, and then 10 M Forskoline and 10 M Dopanie were added at the same time to react for 10 min. 100 L, of pre-cooled 1 M of HClO4 was added and the reaction was terminated at 4 C. for 1 hour. 20 L of 2 M K2CO3 was added to neutralize the reaction. The resulting mixture was centrifugated at 3000 rpm for 15 min, and the precipitate KClO4 was discarded. A certain amount of the supernatant was taken for cAMP detection. Spiperone and Quinpirole were used as positive control.",B,1650.0
15595,CHEMBL3927895,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5F)C(F)(F)F)C3)n2C,Ki,=,4365.16,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,4365.16
15601,CHEMBL3929918,CNCC1Cc2ccc3c(ccn3S(=O)(=O)c4ccccc4)c12,Ki,=,1995.26,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,1995.26
15602,CHEMBL3930825,Cn1c(SCCCN2CC[C@]3(C[C@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1c5cccnn5,Ki,=,1778.28,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1778.28
15604,CHEMBL3931765,CC(O)CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c3ccc(F)cc3)CC1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,B,5000.0
15618,CHEMBL3936289,CN1CC[C@H]2CC(=O)[C@H](Cc3ccccc3)[C@H]4CCC[C@@H]1[C@H]24,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,B,10000.0
15628,CHEMBL3938498,O=S(=O)(c1ccccc1)n2ccc3cc4[C@@H]5CCNCC[C@@H]5c4cc23,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,10000.0
15629,CHEMBL3939830,Cn1c(SCCCN2CC[C@]3(C[C@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1c5ccnnc5,Ki,=,2570.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,2570.4
15631,CHEMBL3940897,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1c5ccnnc5,Ki,=,1548.82,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1548.82
15632,CHEMBL3941102,FC(F)(F)c1ccc(CNC(=O)CCOCCN2CCN(CC2)c3cccnc3c4ccccc4)cc1,Ki,=,2766.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,2766.0
15634,CHEMBL3941520,Cc1nc(ccc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C)C(=O)N,Ki,=,1148.15,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1148.15
15635,CHEMBL3941520,Cc1nc(ccc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C)C(=O)N,Ki,=,2089.3,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,2089.3
15637,CHEMBL3941795,Cl.Clc1ccc2sc(CCCCN3CCC4CCCCC4C3)nc2c1,Ki,=,1087.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,1087.0
15638,CHEMBL3941795,Cl.Clc1ccc2sc(CCCCN3CCC4CCCCC4C3)nc2c1,Ki,=,1096.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,1096.48
15643,CHEMBL3943838,Clc1cccc(N2CCCN(CCCCOc3ccc4CCNC(=O)c4c3)CC2)c1Cl,EC50,=,9870.0,nM,Dopamine D2 receptor,Homo sapiens,"cAMP GloSensor Assay: HEK293T cells co-expressing the cAMP biosensor GloSensor-22F (Promega) and hD2 receptors were seeded (10,000 cells/20 ul/well) into white, clear-bottom, tissue culture plates in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After a one- to two-hour recovery, cells were treated with 10 ul of 3x test or reference drug prepared in HBSS, 10% FBS, 20 mM HEPES, pH 7.4. After 30 minutes, cells were challenged with 10 ul of 1,200 nM (4x) isoproterenol in 8% (4x) GloSensor reagent. Luminescence per well per second was read on a Wallac TriLux microbeta plate counter. Data were normalized to the isoproterenol response (100%) and the maximal quinpirole-induced inhibition thereof (0%) and regressed using the sigmoidal dose-response function built into GraphPad Prism 4.0. Notably, HEK293T cells expressing the GloSensor-22F alone (no hD2) were assayed in parallel and displayed no inhibition of isoproterenol-stimulated cAMP.",B,4935.0
15654,CHEMBL3945776,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(F)cc5C(F)(F)F)C3)n2C,Ki,=,3801.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,3801.89
15662,CHEMBL3946995,O=C(N[C@@H]1CC[C@@H](CCN2CCN(CC2)c3nsc4ccccc34)CC1)c5occc5,EC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 by fluo-4 dye based FLIPR assay,B,5000.0
15666,CHEMBL3947670,Fc1ccc(cc1)c2ncccc2N3CCN(CCOCCC(=O)NCc4ccc(cc4)C#N)CC3,Ki,=,1959.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,1959.0
15677,CHEMBL3950264,Cc1ncoc1c2nnc(SCCCN3CC[C@]4(C[C@H]4c5ccc(F)cc5)C3)n2C,Ki,=,1096.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1096.48
15681,CHEMBL3952251,Cl.Clc1ccc(cc1)C(=O)CCCN2CCc3ccccc3CC2,Ki,=,1170.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,1170.0
15682,CHEMBL3952251,Cl.Clc1ccc(cc1)C(=O)CCCN2CCc3ccccc3CC2,Ki,=,1174.9,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,1174.9
15691,CHEMBL3954490,Cc1ncoc1c2nnc(SCC(O)CN3CC[C@@]4(C[C@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1737.8,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1737.8
15700,CHEMBL3956612,Cn1c(SCCCN2CC[C@]3(C[C@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1c5cccnc5,Ki,=,1348.96,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1348.96
15717,CHEMBL3958949,COc1ncccc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1148.15,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1148.15
15732,CHEMBL3961596,CNCC1Cc2cc3ccn(c3cc12)S(=O)(=O)c4cccc5ccccc45,Ki,=,2511.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,2511.89
15736,CHEMBL3963243,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1C5CCN(CC5)C(=O)N,Ki,=,1174.9,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,B,1174.9
15737,CHEMBL3963688,CN[C@@H]1[C@@H](CCO)c2cc3ccn(c3cc12)S(=O)(=O)c4ccccc4,Ki,=,6309.57,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,6309.57
15746,CHEMBL3964649,Cc1nc(ccc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C)C(=O)O,Ki,=,7585.78,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,7585.78
15747,CHEMBL3966484,CN[C@@H]1[C@@H](CCO)c2ccc3c(ccn3S(=O)(=O)c4ccccc4)c12,Ki,=,15848.93,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,15848.93
15748,CHEMBL3966647,Cc1ncoc1c2nnc(SCCCN3CC[C@@]4(C[C@@H]4c5ccc(F)cc5C(F)(F)F)C3)n2C,Ki,=,2187.76,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,2187.76
15756,CHEMBL3968272,Cc1ncccc1c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1479.11,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1479.11
15758,CHEMBL3969386,Cn1c(SCCCN2CC[C@]3(C[C@@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1c5cccnn5,Ki,=,1380.38,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1380.38
15764,CHEMBL3970994,C(CC1=Cc2ccccc2CC1)N3CCc4ccccc4C3,Ki,=,5647.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,5647.0
15765,CHEMBL3970994,C(CC1=Cc2ccccc2CC1)N3CCc4ccccc4C3,Ki,=,5623.41,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,5623.41
15766,CHEMBL3971039,CN[C@H]1[C@@H](CCO)c2cc3ccn(c3cc12)S(=O)(=O)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,10000.0
15777,CHEMBL3975147,Cc1ncoc1c2nnc(SCCCN3CC[C@@]4(C[C@H]4c5ccc(F)cc5C(F)(F)F)C3)n2C,Ki,=,1288.25,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1288.25
15780,CHEMBL3976192,Cn1c(SCCCN2CC[C@]3(C[C@H]3c4ccc(cc4)C(F)(F)F)C2)nnc1c5cnccn5,Ki,=,1445.44,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1445.44
15786,CHEMBL3976948,Fc1ccc(cc1)c2ncccc2N3CCN(CCOCCC(=O)NCc4ccc(cc4)C(F)(F)F)CC3,Ki,=,3460.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,B,3460.0
15787,CHEMBL3976966,O=C(NC1CCC(CCN2CCC(CC2)c3cccc4OCCc34)CC1)c5ccc6ncccc6c5,Ki,=,3248.0,nM,Dopamine D2 receptor,Homo sapiens,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",B,3248.0
15793,CHEMBL3978642,Cl.O=C1C(CCN2CCc3ccccc3C2)Cc4ccccc14,Ki,=,2583.5,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,2583.5
15795,CHEMBL3979230,CN[C@@H]1[C@@H](CCO)c2c1ccc3c2ccn3S(=O)(=O)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,B,10000.0
15801,CHEMBL3982119,COc1ccc(OC)c2CN3CCc4cc(OC)c(OC)cc4[C@@H]3Cc12,EC50,=,4030.0,nM,Dopamine D2 receptor,Homo sapiens,"Affinity Assay: Each medicament was dissolved in serum-free F12 culture medium containing 100 M of IBMX. CHO cells which can stably express D2 receptor were pre-incubated at 37 C. for 10 min, and then 10 M Forskoline and 10 M Dopanie were added at the same time to react for 10 min. 100 L, of pre-cooled 1 M of HClO4 was added and the reaction was terminated at 4 C. for 1 hour. 20 L of 2 M K2CO3 was added to neutralize the reaction. The resulting mixture was centrifugated at 3000 rpm for 15 min, and the precipitate KClO4 was discarded. A certain amount of the supernatant was taken for cAMP detection. Spiperone and Quinpirole were used as positive control.",B,2015.0
15814,CHEMBL3983684,CN1CCC(CC1=O)c2nnc(SCCCN3CC[C@]4(C[C@@H]4c5ccc(cc5)C(F)(F)F)C3)n2C,Ki,=,1698.24,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,B,1698.24
15826,CHEMBL3986927,O=C(CCCN1CCc2ccccc2C1)c3ccc4NC(=O)Cc4c3,Ki,=,5399.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,5399.0
15827,CHEMBL3986927,O=C(CCCN1CCc2ccccc2C1)c3ccc4NC(=O)Cc4c3,Ki,=,5370.32,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,B,5370.32
15837,CHEMBL4060194,CCN(CC)CC1=Cc2cn(c3cccc(O1)c23)S(=O)(=O)c4ccccc4,Ki,=,4351.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,4351.0
15904,CHEMBL4060837,Cc1ccc(cc1)S(=O)(=O)[O-].O=C(NCCCCN2CC[N+]3(CCOc4ccccc34)CC2)c5cc6ccccn6n5,Ki,=,6300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,B,6300.0
15905,CHEMBL4060837,Cc1ccc(cc1)S(=O)(=O)[O-].O=C(NCCCCN2CC[N+]3(CCOc4ccccc34)CC2)c5cc6ccccn6n5,Ki,=,4500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,B,4500.0
15908,CHEMBL4061131,Fc1cccc(c1)N2CCN(CCC3CCN(CC3)S(=O)(=O)c4cncc5ccccc45)CC2,Ki,=,1011.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,B,1011.0
15909,CHEMBL4061189,CN(C)CC1=CC2=CN(C3=CC=CC(O1)C23)S(=O)(=O)c4ccccc4,Ki,=,6698.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,6698.0
15916,CHEMBL4062165,CCCCN1CCc2cc(ccc2C1)C#N,Ki,=,8300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,8300.0
15918,CHEMBL4062165,CCCCN1CCc2cc(ccc2C1)C#N,Kb,=,1660.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,1660.0
15920,CHEMBL4062553,COc1ccccc1N2CCC3(CCN(CCCSc4nnc(c5ccccc5)n4C)CC3)C2,Ki,=,6168.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,6168.0
15943,CHEMBL4063176,O=C1CCc2ccccc2N1CCCN3CCN(CCc4ccccc4)CC3,Ki,=,5754.4,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,A,5754.4
15957,CHEMBL4063564,C[C@@H](O)CN1CCN(CC1)c2cccc(Cl)c2Cl,Ki,=,1400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,B,1400.0
15958,CHEMBL4063748,CC1=C(CCN2CCN(CC2)c3ncnc4sccc34)C(=O)N5CCCCC5=N1,IC50,=,5530.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,2765.0
15963,CHEMBL4064191,Oc1ccc(N2CCNCC2)c3C=CC(=O)Nc13,Ki,=,5300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,5300.0
15964,CHEMBL4064191,Oc1ccc(N2CCNCC2)c3C=CC(=O)Nc13,Ki,=,1200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,1200.0
15965,CHEMBL4064222,CCCCN1CCN(CCCN2C(=O)CCc3ccccc23)CC1,Ki,=,5128.61,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,A,5128.61
15966,CHEMBL4064609,CC1=C(CCN2CCN(CC2)c3ncnc4sccc34)C(=O)N5CCCC(O)C5=N1,IC50,=,6660.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,3330.0
15975,CHEMBL4064759,CN1CCN(CC1)c2ccc(O)c3OCCOc23,Ki,=,3200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,3200.0
15976,CHEMBL4064759,CN1CCN(CC1)c2ccc(O)c3OCCOc23,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,1500.0
15977,CHEMBL4064919,CCCC(CCC)NC(=O)c1cc2ccccc2[nH]1,Ki,=,13400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,13400.0
15983,CHEMBL4065455,COc1cc(CCN2CCC(O)(CC2)c3ccc(Cl)cc3)ccc1OCCSSCCN.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,B,1500.0
15984,CHEMBL4065455,COc1cc(CCN2CCC(O)(CC2)c3ccc(Cl)cc3)ccc1OCCSSCCN.OC(=O)C(F)(F)F.OC(=O)C(F)(F)F,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,B,1500.0
16012,CHEMBL4066916,Oc1ccc(N2CCNCC2)c3OCCOc13,Ki,=,6900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,6900.0
16013,CHEMBL4066916,Oc1ccc(N2CCNCC2)c3OCCOc13,Ki,=,6000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,6000.0
16046,CHEMBL4067792,O=C(NC[C@@H]1C[C@H]1CN2CCc3ccc(cc3C2)C#N)c4ccnc5ccccc45,Ki,=,1440.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,1440.0
16056,CHEMBL4068455,CCCN(CCC)[C@H]1CN2C(=O)N(CCCCNC(=O)c3cc4ccccc4[nH]3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16064,CHEMBL4068455,CCCN(CCC)[C@H]1CN2C(=O)N(CCCCNC(=O)c3cc4ccccc4[nH]3)c5cccc(C1)c25,IC50,=,3647.5,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,1823.75
16068,CHEMBL4068455,CCCN(CCC)[C@H]1CN2C(=O)N(CCCCNC(=O)c3cc4ccccc4[nH]3)c5cccc(C1)c25,IC50,=,2013.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,1006.85
16092,CHEMBL4068850,OCC1=Cc2cn(c3cccc(O1)c23)S(=O)(=O)c4cccc5ccccc45,Ki,=,4287.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,4287.0
16128,CHEMBL4069306,C(Cc1ccccc1)C2CN(Cc3c[nH]c4ccccc34)CCO2,Ki,=,1300.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,1300.0
16165,CHEMBL4071189,COc1ccccc1N2CC3(CCN(CCCSc4nnc(c5ccccc5)n4C)CC3)C2,Ki,=,37579.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,37579.0
16170,CHEMBL4071729,OC(=O)C(F)(F)F.OC1(CCN(CCNC(=O)NCCN2C(=O)C=CC2=O)CC1)c3ccc(Cl)cc3,Ki,=,2200.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,B,2200.0
16171,CHEMBL4071729,OC(=O)C(F)(F)F.OC1(CCN(CCNC(=O)NCCN2C(=O)C=CC2=O)CC1)c3ccc(Cl)cc3,Ki,=,1500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,B,1500.0
16199,CHEMBL4072785,Oc1ccc(N2CCCNCC2)c3OCC(=O)Nc13,Ki,=,14000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,14000.0
16200,CHEMBL4072785,Oc1ccc(N2CCCNCC2)c3OCC(=O)Nc13,Ki,=,8900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,8900.0
16214,CHEMBL4073520,CC(C)NC(=O)c1cc2ccccc2[nH]1,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,100000.0
16218,CHEMBL4073927,Cn1c(SCCCN2CCC3(CC2)CCN(CC3)c4ccc(F)cc4)nnc1c5ccccc5,Ki,=,9792.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,9792.0
16219,CHEMBL4074104,CC1CCN(CCCN2C(=O)CCc3ccccc23)CC1,Ki,=,4466.84,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,A,4466.84
16224,CHEMBL4075422,O=S(=O)(N1CCC(CCN2CCN(CC2)c3ccccc3)CC1)c4cncc5ccccc45,Ki,=,1218.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,B,1218.0
16228,CHEMBL4076086,Cn1c(SCCCN2CCC3(CC2)CCN(CC3)c4cccc(c4)C#N)nnc1c5ccccc5,Ki,=,57101.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,57101.0
16232,CHEMBL4076129,CN[C@H]1CN2C(=O)N(CCCCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16234,CHEMBL4076129,CN[C@H]1CN2C(=O)N(CCCCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,=,2529.3,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,1264.65
16236,CHEMBL4076129,CN[C@H]1CN2C(=O)N(CCCCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16238,CHEMBL4076129,CN[C@H]1CN2C(=O)N(CCCCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,2500.0
16240,CHEMBL4076129,CN[C@H]1CN2C(=O)N(CCCCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,=,4487.5,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,2243.75
16242,CHEMBL4076129,CN[C@H]1CN2C(=O)N(CCCCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,2500.0
16247,CHEMBL4076516,COc1ccccc1N2CCC3(CCN(CCCSc4nnc(c5ccccc5)n4C)C3)C2,Ki,=,6370.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,6370.0
16249,CHEMBL4076527,Cn1c(SCCCN2CCC3(CC2)CCN(CC3)c4ccccn4)nnc1c5ccccc5,Ki,=,83671.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,83671.0
16250,CHEMBL4076796,N#Cc1ccc2CNCCc2c1,Ki,=,53800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,53800.0
16252,CHEMBL4076796,N#Cc1ccc2CNCCc2c1,Kb,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,10000.0
16254,CHEMBL4076903,O=S(=O)(N1CCC(CCN2CCN(CC2)c3ccccc3)CC1)c4cccc5ncccc45,Ki,=,1237.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,B,1237.0
16257,CHEMBL4077251,COc1ccccc1N2CC3(CN(CCCSc4nnc(c5ccccc5)n4C)C3)C2,Ki,=,21216.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,21216.0
16261,CHEMBL4077430,CN[C@H]1CN2C(=O)N(CCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16265,CHEMBL4077430,CN[C@H]1CN2C(=O)N(CCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16269,CHEMBL4077430,CN[C@H]1CN2C(=O)N(CCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,=,4102.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,2051.0
16273,CHEMBL4077430,CN[C@H]1CN2C(=O)N(CCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,2500.0
16279,CHEMBL4077538,Fc1cccc(c1)N2CCN(CCC3CCN(CC3)S(=O)(=O)c4cccc5ncccc45)CC2,Ki,=,1821.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,B,1821.0
16329,CHEMBL4079631,O=CC1=Cc2cn(c3cccc(O1)c23)S(=O)(=O)c4cccc5ccccc45,Ki,=,5162.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,5162.0
16334,CHEMBL4079642,COc1ccccc1N2CCC23CN(CCCSc4nnc(c5ccccc5)n4C)C3,Ki,=,114945.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,114945.0
16364,CHEMBL4083059,CN(C)CC1=Cc2cn(c3cccc(O1)c23)S(=O)(=O)c4cccc5ccccc45,Ki,=,1489.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,1489.0
16384,CHEMBL4084262,COc1ccccc1N2CCC3(CCN(CCCSc4nnc(c5ccccc5)n4C)CC3)CC2,Ki,=,10895.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,10895.0
16393,CHEMBL4084690,Oc1ccc(N2CCCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c5C=CC(=O)Oc15,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human D2S receptor expressed in HEK293T cell membranes coexpressing Galphao1 assessed as induction of nucleotide exchange preincubated for 30 mins followed by addition of [35S]GTPgammaS measured after 30 mins by [35S]GTPgammaS binding assay,B,2500.0
16397,CHEMBL4084712,CN1CCCN(CC1)c2ccc(O)c3NC(=O)COc23,Ki,=,6400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,6400.0
16398,CHEMBL4084712,CN1CCCN(CC1)c2ccc(O)c3NC(=O)COc23,Ki,=,3400.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,3400.0
16403,CHEMBL4085282,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16407,CHEMBL4085282,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16411,CHEMBL4085282,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,2500.0
16415,CHEMBL4085282,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,2500.0
16431,CHEMBL4085780,O=C1CCc2ccccc2N1CCCN3CCN(CC3)c4ccccc4,Ki,=,1096.48,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,A,1096.48
16453,CHEMBL4087187,COc1ccccc1N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2,EC50,=,3019.95,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,1509.975
16455,CHEMBL4087187,COc1ccccc1N2CCN(CCCCOc3ccn4nc(C=O)cc4c3)CC2,EC50,=,2900.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human Dopamine D2S receptor expressed in HEK293T cell membranes coexpressing Galphai2 incubated for 30 mins measured after 75 mins by [35S]GTPgammaS binding assay,B,1450.0
16465,CHEMBL4087513,O=C(NC[C@@H]1C[C@H]1CN2CCc3cc(ccc3C2)C#N)c4ccnc5ccccc45,Ki,=,9500.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,9500.0
16467,CHEMBL4087513,O=C(NC[C@@H]1C[C@H]1CN2CCc3cc(ccc3C2)C#N)c4ccnc5ccccc45,Kb,=,1740.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,1740.0
16473,CHEMBL4088416,OCC1=Cc2cn(c3cccc(O1)c23)S(=O)(=O)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,10000.0
16480,CHEMBL4089290,COc1ccccc1N2CCC3(CN(CCCSc4nnc(c5ccccc5)n4C)C3)C2,Ki,=,60152.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,60152.0
16510,CHEMBL4090862,CC1=C(CO)Oc2cccc3c2c1cn3S(=O)(=O)c4cccc5ccccc45,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,10000.0
16512,CHEMBL4091058,O=C1CCc2ccccc2N1CCCN3CCN(Cc4ccccc4)CC3,Ki,=,3801.89,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,A,3801.89
16540,CHEMBL4092015,COc1ccccc1N2CCC23CCN(CCCSc4nnc(c5ccccc5)n4C)CC3,Ki,=,29300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,29300.0
16548,CHEMBL4092462,CCCN1CCN(CC1)c2ccc(O)c3NC(=O)C=Cc23,Ki,=,1900.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,1900.0
16555,CHEMBL4092619,O=C(NCC1CC1)c2cc3ccccc3[nH]2,Ki,>,100000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,100000.0
16563,CHEMBL4093477,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)N(CCC)c5cccc(C3)c45,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16567,CHEMBL4093477,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)N(CCC)c5cccc(C3)c45,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16571,CHEMBL4093477,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)N(CCC)c5cccc(C3)c45,IC50,=,2971.7,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,1485.85
16575,CHEMBL4093477,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@H]3CN4C(=O)N(CCC)c5cccc(C3)c45,IC50,=,4529.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,2264.5
16577,CHEMBL4093493,Oc1ccc(N2CCNCC2)c3OCC(=O)Nc13,Ki,=,8300.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,8300.0
16578,CHEMBL4093493,Oc1ccc(N2CCNCC2)c3OCC(=O)Nc13,Ki,=,1800.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,1800.0
16616,CHEMBL4094900,CCCN1CCN(CC1)c2ccc(O)c3OCCOc23,Ki,>,15000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,B,15000.0
16617,CHEMBL4094900,CCCN1CCN(CC1)c2ccc(O)c3OCCOc23,Ki,=,5700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,B,5700.0
16619,CHEMBL4095082,Cc1ccc(cc1C)N2CCN(CCC3C(=O)Nc4ccccc34)CC2,Ki,=,1842.0,nM,Dopamine D2 receptor,Homo sapiens,Inhibition of human dopamine D2 receptor,B,1842.0
16627,CHEMBL4095452,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16631,CHEMBL4095452,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16633,CHEMBL4095452,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,EC50,=,3981.1,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,1990.55
16635,CHEMBL4095452,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,2500.0
16639,CHEMBL4095452,CN[C@H]1CN2C(=O)N(CCOCCOCCOCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,2500.0
16654,CHEMBL4096141,CC1=C(CO)Oc2cccc3c2c1cn3S(=O)(=O)c4ccccc4,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,10000.0
16663,CHEMBL4096422,CN(CCCCOc1ccc2CCC(=O)Nc2c1)[C@H]3CN4C(=O)Nc5cccc(C3)c45,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16673,CHEMBL4096858,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,4000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,B,4000.0
16674,CHEMBL4096858,CC(C)(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2,Ki,=,2700.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,B,2700.0
16705,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16707,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as cAMP inhibition by BRET assay,B,2500.0
16710,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,2500.0
16712,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16714,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 by BRET assay,B,2500.0
16716,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,2500.0
16718,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 by BRET assay,B,2500.0
16720,CHEMBL4097572,CN[C@H]1CN2C(=O)N(CCCCCCCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,2500.0
16724,CHEMBL4097669,O=C(NC[C@@H]1C[C@H]1CCN2CCc3ccc(cc3C2)C#N)c4cc5ccccc5[nH]4,Kb,=,1740.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,1740.0
16734,CHEMBL4098399,Cn1c(SCCCN2CC3(CCN3c4ccc(F)cc4)C2)nnc1c5ccccc5,Ki,>,109574.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,109574.0
16785,CHEMBL4099491,N#Cc1cccc(c1)N2CCNCC2,Ki,=,4890.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,4890.0
16787,CHEMBL4099491,N#Cc1cccc(c1)N2CCNCC2,Kb,=,2090.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at D2 long receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine induced beta-arrestin recruitment after 90 mins by DiscoveRx PathHunter assay,B,2090.0
16814,CHEMBL4100322,CN[C@H]1CN2C(=O)N(CCOCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16815,CHEMBL4100322,CN[C@H]1CN2C(=O)N(CCOCCOCCCCc3ccccc3)c4cccc(C1)c24,EC50,=,2471.7,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,1235.85
16817,CHEMBL4100322,CN[C@H]1CN2C(=O)N(CCOCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16821,CHEMBL4100322,CN[C@H]1CN2C(=O)N(CCOCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,2500.0
16825,CHEMBL4100322,CN[C@H]1CN2C(=O)N(CCOCCOCCCCc3ccccc3)c4cccc(C1)c24,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,2500.0
16827,CHEMBL4100358,CCCC(C)NC(=O)c1cc2ccccc2[nH]1,Ki,>,30000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,30000.0
16831,CHEMBL4100699,COc1ccc(cc1)N2CCC3(CCN(CCCSc4nnc(c5ccccc5)n4C)CC3)CC2,Ki,=,104847.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,104847.0
16835,CHEMBL4100734,CN[C@H]1CN2C(=O)N(CCCCCCCCCCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells assessed as reduction in quinpirole-mediated cAMP inhibition preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16837,CHEMBL4100734,CN[C@H]1CN2C(=O)N(CCCCCCCCCCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,EC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Agonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as induction of beta-arrestin 2 recruitment by BRET assay,B,2500.0
16839,CHEMBL4100734,CN[C@H]1CN2C(=O)N(CCCCCCCCCCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,B,2500.0
16843,CHEMBL4100734,CN[C@H]1CN2C(=O)N(CCCCCCCCCCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,B,2500.0
16847,CHEMBL4100734,CN[C@H]1CN2C(=O)N(CCCCCCCCCCCCOc3ccc4CCC(=O)Nc4c3)c5cccc(C1)c25,IC50,>,5000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,B,2500.0
16851,CHEMBL4101993,Cn1c(SCCCN2CCC3(CC2)CCN(CC3)c4cccc(Cl)c4Cl)nnc1c5ccccc5,Ki,=,7501.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,B,7501.0
16900,CHEMBL4103891,O=S(=O)(c1cccc2ccccc12)n3cc4C=C(Oc5cccc3c45)C#N,Ki,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),B,10000.0
16927,CHEMBL4105102,CC1=C(CCN2CCN(CC2)c3cccc4scnc34)C(=O)N5CCCC(O)C5=N1,IC50,>,10000.0,nM,Dopamine D2 receptor,Homo sapiens,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,B,5000.0
16930,CHEMBL4105375,O=C(NC[C@@H]1C[C@H]1CN2CCN(CC2)c3cccc(c3)C#N)c4ccnc5ccccc45,Ki,=,2290.0,nM,Dopamine D2 receptor,Homo sapiens,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,B,2290.0
